home *** CD-ROM | disk | FTP | other *** search
Wrap
Text File | 1996-02-04 | 1.1 MB | 24,234 lines
Text Truncated. Only the first 1MB is shown below. Download the file for the complete contents.
* Research Request: Information on Rosacea Synonyms ------- Adult Acne Acne Erythematosa Rosacea Hypertrophic Rosacea Rhinophyma Acne Conglobata Acne Vulgaris Acne Fulminans Excoriated Acne of Young Women Chloracne Atypical Acneiform eruptions General Description ------------------ Acne Rosacea is a skin disorder limited to the nose, cheeks and forehead, typically beginning during adulthood. The facial skin becomes oily, reddened and bumpy. Small red blood vessels are visible. In extreme cases, the nose may appear very red and bulbous. Symptoms -------- Acne Rosacea affects the skin of the nose, surrounding cheeks and forehead areas. The skin becomes oily and progressively reddened (erythematous) with enlarged blood vessels apparent in the skin (telangiectasias). Typically, small elevated growths (papules), some containing dead skin cells and fluid (pustules) develop over the central area of the face. Scarring usually does not occur. In very severe cases, the skin of the nose becomes extremely red and bulbous (rhinophyma). Causes ------ The exact cause of Acne Rosacea is not known. Scientists believe a genetic predisposition to the disorder may exist. Symptoms can be intensified by hot liquids, spicy foods, alcohol consumption (although this is not always a cause; many cases occur among teetotalers), vigorous exercise, heat, exposure to sun and wind, certain vitamin deficiencies, endocrine disturbances and/or emotional stress. Affected Population ------------------- Acne Rosacea usually begins between the ages of thirty and fifty years of age, but can occur at any age. The disorder tends to affect females more than males, although cases among males tend to be more severe. Related Disorders ----------------- Symptoms of the following disorders can be similar to those of Acne Rosacea. Comparisons may be useful for a differential diagnosis: Acne Conglobata may occur alone, or may be part of a symptom complex in conjunction with Hidradenitis Suppurativa and connective tissue inflammation (cellulitis) of the scalp. Lesions usually occur on the neck and upper trunk, but may extend to the upper arms, lower back, buttocks, and thighs. The typical acne skin eruptions are present, but symptoms are chronic with abscesses and the development of connective formations between inflamed skin growths (nodules) and cysts. The cysts contain foul-smelling fluid, and severe scarring is common. Although this form of acne resists treatment with systemic antibiotics, symptoms may be controlled by the use of isotretinoin in some cases. Acne Vulgaris is the most common form of acne which affects many adolescents during puberty. The skin eruptions primarily appear on the face, upper back and/or chest due to overactive oil-secreting (sebaceous) glands related to changes in hormonal activity. Acne Fulminans is a rare variant of acne seen predominately among adolescent males. Mild Acne Vulgaris initially develops but it is unexpectedly followed by markedly inflamed and painful lesions on the upper trunk and occasionally the face. Lesions may bleed and/or crust, and may be accompanied by fever and other systemic abnormalities. Treatment with isotretinoin, with or without systemic corticosteroid drugs and antibiotics, can be effective in most cases. Excoriated Acne of Young Women (Acne Excorie Des Jeunes Filles) is a variant of acne produced by excessive manipulation of acne lesions resulting in increased scarring. Although it is often found among young women, it can be found in any age group and both sexes. Chloracne may develop among workers exposed to chlorinated hydrocarbons. Treatment of the skin lesions should be accompanied by removal of the irritating substance from the environment. Atypical Acneiform eruptions are seen in any age group and are not always limited to oil-secreting (sebaceous) glands. These eruptions may appear as a result of corticosteroid, androgen, or progesterone drug therapy. Occupational problems including ingestion of iodine or bromine salts, or skin contact with machine oils such as insoluble cutting oils, may also cause this type of acne. Additionally, drugs such as diphenylhydantoin and lithium can induce this skin condition. Therapies: Standard -------------------- Although there is no cure for Acne Rosacea, symptoms can be controlled. Antibiotics can control inflammation, but may cause adverse reactions in some patients. Carbon Dioxide laser and conventional surgery are used to remove excess skin growth (rhinophyma) as a temporary measure. Argon lasers have been effective in reducing redness in the nose area, but only in mild cases which have not progressed to rhinophyma. The orphan drug metronidazole (Metrogel) was approved in 1988 by the FDA for treatment of Acne Rosacea. This drug is manufactured by Curatek Pharmaceuticals of Elk Village, IL. Other treatment is symptomatic and supportive. The orphan drug Sprelin injection was recently approved by the FDA for the treatment of Precocious Puberty. Resources --------- For more information on Acne Rosacea, please contact: Acne Research Institute 1236 Somerset Lane Newport Beach, CA 92260 (914) 722-1805 NIH/National Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Information Clearinghouse 9000 Rockville Pike Bethesda, MD 20892 (301) 495-4484 ! * Research Request: ADDISON'S DISEASE Sources of Information: National Adrenal Diseases Foundation; The Mosby Medical Encyclopedia; NORD Synonyms -------- Addisonism Addison's Syndrome Adrenal Crisis Adrenal Hypoplasia Adrenocortical Hypofunction Adrenocortical Insufficiency Chronic Adrenocortical Insufficiency Hypoadenalism Primary Adrenal Insufficiency Primary Failure Adrenocortical Insufficiency Other diseases which are similar or may be linked to Addison's Disease are: Adrenoleukodystrophy Amyloidosis ACTH Deficiency Adrenal Hyperplasia Cushing's Syndrome Schmidt Syndrome DESCRIPTION: Addison's disease is a life-threatening disease caused by partial or complete failure of the outer layer of the adrenal glands, this outer layer is called the adrenal cortex. This gland produces hormones that control many body functions. In Addison's Disease, there is a deficiency of cortisol and aldosterone (hormones made in the adrenal glands). When the body is deficient in these hormones, the result is high levels of potassium and low levels of salt, which causes an electrolyte imbalance in the body. This electrolyte imbalance can cause hypotension (low blood pressure) and loss of water. SYMPTOMS: -------- Addison's Disease is marked by weakness, loss of strength, loss of hunger, loss of water, weight loss and darkening of the skin, especially that of scars, wrinkled portions of the skin and mucous membranes. Dark freckles may appear on the head and shoulders of Addison's Disease sufferers. Other symptoms which may appear later are: stomach and intestinal pain due to nausea, vomiting, dizziness and diarrhea. Restlessness, depression, and extreme sensitivity to cold may also occur later in the disease. The onset of Addison's Disease is usually gradual, over a period of weeks or months. An extreme insufficiency of adrenocortical hormones (adrenal crisis) may occur in people with Addison's Disease. This crisis may begin as a sudden loss of strength, severe pain in the abdomen, lower back, and/or kidney failure. Adrenal crisis is LIFE THREATENING. If an Addison sufferer experiences any of these symptoms, SEEK IMMEDIATE ATTENTION FROM YOUR PHYSICIAN. A person in adrenal crisis needs immediate intravenous administration of high-dose hydrocortisone succinate or phosphate and electrolyte replacement; drugs called vasopressors may also be needed to maintain blood pressure. Patients are urged to carry a card or wear an identification necklace or bracelet, stating that they have Addison's disease, so that they will receive proper medical treatment in case of emergency. CAUSES OF ADDISON'S DISEASE: ------ Although the exact cause of Addison's Disease is not known, it is believed to be an autoimmune disease. An Autoimmune Disease is when the body's own immune system (antibodies,lymphocytes, etc.), begins attacking healthy tissue in error. Approximately 75 percent of cases of Addison's Disease are thought to be autoimmune related. Other disorders which can cause the partial destruction of the adrenal cortex and can trigger the onset of Addison's Disease are: tumor, tuberculosis, or amyloidosis, which is the abnormal accumulation of a fatty-like substance within the adrenal glands. METHODS OF TREATMENT: -------------------- Addison's Disease is usually treated with replacement therapy that consists of cortisone and fludrocortisone; these replacement hormones are taken with meals. The dosage of these drugs should be increased during times of infection, trauma, surgery, and other stress periods in order to prevent an acute adrenal crisis. Resources --------- For more information on Addison's Disease, please contact: The National Adrenal Diseases Foundation, Inc. 500 Northern Blvd., Suite 200 Great Neck, NY 11021 (516) 487-4992 NIH/National Digestive Diseases Information Clearinghouse (NDDIC) 9000 Rockville Pike Bethesda, MD 20892 (301) 654-3810 National Organization for Rare Disorders (NORD) P.O. Box 8923 New Fairfield, CT 06812-1783 (203) 746-6518 (203) 746-6927 (TDD for the hearing impaired) ! * ADULT IMMUNIZATIONS QUESTION: I am a 28-year-old woman in good health. How can I tell if I am adequately immunized against serious disease? Should I be receiving any vaccinations at my age? Thanks to the very successful immunization programs we have in this country, young children rarely get measles, rubella (German measles), mumps, tetanus (lockjaw) or diphtheria. Unfortunately, however, a surprising number of adults still do get them; they may have moved here from another country, a childhood disease may have been misdiagnosed, or certain vaccines may have been unavailable when they were children. Inadequate immunization against measles and mumps has proven to be a particular problem among people your age, who may have been too old to receive the vaccine when it was introduced, and may have missed getting these diseases. Also, before the live virus vaccine was perfected in the 1960s, many children received a vaccine made of killed viruses, which was ineffective. If you have no memory or record of having these diseases or of being vaccinated, you can find out through a blood test if you are immune. If the test shows that you are not immune, you should be vaccinated, since adults who get measles and mumps run a higher risk than children of developing serious complications. A surprising number of adults either have not had rubella or were never vaccinated against that disease. This disease, ordinarily mild in children, can cause devastating birth defects in fetuses carried by women who get infected during pregnancy. All women of childbearing age should have a blood test to see if they are immune to rubella; if not, they should be vaccinated at least three months before they plan on becoming pregnant. In fact, some states require a rubella test prior to marriage. Health workers who come into contact with pregnant women also should make sure they are immune to rubella. Although tetanus and diphtheria are quite rare thanks to longstanding immunization practices, occasional cases do occur in adults who have never been vaccinated. After primary immunization from both diseases during childhood, a booster shot is recommended every 10 years to preserve your immunity. Many doctors suggest getting it on your mid-decade birthdays-- 25,35,45, and so on--to help you remember. Since you are not in a high-risk group by virtue of age or chronic illness, these are probably the only immunizations you should be concerned about. An annual "flu shot" is strongly recommended for people over 65, as well as people of any age with a chronic disease, especially of the heart or lungs. This same high-risk group also should receive a vaccine every five years against bacterial pneumonia and other related infections. In general, healthy young adults do not need to be immunized against influenza, since the disease is not as debiliating for them, and the vaccine is available only in limited quantities. If you work in a hospital or health- care setting, however, it may be wise to receive the shot so that you do not transmit the flu viruses to your patients. A vaccine is now available that offers protection from acute hepatitis B, a viral infection of the liver that may eventually cause such serious complications as scarring of the liver. The disease is contagious only through blood and contact with blood, and therefore is recommended only for certain health-care workers, travelers to parts of the world where the disease is endemic, homosexually active men and drug abusers. It is not recommended for anyone whose immune system is already compromised by such a disease as AIDS. ! * Aging Research: Practice, Promise, & Priorities National Institute on Aging National Institutes of Health NIA is responsible for the "conduct and support of biomedical, social, and behavioral research, training, health information dissemination, and other programs with respect to aging process and the diseases and other special problems and needs of the aged." Research on Aging Act of 1974, as amended in 1990 by P.L. 101-557 Aging Research: Practice, Promise, & Priorities Are scientists close to finding a cure for Alzheimer's disease? Do older people need as much sleep as younger people? Should drivers be retested regularly after age 65 in order to keep their license? These are a few of the questions scientists hope to answer as we come to understand aging, basic aging processes, the difference between normal aging and disease, and ways to slow deterioration in various body systems. Increasingly research holds the promise that illnesses and disabilities associated with old age can be reduced or eliminated. Aging Research: Practice, Promise, & Priorities looks at the vital role research plays in improving the health of older Americans. Fundamental to the practice of clinical medicine, research enables doctors to effectively diagnose and treat their older patients. For example, recent studies on incontinence show symptoms can be reduced in a majority of people through behavioral therapy, without resorting to drug treatment or invasive surgical procedures. Research also yields information on how to prevent health problems-such as the use of exercise by frail older people to develop the body strength necessary for preventing fall accidents and related injuries. The National Institute on Aging (NIA) was established in 1974 when Congress authorized the Research on Aging Act, and through later amendments to the Public Health Service Act (sections 443-445F). NIA is one of 19 institutes at the National Institutes of Health (NIH) and leads the federal effort on aging research. To carry out its mission, NIA engages in collaborative activities with other NIH institutes and federal agencies. NIA Priorities The field of aging includes a broad range of health issues that affect older people. Which topics are designated priorities depends on such factors as severity of the condition, the number of Americans affected, and the burden of cost. While the institute supports studies in a large number of areas, it focuses particular attention on the following topics. Alzheimer's Disease Alzheimer's disease (AD) is a progressive disorder characterized by changes in brain function that impairs the cognitive capacity of patients. Researchers estimate that more than 4 million people in the United States have some form of dementia, costing the Nation over $90 billion annually. NIA is especially interested in identifying interventions that may delay the development of clinical signs of AD. Even a 5-year delay could substantially cut the prevalence of the disease, saving immense suffering and billions of dollars each year. Understanding Aging NIA-funded research seeks to identify genetic and environmental factors associated with aging processes. Scientists are isolating genes believed responsible for the onset of age-related diseases, as well as those conferring health and longevity. Other areas of interest are the modifications proteins undergo with age; control of cell proliferation; biomarkers of aging; relationships between healthy aging and disease; effects of aging on the body's immune, endocrine, and other physiologic systems; the neuropsychology and cognitive psychology of aging; and lifestyle factors affecting health and disease, such as diet and exercise. Frailty, Disability, and Rehabilitation NIA supports studies on osteoporosis, as well as on falls and gait disorders which so often lead to frailty and disabilities in older people. Hip fractures in frail older people are a major epidemic today, causing extended hospitalization, institutionalization, and the loss of independence-all at great personal and financial cost. The institute sponsors clinical trials to identify interventions for reducing the physical frailty and balance problems associated with falls and hip fractures. NIA also sponsors clinical trials to develop treatments for preventing osteoporotic bone loss in the hips. Health and Independence in Later Years Research supported by NIA emphasizes strategies for maintaining health and independence, improving quality of life, and preventing or postponing disabilities during the later years. Adequate nutrition is important to ensure good health throughout life. In this area, researchers are studying changes in the ability of older individuals to taste and smell, changes in their eating patterns, and metabolic disease (such as diabetes) or dietary factors that are associated with depressed immunocompetence and cognitive function. Research in exercise physiology is designed to assess the effects of physical activity on the health of older people, as well as the ability of exercise to prevent physical decline and various diseases-including diabetes, hypertension, osteoporosis, and stroke. Long-Tern Care for Older Adults Researchers are looking for ways to reduce the need for long-terms care and institutionalization. They are also studying ways to enhance the quality of long-term care, ease the burden of family care, and forecast the requirements for long-term care. Minority Populations Improving the health and longevity of minority populations in possible with continuing progress in research-such as on life expectancy, family structures and social networks, and environmental influences, as well as the development of special interventions for minorities. NIA also actively encourages the participation of minorities as researchers in the field of aging. Demographics of Aging Institute research examines the socioeconomic and demographic characteristics of older people, with special attention to populations such as the oldest old, minorities, older adults who are handicapped, and rural populations. Women's Health and Aging Because the majority of people over age 65 are women, the institute eagerly supports research on older women's health. Activities include the longitudinal Women's Health and Aging Study,m which examines the causes and progression of disability in older women. Other institute studies examine osteoporosis, menopause, and hormone replacement therapy. Training and Career Development NIA uses a variety of funding mechanisms to train individuals for careers in geriatric research and teaching, offering special encouragement of minority members developing health science careers. The Claude D. Pepper Older Americans Independence Centers is one approach taken by the institute for training future academic leaders in geriatric medicine. International Activities International studies on the health of different racial and ethnic populations offer scientists unique research opportunities. NIA scientists working in intramural research programs host foreign investigators under NIH's Fogarty International Visiting Program. The institute sponsors cross-national research by foreign and domestic investigators through its extramural program. Support for these research activities, including conferences, is provided by a number of international agreements. NIA is designated as a World Health Organization Collaborating Center for Research on Health of Elderly. Researchers participate in a comprehensive, multinational program that focuses on dementia, determinants of healthy aging, immunology, and nutritional aspects of osteoporosis. Health Information Dissemination Educating the public about new research findings and the benefits of a healthy lifestyle is an important institute objective. NIA's Public Information Office produces materials (such as articles, brochures, reports, and fact sheets) covering a broad range of aging topics for older people and their families, health professionals, media reporters, government agencies, the general public, and groups with a special interest in aging. Special activities and media presentations also help increase public awareness of health issues, reinforce knowledge of helpful behaviors, and encourage Americans to become active in safeguarding their health. Organization NIA sponsors research through intramural and extramural programs. The intramural program conducts basic and clinical research in Baltimore, MD, and on the NIH campus in Bethesda, MD. The extramural program funds research and training at universities, hospitals, medical centers, and other public and private organizations nationwide. NIA Organization Chart <the organizational chart was deleted as it could not be formatted as text--the major organizations are presented in outline form> Office of the Director and Deputy Director Office of Administrative Management Office of Alzheimer's Disease Research Public Information Office Office of Extramural Affairs Office of Planning, Analysis, and International Activities Extramural Programs Behavioral and Social Program Biology of Aging Program Geriatrics Program Neuroscience and Neuropsychology of Aging Program Intramural Programs Intramural Research Program (Gerontology Research Center) Laboratory of Behavior Sciences Laboratory of Biological Chemistry Laboratory of Cardiovascular Science Laboratory of Cellular and Molecular Biology Laboratory of Clinical Physiology Laboratory of Molecular Genetics Laboratory of Neuroscience Laboratory of Personality and Cognition Longitudinal Studies Branch Research Resources Branch Epidemiology, Demography, and Biometry Program Intramural Research Program The intramural program is located at the Gerontology Research Center in Baltimore (the Laboratory of Neurosciences and the Epidemiology, Demography, and Biometry Program are in Bethesda). Intramural scientists study aging processes, develop interventions that will restore or maintain normal function in older individuals, and contribute new knowledge to prevent and treat age-associated diseases and disabilities. The intramural program offers postdoctoral training to promising investigators (m.D.s and Ph.D.s) for research careers in gerontology and geriatrics. It also conducts the landmark Baltimore Longitudinal Study of Aging (BLSA). Begun in 1958, the BLSA seeks to understand how and why we age by following over, 1,100 men and women who return to Baltimore every 2 years for intensive evaluation. The Epidemiology, Demography, and Biometry Program conducts intramural research on the epidemiology of health and disease, as well as on demographic, social, metabolic, and genetic factors affecting the health of older people. Staff collect and analyze information from established community and special populations, surveys conducted by the National Center for Health Statistics, and other sources. Extramural Research Program NIA's extramural research consists of four program areas: Behavioral and Social Research, Biology of Aging, Geriatrics, and Neuroscience and Neuropsychology of Aging. The Behavioral and Social Research Program supports social and behavioral research and training on aging processes and the role of older people in society. It focuses on changes, as well as aspects of stability, in psychological and cognitive functioning and the relationship of older people to their family and community. Demographic research on the changing age composition of the population and the impact of the aging population on society are also emphasized. Special attention is given to studies on how to maintain and even enhance health and independence in later years, improve long-term care, expand opportunities for older workers, and understand the impact and implications of retirement. The Biology of Aging Program supports research on the basic mechanisms involved in aging processes and the onset of age-related disease. It funds research and training in biochemistry, molecular and cell biology, genetics, immunology, endocrinology, nutrition, and pathobiology. The program also assists facilities that provide investigators with aging animals and cell cultures for use in research. The Geriatrics Program sponsors research on the causes, prevention, and treatment of older people's health problems. It supports research on physical frailty, osteoporosis, musculoskeletal and cardiovascular disorders, nutrition, infections, and endocrinology. The program also maintains research training through programs such as the Claude D. Pepper Older Americans Independence Centers. The Neuroscience and Neuropsychology of Aging Program supports research on the structure and function of the aging nervous system, and the behavioral manifestations of the aging brain. Research areas include age-related changes in the nervous system, especially as they affect sensory processes, learning, memory, and sleep. Of special interest are studies on the epidemiology, cause, diagnosis, treatment, and management of symptoms of Alzheimer's disease and other disorders associated with the aging nervous system. The Office of Alzheimer's Disease Research (OADR) is located within NIA. The institute is the lead agency in federal efforts to study the disease. OADR coordinates research activities and advises the director and other staff on Alzheimer'-related issues. It also manages the NIH Coordinating Committee on Alzheimer's Disease, supports collaborative efforts with outside agencies, and sponsors international scientific workshops. The Public Information Office plans and carries out a legislatively mandated program to educate the general public, media, physicians and health care workers, other government agencies, and service organizations about aging research. The Promise of Research Today's need for reducing health care costs demands the rapid passage of new scientific information from laboratory to clinical practice. Since the institute was established 20 years ago, NIA-funded scientists have reported progress in many areas of aging. The research advances on the following pages are a selection of recent findings. Brain Changes and Intellectual Function Scientists have identified the common gene apolipoprotein E, usually associated with moving cholesterol in the blood, as an important risk-factor associated with late-onset Alzheimer's disease, one of the most frequent forms of this disease. Cognitive training can improve the intellectual abilities of older people. Early training sessions have been found to offer the greatest benefit for those older people who start at a low, cognitively disadvantaged level. Accidents involving older drivers are a problems, with most happening at intersections, rights-of-way, and during lane changes. A strong predictor of driving accidents in older people is the Useful Field of View test that measures the spatial area in which someone can rapidly take in information from multiple sources. Promoting Good Health Research increasingly shows people can stay vigorous into their later years by avoiding smoking and obesity and by getting moderate exercise. Scientists conduct animal studies to better understand the role of diet in humans. They found that rodents who consumed 40 percent fewer calories not only lived longer, but also had significantly fewer signs of disease and cancerous tumors than those on a regular diet. Those men and women with higher levels of education-regardless of race-can expect to stay healthier 2 1/2 to 4 years longer than people with less schooling. A higher bone mass protects against osteoporotic fractures in both older women and men. A recent study added to our understanding of the effects of bone density by showing greater bone mass is linked with increased calcium intake during childhood. Falls and impaired mobility in frail older people are often linked to muscle weakness in the lower body. Scientists looking for ways to increase lower body strength found that even nursing-home residents in their nineties participating in strength-training exercises improved their strength, gait speed, and ability to climb stairs. Their peers who took nutritional supplements instead of exercising had no improvement. Older people with risk factors for falling can also dramatically reduce the chance of a fall by learning safer ways to walk and by substituting or stopping certain medicines. Physicians may be able to detect prostate cancer years earlier than was previously possible by monitoring yearly changes in the level of an enzyme, prostate specific antigen (PSA). Women' Health The number of people age 85 and older is growing rapidly and is soon expected to make up almost a quarter of the older population, with women outnumbering men 5 to 2. Disability rates in this group are high and poverty is prevalent. Moreover, women 85 and over are among those most likely to be poor and institutionalized. Biofeedback and exercise can be highly effective in reducing incontinent episodes for many women. Scientists found that both biofeedback and pelvic muscle exercises could reduce incidents by as much as 50 to 99 percent in some individuals. The Heart Older people with isolated systolic hypertension (in which the upper number [systolic] in the blood pressure ratio is elevated while the lower number [diastolic] remains normal) benefit from a low dose of a diuretic reduces the systolic pressure, lowering the risk of stroke and coronary heart disease. Scientists are learning more about atherosclerosis by examining the smooth cells that make up blood vessels. When these cells are injured by fatty streaks or plaques, they tend to migrate toward the inside surface of the vessel and quickly divide. This altered structure and function of smooth cells contributes to the destruction of normal tissue and disease. Genetics and Aging Gene therapy allows the manufacture of a product, such as a missing enzyme or a desired hormone, in the patient's won body. The recent discovery of an effective cellular vehicle to deliver such a therapeutic product brings scientists closer to being able to use gene therapy to retard or reverse some of the consequences of aging. Older people are often more susceptible to environmental stresses, such s hot or cold temperatures, than younger people. Shedding light on a possible cause for this susceptibility, rodent studies show the heat shock response (a selective expression of specific genes to heat or other types of stress) becomes altered in older animals and this could reduce the animal's ability to respond effectively to extreme temperatures. Additional Information: NIA Programs and Research Public Information Office Building 31, Room 5C27 Bethesda, MD 2089 (301) 496-1752 Publications by NIA NIA Information Center (800) 222-2225 (800)222-4225 for TTY Alzheimer's Disease Alzheimer's Disease Education and Referral Center (ADEAR) P.O. Box 8250 Silver Spring, MD 20910 (800) 438-4380 U.S. Department of Health and Human Services Public Health Service National Institutes of Health March 1994 ! * What's Your Aging I.Q.? True or False 1.Baby boomers are the fastest growing segment of the population. 2.Families don't bother with their older relatives. 3.Everyone becomes confused or forgetful if they live long enough. 4.You can be too old to exercise. 5.Heart disease is a much bigger problem for older men than for older women. 6.The older you get, the less you sleep. 7.People should watch their weight as they age. 8.Most older people are depressed. Why shouldn't they be? 9.There's no point in screening older people for cancer because they can't be treated. 10.Older people take more medications than younger people. 11.People begin to lose interest in sex around age 55. 12.If your parents had Alzheimer's disease, you will inevitably get it. 13.Diet and exercise reduce the risk for osteoporosis. 14.As your body changes with age, so does your personality. 15.Older people might as well accept urinary accidents as a fact of life. 16.Suicide is mainly a problem for teenagers. 17.Falls and injuries "just happen" to older people. 18.Everybody gets cataracts. 19.Extremes of heat and cold can be especially dangerous for older people. 20."You can't teach an old dog new tricks." Answers 1. False. There are more than 3 million Americans over the age of 85. That number is expected to quadruple by the year 2040, when there will be more than 12 million people in that age group. The population age 85 and older is the fastest growing age group in the U.S. 2. False. Most older people live close to their children and see them often. Many live with their spouses. An estimated 80 percent of men and 60 percent of women live in family settings. Only 5 percent of the older population lives in nursing homes. 3. False. Confusion and serious forgetfulness in old age can be caused by Alzheimer's disease or other conditions that result in irreversible damage to the brain. But at least 100 other problems can bring on the same symptoms. A minor head injury, high fever, poor nutrition, adverse drug reactions, and depression also can lead to confusion. These conditions are treatable, however, and the confusion they cause can be eliminated. 4. False. Exercise at any age can help strengthen the heart and lungs and lower blood pressure. It also can improve muscle strength and, if carefully chosen, lessen bone loss with age. See a physician before beginning a new exercise program. 5. False. The risk of heart disease increases dramatically for women after menopause. By age 65, both men and women have a one in three chance of showing symptoms. But risks can be significantly reduced by following a healthy diet and exercising. 6. False. In later life, it's the quality of sleep that declines, not total sleep time. Researchers have found that sleep tends to become more fragmented as people age. A number of reports suggest that older people are less likely than younger people to stay awake throughout the day and that older people tend to take more naps than younger people. 7. True. Most people gain weight as they age. Because of changes in the body and decreasing physical activity, older people usually need fewer calories. Still, a balanced diet is important. Older people require essential nutrients just like younger adults. You should be concerned about your weight if there has been an involuntary gain or loss of 10 pounds in the past 6 months. 8. False. Most older people are not depressed. When it does occur, depression is treatable throughout the life cycle using a variety of approaches, such as family support, psychotherapy, or antidepressant medications. A physician can determine whether the depression is caused by medication an older person might be taking, by physical illness, stress, or other factors. 9. False. Many older people can beat cancer, especially if it's found early. Over half of all cancers occur in people 65 and older, which means that screening for cancer in this age group is especially important. 10 True. Older people often have a combination of conditions that require drugs. They consume 25 percent of all medications and can have many more problems with adverse reactions. Check with your doctor to make sure all drugs and dosages are appropriate. 11. False. Most older people can lead an active, satisfying sex life. 12. False. The overwhelming number of people with Alzheimer's disease have not inherited the disorder. In a few families, scientists have seen an extremely high incidence of the disease and have identified genes in these families which they think may be responsible. 13. True. Women are at particular risk for osteoporosis. They can help prevent bone loss by eating foods rich in calcium and exercising regularly throughout life. Foods such as milk and other dairy products, dark green leafy vegetables, salmon, sardines, and tofu promote new bone growth. Activities such as walking, biking, and simple exercises to strengthen the upper body also can be effective. 14. False. Research has found that, except for the changes that can result from Alzheimer's disease and other forms of dementia, personality is one of the few constants of life. That is, you are likely to age much as you've lived. 15. False. Urinary incontinence is a symptom, not a disease. Usually, it is caused by specific changes in body function that can result from infection, diseases, pregnancy, or the use of certain medications. A variety of treatment options are available for people who seek medical attention. 16. False. Suicide is most prevalent among people age 65 and older. An older person's concern with suicide should be taken very seriously and professional help should be sought quickly. 17. False. Falls are the most common cause of injuries among people over age 65. But many of these injuries, which result in broken bones, can be avoided. Regular vision and hearing tests and good safety habits can help prevent accidents. Knowing whether your medications affect balance and coordination`1 also is a good idea. 18. False. Not everyone gets cataracts, although a great many older people do. Some 18 percent of people between the ages of 65 and 74 have cataracts, while more than 40 percent of those between 75 and 85 have the problem. Cataracts can be treated very successfully with surgery; more than 90 percent of people say they can see better after the procedure. 19. True. The body's thermostat tends to function less efficiently with age, making the older person's body less able to adapt to heat or cold. 20. False. People at any age can learn new information and skills. Research indicates that older people can obtain new skills and improve old ones, including how to use a computer. U.S. Department of Health and Human Services Public Health Service National Institutes of Health October 1991 ! * SOMETHING IN THE AIR ABOUT AIRBORNE ALLERGENS National Institutes of Health National Institute of Allergy and Infectious Diseases Contents Introduction Symptoms of Allergies to Airborne Substances Pollen Allergy Mold Allergy Dust Allergy Animal Allergy Chemical Sensitivity Diagnosing Allergic Diseases Treating Allergic Diseases Allergy Research Introduction When is sneezing not a symptom of a cold? Very often, when it represents an allergic reaction to something in the air. It is estimated that 35 million Americans suffer from upper respiratory allergic reactions to airborne pollen. Pollen allergy, commonly called hay fever, is one of the most common chronic diseases in the United States. Worldwide, airborne dust causes the most problems for people with allergies. The respiratory symptoms of asthma, which affects approximately 15 million Americans, are often provoked by airborne allergens (substances that cause an allergic reaction). Allergic diseases are among the major causes of illness and disability in the United States, affecting as many as 40 to 50 million Americans. The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, conducts and supports research on allergic diseases. The goals of this research are to provide a better understanding of the cause of allergy, to improve the methods for diagnosing and treating allergic reactions, and eventually to prevent allergies. This booklet summarizes what is known about the causes and symptoms of allergic reactions to airborne allergens, how these reactions are diagnosed and treated, and what medical researchers are doing to help people who suffer from these allergies. What is an allergy? An allergy is a specific immunologic reaction to a normally harmless substance, one that does not bother most people. Allergic people often are sensitive to more than one substance. Types of allergens that cause allergic reactions include food, dust particles, medicines, insect venom, mold spores, or pollen. Why are some people allergic to these substances while others are not? Scientists think that people inherit a tendency to be allergic, although not to any specific allergen. Children are much more likely to develop allergies if their parents have allergies. Even if only one parent is allergic, a child has a one in four chance of developing allergies. Exposure to allergens at certain times when the body's defenses are lowered or weakened, such as after a viral infection, during puberty, or during pregnancy, seems to contribute to the development of allergies. WHAT IS AN ALLERGIC REACTION? Normally, the immune system functions as the body's defense against invading agents such as bacteria and viruses. In most allergic reactions, however, the immune system is responding to a false alarm. When allergic persons first come into contact with an allergen, their immune systems treat the allergen as an invader and mobilize to attack. The immune system does this by generating large amounts of a type of antibody (a disease-fighting protein) called immunoglobulin E, or IgE. Only small amounts of IgE are produced in nonallergic people. Each IgE antibody is specific for one particular allergenic (allergy-producing) substance. in the case of pollen allergy, the antibody is specific for each type of pollen: one antibody may be produced to react against oak pollen and another against ragweed pollen, for example. These IgE molecules attach themselves to the body's mast cells, which are tissue cells, and to basophils, which are blood cells. When the allergen next encounters the IgE, it attaches to the antibody like a key fitting into a lock, signalling the cell to which the IgE is attached to release (and in some cases to produce) powerful inflammatory chemicals like histamine, prostaglandins, and leukotrienes. These chemicals move into various parts of the body, such as the respiratory system, and cause the symptoms of allergy. Some people with allergy develop asthma. The symptoms of asthma include coughing, wheezing, and shortness of breath due to a narrowing of the bronchial passages (airways) in the lungs and to excess mucus production. Asthma can be disabling and sometimes can be fatal. If wheezing and shortness of breath accompany allergy symptoms, it is a signal that the bronchial tubes also have become involved, indicating the need for medical attention. SYMPTOMS OF ALLERGIES TO AIRBORNE SUBSTANCES The signs and symptoms are familiar to many: Sneezing often accompanied by a runny or clogged nose Coughing and postnasal drip Itching eyes, nose, and throat Allergic shiners (dark circles under the eyes caused by increased blood flow near the sinuses) The "allergic salute" (in a child, persistent upward rubbing of the nose that causes a crease mark on the nose) Watering eyes Conjunctivitis (an inflammation of the membrane that lines the eyelids, causing red-rimmed, swollen eyes and crusting of the eyelids). In people who are not allergic, the mucus in the nasal passages simply moves foreign particles to the throat, where they are swallowed or coughed out. But something different happens to a person who is sensitive to airborne allergens. As soon as the allergen lands on the mucous membranes lining the inside of the nose, a chain reaction occurs that leads the mast cells in these tissues to release histamine. This powerful chemical enlarges the many small blood vessels in the nose. Fluids escape through these expanded vessel walls, which causes the nasal passages to swell, resulting in nasal congestion. Histamine can also cause sneezing, itching, irritation, and excess mucus production, which can result in allergic rhinitis (runny nose). Other chemicals made and released by mast cells, including prostaglandins and leukotrienes, also contribute to allergic symptoms. POLLEN ALLERGY Each spring, summer, and fall tiny particles are released from trees, weeds, and grasses. These particles, known as pollen, hitch rides on currents of air. Although their mission is to fertilize parts of other plants, many never reach their targets. Instead, they enter human noses and throats, triggering a type of seasonal allergic rhinitis called pollen allergy, which many people know as hay fever or rose fever (depending on the season in which the symptoms occur). Of all the things that can cause an allergy, pollen is one of the most widespread. Many of the foods, drugs, or animals that cause allergies can be avoided to a great extent- even insects and household dust are escapable. Short of staying indoors when the pollen count is high-and even that may not help-there is no easy way to evade windborne pollen. People with pollen allergies often develop sensitivities to other troublemakers that are present all year, such as dust. For these allergy sufferers, the "sneezin' season" has no limit. Year-round airborne allergens cause perennial allergic rhinitis, as distinguished from seasonal allergic rhinitis. WHAT IS POLLEN? Plants produce microscopic round or oval pollen grains to reproduce. In some species, the plant uses the pollen from its own flowers to fertilize itself Other-types must be cross-pollinated; that is, in order for fertilization to take place and seeds to form, pollen must be transferred from the flower of one plant to that of another plant of the same species. Insects do this job for certain flowering plants, while other plants rely on wind transport. The types of pollen that most commonly cause allergic reactions are produced by the plain-looking plants (trees, grasses, and weeds) that do not have showy flowers. These plants manufacture small, light, dry pollen granules that are custom-made for wind transport. Samples of ragweed pollen have been collected 400 miles out at sea and 2 miles high in the air. Because airborne pollen is carried for long distances, it does little good to rid an area of an offending plant-the pollen can drift in from many miles away. In addition, most allergenic pollen comes from plants that produce it in huge quantities. A single ragweed plant can generate a million grains of pollen a day. The chemical makeup of pollen is the basic factor that determines whether it is likely to cause hay fever. For example, pine tree pollen is produced in large amounts by a common tree, which would make it a good candidate for causing allergy. The chemical composition of pine pollen, however, appears to make it less allergenic than other types. Because pine pollen is heavy, it tends to fall straight down and does not scatter. Therefore, it rarely reaches human noses. Among North American plants, weeds are the most prolific producers of allergenic pollen. Ragweed is the major culprit, but others of importance are sagebrush, redroot pigweed, lamb's quarters, Russian thistle (tumbleweed), and English plantain. Grasses and trees, too, are important sources of allergenic pollens. Although more than 1,000 species of grass grow in North America, only a few produce highly allergenic pollen. These include timothy, Johnson, Bermuda, redtop, orchard, sweet vernal, and Kentucky bluegrass. Trees that produce allergenic pollen include oak, ash, elm, hickory, pecaii, box elder, and mountain cedar. It is common to hear people say that they are allergic to colorful or scented flowers like roses. In fact, only florists, gardeners, and others who have prolonged, close contact with flowers are likely to become sensitized to pollen from these plants. Most people have little contact with the large, heavy, waxy pollen grains of many flowering plants because this type of pollen is not carried by wind but by insects such as butterflies and bees. WHEN DO PLANTS MAKE POLLEN? One of the most obvious features of pollen allergy is its seasonal nature-people experience its symptoms only when the pollen grains to which they are allergic are in the air. Each plant has a pollinating period that is more or less the same from year to year. Exactly when a plant starts to pollinate seems to depend on the relative length of night and day and therefore on geographical location-rather than on the weather. (On the other hand weather conditions during pollination can affect the amount of pollen produced and distributed in a specific year.) Thus, the farther north you go, the later the pollinating period and the later the allergy season. A pollen count which is familiar to many people from local weather reports, is a measure of how much pollen is in the air. This count represents the concentration of all the pollen (or of one particular type, like ragweed) in the air in a certain area at a specific time. It is expressed in grains of pollen per square meter of air collected over 24 hours. Pollen counts tend to be highest early in the morning on warm, dry, breezy days and lowest during chilly, wet periods. Although a pollen count is an approximate and fluctuating measure, it is useful as a general guide for when it is advisable to stay indoors and avoid contact with the pollen. MOLD ALLERGY Along with pollens from trees, grasses, and weeds, molds are an important cause of seasonal allergic rhinitis. People allergic to molds may have symptoms from spring to late fall. The mold season often peaks from July to late summer. Unlike pollens, molds may persist after the first killing frost. Some can grow at subfreezing temperatures, but most become dormant. Snow cover lowers the outdoor mold count drastically but does not kill molds. After the spring thaw, molds thrive on the vegetation that has been killed by the winter cold. In the warmest areas of the United States, however, molds thrive all year and can cause year-round (perennial) allergic problems. In addition, molds growing indoors can cause perennial allergic rhinitis even in the coldest climates. WHAT IS MOLD? There are thousands of types of molds and yeast, the two groups of plants in the fungus family. Yeasts are single cells that divide to form clusters. Molds consist of many cells that grow as branching threads called hyphae. Although both groups can probably cause allergic reactions only a small number of molds are widely recognized offenders. The seeds or reproductive particles of fungi are called spores. They differ in size, shape, and color among species. Each spore that germinates can give rise to new mold growth, which in turn can produce millions of spores. WHAT IS MOLD ALLERGY? When inhaled, microscopic fungal spores or, sometimes, fragments of fungi may cause allergic rhinitis. Because they are so small, mold spores may evade the protective mechanisms of the nose and upper respiratory tract to reach the lungs and bring on asthma symptoms. Build-up of mucus, wheezing, and difficulty in breathing are the result. Less frequently, exposure to spores or fragments may lead to a lung disease known as hypersensitivity pneumonitis, which will be discussed later. In a small number of people, symptoms of mold allergy may be brought on or worsened by eating certain foods, such as cheeses, processed with fungi. Occasionally, mushrooms, dried fruits, and foods containing yeast, soy sauce, or vinegar will produce allergic symptoms. There is no known relationship, however, between a respiratory allergy to the mold Penicillium and an allergy to the drug penicillin, made from the mold. WHERE DO MOLDS GROW? Molds can be found wherever there is moisture, oxygen, and a source of the few other chemicals they need. In the fall they grow on rotting logs and fallen leaves, especially in moist, shady areas. In gardens, they can be found in compost piles and on certain grasses and weeds. Some molds attach to grains such as wheat, oats, barley, and corn, making farms, grain bins, and silos likely places to find mold. Hot spots of mold growth in the home include damp basements and closets, bathrooms (especially shower stalls), places where fresh food is stored, refrigerator drip trays, house plants, air conditioners, humidifiers, garbage pails, mattresses, upholstered furniture, and old foam rubber pillows. Bakeries, breweries, bams, dairies, and greenhouses are favorite places for molds to grow. Loggers, mill workers, carpenters, furniture repairers, and upholsterers often work in moldy environments. WHICH MOLDS ARE ALLERGENIC? Like pollens, mold spores are important airborne allergens only if they are abundant, easily carried by air currents, and allergenic in their chemical makeup. Found almost everywhere, mold spores in some areas are so numerous they often outnumber the pollens in the air. Fortunately however only a few dozen different types are significant allergens. In general, Alternaria and Cladosporium (Hormodendrum) are the molds most commonly found both indoors and outdoors throughout the United States. Aspergillus, Penicillium, Helminthosporium, Epicoccum, Fusarium, Mucor, Rhizopus, and Aureobasidium (Pullularia) are also common. ARE MOLD COUNTS HELPFUL? Similar to pollen counts, mold counts may suggest the types and relative quantities of fungi present at a certain time and place. For several reasons, however, these counts probably cannot be used as a constant guide for daily activities. One reason is that the number and types of spores actually present in the mold count may have changed considerably in 24 hours because weather and spore dispersal are directly related. Many of the common allergenic molds are of the dry spore type-they release, their spores during dry, windy weather. Other fungi need high humidity, fog, or dew to release their spores. Although rain washes many larger spores out of the air, it also causes some smaller spores to be shot into the air. In addition to the effect of day-to-day weather changes on mold counts, spore populations may also differ between day and night. Day favors dispersal by dry spore types and night favors wet spore types. ARE THERE OTHER MOLD-RELATED DISORDERS? Fungi or microorganisms related to them may cause other health problems similar to allergy. Some kinds of Aspergillus especially may cause several different illnesses, including both infections and allergy. These fungi may lodge in the airways or a distant part of the lung and grow until they form a compact sphere known as a "fungus ball." In people with lung damage or serious underlying illnesses, Aspergillus may grasp the opportunity to invade and actually infect the lungs or the whole body. In some individuals, exposure to these fungi can also lead to asthma or to an illness known as "allergic bronchopulmonary aspergillosis." This latter condition, which occurs occasionally in people with asthma, is characterized by wheezing, low-grade fever, and coughing up of brown-flecked masses or mucous plugs. Skin testing, blood tests, x-rays, and examination of the sputum for fungi can help establish the diagnosis. Corticosteroid drugs are usually effective in treating this reaction; immunotherapy (allergy shots) is not helpful. The occurrence of allergic aspergillosis suggests that other fungi might cause similar respiratory conditions. Inhalation of spores from fungus-like bacteria, called actino- mycetes, and from molds can cause a lung disease called hypersensitivity pneumonitis. This condition is often associated with specific occupations. For example, farmers's lung disease results from inhaling spores growing in moldy hay and grains in silos. Occasionally, hypersensitivity pneumonitis develops in people who live or work where an air conditioning or a humidity unit is contaminated with and emits these spores. The symptoms of hypersensitivity pneumonitis may resemble those of a bacterial or viral infection such as the flu. Bouts of chills, fever, weakness, muscle pains, cough, and shortness of breath develop 4 to 8 hours after exposure to the offending organism. The symptoms gradually disappear when the source of exposure is removed. If this is not possible, such as in occupational settings, it may be necessary to increase the ventilation of the workplace, wear a mask with a filter capable of removing spores, or change jobs. If hypersensitivity pneumonitis is allowed to progress, it can lead to serious heart and lung problems. DUST ALLERGY An allergy to dust found in houses is perhaps the most common cause of perennial allergic rhinitis. House dust allergy usually produces symptoms similar to pollen allergy. What is house dust? Rather than a single substance, house dust is a varied mixture of potentially allergenic materials. It may contain fibers from different types of fabrics; cotton lint, feathers, and other stuffing materials; bacteria; mold and fungus spores (especially in damp areas); food particles; bits of plants and insects; and other allergens peculiar to an individual home. Dust also may contain microscopic mites. These mites, which also live in bedding, upholstered furniture, and carpets, thrive in summer and die in winter. However, in a warm, humid house, they continue to thrive even in the coldest months. The particles seen floating in a shaft of sunlight are dead dust mites and their waste products. These waste-products, which are proteins, actually provoke the allergic reaction. House dust mite allergy is the major year-round allergy in the world, though ragweed allergy is more prevalent in the United States. Waste-products of cockroaches are also an important cause of allergy symptoms from household allergens, particularly in some urban areas of the United States. ANIMAL ALLERGY Household pets are the main culprits in causing allergic reactions to animals. It was once thought that pet allergy was provoked by dander or fur from cats and dogs. Now, however, the allergen is known to be proteins in the saliva that is present on the dander or fur. Cats win the prize for causing the most allergic reactions. One reason may be that cats preen themselves more than other furry pets. This preening coats the hairs with saliva containing allergens, which become airborne when the saliva dries. Also, it may be because cats are held more and often spend more time in the house, close to humans, than do dogs. Some rodents, such as guinea pigs and gerbils, have become increasingly popular as household pets. They, too, can cause allergic reactions in some people. Urine is the major source of allergens from these animals. Allergies to animals can take 2 years or more to develop and may not subside until 6 months or more after ending contact with the animal. Carpet and furniture are a reservoir for pet allergens, and the allergens can remain in them for 4 to 6 weeks. In addition, these allergens can stay in household air for months after the animal has been removed. Therefore, it is wise for people with an animal allergy to check with the landlord or previous owner to find out if furry pets had lived previously on the premises. CHEMICAL SENSITIVITY "Allergic to the twentieth century" is a phrase that has been used to describe people who seem to react to everything in their environment-indoors and outdoors. These allergy-like reactions can result from exposure to man-made substances, such as those found in paints or carpeting, or to natural substances, such as odors emitted by plants and flowers. Although the symptoms may resemble some of the manifestations of true allergies, sensitivity to chemicals does not represent a true allergic reaction. DIAGNOSING ALLERGIC DISEASES People with allergy symptoms, such as allergic rhinitis, may at first suspect they have a cold-but the "cold" lingers on. It is important to see a doctor about any respiratory illness that lasts longer than a week or two. When it appears that the symptoms are caused by an allergy, the patient should see a physician who understands the diagnosis and treatment of allergies. If the patient's medical history indicates that the symptoms recur at the same time each year, the physician will work under the theory that a seasonal allergen (like pollen) is involved. Properly trained specialists recognize the patterns of the local seasons and the association between these patterns and symptoms. The medical history suggests which allergens are the likely culprits. The doctor will also examine the mucous membranes, which often appear swollen and pale or bluish in persons with allergic conditions. Skin Tests To confirm which allergen is responsible, skin testing may be recommended using extracts from allergens such as dust, pollens, or molds commonly found in the local area. A diluted extract of each kind of allergen is injected under the patient's skin or is applied to a scratch or puncture made on the patient's arm or back. With a positive reaction, a small, raised, reddened area with a surrounding flush (called a wheal and flare) will appear at the test site. The size of the wheal can provide the physician with an important diagnostic clue, but a positive reaction does not prove that a particular pollen is the cause of a patient's symptoms. Although such a reaction indicates that IgE antibody to a specific allergen is present in the skin, respiratory symptoms do not necessarily result. Blood Tests Skin testing is not advisable in some people such as those with widespread skin conditions like eczema. Diagnostic tests can be done using a blood sample from the patient to detect levels of IgE antibody to a particular allergen. One such blood test is called the RAST (radioallergosorbent test), which can be performed when eczema is present or if a patient has taken medications that interfere with skin testing. It is expensive to perform, takes several weeks to yield results, and is somewhat less sensitive than skin testing. Overall, skin testing is the most sensitive and least costly diagnostic tool. TREATING ALLERGIC DISEASES There are three general approaches to the treatment of these allergies: avoidance of the allergen, medication to relieve symptoms, and allergy shots. Although no cure for allergies has yet been found, one of these strategies or a combination of them can provide varying degrees of relief from allergy symptoms. Avoidance Complete avoidance of allergenic pollen or mold means moving to a place where the offending substance does not grow and where it is not present in the air. But even this extreme solution may offer only temporary relief since a person who is sensitive to a specific pollen or mold may subsequently develop allergies to new allergens after repeated exposure. For example, people allergic to ragweed may leave their ragweed-ridden communities and relocate to areas where ragweed does not grow, only to develop allergies to other weeds or even to grasses or trees in their new surroundings. Because relocating is not a reliable solution, allergy specialists do not encourage this approach. There are other ways to evade the offending pollen: remaining indoors in the morning, for example, when the outdoor pollen levels are highest. Sunny, windy days can be especially troublesome. If persons with pollen allergy must work outdoors, they can wear face masks designed to filter pollen out of the air and keep it from reaching their nasal passages. As another approach, some people take their vacations at the height of the expected pollinating period and choose a location where such exposure would be minimal. The seashore, for example, may be an effective retreat for many with pollen allergies. Mold allergens can be difficult to avoid, but some steps can be taken to at least reduce exposure to them. First, the allergy sufferer should avoid those hot spots mentioned earlier where molds tend to be concentrated. The lawn should be mowed and leaves should be raked up, but someone other than the allergic person should do these chores. if such work cannot be delegated, wearing a tightly fitting dust mask can greatly reduce exposure and resulting symptoms. Travel in the country, especially on dry, windy days or while crops are being harvested, should be avoided as should walks through tall vegetation. A summer cabin closed up all winter is probably full of molds and should be aired out and cleaned before a Mold-sensitive person stays there. Around the home, a dehumidifier will help dry out the basement, but the water extracted from the air must be removed frequently to prevent mold growth in the machine. Those with dust allergy should pay careful attention to dust- proofing their bedroom. The worst things to have in the bedroom are wall-to-wall carpets, venetian blinds, down-filled blankets, feather pillows, heating vents with forced hot air, dogs, cats, and closets full of clothing. Shades are preferred over venetian blinds because they do not trap dust. Curtains can be used if they are washed periodically in hot water to kill the dust mites. Bedding should be encased in a zippered, plastic, airtight, and dust-proof cover. Although shag carpets are the worst type for the dust-sensitive person, all carpets trap dust and make dust control impossible. In addition, vacuuming can contribute to the amount of dust, unless the vacuum is equipped with a special high-efficiency particulate air (HEPA) filter. Wall-to-wall carpets should be replaced with washable throw rugs over hardwood, tile, or linoleum floors. Reducing the amount of dust in a home may require new cleaning techniques as well as some changes in furnishings to eliminate dust collectors. Water is often the secret to effective dust removal. Washable items should be washed often using water hotter than 130' Fahrenheit. Dusting with a damp cloth or oiled mop should be done frequently. The best way for a person allergic to pets, especially cats, to avoid allergic reactions is to find another home for the animal. There are, however, some suggestions that help keep cat allergens out of the air: bathe the cat weekly and brush it more frequently, remove carpets and soft furnishings, and use a vacuum cleaner with a high-efficiency filter and a room air cleaner (see section below). Wearing a face mask while house and cat cleaning and keeping the cat out of the bedroom are other methods that allow many people to live more happily with their pets. Irritants such as chemicals can worsen airborne allergy symp- toms and should be avoided as much as possible. For example, during periods of high pollen levels, people with pollen allergy should try to avoid unnecessary exposure to irritants such as dust, insect sprays, tobacco smoke, air pollution, and fresh tar or paint. AIR CONDITIONERS AND FILTERS Use of air conditioners inside the home or in a car can help prevent pollen and mold allergens from entering. Various types of air-filtering devices made with fiberglass or electrically charged plates may help reduce allergens produced in the home. These can be added to the heating and cooling systems. In addition, portable devices that can be used in individual rooms are especially helpful in reducing animal allergens. An allergy specialist can suggest which kind of filter is best for the home of a particular patient. Before buying a filtering device, it is wise to rent one and use it in a closed room (the bedroom, for instance) for a month or two to see whether allergy symptoms diminish. The air-flow should be sufficient to exchange the air in the room five or six times per hour; therefore, the size and efficiency of the filtering device should be determined in part by the size of the room. Persons with allergies should be wary of exaggerated claims for appliances that cannot really clean the air. Very small air cleaners cannot remove dust and pollen-and no air purifier can prevent viral or bacterial diseases such as influenza, pneumonia, or tuberculosis. Buyers of electrostatic precipitators should compare the machine's ozone output with Federal standards. Ozone can irritate the nose and airways of persons with allergies, especially those with asthma, and can increase the allergy symptoms. Other kinds of air filters such as HEPA filters do not release ozone into the air. Medication For people who find they cannot adequately avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal steroids, and cromolyn sodium-any of which can be used alone or in combination. Many effective antihistamines and decongestants also are available without a prescription. Antihistamines. As the name indicates, an antihistamine counters the effects of histamine, which is released by the mast cells in the body's tissues and contributes to allergy symptoms. For many years, antihistamines have proven useful in relieving sneezing and itching in the nose, throat, and eyes and in reducing nasal swelling and drainage. Many people who take antihistamines experience some distress- ing side effects: drowsiness and loss of alertness and coordination. In children, such reactions can be misinterpreted as behavior problems. During the last few years, however, antihistamines that cause fewer of these side effects have become available by prescription. These new nonsedating antihistamines are as effective as other antihistamines in preventing histamine-induced symptoms, but do so without causing sleepiness. Topical nasal steroids. This medication should not be confused with anabolic steroids that have serious side effects. Topical nasal steroids are anti-inflammatory drugs that stop the allergic reaction. In addition to other beneficial actions, they reduce the number of mast cells in the nose and reduce mucus secretion and nasal swelling. The combination of antihistamines and nasal steroids is a very effective way to treat allergic rhinitis. Cromolyn sodium. Cromolyn sodium stops allergic reactions from starting. It is administered as a nasal spray, and it can prevent the release of chemicals like histamine from the mast cell. IMMUNOTHERAPY Immunotherapy, or a series of allergy shots, is the only available treatment that has a chance of reducing the allergy symptoms over the long haul. Patients receive injections of increasing concentrations of the allergen(s) to which they are sensitive. These injections reduce the amount of IgE antibodies in the blood and cause the body to make a protective antibody called IgG. About 85 percent of patients with allergic rhinitis will have a significant reduction in their hay fever symptoms and in their need for medication within 24 months of starting immunotherapy. Many patients are able to stop the injections with good, long-term results. As better allergens for immunotherapy are produced, this technique will become an even more effective treatment. ALLERGY RESEARCH The National Institute of Allergy and infectious Diseases (NIAID) conducts and supports research on allergies focused on understanding what happens to the body during the allergic process-the sequence of events leading to the allergic response and the factors responsible for allergic diseases. This understanding will lead to better methods of preventing and treating allergies. NIAID supports a network of Asthma, Allergic and Immunologic Diseases Cooperative Research Centers throughout the United States. The centers encourage close coordination among scientists studying the immune system, genes, biochemistry, and pharmacology. This interdisciplinary approach helps move research knowledge as quickly as possible from research scientists to physicians and their allergy patients. Educating patients and health care workers is an important tool in controlling allergic diseases. All of these research centers conduct and evaluate educational programs focused on methods to control allergic diseases. NIAID's National Cooperative Inner-City Asthma Study Centers are examining ways to prevent asthma in minority children in inner-city environments. Asthma, a major cause of illness and death among these children, is provoked by a number of possible factors, including allergies to airborne substances. Although several factors provoke allergic responses, scientists know that heredity is a major influence on who will develop an allergy. Therefore, researchers are trying to identify and describe the genes that make a person susceptible to allergic diseases. Other studies are aimed at seeking better ways to diagnose and treat people with allergic diseases and to better understand the factors that regulate IgE production in order to reduce the allergic response in patients. Several research institutions are focusing on ways to influence the cells that participate in the allergic response. These studies offer the promise of improving treatment and control of allergic diseases and the hope that one day allergic diseases will be preventable as well. INFORMATION RESOURCES American Academy of Allergy and Immunology 611 East Wells Street Milwaukee, WI 53202 1-800-822-ASMA Asthma and Allergy Foundation of America 1125 15th Street, NW, Suite 502 Washington, DC 20005 1-800-7-ASTHMA Allergy and Asthma Network 3554 Chain Bridge Road, Suite 200 Fairfax, VA 22030 1-800-878-4403 For information on air-cleaning devices: Environmental Protection Agency Public Information Service 401 M Street, SW Washington, DC 20460 1-800-438-4318 U.S. Dept. of Health and Human Services Public Health Service National Institutes of Health Bethesda, Maryland 20892 ! * Medicine For The Public: Allergic Diseases U.S. Department of Health and Human Services Public Health Service National Institutes of Health Warren Grant Magnuson Clinical Center This patient-oriented publication seeks to increase public awareness and understanding of allergic diseases and provide valuable information on the causes and treatments of allergies, with emphasis on new non-sedating methods of treatment. The production of this publication was made possible by Marion Merrell made possible by Marion Merrell Dow Inc., Kansas City, MO. 64114. A list of Medicine for the Public booklets and videotapes is available by calling 301-496-2563; or by sending a postcard to Clinical Center Communications, National Institutes of Health, 9000 Rockville Pike, building 10, room 1C255, Bethesda, Maryland 20892. Foreword Americans continue to demand a greater role in deciding issues that affect their health. Increased health awareness and the convincing evidence linking lifestyle, risk factors, and specific diseases have accelerated our need to know. The Clinical Center, recognizing the importance of providing information to facilitate intelligent decisions on health issues, created a unique lecture series featuring physician scientists working at the frontiers of biomedical research at the National Institutes of Health. The Medicine for the Public series has provided an opportunity for millions of people to learn more about how their bodies work and what they can do to maintain or improve their health. This publication is one of several adapted from the series. It is our sincere hope that you will find this material interesting and enlightening. Saul Rosen, Ph.D., M.D. Acting Director Warren Grant Magnuson Clinical Center National Institutes of Health Allergic Diseases Who Gets Allergies? Allergies are incredibly common. More than 50 million Americans- I out of 5-suffer from allergic diseases. One out of every 11 office visits to the doctor is for an allergic disease. Inheritance has a major influence on allergy. If one parent has allergies, the odds are that one in three of the children will have allergies. If both parents have allergies, then all the children will probably have allergies. Aside from inheritance, it is not known why some people get allergies and others do not. Some believe that hormonal influences, viral infections, smoking, and a number of other influences affect whether one develops allergies. No one knows all the reasons why people with equal likelihood to develop allergies become allergic to different things, or why some have hay fever and others have asthma. Second, a person has to be exposed to an allergen, a foreign protein that causes allergy. Ragweed pollen is the major cause of allergy in the United States. It is an unusual allergen that is found in high concentrations only in this country. Most people who move to the United States are exposed to ragweed for the first time. Many have never had allergies previously in their families for centuries, yet they develop allergies within two or three years of living in the United States. A large part of why they develop allergies is exposure to ragweed, which is an incredibly potent allergy-producing plant. Each ragweed plant produces about one billion pollen grains during an average allergy season. Those pollen grains are very small-microscopic. They float in the air and may be carried out to sea as many as 300 or 400 miles. So it does not matter if people do not have ragweed plants in their backyards; they are clearly exposed to ragweed every place in the United States except for the and southwest and southern California, where ragweed does not grow. Other major allergens include grass pollens, tree pollens, dust, molds, and animal dander. Worldwide, however, the major allergen is the dust mite. All temperate climate areas in the world have dust mites, which live in carpeting, mattresses, and upholstery. They have to have temperatures above 60 degrees to reproduce. Most people keep the temperature in their homes above 60 degrees all year. Dust mites also need a relative humidity above 50 percent. People are not actually allergic to the dust mite; they are allergic to its feces. The fecal balls are sticky, heavy materials that bind to carpeting or upholstery. One of the worst ways to bring dust mite allergens into the air is to vacuum the floor; this blows the dust up into the air, where it floats for a couple of hours and makes up the moats in a beam of sunlight. How Do Allergies Work? There are three components to allergies: mast cells, which contain chemicals like histamine; antibodies, a specific type of protein made by the immune system, known as IgE; and allergens, which trigger the reaction. Mast cells are the allergy-causing cells and are found in every tissue throughout the body, though they are most heavily concentrated in those tissues that are exposed to the outside world-the skin, linings of the nose and lungs, gastrointestinal tract, and reproductive system. The IgE antibody, which actually causes allergy, sits on the surface of these mast cells. A mast cell has about 1,000 histamine-containing granules in its cytoplasm, and on its surface are between 100,000 and 1 million receptors for IgE. When the IgE encounters the allergen, it triggers the mast cell to release granules from its cytoplasm. Those granules contain histamine and other chemicals. These mediators that are released then interact with the tissues, causing the allergic symptoms. With ragweed, for example, the pollen grains from the plant are male gametes equivalent to sperm. They carry the male genetic code from a male ragweed plant to a female ragweed plant. Since the pollen grains are wind borne and do not have a particular way of finding a female plant, many excess pollen grains are produced in the hopes that one or another will find a female plant and fertilize it. On the surface of a pollen grain are enzymes that help the pollen grain enter female plants. Unfortunately, people breathe in pollen grains that are floating in the air. When a pollen grain gets on the skin that lines the inside of the nose, those enzymes are released from the pollen grain and work their way through the mucus in the nose. The enzymes sensitize the person by initiating the production of IgE antibodies, which then sensitize mast cells that are in the nose. It generally takes about two to five seasons of allergen exposure before a person makes enough IgE to result in allergy symptoms. Everyone makes some IgE. Only people with genetic predispositions toward allergies make large quantities. IgE, like other antibodies that the body produces, is part of the body's defense mechanism. Some antibodies, like IgG, get rid of Streptococcus and help cure those infected with a strep throat. Other antibodies get rid of cold viruses. The IgE antibody is directed against parasites. Its function is to protect the body against parasitic infections. There are few parasites in the United States, but the IgE antibody system reacts against the enzymes from the surface of pollen grains as if they were parasites and elicits an allergic response. The body is misdirecting an extremely important immune response at pollens, dust, dander, and molds. Most antibodies last in the body about three weeks, but IgE may sit on its receptor on mast cells and sensitize the mast cells for years. For example, someone who had an adverse allergic reaction to penicillin as a child could still be allergic to the drug as an adult. The IgE antibody the person made as a 6-year- old child would still be present in the 40-year-old adult. It is sitting on the mast cells, which are long-lived cells, and it conveys incredibly long-lived sensitivity to allergens. In one research study, we looked at mast cell histamine release under the electron microscope. We sensitized a mast cell to IgE, making it allergic to grass, trees, ragweed, and certain breeds of cats and dogs. We then took this mast cell and exposed it to an extract of ragweed. Over a 15-minute period, many of the granules in its cytoplasm disappeared. Fifteen minutes later, the granules were all gone. Although the mast cell had no visible secretary granules in its cytoplasm, it was alive and well; over the next 6 to 24 hours it would reconstitute all the granules that had disappeared. After releasing histamine from its granules, a mast cell can once again do damage to the person the next day when he or she breathes in ragweed. The chemicals that are released from mast cells are the mediators that cause allergies. At last count, there were 28 separate chemicals released by mast cells that orchestrate allergic responses. The allergic symptoms a person experiences depend on the tissue in which the mediators are released. For example, if these chemicals are released in the nose, the person will get hay fever, allergic rhinitis. If they are released in the chest, the person will get asthma or coughing. Chemicals released in the skin will produce hives or eczema, in the intestine will produce food allergy or diarrhea, and in the brain may result in a migraine. There is a whole spectrum of problems that these mediators can cause. Allergic reactions often take place very quickly. Those who experience allergy may go outside on a bright, sunny, windy morning during the ragweed season and within 15 minutes begin to have allergic reactions. This reaction is referred to as immediate hypersensitivity. When mast cells release their chemicals, they cause immediate reactions. Some people also experience late-phase reactions. When mast cells release their chemicals, they cause an inflammatory response. The site of the allergic reaction gets red, swollen, hot, and tender, causing a more prolonged response. A person may go out at 8 a.m. and experience a late reaction at 4 p.m. Such reactions may last one day, two days, one week, or one month from a single allergen exposure. They are part of the underlying problem for chronic asthma, rhinitis, eczema, hives, and other allergic diseases. How Are Allergies Diagnosed? Allergy is diagnosed through skin testing, which shows an immediate reaction to allergens. The procedure traditionally involves introducing a minute amount of allergen into the skin. The tip of the needle is used to puncture the skin, causing an interaction between the allergen and a mast cell. When doctors administer skin tests, they are introducing allergen into the skin and causing the same reaction that the patients experience in their noses or lungs during the allergy season. In the past, doctors used to take small needles and inject them under the skin surface and put a minute amount of allergen in the skin. Within 15 minutes a welt formed, like a mosquito bite, if the patient had a positive reaction. That was minimally uncomfortable, but it was still uncomfortable. Today, doctors use a needle to put a drop of allergen on the skin without breaking the skin surface. They "tent" the skin by putting the needle through the droplet and lifting up the skin without breaking the skin surface. It is essentially painless, yet it is very sensitive and specific. Diagnosis, preferentially, is done by skin testing. Skin tests are fast; they take about 5 minutes to administer and can be read within 15 minutes. They are very sensitive, relatively cheap, cause minimal discomfort, but require some medical expertise. A second way to diagnosis allergy is with a blood test that looks for IgE antibodies. This test is relatively expensive, slightly less sensitive, requires a blood drawing, and does not require expertise. It is done frequently by nonallergists who want to see if the patient has allergies. In proper hands, both tests are equally informative. Allergic Rhinitis Allergic rhinitis (hay fever) is a disease of incredible proportion. Thirty-five million Americans-17 percent of the population-experience allergic rhinitis. It is the single most common chronic disease experienced by human beings. As a single entity, 1 out of every 40 doctor office visits (2.5 percent) are due to allergic rhinitis. Allergic rhinitis is caused by exposure to airborne allergens. The process of allergic rhinitis takes place in the nose. Pollen grains, dust, and dander are trapped by hairs in the nose and are trapped in the mucus that lines the inside of the nose. The allergens release soluble proteins that reach the mucous membranes, causing allergic rhinitis. The skin that lines the inside of the nose is a succulent tissue full of glands and blood vessels. The submucous glands in this living tissue produce the mucus in the nose. In fact, that is why the lining is called a mucous membrane-it specifically makes mucus. Although many people think of mucus as a bother, mucus is quite helpful. Mucus is important because it humidities and protects the mucous membrane. It contains antimicrobial factors that protect people from both bacterial and viral infections. When people get colds, it is despite the fact that they have mucus; if they did not have that mucus, they would have infections all the time. What about nasal congestion? The body has cavities in the lining of the nose where blood can pool. The nose can become swollen with blood pooling in these sinusoids. When blood is diverted into these sinusoids, this tissue gets markedly enlarged and the person cannot breathe through his or her nose. Everyone experiences nasal congestion; every 45 minutes to 2 hours, one side of the nose congests and the other side constricts. People breathe preferentially through one side, resting the other side, and then alternating sides. One never breathes evenly through both sides of the nose because of this process of congestion. Of course, during allergic rhinitis it gets much worse and the allergy sufferer experiences more severe, chronic nasal congestion. What can the mucous membrane do? It can congest by pooling blood in these sinusoids; it can become itchy or sneezy by stimulating some of the sensory nerves in the nose; and it can produce secretions. These are the processes that people experience when they have rhinitis-allergic rhinitis, vasomotor rhinitis, rhinitis from colds, or from eating hot and spicy foods. The most common features of allergic rhinitis are sneezing attacks and itching of the nose, eyes, pharynx, and palate. Clicking the tongue on the top of the mouth is the way one scratches the soft palate, and the soft palate itches if one has allergic rhinitis. One also gets a runny nose or congestion of the nose. To confirm a diagnosis of allergic rhinitis, the doctor performs a nasal examination and looks for changes in the mucous membrane. If the patient has allergic rhinitis, the mucous membrane becomes very pale because it is swollen. In fact, it takes on a whitish- blue tint. It is very wet with a watery secretion. A smear of the mucus would be loaded with a type of white blood cell known as an eosinophil, which is very characteristic of allergic diseases, and the patient would have an increase of eosinophils in his or her blood. If the doctor does a skin test or a blood test, called a RAST test, which measures an increase in the patient's IgE antibody, both would be positive. There are two kinds of allergic rhinitis-seasonal and perennial. Seasonal allergic rhinitis characteristically occurs as spring- fall allergies. Springtime begins with tree allergies. Grass is another major springtime allergen. In the eastern United States, there are few allergens in July and early August, and individuals with allergic rhinitis get better. Pollen from plants that bloom in the summer is spread by the insects, not by the wind, so that is a good time for most people unless they are allergic to molds. Seasonal allergies begin again when ragweed pollinates, starting from mid-August and lasting until the first frost. Some people also have seasonal allergies to dust during the winter months when the house is closed up and the dust mite feces are richest in the air. But most people with dust allergy have year-round-perennial- symptoms. Other things that cause year-round allergies are molds. Many people who live in humid areas have damp cellars in which molds form. These molds cause major problems for people with mold allergies. The other common cause of year-round allergies is allergens from pets. Cats are the worst source of pet allergens, much worse than dogs. The source of allergen from cats is not their fur or skin; it is their saliva, or the proteins in their saliva. And what do cats do all day? They preen. They put saliva on their fur, the saliva dries, aerosolizes, and is the source for the allergen. Dogs-sloppy, friendly little animals that they are- only preen selected parts of their body and are much less likely to expose humans to salivary allergens. Dogs are still a major source of allergy, especially if they slobber, but if one had to choose between the two, one would choose a dog over a cat. Ideally, allergy sufferers would not have any furred animals in the house because they all cause allergy. Cockroaches also are a major source of year-round allergens. How Is Allergic Rhinitis Treated? Seasonal allergic rhinitis generally has a better prognosis because it is not a year-round exposure. It is easier to treat and tends to be much less severe. By contrast, perennial disease tends to be much more difficult to treat and is harder to control. When treating patients with allergic rhinitis, doctors try specifically to take away the causes of the disease. By using allergy avoidance, they get rid of the allergen and the patient is better. Other common treatments include antihistamines, allergy immunotherapy (allergy shots), a drug called cromolyn sodium, and topical corticosteroids. To avoid pollen allergens, one must know when the pollen counts are highest. They are generally highest early in the morning, about 6 a.m., on a bright, sunny, breezy day. That is the time allergy sufferers should try to stay inside. If they ride in a car, they should use the car air conditioner. Allergy sufferers should use their house air conditioner, too. Air conditioning filters the air very well, taking out more than 99 percent of all the pollen- and allergen-producing material in the air. If people who are very sensitive during the ragweed, grass, or tree season must go outside in the yard, they should wear nuisance masks, which are like surgical masks and available in drug stores. They are comfortable and will reduce the likelihood of inhaling allergens. Those with dust allergy should design their bedrooms accordingly. The worst things to have in the bedroom of an allergic person are venetian blinds, which are dust traps; down-filled blankets; feather pillows; heating vents with forced hot air; carpeting; dogs; cats; and closets full of clothing. Instead of venetian blinds, people should have shades over the windows because they cannot trap dust. If curtains are used, they should be washable curtains that are cleaned periodically in hot water to kill the dust mites. A hardwood or linoleum floor is best, but a washable throw rug is acceptable if it is cleaned in hot water regularly. The bedding should be encased within allergen-proof encasements that are airtight to keep in dust mites, along with their feces. Pillows should be hypoallergenic and replaced every one to two years because when people sleep, they sweat and the sweat makes the pillows moldy over time. Blankets and bedding should be hypoallergenic-definitely not down filled. If at all possible, clothing should be kept in another room. Ideally, the closets would be empty in order to remain dust free. Heat registers should be covered with a filter. New products are appearing in the market that can kill dust mites in carpeting and may prove to be a boon to allergy sufferers. Allergy shots are extremely effective. Eighty-five percent of the people who receive allergy shots to treat hay fever due to grass, ragweed, trees, and dust get better. It usually takes one to two years. Many people get better for years, and some even permanently. Allergy shots, which are the only known way to turn off allergic disease, reduce the production of IgE and cause the body to make another class of antibody called IgG, which actually protects people from allergic diseases. Shots are the only method available for long-lasting protection from allergies. Patients with problems only two to four weeks of the year usually are treated with medications. Those with perennial disease are more likely to be put on allergy shots unless their condition can be controlled completely with allergy medications. There are several medications available to treat allergic rhinitis. One is cromolyn sodium administered in the nose, which prevents allergic reactions from taking place. This drug actually stops the release of chemical mediators like histamine from the mast cell. It is often a very effective therapy. Unfortunately, it must be used about four times a day as a nasal spray. A second major improvement in therapy of allergic rhinitis has been the use of topical nasal steroids. These steroids are not anabolic steroids. They are anti-inflammatory steroids that stop the late phase reaction. They reduce the number of mast cells in the nose, reduce mucus secretion and swelling, and have other beneficial actions. Because they are given topically, they have no effects elsewhere in the body-only in the nose. The other major medication used is antihistamines. Over the last five or six years, nonsedating antihistamines have become available. These antihistamines are just as effective as older antihistamines, but they do not cause sleepiness. However, they are considerably more expensive than some of the over-the-counter antihistamines. Antihistamines work beautifully for immediate hypersensitivity. They reduce sneezing, itching, runny nose, and partially reduce the congestion of allergic rhinitis. Unfortunately, they have no effect on late phase reactions. Antihistamines and nasal steroids are effective combinations to treat allergic rhinitis. Asthma Fifteen million people-seven percent of those who live in the United States-have asthma. It is the number one cause for school absenteeism among all chronic diseases. It is the number six cause for hospitalization of all diseases and the number one cause for hospitalization of children. It is estimated that $4.5 billion is spent every year on medically related charges for the treatment of asthma. That includes hospital and doctor visits. This is an extremely important disease that kills as many as 4,000 Americans a year. Asthma is a disease of the airways, the tubes through which people breathe. The causes of airflow obstruction in asthma are swelling of the airways, excessive mucus production, inflammation of the airways with eosinophils and neutrophils, and airway smooth muscle contraction. Asthmatic airways are full of secretions, mucus containing eosinophils and neutrophils-white blood cells-that reflect the underlying inflammation. The epithelial cells that line the airways have been lifted off and the airways are denuded. The muscles contract, closing the airways, and the glands are very reactive and produce large quantities of mucus. Asthma is an inability to breathe out. Normally when people breathe in, they lower their diaphragms, raise their ribs, and breathe in. It is an active process. To breathe out, they stop breathing in. Breathing out is passive. They breathe out because the lungs are made of elastic tissue, like a rubber band. When a person stops breathing in, the lungs try to assume their relaxed size and do so by letting the air out-if there is no obstruction. Asthmatic airways have excess mucus, are swollen and inflamed, and have their muscles contracted. As people with asthmatic airways breathe in, they open up their chests and their lungs get bigger. As a result, the airways get bigger and they can move air around these obstructions. They have opened up the airways. When they stop breathing in to breathe out, these obstructions close, thereby trapping the air in the lungs. Take a deep breath to the maximum and do not let it out for the next minute. Breathe at the top of your lungs and do not let out any air. That is what it feels like to have asthma. Asthmatics trap 2 liters of air in their chests, which is the amount of air in a basketball. They have to breathe at the top of their lungs. It is exhausting and feels terrible. What Causes Asthma? The most common cause of asthma is allergy. Of the children under 16 years old who have asthma, 90 percent are allergic. Of the people under 30 who have asthma, 70 percent are allergic. Of the people over 30, 50 percent have allergies. Asthma also may be caused by infections such as bronchiolitis, which is a wheezing disease that effects children less than 2 years old and is caused by a viral infection of the airways. This disease leads to asthma; more than half the children who get bronchiolitis have asthma until they are at least 7 years old. Adults with asthma also get infections that make their asthma worse. They will have colds that commonly develop into bronchitis. Because their lungs are inflamed, the lungs get irritated by a cold very readily and go into an asthmatic attack. Drugs like aspirin cause asthma in 10 percent of asthmatics. Aspirin and aspirin like drugs specifically cause asthma in a population of patients that have recurring sinusitis, or infections of the sinuses, and have nasal polyps. Other drugs that may cause asthma or make it worse are beta- adrenergic blocking agents, which are used for treatment of such conditions as migraine, too rapid a heart rate, congestive heart failure, tremor, and glaucoma. A third type of agent that may cause asthma is sulfiting agents, which are chemicals that are added to processed foods to keep them from turning brown. If a food should ordinarily turn brown and has not, it has sulfiting agents in it. This includes dried fruits, fruit juices, vegetables, and wines. As sulfites are eaten, they mix with acids in the stomach and become sulfuric acid, which is a gas. The gas travels up through the esophagus, is breathed in, and provokes asthma. Industrial and occupational exposures also have a bad effect on asthma. On smoggy days, the air is loaded with exhaust from motor vehicles. This is a major source of pollutants, and people with asthma experience increased asthmatic symptoms as a result. How Is Asthma Diagnosed? An allergist will do spirometry to measure the patient's ability to blow air out of the chest. The patient takes a deep breath and blows into a machine called a spirometer. The doctor then measures how much and how quickly air was blown out. Most people blow all the air in their chest out within 3 seconds; 75 percent of the air is exhaled within 1 second. The point of maximum expiration is called the "peak flow." Asthmatics have trouble blowing out the air. That is because of airflow obstruction during breathing out. As a result, they have a very hard time blowing out air and it takes much longer. Over the past few years, the availability of inexpensive and accurate peak flow meters has made life easier for doctors. Patients can measure their own peak flow in the morning and evening. The patient blows into the flow meter and it measures the peak expiratory flow rate. For home use it is reliable and inexpensive. A patient can use it before and after taking bronchodilators. It tells the doctor how much airflow increased with the use of bronchodilators and can be used to regulate medications. It also tells the doctor when the patient is doing well, and warns when trouble is coming. Airway hyperresponsiveness is increased reactivity of the airways, a "twitchiness" of the airways. Asthmatics have nonspecific airway responsiveness. They react when breathing in certain chemicals, including irritants and chemical mediators, or under certain physical conditions like exercise. The importance of airway hyperreactivity is that it clearly separates those who do not have hyperreactivity from asthmatics. Airway hyperreactivity actually predicts who will develop asthma. Patients who have abnormal hyperreactivity are very likely to be predisposed to developing asthma under the right conditions. There is a range of abnormal airway hyperreactivity among people with asthma, ranging from mild to severe, and doctors can use that range of near normal to very abnormal to determine which medications are required. Airway hyperreactivity gets worse with allergic reactions that cause late phase reactions. But airway hyperreactivity can get better if the patient avoids allergens, goes on allergy shots, and uses inhaled cromolyn or corticosteroids. Recently, it has been recognized that one of the major targets for the treatment of asthma is airway reactivity. How Is Asthma Treated? In order to treat asthma and airway reactivity, doctors recommend that asthma patients avoid the allergens to which they are sensitive whenever possible. They put the patients on allergy shots if they have allergic asthma in hopes of reducing the allergic contribution to the asthma. They use inhaled cromolyn, which stops allergic reactions, and often use inhaled corticosteroids, which stop inflammation of the airways and reduce airway hyperreactivity. With all patients, doctors also use symptomatic treatment of asthma involving agents that relax the airways. These agents include beta-adrenergic agonists, theophylline, anti- cholinergics, and occasionally expectorants and mucolytics. These medications are employed to try to reverse the airflow obstruction, but they do not have any effect on the underlying causes of asthma. Until recently, the therapy of asthma was based on the drug theophylline. This drug is an excellent, time-proven, time- tested, and very reliable bronchodilator that opens up asthmatic airways. It was the foundation of asthma therapy from 1970 to 1990. In the 1980's beta-adrenergic agents became available. These medications relax the airways and make many people better. They became very important in asthma therapy, and have become the predominant drug used to relax airways. In 1990, asthma therapy shifted so that all asthmatics are now treated with specific therapy aimed at the underlying causes of the disease-allergy avoidance, inhaled corticosteroids, perhaps allergy shots, and perhaps inhaled cromolyn. Nearly all patients use inhaled corticosteroids or cromolyn for the treatment of their airway inflammation. For control of airway obstruction, patients use beta-adrenergic agonists, as well as theophylline and ipratropium, which is an anti-cholinergic agent. Theophylline, however, has gone from being the foundation of treatment to a second-line therapy It is added later and taken away sooner. What about general treatments? It is recommended that all asthmatics exercise. Some patients have exercise-induced asthma, so it sounds contradictory, but with the proper medications every asthmatic-particularly children-can and should exercise. Swimming is the preferred form of exercise; biking is the second preferred; and running is the least preferred. It is recommended that asthmatics do not smoke, and that people with asthmatic children stop smoking. Patients are advised to monitor their pulmonary function with a home peak flow meter and learn as much as possible about asthma. Questions and Answers Q. Nobel Laureate Linus Pauling made mention of the fact that vitamin C has some effect on allergic reactions. What is the latest on that? A. Scientifically it has not been proven that vitamin C has any effect, beneficial or detrimental, on allergies. It is not harmful, at least in reasonable doses, but it will not help the disease. Q. How are food allergies effectively identified and then treated? A. Dr. Dean Metcalfe, here at the National Institute of Allergy and Infectious Diseases, screened adults for food allergy, and he found that when people came in and said, "I'm allergic to strawberries," they were likely to be allergic to strawberries. If people came in and said, "I'm allergic to food," they were almost never allergic to food. When people come in and can identify the food to which they are sensitive, we can confirm that by skin testing. In the case of a specific allergen, the skin tests are positive almost all the time. And, if we do a double-blind food challenge, it is frequently positive. We have many examples where people have said, "I haven't been able to eat eggs for 25 years," and we skin tested them and the tests were negative. We did a provocation challenge, and the only response was they did not care for the taste of eggs. So, the skin test plus a good history is how we screen for food allergies. Q. Have you ever observed any ophthalmological effects from allergies such as double vision? A. The eye is always involved in allergy, but the symptoms are generally itching, swelling, and redness. Eye movement and visual acuity are not affected. Q. What advice would you give to parents, both of whom suffer from allergies, regarding the introduction of foods for their infant children? A. Our instructions are very simple. We would recommend, especially if you have two allergic parents, that solids not be introduced until the children are at least 6 months of age. We recommend exclusive breast-feeding through at least the first 6 months. There is some suggestion that very allergenic foods, like cow's milk and peanuts, should be avoided by the mother during breast-feeding because she can transfer some allergens in breast milk. But the opportunity for a child to become allergic to allergens in breast milk is very limited versus drinking cow's milk. Thus, breast-feeding is highly recommended. Q. I have two questions. First, what are the possible side effects of allergy medications and how often do they occur? Second, I read that in some cases either asthma or hay fever, or some combination, can be due to emotional problems. Is there any information about that? A. It has often been claimed that asthma is a psychological disease. That is not the case. Asthma is a real, very important disease that can kill you. It may be worsened by psychological stresses, but it is not caused by stress. It is not psychological. The parents of asthmatics often feel very guilty that their child has asthma, and they wonder if it is their fault in some way that influenced their child's asthma. That is not the case. The side effects for drugs is a very broad question, very hard to answer, but I can tell you that the agents that we use today have been selected from many others because of their efficacy versus their very limited side effects. And the reason that theophylline is being used less today is because it has some side effects we wish to avoid. Q. 1 would like your comment on sinusitis. Is it associated with allergies? A. Sinusitis is an infection of the sinus areas of the skull, which are between the eyes, on either side of the cheeks, in the forehead, and center of the head. They are frequently associated with allergies and the development of sinus congestion; sinus infections are frequent accompaniments of allergy Q. What about the long-term effects of corticosteroids? Did I understand you to say that was no problem? A. Corticosteroids have major complications associated with them. In the past, we balanced the use of oral corticosteroids, which have systemic side effects, with the effects of the disease. When the disease was bad enough, we gave oral steroids and accepted the side effects if we had to. Now, with topical, inhaled steroids we have little or no systemic effects, so we get all the beneficial capabilities of steroids with none of the unwanted side effects. Q. Why do some medications like Benadryl, which you might give a child for hives, say, "Do not give to a child with asthma"? Is it dangerous to give a child Benadryl when he or she has hives and not asthma? A. That is an interesting and good question. The classical (older) antihistamines, like Benadryl, if you read the label, are not supposed to be used in asthma. Testing in the early 1950's suggested that antihistamines made asthma worse. So there is a label insert that says they should not be used in asthma. We do not use any of the classical or older antihistamines for the treatment of asthma because they do not work very well. Despite the labeling, however, we do not believe they have any danger for people with asthma. Some of the new, nonsedating antihistamines do have some efficacy in asthma, and they are being used cautiously for asthma treatment. These new antihistamines have no limitations on their use in asthma and may, indeed, be useful. Q. I wondered if there has ever been a program to eradicate ragweed. A. Yes, there has been. A woman in the Pennsylvania area and her family had terrible ragweed allergies and she organized the community to eradicate ragweed. It did not make any difference because ragweed moves through the air for such a long distance. Q. Many of the over-the-counter antihistamines say, "Do not take it for more than seven days." If I want to take them longer, should I get a prescription from a doctor? A. Antihistamines have been available since the 1940's and many people have taken antihistamines for more than 30 years, They have been among the world's safest drugs. That does not mean that you should use an over-the-counter antihistamine without caution. By and large, we would recommend that everyone would benefit from an appropriate diagnosis and proper therapy, which might include over-the-counter drugs, but might also include prescription drugs, which are really quite a bit more potent and maybe more specific. Biographical Note Michael A. Kaliner, M.D. Head, Allergic Diseases Section Laboratory of Clinical Investigation National Institute of Allergy and Infectious Diseases A native of Baltimore, Dr. Michael Kaliner received his bachelor's degree and medical degree from the University of Maryland. He completed his residency in medicine at the University of California at San Francisco, and his fellowship in allergy/immunology and rheumatology at Robert B. Brigham Hospital in Boston. He joined the National Institute of Allergy and Infectious Diseases in 1975, became head of the Allergic Disease Section and director of the Allergic Diseases Center in 1978, and was named director of the Outpatient Department, NIAID, in 1981. He currently serves as a consultant at Walter Reed Army Medical Center and at the U.S. Department of Health and Human Services. Dr. Kaliner's research focuses on the mechanics and controls of allergic asthma, rhinitis, anaphylaxis, and urticaria. By understanding the origin and physiology of these diseases, researchers can employ available therapy more effectively and develop new treatments. Respected internationally, Dr. Kaliner recently was appointed for two years to the International Scientific Board of the Pharmacia Allergy Research Foundation. He is active on many committees, including the Executive Committee of the American Academy of Allergy and Immunology, the Presidential Advisory Committee and Executive Committee of the International Association of Allergology and Clinical Immunology. He is treasurer of the American Academy of Allergy and Immunology. He serves on the editorial board of several professional journals. Dr. Kaliner serves on the Executive Committee of the National Allergy and Asthma Network, the organization that publishes the Mothers of Asthmatics report. He received many distinguished awards during his career, including the USPHS Commendation Medal for Meritorious Service, USPHS Outstanding Service Award, Roy Patterson Lectureship with American Academy of Allergy and Immunology, and the Von Pirquet Lectureship and Award from the Georgetown University Medical School. Clinical Center Office of Communications National Institutes of Health April 1991 ! * American College of Allergy, Asthma and Immunology Advice From Your Allergist: Allergic Rhinitis You may have allergic rhinitis if . . . You sneeze a lot, often in rapid succession . . . your nose is runny, congested or stuffy . . . you're bothered by itching of the nose, eyes, throat or roof of the mouth . . . you're nagged by postnasal drip . . . your ears pop or are plugged . . . you have a decreased sense of smell . . . and/or you get sinus headaches. What is allergic rhinitis? Known to most people as hay fever (see box below), allergic rhinitis is a very common medical problem affecting more than 15% of the population, both adults and children. Allergic rhinitis takes two different forms╨seasonal and perennial. Symptoms of seasonal allergic rhinitis surface in spring, summer and/or early fall and are usually caused by allergic sensitivity to pollens from trees, grasses or weeds, or to airborne mold spores. Other people experience symptoms year-round, a condition called perennial allergic rhinitis. It's generally caused by sensitivity to house dust, house dust mites, animal danders and/or mold spores. Underlying or hidden food allergies are considered a controversial cause of perennial nasal symptoms. Some people may experience both types of rhinitis, with perennial symptoms worsening during specific pollen seasons. As will be discussed later, there are also other causes for rhinitis. What causes the sneezing, itchy eyes and other symptoms? When a sensitive person inhales an allergen (allergy-causing substance) like ragweed pollen, the body's immune system reacts abnormally with the allergen. The allergen binds to allergic antibodies (immunoglobulin E) that are attached to cells that produce histamine and other chemicals. The pollen "triggers" these cells in the nasal membranes, causing them to release histamine and the other chemicals. Histamine dilates the small blood vessels of the nose and fluids leak out into the surrounding tissues, causing runny noses, watery eyes, itching, swelling and other allergy symptoms. Is allergic rhinitis ever the cause of other problems? Some known complications include ear infections, sinusitis, recurrent sore throats, cough, headache, fatigue, irritability, altered sleep patterns and poor school performance. Occasionally, children may develop altered facial growth and orthodontic problems. Allergy treatment can eliminate or alleviate most of these problems. Are all cases of rhinitis caused by allergies? No. Not all rhinitis symptoms are the result of allergies. Below are listed the three most common causes of rhinitis with some of their characteristics. Rhinitis Common Allergic Duration of Type Name Sensitivity Causes Symptoms Allergic Hay fever Yes Dusts, animals Perennial pollens, molds, and/or foods seasonal Infectious Colds-flu No Viruses, bacteria 3-7 days Nonallergic Irritant No Smoke, air pollu- Perennial tion, exhaust and/or fumes, aerosol following sprays, fragrance, exposure paint fumes, etc. No Hay, No Fever ╨ So Why Hay Fever? "Hay fever" is a turn-of-the-century term which has come to describe the symptoms of allergic rhinitis, especially when it occurs in the late summer. However, the symptoms are not caused by hay (ragweed is one of the main culprits) and are not accompanied by fever. So physicians prefer the term "allergic rhinitis" because it's more accurate. Similarly, springtime symptoms are sometimes called "rose fever," but it's just coincidental that roses are in full-bloom during the grass-pollinating season. Roses and other sweet-smelling, showy flowers rely on bees, not the wind, for pollination, so not much of their pollen gets into the air to cause allergies. Ñ The common cold is a good example of an infectious rhinitis. Most infections are relatively short-lived, lasting from 3 to 7 days. Ñ Irritant rhinitis also is called vasomotor or nonallergic rhinitis. People with irritant rhinitis develop swelling and congestion of the nose when they are exposed to irritating substances that may not cause symptoms in other people. The symptoms of allergic and irritant rhinitis can be the same. Many people experience a combination of both types of rhinitis. How is allergic rhinitis diagnosed? Your allergist may begin by taking a detailed history, looking for clues in your lifestyle that will help pinpoint the cause of your symptoms. You'll be asked about your work and home environments . . . your eating habits . . . your family's medical history . . . the frequency and severity of your symptoms . . . and miscellaneous matters such as if you have pets. Then, you may require some tests. Your allergist may employ skin testing, in which small amounts of suspected allergen are introduced into the skin. Skin-testing is the easiest, most sensitive and generally least expensive way of making the diagnosis. Another advantage is that results are available immediately. In rare cases, it also may be necessary to do a special blood test for allergens, using the RAST or other methods. Once allergic rhinitis is diagnosed, what can be done to alleviate the symptoms? Avoidance, medication and immunotherapy ╨ or allergy shots ╨ are the main treatments for allergic rhinitis. Ñ Avoidance ╨ a single ragweed plant may release one million pollen grains in just one day. The pollen from ragweed, grasses and trees is so small and buoyant that the wind may carry it miles from its source. Mold spores, which grow outdoors in fields and on dead leaves, also are everywhere and may outnumber pollen grains in the air even when the pollen season is at its worst. While it's difficult to escape pollen and molds, here are some ways to lessen exposure. ╨Keep windows closed and use air-conditioning in the summer, if possible. A HEPA (High Energy Particulate Air) filter or an electrostatic precipitator may help clean pollen and mold from the indoor air. Automobile air conditioners help, too. ╨ Don't hang clothing outdoors to dry. Pollen may cling to towels and sheets. ╨ The outdoor air is most heavily saturated with pollen and mold between 5 and 10 a.m., so early morning is a good time to limit outdoor activities. ╨ Wear a dust mask when mowing the lawn, raking leaves or gardening, and take appropriate medication beforehand. Ñ Medication ╨ When avoidance measures don't control symptoms, medication may be the answer. Antihistamines and decongestants are the most commonly used medications for allergic rhinitis. Newer medications, such as cromolyn, inhibit the release of chemicals that cause allergic reactions. Medications help to alleviate nasal congestion, runny nose, sneezing and itching. They are available in many forms, including tablets, nasal sprays, eye drops and liquids. Some medications may cause side effects so its best to consult your allergist if there's a problem. Ñ Immunotherapy╨Allergen immunotherapy, known as "allergy shots," may be recommended for persons who don't respond well to treatment with medications, experience side-effects from medications or have allergen exposure which is unavoidable. Immunotherapy does not cure allergies but can be very effective in controlling allergic symptoms. Allergy injections are usually given at variable intervals over a period of two to five years. There are many ways of treating allergies, and each person's treatment must be individualized based on the frequency, severity and duration of symptoms and on the degree of allergic sensitivity. If you have more questions, your allergist will be happy to answer them. RAGWEED DENSITY IN THE UNITED STATES Is There Any Escape? A common question from allergic rhinitis sufferers is: Can I move someplace where my allergies will go away? Some allergens are tough to escape. The above map shows how thoroughly ragweed╨which affects 75% of allergic rhinitis sufferers╨blankets most of the United States. Less ragweed is found in a band along the West Cost, the southern- most tip of Florida and northern Maine, but it is still present. Even Alaska and Hawaii have a little ragweed. Allergists seldom recommend moving to another locale as a cure for allergies. A move may be of questionable value because a person may escape one allergy╨to ragweed, for example╨only to develop sensitivity to grasses or other allergens in the new location. Since moving can have a disrupting effect on a family financially and emotionally, relocation should be undertaken only after careful consultation with an allergist. For more information, please contact: American College of Allergy, Asthma and Immunology 85 West Algonquin Road, Suite 550 Arlington Heights, IL 60005 (708) 427-1200 ! * American College of Allergy, Asthma and Immunology Advice From Your Allergist: Here's some food for thought Allergies, including hay fever, asthma and skin disorders, affect 58.7 million Americans, or 25% of the population. Although the true incidence of food allergy is unknown, a recent study suggests that about 5% of the population may suffer from adverse reactions to food. Historical records show that people have long been aware of food allergy. Hippocrates noted that cow's milk could cause gastric upset and hives. The Roman poet Lucretius said, "One man's meat is another man's poison." And some scholars believe Old Testament dietary restrictions were based upon the awareness that certain foods could cause adverse reactions. However, the serious study of food allergy began at the start of this century. Since then, research has led to effective procedures for the diagnosis and treatment of food allergy, relieving the symptoms of millions with this problem. What are some common symptoms of food allergy? Vomiting, nausea, stomach cramps, indigestion, diarrhea, hives, eczema, headaches, asthma, earaches and rhinitis (itchy, stuffy, runny nose; sneezing, and phlegm in the throat) are among the most common symptoms. In fact, many parts of the body can be affected by food allergy. The frequency and severity of symptoms vary widely from one person to another. Highly allergic persons may experience severe and life-threatening reactions such as upper airway swelling of the tongue and lips while, in milder cases, other may only suffer a minor case of sniffles. Because these symptoms can be caused by a number of diseases, your allergist may want to examine you to rule them out as the source of your problem. Not all adverse reactions to foods are due to allergy. Some reactions to milk, for example, are related to a deficiency of an enzyme (lactase) which normally breaks down a sugar in milk (i.e. lactose). This deficiency in some individuals causes a reaction similar to food allergy when milk is ingested. What causes my symptoms? Allergy is caused when your body's immune system over-reacts to the introduction of offending substances. Normally, your body's defense mechanisms (antibodies) keep you healthy by fighting such invaders as bacteria and viruses, which can cause infections, and inactivating allergens, which can cause allergic reactions. The body produces several types of antibodies, or immunoglobulins. When antibodies battle with allergens, chemicals, including histamine, are released as a part of the body's reaction to these substances. One antibody in particular, immunoglobulin E╨or IgE for short╨is produced in greater quantities than normal by persons with allergies. In large amounts, IgE-released chemicals can cause blood vessels to widen, smooth muscles to contract and affected skin areas to become red, itchy and swollen, resulting in an allergic reaction. In fact, these IgE antibodies found in tissues and secretions are thought to be responsible for classic allergy symptoms such as hives, swollen nasal membranes, diarrhea and wheezing. Why me? Why have I developed food allergy? You probably inherited it. Heredity seems to be the prime reason some people have allergies and others don't. If both your parents have allergies, you have a 75% chance of being allergic. If one parent is allergic╨or you have relatives on one side with allergies╨you have a 50% chance of becoming allergic. Although food allergy occurs most often in infants and children, it can appear at any age . . . and can be caused by foods that have been eaten for years without any problems. Other factors also come into play. For instance, excessive exposure to a particular food may create sensitivity to that food as testified to by the high incidence of fish allergy among Scandinavians . . . and of rice allergy among the Japanese. Some foods are more potent allergens than others. More people suffer reactions from peas than from carrots, from citrus fruits than from pears. Also, your reaction to a particular food can be affected by your physical condition at the time. If you have a cold, an upset stomach or a non-food allergy╨hay fever, for example, during high pollen season╨you may be more susceptible to food allergy. Emotional stress also may aggravate allergic symptoms. What foods are most likely to cause allergy? Eggs, milk, nuts, soy, seafood, fish, corn and wheat are the most common allergy- causing foods, but almost any food can cause allergy. Keep in mind that, if you are allergic to a particular food, you might be allergic to related foods. For example, a person allergic to avocado also may react to bay leaves because they're in the same botanical family. Likewise, a person allergic to peanuts often cannot tolerate other members of the legume family whose members include peas, beans and licorice. How do allergists determine which foods make me sick? The procedure varies from patient to patient. Some persons know exactly what food causes their allergies. They eat strawberries and immediately break out with hives, or they drink milk and immediately begin vomiting or get diarrhea. Sometimes, however, they need their allergist's help in determining the "culprit," especially when symptoms show up many hours after ingesting an offending food. Your allergist may begin by taking a detailed history. He'll look for clues in your lifestyle that will help pinpoint the cause of your problem. You'll be asked about your work and home environments . . . your eating habits . . . your family's medical history and miscellaneous matters, such as what kind of heating and cooking fuels you use, and if you have pets! But some of these questions don't have anything to do with food! These questions are necessary because your allergist wants to eliminate the possibility that another problem or multiple allergies may be causing your symptoms. For example, a patient's allergy to pollen or mold may trigger his allergy to eggs, so that in the summer, when mold and pollen are everywhere, he may not be able to eat eggs even though he can eat them safely the rest of the year. What's next, after taking the history? You may require some tests. Your allergist may employ skin testing, in which small amounts of the suspected allergen are introduced into the skin. A positive reaction╨a wheal, swelling or flare in the surrounding red area╨indicates the presence of allergic antibodies. Some patients are given RAST tests, which use blood samples to determine the extent of antibody production against an allergen. Will these allergy tests pinpoint my problem? Although these tests give your allergist further clues for the diagnosis, they are not 100% reliable. With the information gained from your history, physical exam and the tests, your allergist may further narrow down the suspected foods by placing you on a special diet. If your symptoms occur only occasionally, the culprit is a food that is eaten infrequently. Your allergist may ask you to keep a daily food diary listing all food and medication ingested, along with your symptoms for the day. By comparing "good days" with "bad days," you and your allergist can determine which foods are prime suspects. Then you may be asked to follow a trial diet, which alternates days of consumption and avoidance of suspected foods. If your symptoms subside during abstinence╨and flare up when you eat the food again╨the problem food has been identified. But I have allergy symptoms every day. How do my allergist and I begin to identify what foods I'm allergic to? Your allergist may ask you to go on an elimination diet tailor-made for you. You may be asked to eliminate foods implicated on the basis of your history, foods known to be highly allergenic and foods indicated in positive skin tests. After several weeks on the elimination diet, your system should be cleared of allergenic foods. When your symptoms cease, your allergist may reintroduce foods one at a time to your diet╨and watch for reactions. This reintroduction is called a "challenge." Many challenges may be necessary to identify which foods are safe for you and which will make you sorry. In some cases, not all offending foods or additives can be identified. Then your allergist may prescribe drugs to ease the symptoms. Once my allergy is identified, how is it treated? Avoidance of the allergenic food is the best policy. You must be vigilant in checking ingredient labels of food products to make sure an offending food or food additive is not present. For example, a person allergic to milk must avoid ice cream, cheese, chocolate bars, many cake mixes, and luncheon meats in which milk is used as a filler. If you are allergic to fish, be aware that glue on envelopes sometimes is made with fish products and could cause an allergic reaction. Special food-allergy cookbooks are widely available. Your allergist can recommend some to you. Will I ever be able to eat these foods again? If you have a severe immediate-type reaction to certain foods, NEVER taste them again. In some very sensitive persons a small taste of an allergenic food can produce a life-threatening reaction. However, if your symptoms are milder, you may be able to try a problem food again. After you have abstained from allergenic foods for a period of at least six months or longer, your allergist may suggest that you try a small portion of a problem food. If you have no reaction, you may be able to eat this food occasionally and in moderation. Allergic reactions to foods have been known to disappear for months or years, then reappear. In some cases, the allergy disappears for good. If you use caution and carefully follow your allergist's advice, you can bring your food allergy under control. If you have more questions, your allergist will be happy to answer them. For more information, please contact: American College of Allergy, Asthma and Immunology 85 West Algonquin Road, Suite 550 Arlington Heights, IL 60005 (708) 427-1200 ! * American College of Allergy, Asthma and Immunology Advice From Your Allergist: Pets May Cause Havoc for Allergic and Asthmatic Patients Keeping domestic animals as household pets is a universal activity. Pets provide companionship, security, and a sense of comfort. Children often learn responsibility and lessons about life and death from pets. However, people with allergies should be cautious in deciding what type of animal can safely be brought into their home. Pets can cause problems to allergic patients in several ways. Their dander (skin flakes) can cause an allergic reaction, as well as their saliva and urine. The animal hair itself is not considered to be a very significant allergen. However, the hair or fur can collect pollen, dust, mold, and other allergens. The best types of pets for an allergic patient are tropical fish, snakes, lizards, turtles, salamanders, ants and certain types of insects, frogs, spiders and tortoises. All of these pets do not shed dander, have hair or fur, nor does their excrement create allergic problems. However, patients should keep in mind that large aquariums can add to the amount of water vapor in a room, thus increasing mold and house dust mite concentrations in their home. Most Common Pets The most common household pets are dogs, cats, birds, hamsters, rabbits, mice, rats and guinea pigs. Larger animals such as horses, goats, cows, chickens, ducks, and geese, even though kept outdoors, can also cause problems if kept as pets. It is estimated that 25% of children are exposed to horses either by riding them or by being in their barns or pens. The number of pets in the United States is estimated at more than 100,000,000. This large number also increases the likelihood of accidental exposure to animals by the allergic patient when visiting homes, farms, etc. Both feathers and the droppings from birds, another common pet, can increase the allergen exposure. The allergic patient should not use feather pillows or down comforters. If a feather pillow is used, it should be placed in a plastic encasing. An encasing with a zipper is recommended, so none of the feathers can escape. Bird Droppings Bird droppings can be a source of bacteria, dust, fungi and mold. This also applies to the droppings of other caged pets, such as gerbils, hamsters and mice. The ideal situation for an allergic patient would be to have no pet at all. However, many pet owners feel strongly about their pets, and would rather remove the allergic individual from the home than the pet! A pet such as a dog or cat should, at the very least, be kept out of the allergic patient's bedroom. The avid pet owner may claim that exposure to his or her pet does not cause them any problems. This however, should be viewed skeptically, since pet ownership is an emotionally-charged subject. Also, many allergic pet owners are rarely away from their pets, so an accurate reporting of pet-related symptoms may not be possible. Testing to determine an allergy to animals is not always accurate. Skin tests or radioallergosorbent tests (a blood test for allergens) can give a "false" negative reaction. To gain confirmation about a pet's significance as an allergen, the pet should be removed from the home for several weeks and a thorough cleaning done to remove the hair and dander. It should be understood that it can take weeks of meticulous cleaning to remove all the animal hair and dander before a change in the allergic patient is noted. A frequently mistaken idea is that short-haired animals cause fewer problems. It is the dander (flakes of skin) that cause the most significant allergic reactions, not the length or amount of hair on the pet. As stated previously, allergens are also found in the pet's saliva and urine. In addition, dogs have been reported to cause acute symptoms of allergic conjunctivitis (inflammation of the eye) and hay fever after running through fields and then coming back into contact with their owners. Severe Reactions Some allergic patients may have severe reactions (wheezing and shortness of breath) after exposure to such pets as cats, rats, horses and guinea pigs. Also, a chronic, slowly progressive feeling of shortness of breath, loss of energy and feeling of fatigue can result from long-term exposure to birds and their droppings. This type of disease is known as hypersensitivity pneumonitis and can result in severe disability. In the event of these severe cases, removal of the offending animal is mandatory. In summary, pets can cause direct and indirect allergic problems, both from the dander and from pollen accumulated on the fur. Allergic children and adults should not pet, hug or kiss their pets, because of the allergens on the animal's fur or saliva. Those pets that are known to cause allergic reactions should be removed from the home of the allergic patient. If the family is unwilling to do this, the pet should be kept out of the patient's bedroom and, if possible, outdoors. Limit Pets to Few Rooms Indoor pets should be restricted to few rooms in the home if possible. Isolating the pet to one room, however, will not limit the allergens to that room. Air currents from forced-air heating and air-conditioning will spread the allergens throughout the house. Homes with forced-air heating and/or air-conditioning may be fitted with a central air cleaner. This may remove significant amounts of pet allergens from the home. The air cleaner should be used at least four hours per day. Text developed by ACAAI members: Gerald L. Klein, M.D., Robert W. Ziering, M.D., Vista, CA. For more information, please contact: American College of Allergy, Asthma and Immunology 85 West Algonquin Road, Suite 550 Arlington Heights, IL 60005 (708) 427-1200 ! * American College of Allergy, Asthma and Immunology Advice From Your Allergist: What is rhinitis? Rhinitis is not a disease; it is simply a term describing the symptoms produced by nasal irritation or inflammation. Symptoms of rhinitis include runny nose (rhinorrhea), itching (pruritus), sneezing and stuffy nose (blockage or congestion). These symptoms are the nose's natural response to inflammation and irritation. The nose normally produces mucus, which traps substances like dust, pollen, pollution, and germs such as bacteria and viruses. Mucus flows from the front of the nose to the back and is swallowed, but when mucus production is excessive, it can flow from the front (runny nose) or become noticeable from the back (post- nasal drip). Nasal mucus, normally a thin, clear liquid, can become thick or colored, perhaps due to dryness, infection, or pollution. When post-nasal drip is excessive, thick, or contains irritating substances, cough is the natural response for clearing the throat. Itching and sneezing are also natural responses to irritation caused by allergic reactions, chemical exposures (like cigarette smoke), temperature changes, infections and other factors. The nasal tissues congest and decongest periodically. In most people, nasal congestion switches back and forth from side to side of the nose in a cycle several hours long. Some people, especially those with narrow nasal passages, notice this nasal cycle more than others. Strenuous exercise or changes in head position can affect nasal congestion. Nasal congestion is also the natural response to irritation and inflammation. Severe congestion can result in facial pressure and pain, as well as dark circles under the eyes. What is sinusitis? Sinusitis is inflammation or infection of any of the four groups of air sinus cavities in the skull, which open into the nasal passages. Sinusitis is not the same as rhinitis, although the two may be associated and their symptoms may be similar. The terms "sinus trouble" or "sinus congestion" are sometimes wrongly used to mean congestion of the nasal passage itself. Most cases of nasal congestion, though, are not associated with sinusitis. What causes rhinitis? Arbitrarily, rhinitis lasting less than six weeks is called acute rhinitis, and persistent symptoms are called chronic rhinitis. Acute rhinitis is usually caused by infections or chemical irritation. Chronic rhinitis may be caused by allergy or a variety of other factors. The symptoms of allergic rhinitis (called "hay fever" sometimes, but not caused by hay and not associated with fever) are caused by exposure to substances (allergens) to which the patient has become allergic. Common allergens are tree, grass, and weed pollens, molds, animal hair and dander, and house dust mites. In general, pollen (and sometimes mold) allergy causes symptoms at certain times of the year, while mold, animal dander, and dust mites cause symptoms year round. People with allergies have developed antibodies to these allergens. These antibodies circulate in the blood stream, but localize in the tissues of the nose and in the skin. This makes it possible to demonstrate presence of these antibodies by skin testing, or less commonly, by a special blood test. A positive skin test mirrors the type of reaction going on in the nose. Not everyone with symptoms of rhinitis has allergies, and not everyone with allergies has rhinitis. Rhinitis may result from many causes other than allergic reaction. In fact, the most common condition causing rhinitis is the common cold. Colds can be caused by any of more than 200 viruses. Children, particularly young children in school or day care centers, may have from 8-12 colds each year. Fortunately, the frequency of colds lessens after immunity has been produced from exposure to many viruses. Colds usually begin with a sensation of decongestion, rapidly followed by runny nose and sneezing. Over the next few days, congestion becomes more prominent, the nasal mucus may become colored, and there may be a slight fever and cough. Cold symptoms resolve within a couple of weeks, although a cough may sometimes persist. Cold symptoms that last longer may be due to other causes of chronic rhinitis or to sinusitis. What are other causes of rhinitis? Not all symptoms in the nasal passage are caused by allergy or infection. Similar symptoms can be caused by mechanical blockage, use of certain medications, irritants, temperature changes, or other physical factors. Rhinitis can also be a feature of other diseases and medical conditions. Drug-induced nasal congestion, called "rhinitis medicamentosa," can be caused by birth control pills and other female hormone preparations, certain blood pressure medications (beta blockers and vasodilators), and prolonged use of decongestant nasal sprays. Decongestant nasal sprays work quickly and effectively, but they alter normal nasal physiology. After a few weeks of use, nasal tissues swell after the medication wears off. The only thing that seems to relieve the obstruction is more of the medicine, and the medication's effect lasts shorter lengths of time. Permanent damage to the nasal tissues may result. Consultation with a physician to "get off" the medication is often necessary. Cocaine also alters normal physiology, causing a condition identical to that produced by decongestant nasal sprays. If you use cocaine, it is important to tell your physician so that appropriate therapy can be prescribed. "Vasomotor rhinitis" is a term used to describe a group of poorly understood causes of rhinitis, with symptoms not caused by infection or allergy. Many people have recurrent nasal congestion, excess mucus production, itching, and other nasal symptoms similar to those of allergic rhinitis, but the disorder is not caused by allergy. What triggers vasomotor rhinitis? Irritants that can trigger vasomotor rhinitis include cigarette smoke, strong odors and fumes (perfume, hair spray, other cosmetics, laundry detergents, cleaning solutions, pool chlorine, car exhaust, and other air pollution). Spices used in cooking can cause nasal irritation, producing a condition called "gustatory rhinitis." Other things that can aggravate vasomotor rhinitis are alcoholic beverages (particularly beer and wine), aspirin, and certain blood pressure medications, such as reserpine and propranolol. Some people are very sensitive to abrupt changes in weather or temperature. Skiers often develop a runny nose ╨ "skier's nose" ╨ but in some people any cold exposure may cause a runny nose. Others start sneezing when leaving a cold, air conditioned room. These agents are not allergens, do not induce formation of allergic antibodies, and do not produce positive skin test reactions. Occasionally, one or two positive skin tests may be observed, but they do not correlate with the history and are not relevant or significant. The cause of vasomotor rhinitis is not well understood. In a sufficiently high concentration, many odors will cause nasal irritation in almost anyone. Some people, though, are unusually sensitive to irritation, and will have significant nasal symptoms even when exposed to low concentrations of irritants. Thus, vasomotor rhinitis seems to be an exaggeration of the normal nasal response to irritation, occurring at levels of exposure which don't bother most people. It occurs more often in smokers and older individuals. As is the case with allergic rhinitis, vasomotor rhinitis often can't be cured. Fortunately, symptoms can be kept under control by avoiding or reducing exposure to substances that cause symptoms, and by taking medications when needed. Patients with vasomotor rhinitis should not smoke or permit smoking in their homes. Dryness of the nasal tissues can be a normal effect of aging, or a characteristic of "rhinitis sicca, " which may be associated with a foul smelling nasal discharge. Rhinitis can also be a feature of endocrine disease like hypothyroidism or can occur during pregnancy. Rhinitis can be made worse or even improved during pregnancy. Alcoholic beverages can cause the blood vessels in the nose to enlarge temporarily and produce significant nasal congestion. How do you know what kind of rhinitis you have? Consult your physician. Sometimes several of the above conditions can coexist in the same person. In a single individual, allergic rhinitis could be complicated by vasomotor rhinitis, septal deviation (curvature of the bone separating the two sides of the nose) or nasal polyps. Use of spray decongestants because of chronic sinusitis, septal deviation or vasomotor rhinitis may cause rhinitis medicamentosa. Any of these conditions will be made worse by catching a cold. Nasal symptoms caused by more than one problem can be difficult to treat, often requiring the collaboration of an allergist and an otolaryngologist (ear, nose and throat specialist). How is rhinitis treated? Nasal surgery will usually cure or improve symptoms caused by mechanical blockage or chronic sinusitis not responsive to prolonged antibiotics and nasal steroid sprays. Stopping the use of offending medications will cure rhinitis medicamentosa, providing that there is no underlying disorder. When no specific cure is available, options are ignoring your symptoms, avoiding or decreasing exposure to irritants or allergens to the extent practical, and taking medications for symptom relief. Antihistamines are the most inexpensive and commonly used treatment for rhinitis. They dry excess secretions and reduce itching and sneezing, but may not do much for nasal congestion. There are dozens of different antihistamines and wide variations in how individual patients respond to them. Some are available over the counter and others require a prescription. Generally, they work well and produce only minor side effects. Persons with nasal dryness or thick nasal mucus should avoid taking antihistamines without consulting a physician. Contact your physician for advice if an antihistamine causes drowsiness or other side effects. Non-prescription decongestant nasal sprays work within minutes and lasts for hours, but can't be used for more than a few days at a time without a physician's order. Oral decongestants are found in many over the counter and prescription medications, and may be the treatment of choice for nasal congestion. They don't cause rhinitis medicamentosa, but need to be avoided be some patients with high blood pressure. If you have high blood pressure, you should check with your physician before using them. Using an over the counter saline nasal spray will help counteract symptoms of dry nasal passages or thick nasal mucus. Unlike decongestant nose sprays, a saline nose spray can be used as often as needed. Sometimes, your physician may recommend washing (douching) of the nasal passage. Corticosteroids counteract the inflammation caused by release of allergic mediators, as well as that caused by other nonallergic factors. Thus, they generally work for many causes of rhinitis symptoms and are sometimes useful for chronic sinusitis. Corticosteroids are sometimes injected or taken orally, but usually on a short term basis for extremely severe symptoms. Physicians warn that injected or oral steroids may produce severe side effects when used for long periods or used repeatedly and, for this reason, they should be used with extreme caution. In rhinitis, a corticosteroid is much safer when used topically be spraying it into the nose. Cromolyn is a medication that blocks the release of chemical mediators. It does not work in all patients. It must be used at least four times daily, and improvement may take several weeks to occur. Atropine and the related drug ipratropium bromide are sometimes used to relieve symptoms of rhinitis; in fact, most antihistamines have a slight atropine-like effect. Atropine can be taken orally, and it is a component of some antihistamine decongestant preparations. Atropine and ipratropium are not yet commercially available as nasal sprays. Antibiotics are for the treatment of bacterial infections. They do not affect the course of uncomplicated viral upper respiratory infections (common colds), and are of no benefit for non-infectious rhinitis, including allergic rhinitis. In chronic sinusitis, antibiotics may help only temporarily, and surgery may be needed. One or more of the above medications, accompanied by appropriate avoidance measures, will usually control most symptoms of nasal allergy. If not, immunotherapy (allergy shots, desensitization) may provide additional relief. The treatment program consists of injections of a diluted extract, administered frequently in increasing doses until a maintenance dose is reached. Then, the injection schedule is changed so that the same dose is given with longer intervals between injections. Immunotherapy helps the body build resistance tot he effects of the allergen, reduces the intensity of symptoms provoked by allergen exposure, and sometimes can actually make skin test reactions disappear. As resistance develops, symptoms should improve, but the improvement from immunotherapy will take several months to occur. Immunotherapy does not help the symptoms produced by nonallergic rhinitis. For more information, please contact: American College of Allergy, Asthma and Immunology 85 West Algonquin Road, Suite 550 Arlington Heights, IL 60005 (708) 427-1200 ! * Tipsheet: What's New in Allergy Research NIAID TIPSHEET May 1995 One out of five Americans -- some 50 million people -- suffers from an allergic disease, which results from the immune system reacting to a normally innocuous substance such as pollen or dust. Most of these people have allergies that affect nasal passages and sinuses, including allergies to pollen ("hay fever"), and allergic reactions in the airways of the lungs, which contribute to asthma. Hay fever alone affects some 22 million Americans, who in total see their doctors 9.4 million times a year. Asthma, which afflicts 10 to 15 million Americans, costs the country more than $6.2 billion annually in direct and indirect costs. Although researchers have developed useful therapies to treat allergic diseases, much remains to be learned about the basic nature of the allergic response and how to better treat and prevent allergies and related conditions. Recently, investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) have reported important findings that may lead to new ways to reduce the burden of allergic diseases. Some of these are summarized below. To pursue these or related stories, call Greg Folkers in the NIAID Office of Communications at (301) 402-1663. In this tipsheet: The Basics of Allergy - a Brief Primer Is It All in the Genes? New Hope for Allergic Seafood Lovers Why Both Nuts and Beans Bedevil Some Allergic People The Dope on the Docking Molecule How do Allergy Shots Work? Combatting Cat Allergy Managing Mast Cells NIAID is one of 17 institutes of the National Institutes of Health (NIH), the federal focal point for biomedical research. NIH is an agency of the U.S. Public Health Service, Department of Health and Human Services. NIAID conducts allergy research in its intramural laboratories in Bethesda and Rockville, Md., as well as through an extensive extramural program administered by the Division of Allergy, Immunology and Transplantation. THE BASICS OF ALLERGY - A BRIEF PRIMER An allergic response begins with a process called sensitization. When a foreign substance such as pollen (an allergen) first enters the body of an allergic person, cells called macrophages engulf the invader, chop it into pieces and display the pieces on their surfaces. T-helper cells recognize certain allergen fragments and bind to the macrophages. This process causes the T-helper cells to secrete signalling molecules, including interleukin-4 (IL-4). IL-4, in turn spurs nearby B cells to mature into plasma cells. Plasma cells produce Y-shaped antibody proteins. One class of antibodies of great importance in allergic diseases and asthma is immunoglobulin E (IgE). The two "arms" of IgE are tailor-made to specifically attach to the allergen. The "stem" of the IgE molecule attaches to two classes of immune cells: mast cells, which concentrate in tissues exposed to the outside world, especially the skin, and the linings of the nose, lungs and gastrointestinal tract, and basophils, which circulate in the blood. When the same allergen next enters the person's body, it binds to the arms of the IgE molecules protruding from the surfaces of mast cells and basophils. The interaction of an allergen with two IgE molecules triggers enzymes associated with the cell membrane such as tyrosine kinases. The enzymes start a series of biochemical reactions in the cell, which causes the cell to release chemicals, including histamine, from storage pouches in the cell interior called granules. These chemicals allow fluid to leak from blood vessels, producing symptoms such as redness and swelling in nearby tissues, and also constrict smooth muscles and stimulate mucus production. The substances also cause such symptoms as a runny nose, sneezing, itching, hives or abdominal cramps. In severe cases, anaphylactic shock may occur following the massive release of such chemicals. Other enzymes in the cell membrane cause mast cells and basophils to produce lipid molecules called prostaglandins and leukotrienes, which, like histamine, can constrict the lungs' airways. In addition, mast cells secrete chemical messengers that recruit other cells from the bloodstream into the tissues, including T lymphocytes, basophils and eosinophils. In the tissues, some of the recently arrived cells release substances that can increase and prolong early symptoms and may injure and inflame local tissue. Such responses often occur several hours after the initial encounter with an allergen. Collectively, they are called the late-phase reaction. The cells present in late-phase reactions are quite similar to those cells found in the tissues of patients with chronic allergic rhinitis and asthma. IS IT ALL IN THE GENES? Many studies suggest that some allergic diseases and asthma can be inherited. Until recently, however, the specific genes responsible for these diseases had not been identified. Now, investigators have found abnormalities of genes associated with asthma and allergic diseases, offering the possibility of treating the primary causes of allergy rather than merely the symptoms. One day, it may be possible to identify, even before birth, people at risk for allergic diseases. This would make efforts such as allergen avoidance more efficient by identifying susceptible individuals. Studies in the Amish and Dutch. At The Johns Hopkins University, NIAID grantee David Marsh, M.D., and colleagues have used genetic analyses of Amish families to show that a gene regulating the level of IgE in the bloodstream is located in a specific region of chromosome 5. Eugene Bleecker, M.D., of the University of Maryland and colleagues report similar findings in their studies of families in the Netherlands. Because high IgE levels in the blood are associated with allergies, as well as with bronchial hyperactivity and asthma, it is possible that abnormalities in this gene are associated with allergic conditions. Previous research shows that the gene for IL-4, an important regulator of IgE levels is on the same region of chromosome 5. Researchers now speculate that the IL-4 gene and the gene on chromosome 5 associated with IgE levels might be one and the same. Zeroing in on an "allergy gene." Grantee Lanny Rosenwasser, M.D., and colleagues at the National Jewish Center for Immunology and Respiratory Medicine in Denver, Colo., have found a specific segment of the IL-4 gene that appears to be different in members of families prone to asthma and allergy compared to non-allergic individuals. If this gene segment can be shown to correlate with high IgE levels, a strong link between the IL-4 gene and the chromosomal region studied by Dr. Marsh would be established. Researchers might then be able to design strategies to use the gene or its protein products as a target for therapy in allergic individuals. NEW HOPE FOR ALLERGIC SEAFOOD LOVERS NIAID intramural researcher Dean Metcalfe, M.D., and his colleagues are working to characterize the specific parts, or epitopes, of food proteins that bind to IgE and cause allergic reactions in susceptible people. Very few of these epitopes are known, but the identification of these allergy-causing molecules is an important step in designing approaches to immunotherapy and diagnostic tools for food allergy. Muscle protein the culprit in shrimp allergy. Recently, Dr. Metcalfe and collaborators in the United States and India identified two specific regions of a shrimp muscle protein called tropomyosin that may trigger the adverse reactions suffered by people allergic to shrimp. The researchers also found similar regions in muscle proteins of other shellfish, which may explain why people allergic to shrimp often are allergic to lobster, crab and other crustaceans as well. The researchers have created small synthetic proteins that correspond to the allergy-causing regions of the shrimp protein. These peptides may prove useful in immunotherapy and in developing a specific test for shrimp allergy. WHY BOTH NUTS AND BEANS BEDEVIL SOME ALLERGIC PEOPLE Many people who are allergic to peanuts are allergic to other legumes (peas, nuts, beans) as well. Research by Wesley Burks, M.D., and his colleagues at the University of Arkansas has helped explain why. Dr. Burks and his colleagues have shown that the gene that codes for Ara h I, one of the two main peanut allergens, is similar to genes from legumes that produce proteins called vicilins. The researchers found that IgE from peanut-allergic patients also bound to vicilins from other plants, which explains the cross-reactivity of peanuts and legumes in allergic people. THE DOPE ON THE DOCKING MOLECULE NIAID researcher Jean-Pierre Kinet, M.D., and his colleagues have proven that a docking molecule on mast cells and basophils to which IgE attaches, the high-affinity IgE receptor, is necessary for allergic reactions. A therapy that blocks this receptor could be effective in treating allergies. They developed a mouse that lacks a gene to make part of the high-affinity IgE receptor called the alpha chain. Without the alpha chain, the IgE receptor of these mice is unable to bind to IgE, thwarting an allergic reaction. Under experimental conditions, Dr. Kinet's "knockout mice" (the gene is "knocked out" using laboratory techniques) did not suffer allergic reactions, whereas ordinary mice with the receptor had the expected allergic reactions in similar experiments. These results confirmed that the high-affinity IgE receptor has a key role in allergy. In other experiments, Dr. Kinet and his team demonstrated that the other chains of the high-affinity IgE receptor, the beta and gamma chains, work together to activate the cascade of enzymes that result in mast cells and basophils releasing inflammatory chemicals following an encounter with an allergen. A further understanding of the interactions of the molecules in the receptor and the activation of signals in the mast cells and basophils could provide targets for therapies to prevent allergic reactions. A mouse with human genes. Dr. Kinet and his team are developing a mouse with genes for the human high-affinity IgE receptor, which differs slightly from the mouse receptor. These mice will allow scientists to test potential allergy treatments that inhibit the interaction of human IgE with the human high-affinity IgE receptor, or the signalling pathways in the cell. HOW DO ALLERGY SHOTS WORK? Allergen immunotherapy has been used since 1911, but the reasons why it works are unclear. Researchers are now beginning to understand the mechanisms behind the proven effectiveness of allergy shots. NIAID grantee Dale Umetsu, M.D., Ph.D., and his colleagues at Stanford University have demonstrated that T cells taken from patients with allergies produce large amounts of IL-4, but that IL-4 production is greatly reduced in allergic patients given allergy shots. Reduction in IL-4 production correlated with improvement in allergy symptoms, indicating that decreased IL-4 may be a key to future therapies for allergies. Dr. Umetsu and his colleagues are now studying how IL-4 production is regulated, and looking for more efficient ways to reduce IL-4 synthesis in T cells. COMBATTING CAT ALLERGY NIAID grantee Philip Norman, M.D., of Johns Hopkins University and his colleagues are studying immunotherapy using small portions of allergens called peptides, synthesized in the laboratory. Peptides may have fewer side effects than whole allergens when given as allergy shots, allowing for higher doses that may improve the effectiveness of immunotherapy. Recently, Dr. Norman and his co-workers reported results of the first clinical trial using peptide immunotherapy for people allergic to cats, employing peptides based on the Fel d 1, the principal cat allergen found in the animals' saliva. The investigators gave 91 cat-allergic patients four weekly injections of the peptides or a placebo. Six weeks later, the team evaluated results of the treatment by exposing the subjects to live cats in the Hopkins "cat room." In patients receiving high doses of the peptides, the treatment reduced allergy symptoms by about 50 percent. Among eight patients receiving the highest dose and followed for eight months, four had reductions in symptoms that were maintained or improved, two maintained some benefit, and two lost benefit. A low-tech approach. NIAID grantee Tom Platts-Mills, M.D., Ph.D., and colleagues at the University of Virginia have shown that washing a cat with tap water can reduce the amount of airborne Fel d 1. Two cats were washed in tap water for five minutes, and significant amounts of Fel d 1 were found in the bath water. Airborne allergen levels were measured in an airtight room, and reductions in cat allergen ranged from 7 to 56 percent after the initial wash, and 36 to 60 percent after repeated immersions. MANAGING MAST CELLS Mast cells are the big guns in the allergic response, initiating many of the symptoms of allergy and asthma. A number of researchers are studying the factors that control mast cell growth and activation, with an eye toward containing allergic symptoms by limiting mast cells. NIAID intramural researcher Dean Metcalfe, M.D., and his co-workers showed that the immune system molecules IL-3 and stem cell factor (SCF) both stimulate the growth of human mast cells from their bone marrow precursor cells. IL-3 appears to be important for early mast cell proliferation, while SCF maintains the cells' viability and promotes maturation. Using cultures of mouse mast cells, the researchers found that removing IL-3 causes cells to undergo a kind of cellular suicide called apoptosis. However, adding SCF to the cultures prevents the cellular suicide by linking to surface receptors known as c-kit. Another immune system molecule, transforming growth factor beta, prevents the "rescue" of cells by SCF. These and other studies of mast cell growth factors suggest that it may be possible to alleviate allergy symptoms by deleting some of an allergic person's mast cells. Possible treatments include drugs or cytokines that block IL-3 or SCF. Alternately, it may be possible to selectively block the action of SCF by using antibodies that bind to its receptor, or to employ fragments of the receptor itself that act as decoys for SCF. Dr. Metcalfe and his colleagues also have identified several of the substances to which mast cells bind in the body. They are working to develop ways to limit mast cell migration into tissues and subsequent adhesion, thereby reducing allergic responses. ! * When Should I See an Allergist? Asthma and allergies are among the most common health problems, with as many as 50 million Americans afflicted with asthma, hay fever or other allergy-related conditions. Some allergies -- such as a mild case of hay fever -- may require no treatment, or may be controlled with the occasional use of over-the-counter medications. Others, however, may interfere with day-to-day activities, lessen the quality of life or, sometimes, be life-threatening. In these cases, individuals should seek the care of a physician to help them manage their disease. The allergist treats asthma and allergies A physician who specializes in the diagnosis and treatment of asthma and allergies is an allergist. The allergist has passed a qualifying examination and is specially trained to identify the factors that trigger asthma or allergies, and help the patient to prevent or treat the condition. After earning a medical degree, the allergist completes a three-year residency training program in either internal medicine or pediatrics, followed by a two- or three-year program of study in the field of allergy and immunology. You can be certain that your doctor has met these requirements if he or she is certified by the American Board of Allergy and Immunology. When to see an allergist If you suffer from asthma or allergies -- or suspect that you may have either -- an allergist will help you learn more about your condition and provide treatment that controls or eliminates your symptoms. Often, the symptoms of asthma or allergies develop gradually over a period of time. Allergy sufferers may become so accustomed to chronic symptoms as sneezing, nasal congestion or wheezing that they do not consider their symptoms to be unusual. Yet, with the help of an allergist, these symptoms can usually be prevented or controlled and the patient╒s quality of life greatly improved. What is an allergy? One of the marvels of the human body is that it can defend itself against harmful invaders such as viruses or bacteria. But sometimes the defenses are too aggressive, and harmless substances such as dust, mold or pollen are mistakenly identified as dangerous. The immune system then rallies its defenses, launching a host of complex chemical weapons to attack and destroy the supposed enemy. In the process, some unpleasant and, in extreme cases, life-threatening symptoms may be experienced by the allergy-prone individual. The cause of allergic reactions There are hundreds of ordinary substances that can trigger allergic reactions. Among the most common are plant pollens, molds, household dust (dust mites), animal dander, industrial chemicals, foods, medicines, feathers, and insect stings. These triggers are called ╥allergens.╙ An allergic reaction may occur anywhere in the body, but usually appears in the skin, eyes, lining of the stomach, nose, sinuses, throat and lungs -- places where special immune system cells are stationed to fight off invaders that are inhaled, swallowed or come in contact with the skin. Who develops asthma or allergies? Asthma and allergies can affect anyone, regardless of age, gender, race or socioeconomic factors. While it╒s true that asthma and allergies are more common in children, they can occur for the first time at any age or, in some cases, recur after many years of remission. Although the exact genetic factors are not yet understood, the tendency to asthma and allergies is linked to heredity. In susceptible people, factors such as hormones, stress, smoke, perfume or other environmental irritants may also play a role. How an allergist can help Effectively controlling asthma and allergies requires planning, skill and patience. The allergist, with his or her specialized training and expertise in managing asthma and allergies, can develop a treatment plan for your individual condition. The goal will be to enable you to lead a life that is normal and symptom-free as possible. Some of the methods that may be used by the allergist include: Allergy testing. The allergist will usually perform tests to determine what allergens are involved. Prevention. The most effective approach to treating asthma or allergies is to avoid the factors that trigger the condition in the first place. Even when it is not possible to completely avoid allergens, an allergist can design strategies for reducing exposure and preventing symptoms. Prescription Medications. A number of new and effective medications are available to treat both asthma and allergies. Immunotherapy (Allergy Shots). In this treatment, patients are injected over the course of time with gradually increasing doses of the substance to which they are allergic. In many cases, the body╒s reaction to the substance becomes less pronounced over time. Types of Allergies Allergic Rhinitis (Hay Fever). Allergic rhinitis is a general term used to describe the allergic reactions that take place when an airborne allergen, such as pollen or mold, is inhaled through the mouth or nose. Symptoms may include sneezing, congestion, runny nose, excess mucus, weepy eyes and a scratchy or burning palate and throat. These may be seasonal symptoms triggered by plant pollens or molds, in which case the condition is often called ╥hay fever.╙ Sometimes the problem is year-round, in which case the culprit may be dust, dander from household pets or other animals, or, less frequently, a food allergy. Contact Dermatitis, Skin Allergies. Contact dermatitis, eczema and hives are skin conditions that can be caused by allergens or other irritants. When the skin comes in direct contact with an allergen, usually a chemical, contact dermatitis may result. Often the reaction may take hours or days to develop, as in the case of poison ivy. The most common allergic causes of rashes such as eczema are pollen, foods and animals. Hives, or skin welts, may be triggered by emotional stress or an underlying disease. Allergies to foods, pets and medication, especially penicillin and aspirin, can also be the cause. Asthma. Asthma is caused when muscle spasms constrict the flow of air to the lungs. The linings of airways become inflamed and swollen, and excess mucus may clog the airways. An asthma attack is characterized by labored or restricted breathing, a tight feeling in the chest, coughing and wheezing. The condition can develop quickly and may vary in severity from mild discomfort to life-threatening attacks in which breathing stops altogether. Sometimes a chronic cough is the only symptom, and many cases of the disease go undiagnosed. Anaphylaxis. Anaphylaxis is a rare, potentially fatal allergic reaction that affects many parts of the body at once. The trigger may be an insect sting, a food, such as nuts or shellfish, or medications. Symptoms may include a dangerous drop in blood pressure, flushing, difficulty breathing, swelling of the throat, tongue and nose, and loss of consciousness. Usually these symptoms are immediate and progress rapidly. Emergency medical attention should be sought at the first sign of an anaphylactic reaction. You should see an allergist if: - Your allergies are causing secondary symptoms such as chronic sinus infections, nasal congestion or difficulty breathing. - You experience hay fever or other allergy symptoms several months out of the year. - Antihistamines and other over-the-counter medications do not control your allergy symptoms, or create unacceptable side effects, such as drowsiness. - Your asthma or allergies are interfering with your ability to carry on day- to-day activities. - Your asthma or allergies decrease the quality of your life - You are experiencing warning signs of asthma such as: -- You sometimes have to struggle to catch your breath. -- You often wheeze or cough, especially at night or after exercise. -- You are frequently short of breath of feel a tightness in your chest. -- You have previously been diagnosed with asthma, but despite treatment, you have frequent acute asthma attacks. For more information about asthma and allergies, or a list of board certified allergists in your area, call 1-800-842-7777. ! * Alopecia: A skin disease characterized by loss of hair, partial or total. --------------------------------------------------- Alopecia Alopecia, or hair loss, can be caused by a large number of diverse causes. Alopecia is divided into two basic groups: nonscarring and scarring alopecia. NONSCARRING ALOPECIA: the hair shafts are gone, but the hair follicles are preserved (generally reversible). Examples include: Primary skin disorders 1. Androgenetic alopecia--This is a form of alopecia that results from an increase in circulating androgens (testosterone). This is a common familial form of alopecia that is seen in males. In women, this may occur secondary to dysfunction of the adrenal glands or ovaries. In some cases, the possibility of an adrenal gland tumor must be excluded. A receding hairline is a common finding in androgenetic alopecia. 2. Alopecia areata--alopecia of unknown cause, but there are distinctive pathologic findings on microscopic examination of the skin. Some feel stress and anxiety play a role in this form of alopecia. Baldness is usually patchy and temporary 3. Tinea capitis--a fungal infection that may appear as an area of scaly skin with minimal hair loss, or patches of hair loss with broken hairs and pustules. 4. Traumatic alopecia--broken hairs are commonly seen. Often due to traction with curlers, rubber bands, braiding, exposure to heat or chemicals, or hair pulling. Drug Side effects--generally temporary and regrowth occurs in most cases after stopping the offending agent. Examples include: 1. Warfarin 2. Heparin 3. propylthiouracil 4. Vitamin A 5. Carbimazole 6. Isotretinoin 7. Lithium 8. Beta-blockers 9. Levodopa 10. Amphetamines 11. Thallium 12. Chemotherapeutic agents Systemic Diseases 1. Lupus (also a scarring form of alopecia, see below) 2. Secondary syphilis (scattered hair loss) 3. Hypothyroidism (diffuse thinning) 4. Hyperthyroidism (diffuse thinning) 5. Deficiencies of protein, iron, biotin, or zinc (diffuse thinning) SCARRING ALOPECIA: inflammation, fibrosis, and loss of hair follicles. A smooth scalp with a decreased number of follicular openings. Examples include: Primary Skin Disorders 1. Lichen planus 2. Scleroderma Systemic Diseases 1. Lupus (discoid lupus) 2. Sarcoidosis 3. Skin metastases (cancer) ! * ALZHEIMER'S DISEASE: AN OVERVIEW What is Alzheimer's disease? Alzheimer's disease (pronounced Altz-hi-merz) is a progressive, degenerative disease that attacks the brain and results in impaired memory, thinking and behavior. It affects an estimated 2.5 million American adults. When it was first described by German physician Alois Alzheimer in 1907, Alzheimer's disease was considered a rare disorder. Today, it is recognized as the most common cause of dementia. Dementia is not a disease itself but a group of symptoms that characterize certain diseases and conditions. In the case of Alzheimer's disease, the dementia includes a decline in intellectual functioning that is severe enough to interfere with the ability to perform routine activities. The second most common form of dementia is multi-infarct dementia, which is caused by vascular disease and strokes. Other causes of dementia are Huntington's disease, Parkinson's disease, Pick's disease and Creutzfeldt-Jakob disease. There also are a number of conditions that cause dementia- like symptoms: depression, drug reactions, thyroid disorders, nutritional deficiencies, brain tumors, head injuries, alcoholism, infections (meningitis, syphilis, AIDS) and hydrocephalus. Alzheimer's disease is distinguished from other forms of dementia by characteristic changes in the brain that are visible only upon microscopic examination. At autopsy, Alzheimer's disease brains show the presence of tangles of fibers (neurofibrillary tangles) and clusters of degenerating nerve endings (neuritic plaques) in areas of the brain that are important for memory and intellectual functions. Another characteristic of Alzheimer's disease is the reduced production of certain brain chemicals, especially acetylcholine and somatostatin. These chemicals are necessary for normal communication between nerve cells. Who is affected by Alzheimer's disease? Alzheimer's disease is more likely to occur as a person gets older. Although less than one percent of people age 65 are affected by Alzheimer's disease, it is present in an estimated 25 percent of those age 85 or older. Alzheimer's disease can occur in middle age as well. The youngest documented case is that of a 28-year-old individual. Alzheimer's disease also affects the family of an Alzheimer patient. The emotional, social and financial costs of caring for an Alzheimer patient are high. Family members also often risk their own health in order to care for the Alzheimer patient at home. What are the symptoms? Alzheimer's disease has a gradual onset. Symptoms include difficulty with memory and loss of intellectual abilities severe enough to interfere with routine work or social activities. The Alzheimer patient also may experience confusion, language problems (such as trouble finding words), poor or decreased judgment, disorientation in place and time and changes in behavior or personality. How quickly these changes occur in an Alzheimer patient will vary from person to person. Eventually, the disease leaves its victims totally unable to care for themselves. The course of the disease averages eight years from the time symptoms first appear, although Alzheimer's disease has been known to last as long as 25 years. How is Alzheimer's disease diagnosed? At this time, there is no single diagnostic test for Alzheimer's disease. A complete physical, psychiatric and neurologic evaluation by a physician experienced in the diagnosis of dementing disorders should be obtained when symptoms are noticed. The examination should include a detailed medical history, mental status test, neuropsychological testing, blood work, urinalysis, chest x-ray, electroencephalography (EEG), computerized tomography (CT scan) and electrocardiogram (EKG). Such an evaluation is essential to determine whether the dementia is the result of a treatable illness. When this kind of a detailed examination is done, the accuracy of diagnosis is about 90 percent. However, the only way to confirm a diagnosis of Alzheimer's disease is to examine brain tissue under a microscope. What causes Alzheimer's disease? Scientists are still looking for the cause of Alzheimer's disease, and their research is pointing in several directions. For one form of the disease called Familial or Uncommon Alzheimer's Disease, there is strong evidence that a defect exists in a single gene on Chromosome 21. However, for most Alzheimer's disease patients the genetic involvement is less clear. Although there does seem to be a genetic predisposition for the disease, other factors influence whether or not an individual develops Alzheimer's disease. Scientists continue to explore the importance of such things as a slow virus; environmental toxins, such as aluminum; and other physical conditions of an individual that may interact with the genetic defect. Is Alzheimer's disease fatal? Although Alzheimer's disease is associated with a shortened lifespan, the slow, progressive nature of the disease often means the patient will live for several years after diagnosis. Alzheimer's disease eventually leaves the patient physically less resistant to infections, such as pneumonia, which may be fatal. In addition, Alzheimer's disease generally affects an older population that is subject to other chronic illnesses, and those illnesses, too, may often be the cause of death. Can Alzheimer's disease be treated or cured? At this time, there is no treatment or cure available to stop or reverse the mental deterioration of Alzheimer's disease. However, new research findings give reason for hope. Several drugs used to relieve the symptoms of memory loss are in clinical trials. Other medications are available now to assist in managing some of the most troubling symptoms of Alzheimer's disease. Under a doctor's supervision, medication can be used to control depression, behavioral disturbances and sleeplessness. Can Alzheimer's disease be prevented? Prevention is not possible at this time because the cause of the disease is not known. However, advances in science are bringing us closer to answers that can lead to treatments and/or strategies for prevention. Meanwhile, focus on improved care and support for the caregiver are helping to ease the burden of Alzheimer's disease. Is there help for people affected by Alzheimer's disease? The Alzheimer's Association is the only national voluntary organization dedicated to providing support and assistance to Alzheimer patients and their families. The Alzheimer's Association is continuing research into the cause, treatment and cure of Alzheimer's disease, as well as ways to improve the care and management of current Alzheimer patients. The Alzheimer's Association has more than 1,200 support groups and 190 Chapters nationwide. For more information on Alzheimer's disease and the Alzheimer's Association or to volunteer in the fight against Alzheimer's disease, call the Association's toll-free number for the location of the Chapter nearest you. Glossary Dementia -- This is not a disease in itself but a group of symptoms that characterize certain diseases and conditions. The major symptoms involve a decline in intellectual functioning that is severe enough to interfere with routine activities. Alzheimer's disease is the most common form of dementia. Senility -- This label often was used to describe an individual 65 years or older with dementia. Senility used to be considered a normal part of aging. Today, physicians recognize that dementia is not a normal part of aging but the result of a disease such as Alzheimer's disease. Senile dementia/pre-senile dementia -- Senile dementia is a label that used to apply to patients whose symptoms of dementia appeared after age 65. Pre-senile dementia is a label that used to apply to dementia victims who were younger than age 65. These distinctions have largely been eliminated. Today, most cases of dementia in both groups of patients are diagnosed as Alzheimer's disease. Chronic organic brain syndrome -- This label is sometimes given to patients with a collection of symptoms such as memory loss, disorientation, confusion, personality changes and inability to carry out normal daily activities. The preferred term for these symptoms is dementia or dementing illness. Hardening of the arteries -- The correct medical term is arteriosclerosis. The dementia symptoms associated with arteriosclerosis result only when multiple cerebral infarcts (strokes) have occurred. This condition is called multi-infarct dementia. This brochure is one of a series made available by the Alzheimer's Association with underwriting from American Contract Bridge League, Louis N. Cassett Foundation, the Coca Cola Foundation, Ittleson Foundation, Inc., and Million Dollar Round Table Foundation. ! * ALZHEIMER'S QUESTION & ANSWER SHEET Alzheimer's Disease and Related Disorders Assoc. Inc. 70 E. Lake Street, Suite 600 Chicago, Illinois 60601 What is Alzheimer's Disease? The most common form of dementing illness, Alzheimer's Disease (AD) is a progressive, degenerative disease that attacks the brain, causing impaired memory, thinking and behavior. The person with AD may experience confusion, personality and behavior changes, impaired judgment, and difficulty finding words, finishing thoughts or following directions. It eventually leaves its victims incapable of caring for themselves. What happens to the brain in Alzheimer's Disease? The nerve cells in the part of the brain that controls memory, thinking, are damaged, interrupting the passage of messages between cells. The cells develop distinctive changes that are called neuritic plaques (clusters of degenerating nerve cell ends) and neurofibrillary tangles (masses of twisted filaments which accumulate in previously health nerve cells). The cortex (thinking center) of the brain shrinks (atrophies), The spaces in the center of the brain become enlarged, also reducing surface area in the brain. What are the symptoms of Alzheimer's Disease? Alzheimer's Disease is a dementing illness which leads to loss of intellectual capacity. Symptoms usually occur in older adults (although people in their 40s and 5Os may also be affected) and include loss of language skills -- such as trouble finding words, problems with abstract thinking, poor or decreased judgment, disorientation in place and time, changes in mood or behavior and changes in personality. The overall result is a noticeable decline in personal activities or work performance. Who is affected by Alzheimer's Disease? Alzheimer's Disease knows no social or economic boundaries and affects men and women almost equally. The disease strikes older persons more frequently, affecting approximately 10% of Americans over age 65 and 47% of those over age 85. What causes Alzheimer's Disease? The cause of Alzheimer's Disease is not known. Researchers are investigating suspected causes such as neurological damage, chemical deficiencies, viruses, genetic abnormalities, environmental toxins and malfunctions in the body's disease defense systems. Is Alzheimer's Disease hereditary? There is a slightly increased risk that children, brothers, and sisters of patients with Alzheimer's Disease will get it, but most cases are the only ones in a family. Some patients who develop the disease in middle age (called early onset) have a "familial" type -- more than one case in the family. It is important to note that AD can only be definitively diagnosed after death through autopsy of brain tissue. Thirty percent of autopsies turn up a different diagnosis. Families are encouraged to ask for an autopsy as a contribution to learning more about the genetics of AD. Are there treatments available for Alzheimer's Disease? Presently, there is no definite cure or treatment for Alzheimer's Disease. Unfortunately, there are many unscrupulous individuals who market so-called "cures." These treatments are often expensive and they don't cure AD. However, since senility is such a scary problem and because families are desperate to find help for loved ones, these bogus treatments continue to sell. Most of them have no scientific proof of effectiveness. How is Alzheimer's Disease diagnosed? There is no single clinical test for Alzheimer's Disease. It is diagnosed by ruling out all other curable or incurable causes of memory loss. A positive diagnosis of Alzheimer's Disease can only be made by microscopically studying a small piece of brain tissue after death. The cerebral cortex of an Alzheimer brain will have characteristic abnormalities -- cells marred by plaques and tangles. However, a working diagnosis can be made through various testing procedures that include a thorough physical as well as neurological and psychological examinations. How long do people with Alzheimer's Disease live? People diagnosed with Alzheimer's Disease may live from two to 20 years after the onset of memory loss symptoms. It shortens one's expected life span, but given appropriate care and medical attention, patients often survive for many years at home or in a nursing home. Death can't usually be predicted until the very terminal stages. It is common for patients in terminal-stage Alzheimer's to lose weight, and to have difficulty swallowing, controlling bladder and bowels, walking and speaking. They may curl into a fetal position. Alzheimer victims often succumb to a series of repeated infections such as bladder infections or pneumonia. What is the scope of Alzheimer's Disease? Alzheimer's afflicts approximately 4 million Americans and it's estimated that one in three of us will face this disease in an older relative. More than 100,000 die annually, making Alzheimer's Disease the fourth leading cause of death among adults. Half of all current nursing home patients are affected, making AD a costly public health and long term care problem. An estimated $80 billion is spent annually on the care of AD, including costs diagnosis, treatment, nursing home care, at-home care and lost wages. Alzheimer's also affects the patient's caregivers, who become the second victims. Persons with AD often require 24-hour care and supervision, most of which is provided in the home by family and friends. In addition to the tremendous stress of providing care, families also bear most of the financial burdens of the disease as well. Aren't memory problems normal in old people? Benign, or normal, forgetfulness is part of the normal aging process and usually begins in early middle age. Most people have some experience forgetting names, appointments or where they left their keys. However, normal forgetfulness differs from Alzheimer's Disease in some very important ways. The Alzheimer patient will frequently become lost in familiar surroundings; forget names of familiar people; have problems handing money; forget how to dress, read or write; and lose the ability to use the tools of daily living such as a key or radio. ! * AMYOTROPHIC LATERAL SCLEROSIS The literal meaning of Amyotrophic Lateral Sclerosis is: A - Lack of, MYO - muscle, TROPHIC - nourishment, and SCLEROSIS - hardening of areas in the LATERAL - side (as well as the forward) portions of the spinal cord. Amyotrophic Lateral Sclerosis is commonly reffered to as A.L.S. or Lou Gehrig's Disease (after the famous baseball player who had this illness). Considering the fact that ALS has been known to physicians since the late 1860's, and that during any year approximately 2 of every 125,000 people will develop ALS, the general public has little or no knowlege of the disease. Therefore, the purpose of this article is to help familiarize the public with this disease. ALS typically strikes people between 40 and 70 years old, but can strike people as young as 20 and as old as 80. Men seem to be affected about one and a half times more often than women. Any race or nationality can be affected. The average course of ALS is three to four years. However, recent reports have indicated that 50 percent of ALS patients were living at three years after diagnosis and 10 percent of these were living after 10 years, and 1 percent of these actually improved and appear to no longer have the disease. ALS is a progressive, degenerative muscle disease. In that the weakening of the affected muscles never ceases. ALS is a disease that affects the motor neurons (nerve cells that control muscles) in the brain and spinal cord. Eventually these motor neurons are unable to transmit the signals which the muscles need to work. The easiest way to understand how this works is to think of the motor neurons in ALS as something like worn-out electrical power lines. In a normal motor neuron, electrical signals flow easily to the muscle and the muscle responds by contracting. In an ALS affected motor neuron, the electrical signal has trouble getting through, or may not get to the muscle at all, resulting in the muscle not contracting. An unused muscle will eventually atrophy (shrink and waste-away). The early symptoms of ALS vary, but typically appear as a general feeling of fatigue. As the muscles lose their energy source the patient may experience muscle twitching or muscle cramping. Usually at this point the patient does not even realize there is anything wrong, and therefore, ALS can be present for some time before more extreme symptoms appear. THIS DOES NOT MEAN that everyone who experiences muscle cramping, twitching, and fatigue has ALS. The aforementioned symptoms also could occur in someone who, unused to a vigourous workout, vigourously worked out. More advanced symptoms may appear in any external muscle of the body except those supplying the eyes. Advanced symptoms often begin in the hands and feet and then extend closer to the trunk. Symptoms in the hand may include having difficulty holding unto objects,using all fingers to type, play piano, etc. Symptoms in the feet, may include, foot drop(foot can't be held at a 90 degree angle to the leg). As the disease progresses to the legs the patient usually experiences difficulty with walking, falling down, and rising from a sitting position. I would like to say at this time, that the human body has some amazing resources it applys in the early stages of ALS. While the ALS victim may have moderatley severe weakness in certain muscles, muscles that have not yet been affected will compensate for the affected muscles, i.e. if shoulder muscles are not yet affected they will compensate for weak arm muscles. Therefore, the ALS patient will be able to continue to do ordinary things for a longer period of time. Eventually, as the disease progresses all muscles will be affected except the bladder muscle, the sphincter muscle, and the eye muscles. Typically, the progression starts with hands, and feet, moves to legs, arms and trunk, then to the speech and swallowing process, and finally to the lungs, which results in death. The cause of ALS is unknown at present, therefore, there is no cure. Research is being done and there are various theories, but to date, there is nothing concrete. For more information on ALS you can contact the Muscular Dystrophy Association, 810 Seventh Avenue, New York, NY 10019, or The ALS Association, 15300 Ventura Blvd., Suite 315, Sherman Oaks, CA 91403 ! * ANEURYSM FAQ'S Frequently asked questions/answers prepared by: M. David Tilson, MD Professor of Surgery Columbia University in the City of New York I-way address: mdt1@columbia.edu Compuserve: 73443,244 1. What is an aneurysm? An aneurysm is a dilation of a blood vessel (similar to a balloon) that poses a risk to health from the potential for rupture, clotting, or dissecting. Rupture of an aneurysm in the brain causes stroke, and rupture of an aneurysm in the abdomen causes shock. The abdominal aortic aneurysm (AAA) is the most common, and the rest of this discussion will focus on the AAA. 2. What causes aneurysms? Several new theories have developed over the last 15 years. It appears that the disease probably requires a basic genetic susceptibility that may be traceable to a single major locus, in other words, a single dominant gene. The disease unequivocally runs in families. In addition, there are probably other contributing causes, like smoking and high blood pressure. 3. Who is at greatest risk? White men over age 55 are at the greatest risk. In fact, aneurysms are among the top ten causes of death among this group. By about age 80, over 5% of white males will have developed an aneurysm. AAA's occur less frequently in white women, and they are relatively uncommon in African Americans of both sexes. 4. Why are aneurysms so dangerous? AAA's cause many deaths because they are usually silent until a medical emergency occurs. One author has referred to an AAA as a "U-boat" in the belly, because they are silent, deep, and deadly. 5. How can I find out if I have one? If you are thin and have a moderately large-sized AAA, you or your doctor may be able to feel it below your rib cage. Many are incidentally discovered as a result of medical imaging for other conditions, by ultrasound exams, CAT scans, MRI's, or even plain films of the abdomen. If you are over 55 and other members of your family have had one or more AAA's, you should advise your doctor and have an ultrasound. It is safe, fast and painless. 6. I have an aneurysm. What is the risk of death from rupture? If rupture occurs, few survive. Among celebrities, Roy Rogers survived a rupture, but he was the exception and not the rule. The best predictor of risk of rupture is the size of the aneurysm. The diameter of a normal aorta is about 2 centimeters (cm)(a little less than an inch). Once a AAA has reached 5-6 centimeters (cm) in diameter, about the size of an orange, the risk of rupture is very substantial, probably about 50/50 over the next few years. I think all vascular surgeons would agree that a 5-6 cm aneurysm should be repaired, unless the patient is a prohibitive risk. There is less unanimity of opinion about smaller AAA's, since the risk of rupture is much lower. A few surgeons are now recommending repair of aneurysms over 3 cm, but most would advise watchful waiting for AAA's that small. There is presently a controlled, randomized, multi-center trial being carried out in the Veterans Administration Hospitals to try to answer the question as to when the surgical risk for the patient becomes less than the risk from rupture, depending on the size of the AAA. 7. What is "watchful waiting?" Most vascular surgeons feel comfortable following patients with small AAA's every six months with an ultrasound examination. The average rate of growth of an aneurysm is less than one-half of a centimeter per year, and some grow much slower, remaining relatively stable for fairly long periods of time. Others may enlarge rapidly, and a "growth spurt" is a serious warning sign. 8. Is there anything one can do while "waiting"? Giving up tobacco, making sure of reasonable blood pressure control, and improving physical fitness with a mild exercise program are all prudent. So far, no medication has been proven in a prospective scientific experiment to reduce the growth rate of AAA's in people, although propranolol (a beta-blocker) has been shown to prevent ruptured aneurysms in turkeys and delay aneurysm growth in mice. Retrospective studies at Yale and at the University of Vermont have suggested that propranolol might be beneficial in people, but proof will await a prospective trial. One is being planned now by investigators in Canada and at the University of Vermont. 9. What are the risks of surgical repair? The risk of death from surgery is related to hospital expertise and experience, the skill of the surgeon, and the basic underlying health of the patient. Mortality rates are frequently reported to be as low as 0 to 2% in academic medical centers with vascular specialists and superior intensive care. Rates may be higher in small community hospitals without dedicated vascular specialists. Patients without any history or signs of heart disease generally do very well, because heart attack postoperatively is the leading cause of surgical mortality. Patients with known coronary artery disease should have a thorough cardiological evaluation prior to surgery. 10. How long does it take to recover, and then will I have a normal life? The average hospital stay is 7-10 days, and most patients take about 6 weeks off before returning to work. By that time, they have usually regained their sense of well being, although some bounce back much faster. The vast majority of patients are back on a normal survival curve for life expectancy, consistent with their cohort of persons of similar age and with similar underlying health (e.g., heart condition, renal function, etc.) 11. I've heard of "minimally invasive surgery". Does this work for AAA? Not yet, but progress is being made. An "endovascular" repair (e.g., using tubes, stents, and wires threaded up into the aneurysm from leg arteries) was developed by a surgeon in Argentina and is presently coming into use in the United States. It is presently considered experimental and offered only in selected centers to patients who present a prohibitive risk for a standard surgical approach. 12. Where can I get more information on this subject? I have posted additional files on Compuserve and on the Internet (URL "http://www.cc.columbia.edu/~mdt1/"). Comprehensive home medical books, like the one published by the staff at the Mayo Clinic, are in most large bookstores and may be helpful. If you want to take a plunge into the underlying scientific literature, a gate to Medline like Paperchase on Compuserve will allow you to search thousands of scientific and medical communications (with abstracts available for downloading). Last month (Aug 94) I participated in the organizational meeting of the American Aneurysm Foundation, which has received a tax-exempt charitable charter to raise public awareness of the aneurysm problem and to support the development of new knowledge related to aneurysm prevention and treatment. We will be developing a library of information for both conventional and also electronic distribution. If you would like to be on our mailing list as we get started, please E-mail to mdt1@columbia.edu, or use my Compuserve address (73443,244). ! * Facts About Angina? What is angina? ANGINA PECTORIS ("ANGINA") IS A recurring pain or discomfort in the chest that happens when some part of the heart does not receive enough blood. It is common symptom of coronary heart disease (CHD), which occurs when vessels that carry blood to the heart become narrowed and blocked due to atherosclerosis. Angina feels like a pressing or squeezing pain, usually in the chest under the breast bone, but sometimes in the shoulders, arms, neck, jaws, or back. Angina is usually precipitated by exertion. It is usually relieved within a few minutes by resting or by taking prescribed angina medicine. What brings on angina? Episodes of angina occur when the heart's need for oxygen increases beyond the oxygen available from the blood nourishing the heart. Physical exertion is the most common trigger for angina. Other triggers can be emotional stress, extreme cold or heat, heavy meals, alcohol, and cigarette smoking. Does angina mean a heart attack is about to happen? An episode of angina is not a heart attack. Angina pain means that some of the heart muscle in not getting enough blood temporarily-for example, during exercise, when the heart has to work harder. The pain dose NOT mean that the heart muscle is suffering irreversible, permanent damage. Episodes of angina seldom cause permanent damage to heart muscle. In contrast, a heart attack occurs when the blood flow to a part of the heart is suddenly and permanently cut off. This causes permanent damage to the heart muscle. Typically, the chest pain is more severe lasts longer, and does not go away with rest or with medicine that was previously effective. It may be accompanied by indigestion, nausea, weakness, and sweating. However, the symptoms of a heart attack are varied and may be considerably milder. When someone has a repeating but stable pattern of angina, an episode of angina does not mean that a heart attack is about to happen. Angina means that there is underlying coronary heart disease. Patients with angina are at an increased risk of heart attack compared with those who have no symptoms of cardiovascular disease, but the episode of angina is not a signal that a heart attack is about to happen. In contrast, when the pattern of angina changes--if episodes become more frequent, last longer, or occur without exercise--the risk of heart attack in subsequent days or weeks is much higher. A person who has angina should learn the pattern of his or her angina--what cause an angina attack, what it feels like, how long episodes usually last, and whether medication relieves the attack. If the pattern changes sharply of if the symptoms are those of a heart attack, one should get medical help immediately, perhaps best done by seeking an evaluation at a nearby hospital emergency room. Is all chest pain "angina"? No, not at all. Not all chest pain is from the heart, and not all pain from the heart is angina. For example, if the pain lasts for less that 30 seconds or if it goes away during a deep breath, after drinking a glass water, or by changing position, it almost certainly in NOT angina and should not cause concern. But prolonged pain, unrelieved by rest and accompanied by other symptoms may signal a heart attack. How is angina diagnosed? Usually the doctor can diagnose angina by noting the symptoms and how they arise. However one or more diagnostic tests may be needed to exclude angina or to establish the severity of the underlying coronary disease. These include the electrocardiogram (ECG) at rest, the stress test, and x- rays of the coronary arteries (coronary "arteriogram" or "angiogram"). The ECG records electrical impulses of the heart. These may indicate that the heart muscle is not getting as much oxygen as it needs ("ischemia"); they may also indicate abnormalities in heart rhythm or some of the other possible abnormal features of the heart. To record the ECG, a technician positions a number of small contacts on the patient's arms, legs, and across the chest to connect them to an ECG machine. For many patients with angina, the ECG at rest is normal. This is not surprising because the symptoms of angina occur during stress. Therefore, the functioning of the heart may be tested under stress, typically exercise. In the simplest stress test, the ECG is taken before, during, and after exercise to look for stress related abnormalities. Blood pressure is also measured during the stress test and symptoms are noted. A more complex stress test involves picturing the blood flow pattern in the heart muscle during peak exercise and after rest. A tiny amount of a radioisotope, usually thallium, is injected into a vein at peak exercise and is taken up by normal heart muscle. A radioactivity detector and computer record the pattern of radioactivity distribution to various parts of the heart muscle. Regional differences in radioisotope concentration and in the rates at which the radioisotopes disappear are measures of unequal blood flow due to coronary artery narrowing, or due to failure of uptake in scarred heart muscle. The most accurate way to assess the presence and severity of coronary angiogram, an x-ray of the coronary artery. A long thin flexible tube (a "catheter") is threaded into an artery in the groin or forearm and advanced through the arterial system into one of the two major coronary arteries. A fluid that blocks x-rays (a "contrast medium" or "dye") is injected. X-rays of its distribution show the coronary arteries and their narrowing. How is angina treated? The underlying coronary artery disease that causes angina should be attacked by controlling existing "risk factors." These include high blood pressure, cigarette smoking, high blood cholesterol levels, and excess weight. If the doctor has prescribed a drug to lower blood pressure, it should be taken as directed. Advice is available on how to eat to control weight, blood cholesterol levels, and blood pressure. A physician can also help patients to stop smoking. Taking these steps reduces the likelihood that coronary artery disease will lead to a heart attack. Most people with angina learn to adjust their lives to minimize episodes of angina, by taking sensible precautions and using medications if necessary. Usually the first line of defense involves changing one's living habits to avoid bringing on attacks of angina. Controlling physical activity, adopting good eating habits, moderating alcohol consumption, and not smoking are some of the precautions that can help patients live more comfortably and with less angina. For example, if angina comes on with strenuous exercise, exercise a little less strenuously, but do exercise. If angina occurs after heavy meals, avoid large meals and rich foods that leave one feeling stuffed. Controlling weight, reducing the amount of fat in the diet, and avoiding emotional upsets may also help. Angina is often controlled by drugs. The most commonly prescribed drug for angina is nitroglycerin, which relieves pain by widening blood vessels. This allows more blood to flow to the heart muscle and also decreases the work load of the heart. Nitroglycerin is taken when discomfort occurs or is expected. Doctors frequently prescribe other drugs, to be taken regularly, that reduce the heart's workload. Beta blockers slow the heart rate and lessen the force of the heart muscle contraction. Calcium channel blockers are also effective in reducing the frequency and severity of angina attacks. What if medication fail to control angina? Doctors may recommend surgery or angioplasty if drugs fail to ease angina or if the risk of heart attack is high. Coronary artery bypass surgery is an operation in which a blood vessel is grafted onto the blocked artery to bypass the blocked or diseased section so that blood can get to the heart muscle. An artery from inside the chest (an "internal mammary" graft) or long vein from the leg (a "saphenous vein" graft) may be used. Balloon angioplasty involves inserting a catheter with a tiny balloon at the end into a forearm or groin artery. The balloon is inflated briefly to open the vessel in places where the artery is narrowed. Other catheter techniques are also being developed for opening narrowed coronary arteries, including laser and mechanical devices applied by means of catheters. Can a person with angina exercise? Yes. It is important to work with the doctor to develop an exercise plan. Exercise may increase the level of pain-free activity, relieve stress, improve the heart's blood supply, and help control weight. A person with angina should start an exercise program only with the doctor's advice. Many doctors tell angina patients to gradually build up their fitness level-for example, start with a 5 minute walk and increase over a weeks or months to 30 minutes or 1 hour. the idea is to gradually increase stamina by working at a steady pace, but avoiding sudden burst of effort. What is the difference between "stable" and "unstable" angina? It is important to distinguish between the typical stable pattern of angina and "unstable" angina. Angina pectoris often recurs in a regular or characteristic pattern. Commonly a person recognizes that he or she is having angina only after several episodes have occurred, and a pattern has evolved. the level of activity of stress that provokes the angina is somewhat predictable, and the pattern changes only slowly. This is "stable" angina, the most common variety. Instead of appearing gradually, angina may first appear as a very severe episode or as frequently recurring bouts of angina. Or, an established stable pattern of angina may change sharply; it may by provoked by far less exercise that in the past, or it may appear at rest. Angina in these forms is referred to as "unstable angina" and needs prompt medical attention. The term "unstable angina" is also used when symptoms suggest a heart attack but hospital tests so not support that diagnosis. For example, a patient may have typical but prolonged chest pain and poor response to rest and medication, but there is no evidence of heart muscle damage either on the electrocardiogram or in blood enzyme tests. Are there other types of angina? There are two other forms of angina pectoris. One, long recognized but quite rare, is called Prinzmetal's or variant angina. This type is caused by vasospasm, a spasm that narrows the coronary artery and lessens the flow of blood to the heart. the other is a recently discovered type of angina called microvascular angina. Patients with this condition experience chest pain but have no apparent coronary artery blockages. Doctors have found that the pain results from poor function of tiny blood vessels nourishing the heart as well as the arms and legs. Microvascular angina can be treated with some of the same medications used for angina pectoris. ! * Ankle Sprains Created 1989 THIS IS A HEALTH-LINE MESSAGE FROM THE UNIVERSITY OF WISCONSIN-MADISON. Ankle sprains are common injuries that usually result from a turning-in of the foot. A sprain involves a partial or complete tear of a ligament, the tough tissue that holds together the bones that form joints. When a ligament is partially torn, the intact portion holds the joint together. A complete tear of the ligament may result in abnormal motion of the joint, causing an unstable feeling. When your weight comes down on your turned-in foot you might hear a pop or snap, and feel pain on the outer side of the ankle. Within hours, a moderate amount of swelling is seen. Bleeding from the torn ligaments may cause a purplish discoloration of the skin within 24 hours. Most ankle sprains are of minor severity. They involve moderate pain and swelling on the outside of the ankle without pain on the inner side. If you think you have sprained your ankle, stop the activity you are participating in and protect the weakened ligament from further injury. A plastic bag of ice wrapped in an elastic bandage should then be applied for a period of twenty minutes, four to five times daily, for seventy-two hours. The ice constricts the bleeding vessels in the torn ligaments, preventing swelling. In addition, it relieves pain. Elevation of the affected ankle above the level of the heart and application of an elastic bandage, such as an ace wrap, around the ankle also helps prevent swelling. After 72 hours, a heating pad set at 101-102 degrees Fahrenheit applied over a moist towel for 20 minute periods, 3 times a day, will aid in improving the blood supply to healing ligaments. Crutches with partial weight bearing on the ankle should be used for 4-5 days to protect the damaged ligament and for comfort. Pain on both the inside and outside of the ankle, pain above the ankle, a feeling of instability, gross deformity, or severe swelling are all indications of a more severe injury involving rupture of the ligaments or fracture. These injuries should initially be protected with use of crutches, and treated with ice, elevation, and an ace wrap. Such injuries should also be evaluated by a physician. A completely torn ligament needs to be protected in a cast for 4-6 weeks in order to prevent the ligament from healing in an elongated position. A neglected sprained ankle can cause persistent ankle and leg pain, and can encourage successive sprains. Walking on a sprained ankle does not prove you are brave. If you are uncertain whether you have a sprain or a fracture, be sure to consult a physician. Thank you. ! * Anorexia Nervosa And Bulimia Nervosa THIS IS A HEALTH-LINE MESSAGE FROM THE UNIVERSITY OF WISCONSIN-MADISON. Anorexia nervosa and bulimia nervosa are complex psychophysiologic disorders. Individuals with anorexia have an intense fear of obesity, a disturbed body image, and pursue thinness regardless of their emaciated state. A companion disorder, bulimia nervosa, consists of uncontrollable binge eating, usually followed by self-induced purging such as vomiting or use of laxatives. Bulimia is called the binge/purge syndrome, and occurs across all weight ranges. Both anorexia and bulimia occur at a much higher frequency in females than in males, and a significant increase in their incidence has occurred during the past decade. The cause of eating disorders is still not clear, but we do know there is no single physical or psychological cause. Considerable attention is now being focused on the possible connection between bulimia and depression. It is essential to approach the understanding of eating disorders from a combined biological, psychological, and social perspective. Individuals with eating disorders have learned to use their behaviors to cope, although unsuccessfully, with life's struggles. Problems in self-esteem, self-identity, and assertiveness are all related to eating disorders and are treated with psychotherapy. Close to half of those suffering from eating disorders will have poor psychological and social adjustment to adult life as well as prolonged abnormal eating patterns. Eating disorders can be severe and potentially life threatening. Although they are psychiatric disorders, a wide variety of physical complications may occur as a result of self-induced starvation, vomiting and other behaviors intended to achieve weight loss. The physical complications seen in individuals who have eating disorders are a result of the starvation process itself; the binging behavior; and the attempts by the individual to control weight artificially through self-induced vomiting, and the use of laxatives, diuretics, or diet pills. Almost every organ system in the body can be affected. One of the most frequent complications is the loss of or increasing irregularity of menstrual periods. The long term mortality rate for anorexia nervosa is higher than in any other psychiatric disorder. Death is usually the result of the direct effects of starvation, chemical disturbances affecting the heart, or suicide. Frequent vomiting may cause damage to the esophagus, stomach, teeth and gums, as well as lead to other imbalances of vital body fluids and electrolytes, imbalances which could lead to death. Abuse of laxatives or water pills can also cause these fluid and electrolyte imbalances, and can lead to death. Many other complications have been reported making careful medical management of these conditions essential. The overall treatment of eating disorders requires both medical and psychological support. Less severe cases can be followed with some success by individual physicians and psychotherapists. However, in recent years, multidisciplinary teams have developed to better manage those who are more severely affected. Most individuals with eating disorders can be treated as outpatients. A few individuals who have lost control over their eating or purging habits and are unstable physically or psychologically, may require hospitalization. Many medical centers now offer specialized care in this area. Treatment should include symptom management, medical consultation, nutritional education, and individual and/or family psychotherapy. Cognitive behavioral group psychotherapy has also been helpful, particularly for bulimia. Support groups such as those facilitated by the organization ANAD, which stands for Anorexia Nervosa and Associated Disorders, may be beneficial for both victims and their families. Support groups, however, should not substitute for individualized treatment programming. Thank you. ID: 036-1560. ! * Appendicitis The appendix is the remnant of a primitive extension of the digestive system, and occurs as a small, worm-like pouch arising from the first part of the colon, just after it begins to attach to the small intestine. It has no important function in human digestion. When the opening of the appendix becomes obstructed with a particle of undigestible food, a small calcium-containing stone, or other matter, the chemicals and bacteria within it begin to interact, and swelling and pressure build up. The pressure eventually compresses the draining veins, and the process accelerates. The stretched walls are then invaded by the bacteria, pus is produced from the white cells rushed to the areaby the body, and ultimately the appendix may burst. If this happens, contamination of the usually sterile abdominal cavity and its surrounding sac, the peritoneum, occur. This so-called "acute abdomen" may rapidly be fatal, as blood poisoning nd shock develop. Most victims are between the ages of 5 and 35. Males and females are both affected. No definite causative factors are known; although grape seeds, popcorn and other similar particles are sometimes found to in the appendiceal opening, there is no good evidence linking these statistically with the disease. Symptoms Classically, but by no means consistently, there is a relatively abrupt onset of pain in the upper abdomen or navel area, which later radiates to the right lower abdomen. Nausea or vomiting often will follow. Low grade fever is noted in many patients, rising markedly if perforation occurs. As the disease and symptoms progress in frequency, perforation becomes a concern, and urgency of treatment is obvious. The physician may also look for elevated white blood cell counts, abdominal tenderness, rigidity, and characteristic sounds (or lack of sounds) in the abdomen. In the classical case, the diagnosis is rarely missed. Unfortunately, many cases are not typical. The pain may not occur in the right lower abdomen, or may occur there as well as other areas such as the upper abdomen or back. Differential considerations may include diseases of the colon, gall bladder, ovary, pancreas, small intestine, kidney, or other organs. It is generally recognized that even the most wise, conscientious, and concerned physician will occasionally miss or misdiagnose appendicitis. In fact, most surgeons would agree that the occasional removal of a normal appendix in sincere efforts to remove the diseased ones at an appropriate time is an unfortunate but acceptable price to pay for careful medical practice. The price of NOT removing a truly infected appendix is far greater. Treatment Appendectomy--the removal of the appendix-- is the treatment of choice unless there is some strong medical reason to the contrary. It is interesting that in other countries, treatment is often more conservative, with antibiotics, intravenous fluids, and other measures. This leaves the potential for recurrences, and is only recommended for rare exceptions in current American practice. If perforation has not yet occurred, some 15% of patients may develop some postoperative complication, but these are generally easily managed. On the other hand, if perforation has occurred, up to 50 or 60% of patients have complications. Mortality of appropriately treated appendicitis today is extremely low, and usually occurs in elderly or debilitated patients. The main goal of the patient is to seek care early. It is important to realize that many doctors will take an observational approach early in the disease; this is wise under some circumstance to avoid unnecessary surgery, since many apparent cases will turn out to be some other self-limited disease such as infection, ovarian pain, etc. Careful judgment is called for, and intimate communication between doctor and patient (sometimes entailing hospitalization) is crucial. Preventive appendectomy is not generally necessary (General Eisenhower is said to have done this before going to the front), unless an unrelated surgery is necessary and the appendix is removed incidental to this. No long-term complications of uncomplicated appendectomy are recognized. ! * ARRHYTHMIA/RHYTHM DISORDERS What is arrhythmia? An arrhythmia is a change in the regular beat of the heart. The heart may seem to skip a beat or beat irregularly or very fast or very slowly. Does having an arrhythmia mean that a person has heart disease? Many times, there is no recognizable cause of an arrhythmia. Heart disease may cause arrhythmias. Other causes include: stress, caffeine, tobacco, diet pills, and cough and cold medicines. Are arrhythmias serious? The vast majority of people with arrhythmias have nothing to fear. They do not need extensive exams or special treatments for their condition. In some people, arrhythmia are associated with heart disease. In these cases, heart disease, not the arrhythmia, poses the greatest risk to the patient. In a very small number of people with serious symptoms, arrhythmia themselves are dangerous. These arrhythmias require medical treatment to keep the heartbeat regular. For example, a few people have a very slow heartbeat (bradycardia), Causing them to feel lightheaded or faint. If left untreated, the heart may stop beating and these people could die. How common are arrhythmias? Arrhythmias occur commonly in middle-age adults. As people get older, they are more likely to experience an arrhythmia. What are the symptoms of an arrhythmia? Most people have felt their heart beat very fast, experienced a fluttering in their chest, or notice that their heart skipped a beat. Almost everyone has also felt dizzy, faint, or out of breath or had chest pains at one time of another. One of the most common arrhythmia is sinus arrhythmia, the change in heart rate that can occur normally when we take a breath. These experiences may cause anxiety, but for the majority of people, they are completely harmless. You should not panic if you experience a few flutters or your heart races occasionally. But if you have questions about your heart rhythm or symptoms, check with your doctor. Arrhythmia Types Originating in the Atria Sinus arrhythmia. Cyclic changes in the heart rate during breathing. Common in children and often found in adults. Sinus tachycardia. The sinus node sends out electrical signal faster than usual, speeding up the heart rate. Sick sinus syndrome. The sinus node does not fire its signals properly, so that the heart rate slows down. Sometimes the rate changes back and forth between a slow (bradycardia) and fast (tachycardia) rate. Premature supraventricular contractions or premature atrial contraction (PAC). A beat occurs early in the atria, causing the heart to beat before the next regular heartbeat. Supraventricular tachycardia (SVT), paroxysmal atrial tachycardia (PAT). A series of early beats in the atria speed up the heart rate ( the number of times a heart beats per minutes). In paroxysmal tachycardia, repeated periods of very fast heartbeats begin and end suddenly. Atrial flutter. Rapidly fired signals cause the muscles in the atria to contract quickly, leading to a very fast, steady heartbeat. Atrial fibrillation. Electrical signals in the atria are fired in a very fast and uncontrolled manner. Electrical signals arrive in the ventricles in a completely irregular fashion, so the heart beat is completely irregular. Wolff-Parkinson-White syndrome. Abnormal pathways between the atria and ventricles cause the electrical signal to arrive at the ventricles too soon and to be transmitted back into the atria. Very fast heart rates may develop as the electrical signal ricochets between the atria and ventricles. Originating in the Ventricles Premature ventricular complexes (PVC). An electrical signal from the ventricles causes an early heart beat that generally goes unnoticed. The heart then seems to pause until the next beat of the ventricle occurs in a regular fashion. Ventricular tachycardia. The heart beats fast due to electrical signals arising from the ventricles (rather than from the atria) Ventricular fibrillation. Electrical signals in the ventricles are fired in a very fast and uncontrolled manner, causing the heart to quiver rather than beat and pump blood. What happens in the heart during an arrhythmia? Describing how the heart beats normally helps to explain what happens during an arrhythmia. The heart is a muscular pump divided into four chamber--two atria located on the top and two ventricles located on the bottom. Normally each heartbeat starts in the right atrium. Here, a specialized group of cells called the sinus node, or natural pacemaker, sends an electrical signal. The signal spreads throughout the atria to the area between the atria called the atrioventricular (AV) node. The AV node connects to a group of special pathways that conduct the signal to the ventricles below. As the signal travels through the heart, the heart contracts. First the atria contract, pumping blood into the ventricles. A fraction of a second later, the ventricles contract, the ventricles contract, sending blood throughout the body. Usually the whole heart contracts between 60 and 100 times per minute. Each contraction equals one heartbeat. An arrhythmia may occur for one of several reasons: ■Instead of beginning in the sinus node, the heartbeat begins in another part of the heart. ■The sinus node develops an abnormal rate or rhythm. ■A patient has a heart block. What is a heart block? Heart block is condition in which the electrical signal cannot travel normally down the special pathways to the ventricles. For examples, the signal from the atria to the ventricle may be (1) delayed, but each one conducted; (2) delayed with only some getting through; or (3) completely interrupted. If there is no conduction, the beat generally originates from the ventricles and is very slow. What are the different types of arrhythmias? There are different types of arrhythmia's. Arrhythmias are identified by where they occur in the heart (atria or ventricles) and by what happens to the heart's rhythm when they occur. Arrhythmia arising in the atria are called atria or supraventricular (above the ventricles) arrhythmias. Ventricular arrhythmias begin in the ventricles. In general, ventricular arrhythmias caused by heart disease are the most serious. How does the doctor know that I have arrhythmia? Sometimes an arrhythmia can be detected by listening to the heart with a stethoscope. However, the electrocardiogram is the most precise method for diagnosing the arrhythmia. An arrhythmia may not occur at the time of the exam even though symptoms are present at other times. In such cases, tests will be done if necessary to find out whether an arrhythmia is causing the symptoms. What tests can be done? First the doctor will take a medical history and do a thorough physical exam. Then one or more tests may be used to check for an arrhythmia and to decide whether it is caused by heart disease. Tests for Detecting Arrhythmias ■Electrocardiogram (EGG or EKG). A record of the electrical activity of the heart. Disks are placed on the chest and connected by wires to a recording machine. The heart's electrical signals cause a pen to draw lines across a strip of graph paper in the ECG machine. The doctor studies the shapes of these lines to check for any changes in the normal rhythm. The types of ECGs are: --- Resting ECG. The patient lies down for a few minutes while a record is made. In this type of ECG, disks are attached to the patient's arms and legs as well as to the chest. --- Exercise ECG (stress test). The patient exercises either on a treadmill machine or bicycle while connected to the ECG machine. This test tells whether exercise causes arrhythmias or makes them worse or whether there is evidence of inadequate blood flow to the heart muscle ("ischemia"). --- 24-hour ECG (Holter) monitoring. the patient goes about his or her usual daily activities while wearing a small, portable tape recorder that connects to the disks on the patient's chest. Over time, this test shows changes in rhythm (or "ischemia") that may not be detected during a resting or exercise ECG. --- Transtelephonic monitoring. The patient wears the tape recorder and disks over a period of several days to several weeks. When the patient feels an arrhythmia, he or telephones a monitoring station where the record is made. If access to a telephone is not possible, the patient has the option of activating the monitor's memory function. Later, when a telephone is accessible, the patient can transmit the recorded information from the memory to the monitoring station. Transtelephonic monitoring can reveal arrhythmia that occur only once every few days or weeks. ■Electrophysiologic study (EPS). A test for arrhythmias that involves catheterization. Very thin, flexible tubes (catheters) are placed in a vein of an arm or leg and advanced to the right atrium and ventricle. This procedure allows doctors to find the site and type of arrhythmia and how it responds to treatment. How are arrhythmias treated? Many arrhythmias require no treatment whatsoever. Serious arrhythmias are treated in several ways depending on what is causing the arrhythmia. Sometimes the heart disease is treated using one or more of the following treatments. ■Drugs There are several kinds of drugs used to treat arrhythmias. One or more drugs may be used. Drugs are carefully chosen because they can cause side effects. In some cases, they cause arrhythmias or make arrhythmias worse. For this reason, the benefits of the drug are carefully weighed against any risks associated with taking it. It is important not to change the dose or type of your medication unless you check with your doctor first. If you are taking drugs for an arrhythmia, one of the following , one of the following tests will probably be used to see whether treatment is working: a 24-hour electrocardiogram (ECG) while you are on drug therapy, an exercise ECG, or a special technique to see how easily the arrhythmia drugs may also be checked. ■Cardioversion To quickly restore a heart to its normal rhythm, the doctor may apply an electrical shock to the chest wall. Called cardioversion, this treatment is most used in emergency situations. After cardioversion, drugs are usually prescribed to prevent the arrhythmia from recurring. ■Automatic implantable defibrillators These devices are used to correct serious ventricular arrhythmia that can lead to sudden death. The defibrillator is surgically placed inside the patient's chest. There, it monitors the heart's rhythm and quickly identifies serious arrhythmia. With an electrical shock, it immediately disrupts a deadly arrhythmia. ■Artificial pacemaker An artificial pacemaker can take charge of sending electrical signals to make the heart beat if the heart's natural pacemaker is not working properly or its electrical pathway is blocked. During a simple operation, this electrical device is placed under the skin. A lead extends from the device to the right side of the heart, where it is permanently anchored. ■Surgery When an arrhythmia cannot be controlled by other treatment, doctors may perform surgery. After locating the heart tissue that is causing the arrhythmia, the tissue is altered or removed so that it will not produce the arrhythmia. How can arrhythmias be prevented? If heart disease ids not causing the arrhythmia, the doctor may suggest that you avoid what is causing it. For example, if caffeine or alcohol is the cause, the doctor may ask you not to drink coffee, tea, colas, or alcoholic beverages. Is research on arrhythmias being done? The National Heart, Lung , and Blood Institute (NHLBI) supports basic research on normal and abnormal electrical activity in the heart to understand hoe arrhythmias develop. Clinical studies with patients aim to improve the diagnosis and management of different arrhythmias. These studies will someday lead to better diagnostic and treatment strategies. Where can I find publication about heart disease? To obtain publications about heart disease, you may want to contact your: ■local American Heart Association chapter ■local or state health department The National Heart, Lung, and Blood Institute also has publications about heart disease. For more information, contact: ■NHLBI Communications and Public Information Branch, Building 31, Room 4A21, Bethesda, Maryland 20892. NIH Publication No. 91-2264 April 1991 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Heart, Lung, and Blood Institute ! * ARTHRITIS IN CHILDHOOD AND ADOLESCENCE THOMAS J. A. LEHMAN MD CHIEF, DIVISION OF PEDIATRIC RHEUMATOLOGY THE HOSPITAL FOR SPECIAL SURGERY, AND ASSOCIATE PROFESSOR OF PEDIATRICS CORNELL UNIVERSITY MEDICAL CENTER 212-606-1151 Arthritis in childhood? IsnÆt that only an old personÆs disease? For both children with arthritis and the doctors who care for them public education is one of the greatest challenges. Most lay people and many doctors fail to realize that the problem exists. Many children suffer for months or years before the diagnosis of arthritis is thought of and proper treatment begun. But the problem doesnÆt end there. Children with arthritis frequently experience difficulty because their teachers and schoolmates donÆt believe children can get arthritis and have no idea what to expect from the child with arthritis or about the nature of the illness. As a result, when the child is finally diagnosed with arthritis the family may be told just to put them in a wheel chair because ænothing can be done.Æ This is entirely wrong!! Arthritis affects approximately 1 child in every thousand in a given year. Fortunately most of these cases are mild. However, approximately one child in every ten thousand will have more severe arthritis that doesnÆt just go away. Many children have what is called an acute reactive arthritis following a viral or bacterial infection. This arthritis is often quite severe for a brief period, but usually disappears within a few weeks or months. Juvenile rheumatoid arthritis (JRA) is the most common type of arthritis which persists for months or years at a time. There are three main forms of JRA which are separated by how they begin. Pauciarticular JRA is defined by the involvement of less than four joints at the beginning. This is the form which often begins in young girls as a swollen knee or ankle which appears without injury or explanation. Usually it is æpainlessÆ but someone will have noticed that the knee looks swollen or the child is walking funny. Since arthritis causes morning stiffness parents are slow to get concerned about this because, æShe always looks okay once she gets going.Æ This arthritis is often very mild and treated just with mild nonsteroidal antiinflammatory drugs, but it can cause two important problems. The biggest problem is that many children with pauciarticular JRA develop inflammation of the eye (iridocyclitis). The inflammation is not painful, but if not detected and treated it may lead to scarring of the lens and permanent visual damage (even blindness). At the beginning this inflammation cannot be seen except by an ophthalmologist using a special instrument called a æslit lamp.Æ Because the eye disease is more common in children with a positive test for antinuclear antibodies (ANA) these children are all told they need every three month examinations by an eye specialist. All other children with JRA need eye examinations every six months. No one has been able to completely explain the association of eye disease and arthritis or why it is more frequent in children with ANA. But we do know it happens and its important to make sure every childÆs eyes get checked. The second important problem with pauciarticular JRA is that it may cause the bones in the legs to grow at different rates with the result that one leg is longer than the other. When this happens children are forced to walk with a limp. This damages the knee and the hip leading to premature arthritis from æwearing outÆ the joints by the time the child is an adult and should be prevented. Fortunately we understand how this happens. When the knee or another joint is inflamed by the arthritis its blood supply increases. Then just like a plant that receives more water than the plants around it, it grows faster and larger. We are always trying to stop the inflammation. Most often the therapy is successful and the child does not develop a significant leg length discrepancy. If he or she does we can do two things. First we can put a lift in the shoe on the short side to correct the effect of the different leg lengths. This doesnÆt do anything for the knee, but it prevents excessive wear on the hip and allows the child to walk more normally. The next step is to monitor growth. When the child is getting closer to fully grown an orthopedist can look at X-rays of the legs and try to guess when the bones are going to stop growing. If the leg with arthritis is 3 cm longer than the other leg, they will look at the X-rays and try to guess when there is 3 cm of leg growth left. Then you stop the growth on the leg that is too long and allow the short leg to catch up. This can be done with a very simple operation. Polyarticular JRA is the form in which four or more joints are involved from the beginning. This form is more severe both because of the greater number of joints involved and the fact that it tends to get worse over time. These children may have a great deal of difficulty with normal activities and need to be treated aggressively. From a doctorÆs point of view the most important thing is to bring the disease under control as quickly as possible. This may require use of some fairly strong medications, but itÆs important. One thing to watch out for is using steroids (e.g. prednisone). In severe cases this may be necessary, but it is not a ærealÆ solution. Steroids make patients with arthritis feel wonderful, but its like sweeping dirt under the rug. Everything looks good, but it really isnÆt. Taking too much steroid for a long period causes lots of problems like short stature and weak bones. Whenever we have to put a child on steroids we want to get them off as quickly as possible. Nonsteroidal antiinflammatory drugs are enough for many children with polyarticular JRA, but more severe cases may require ægold shots,Æ or æsecond lineÆ medications like sulphasalazine or methotrexate. Severe cases requiring steroids or æsecond lineÆ medications should be under the care of experienced physicians. The most worrisome form of JRA is systemic onset disease. This form of JRA begins with high fevers and a rash. It is very important in this setting to make sure the patient really has systemic onset JRA and not an infection of some kind. One of the most important findings is that the fever goes away for at least part of every day in someone with systemic onset JRA. Usually the fever is high once or twice each day. At those times the child looks very sick and doesnÆt want to be touched, but when the fever goes down to normal again they look and feel better. This form of arthritis is puzzling to physicians. Sometimes it goes completely away and never comes back again. Other times the fevers and rash go away, but the arthritis progresses over time and can be very severe. This form of JRA can involve the internal organs and rarely is a ælife threateningÆ disease. In addition to their other problems these children have an greater likelihood of bad reactions to medications and must be monitored very carefully. There are several other forms of arthritis which can affect children and adolescents which some doctors lump together with JRA, but have different outcomes and should be considered separately. Interestingly these most often affect older children (greater than eight years of age) and teenagers while typical JRA most often affects young children. One of these is the teenager who has rheumatoid factor positive arthritis with involvement of the small joints in the hands and feet. Rheumatoid factor is a blood test finding which is present in most adults with rheumatoid arthritis, but is absent in most children with JRA. It is present in this group because they usually are teenagers who have adult type rheumatoid arthritis starting early. Because it is starting early this is a very worrisome group and these children need to be treated aggressively. Often they will have lifelong arthritis. A second form of arthritis which is common in this æolderÆ group is spondyloarthropathy. This is a family of diseases in which the arthritis is the same, but the associated problems are very different. The typical findings of a spondyloarthropathy are early involvement of the hips and other large joints. In addition, these forms of arthritis tend to be asymmetric (i.e. one side of the body is more severely affected than the other). The key finding is that these children not only have inflamed joints, but they also have inflammation around their tendons. Often they have ankle or heel pain due to inflammation of the tendons inserting in the foot. In some mild cases the tendon inflammation occurs without obvious swollen joints. It is important to recognize the spondyloarthropathies as different from JRA because the best treatment is different and the outcome is likely to be different. In addition, one must look carefully for evidence of the other diseases that can be associated with spondyloarthropathies. These include inflammatory bowel disease, psoriasis, ReiterÆs syndrome, and BehcetÆs syndrome. The most worrisome children with spondyloarthropathies are the HLA B27 positive boys. They are at risk for developing ankylosing spondylitis. However, most children with spondyloarthropathies seem to do reasonably well. In general for children who are HLA B27 negative and do not have an associated condition the arthritis is more likely than JRA to come and go repeatedly over a period of years, but is less likely to be very severe or destructive. Unfortunately we have only recognized children with spondylo- arthropathies as being ædifferentÆ since the middle 1970Æs so good long term follow-up data is available yet. With proper therapy the children with all of these forms of arthritis will usually get better over time. Indeed the vast majority of children with arthritis grow up to lead normal lives without significant difficulty. Even for severe cases with proper medications, proper physical and occupational therapy, and proper surgery if necessary, virtually no one with arthritis should need a wheel chair. Everyone doctor knows stories of children who looked awful, but did very well or looked like it was ænothing serious,Æ who became very sick, but these are the rare exceptions. We can take good care of children with arthritis. For over 95% of the children with arthritis today we donÆt need new drugs or miraculous inventions, we just need proper application of the resources we already have. There are three important things for every child or adolescent with arthritis. First is proper recognition and diagnosis of the disease. Second is proper treatment by an experienced physician with a multidisciplinary support including physical and occupational therapists and orthopedic surgeons. Third is proper education of the patient and family. People with arthritis are no different from everyone else in the world. They all need to grow up, have jobs, get married and have families. Some will have some difficulty with mechanical problems. Many will have small things they canÆt do if you watch them carefully. Few will go on to be professional athletes or military officers, but even fewer will be ætotally disabledÆ by their disease. IÆve seen far more children who were disabled because they were told they couldnÆt do things than I have who were really disabled by their disease. We should never accept a child with arthritis being told to use a wheel chair. In almost every case we ought to be able to correct the problem and get them walking again. This is why educating the public and physicians is so important. We all need to be aware that children can get arthritis and must be properly diagnosed and treated. But once thatÆs been done we need to make sure they reach their full potential. We all must remember to treat children with arthritis just like everyone else. They need the same discipline, the same allowance, the same grades, and the same respect as all the other children. Arthritis might affect the body, but it must never be allowed to affect the mind. Arthritis in childhood and adolescence - Lehman page 4 ! * Check Your Asthma "I.Q." The following true-or- false statements test what you know about asthma. Be sure to read the correct answers and explanation on the back of this sheet. T F 1. Asthma is a common disease among children and adults in the United States. T F 2. Asthma is an emotion or psychological illness. T F 3. The way that parents raise their children can cause asthma. T F 4. Asthma episodes may cause breathing problems, but these episodes are not really harmful or dangerous. T F 5. Asthma episodes usually occur suddenly without warning. T F 6. Many different things can bring on an asthma episode. T F 7. Asthma cannot be cured, but it can be controlled. T F 8. There are different types of medicine to control asthma. T F 9. People with asthma have no way to monitor how well their lungs are functioning. T F 10.Both children and adults can have asthma. T F 11.Tobacco smoke can make an asthma episode worse. T F 12.People with asthma should not exercise. 11-12 correct = Congratulations! You know a lot about asthma. Share this information with your family and friends. 10-11 correct = Very good Fewer than 10 correct = Go over the answers and try to learn more about asthma. Answers to the Asthma "I.Q." Quiz 1. TRUE. Asthma is a common disease among children and adults in the United States, and it is increasing. About 10 million people have asthma, of whom 3 million are under 18 years of age. 2. FALSE. Asthma is not an emotional or psychological disease, although strong emotions can sometimes make asthma worse. People with asthma have sensitive lungs that react to certain things, causing the airways to tighten, swell, and fill with mucus. The person then has trouble breathing and may cough and wheeze. 3. FALSE. The way parents raise their children does not cause asthma. It is not caused by a poor parent-child relationship or by being overprotective. 4. FALSE. Asthma episodes can be harmful. People can get very sick and need hospitalization. Some people have died from asthma episodes. Frequent asthma episodes, even if they are mild, may cause people to stop being active and living normal lives. 5. FALSE. Sometimes an asthma episode may come on quite quickly. However, before a person has any wheezing or shortness of breath there are usually symptoms such as a cough, a scratchy throat, or tightness in chest. Most patients learn to recognize these early symptoms and can take medicine to prevent a serious episode. 6. TRUE. For most people with asthma, an episode can start from many different "triggers." Some of these things are pollen from trees or grasses; molds or house dust; weather changes; strong odors; cigarette smoke; and certain foods. Other triggers include being upset; laughing or crying hard; having a cold or the flu; or being near furry or feathered animals. Each person with asthma has an individual set of asthma " triggers". 7. TRUE. There is no cure yet for asthma.. However asthma patients can control it to a large degree by: ■Getting advice from a doctor who treats asthma patients ■Learning to notice early signs of an asthma episode and to start treatment. ■Avoiding things that can cause asthma episodes ■Taking medicine just as the doctor says ■Knowing when to get medical help with a severe episode 8. TRUE. Several types of medicines are available to control asthma. Some people with mild asthma need to take medication only when they have symptoms. But most people need to take medicine every day to prevent symptoms and also to take medicine when symptoms do occur. A doctor needs to decide the best type of medicine for each patient and how often it should be taken. Asthma patients and their doctors need to work together to manage the disease. 9. FALSE. People with asthma can monitor how well their lungs are functioning with a peak flow meter. This small device can be used at home, work, or school. The peak flow meter may show that the asthma is getting worse before the usual symptoms appear. 10. TRUE. Both children and adults can have asthma . Sometimes, but not always, symptoms will go away as children get older. However, many children continue to have asthma symptoms throughout adulthood. In some cases, symptoms of asthma are not recognized until a person is an adult. 11. TRUE. Smoke from cigarettes, cigars and pipes can bring on an asthma attack.. Indoor smoky air from fireplaces and outdoor smog can make asthma worse. Some can also "set off" other triggers. Smokers should be asked not to smoke near someone with asthma. Moving to another room may help, but smoke travels room to room. No smoking is best for everyone! 12. FALSE. Exercise is goo for most people -with or without asthma. When asthma is under good control, people with asthma are able to play most sports. For people whose asthma is brought on by exercise, medicines can be taken before exercising to help avoid an episode. A number of Olympic medalists have asthma. For more information on asthma, write: National Asthma Education Program P.O. Box 30105 Bethesda, MD 20824-0105 National Asthma Education ProgramU.S. Department Of Health And Human Services Coordinated by the Office of Prevention,Public Health Service Education, and Control National Institute of Health National Heart, Lung, and Blood InstituteNIH Publication No. 92-1128 Reprinted October 1992 ! * American College of Allergy, Asthma and Immunology Advice From Your Allergist: Asthma Asthma affects more than 10 million Americans and is one of the leading causes of school and work absences. Over one billion dollars is spent each year on health care for asthma. Although its exact cause remains a mystery and no cure exists, many excellent treatment options are available to control and reverse this chronic obstruction of the airways. What is asthma? Asthma is a respiratory condition characterized by episodes of airflow obstruction in the bronchial tubes. Symptoms caused by this obstruction include coughing, chest tightness, wheezing and shortness of breath. Although problems are often separated by symptom-free periods, asthma is a chronic illness. Who gets asthma? Asthma tends to occur within families. The role of inheritance plays a less clearer role in adult-onset asthma. People of any age may suffer from asthma, but more than half the cases are found in children between the ages of 2 and 17. In young children, boys are nearly twice as likely to develop asthma as girls, but this sex difference tends to disappear in older age groups. What causes an asthma attack? A wide variety of "triggers" may initiate an episode of asthma. The most common triggers are allergens, aspirin and tartrazine, irritants, food additives and preservatives, viral respiratory infections and physical exertion. Allergens are substances to which susceptible individuals may become allergic. They are a major source of problems in children and adults. Common allergens include plant pollen (tree, grass and weed), animal dander, housedust mites, molds and certain foods. When an allergic individual comes in contact with one of these allergens, a complicated series of events causes the body to release certain chemicals (mediators). These mediators then trigger asthma. Aspirin and aspirin-containing products can trigger asthma attacks in susceptible individuals. The exact cause of the reaction is unclear, but it does not appear to be an allergic reaction. Ten to twenty percent of asthmatics experience a significant decrease in their lung function after taking aspirin. Similar reactions can occur with a related group of medications called nonsteroidal anti-inflammatory agents and with tartrazine (yellow food dye #5). As a general rule, asthmatics should avoid these products. Cold air, smoke, industrial chemicals, perfume, paint and gasoline fumes are all examples of irritants that can provoke asthma. These irritants probably trigger asthma by stimulating irritant receptors in the respiratory tract. These receptors, in turn, cause the muscles surrounding the airway to constrict, resulting in an asthma attack. Although food additives can trigger asthma, this is rare. The most common trigger is sulfites, which are used to preserve certain foods and medications. Viral respiratory infections are the leading cause of acute asthma attacks. Surprisingly, bacterial infections (except sinusitis) do not usually provoke acute asthma attacks. What happens during an asthma attack? An asthmatic's breathing tubes are "twitchy." That is, an asthmatic's bronchial tubes narrow in response to certain triggers. Because individuals without asthma do not react to these stimuli, an asthmatic's bronchi are described as hyperactive. During and attack, muscles surrounding the bronchial tubes contract, narrowing the air passages. Inflammation also occurs along the lining of the airways which produces swelling and further reduction of airway size. In addition, mucus glands along the inside of the air passages produce excess mucus which accumulates in the already narrowed air passages. The end result is that breathing, especially exhaling, becomes extremely difficult. Air becomes trapped behind the narrowed bronchial passages and there is a decrease in the oxygen available to the body. How long does an asthma attack last? The duration varies according to the severity of the attack. Mild episodes may only last a few hours. Severe episodes, however, may go on for days or even weeks. Mild attacks can resolve spontaneously or may require medication. More severe attacks can also be treated with medications but may require hospitalization. What should be done during an attack? Always follow the instructions of your allergist. In general, it is important to stay calm and take your prescribed medications. Bronchodilators are the most commonly prescribed drugs to treat asthma. They relax the muscles surrounding the airways, resulting in dilation of the bronchial tubes. Bronchodilators may be inhaled, taken orally or injected. Why does physical exertion cause an attack? During exercise, rapid breathing occurs through the mouth. As a result, the air which reaches the bronchial tubes has not been warmed and humidified by passing through the nose. This cold, dry air can trigger asthma. Asthma symptoms are generally at their worst after six to eight minutes of aerobic exercise. Over 70% of all asthmatics suffer some degree of exercise-induced asthma. Should asthmatics avoid sports and exercise? By taking preventive measures, asthmatics should be able to compete in any sport. Not all sports, however, are equally tolerated. In general, exercise and sports that involve prolonged periods of running are more likely to provoke asthma attacks than nonaerobic ones. Swimming is one of the best tolerated sports. In most instances, exercise induced asthma can be controlled to allow participation in any sport. Many Olympic athletes, including several gold medal winners, have had asthma. What is the difference between allergies and asthma? Asthma is obstruction of airflow in the bronchial tubes that is reversible. Allergies are one of the factors that can trigger asthma attacks. Not all asthmatics are allergic and there are many people who are allergic but do not have asthma. Is there a cure for asthma? Though it has long been treatable, a cure for asthma remains elusive. Preventive treatment, however, may minimize the difficulty an individual experiences with asthma. What's the best treatment? Prevention is always the best form of treatment. It is important for an asthmatic to learn what conditions prompt an attack and avoid them whenever possible. When avoidance is impossible, preventive treatment is desirable. Various forms of preventive therapy are available. Medications may be started prior to exercise or exposure to environments that predictably produce an attack. If the asthma attacks are frequent or unpredictable, your allergist may advise you to take medications on a routine basis. Drugs used for this purpose include long-acting theophyllines, inhaled or oral beta agonists, cromolyn and inhaled or oral steroids. For allergic asthmatics, immunotherapy (allergy shots) may offer relief from allergens that cannot be avoided. Immunotherapy increases a patient's tolerance to the allergens that prompt asthma symptoms. Is asthma a psychological disorder? No, but emotions can worsen asthma. Panic can prevent an asthmatic from relaxing and following instructions properly, both of which are essential during an attack. Also, scientists have found that strong emotions can cause an asthmatic's bronchial tubes to constrict, which may provoke or worsen an attack. Asthma can cause emotional strain. Depression often sets in when asthmatics cannot participate in normal activities. Asthma is a leading cause of school absences, which can have far reaching effects on the child's emotional well-being and education. Finally, it must also be remembered that asthma can be a major emotional and financial strain on the entire family. Will some children outgrow asthma? The idea that asthma will be outgrown is more a myth than reality. True, some individuals may reach a point where they no longer suffer asthmatic symptoms as they did in earlier years. But sophisticated testing would show these individuals still run the risk of attacks later in life. Is asthma life-threatening. In severe cases, asthma can be life threatening. Deaths occur more frequently in adults. More than 80% of the 3,880 deaths related to asthma in 1985 occurred in asthmatics over age 45. Usually, however, the airways can be opened and the attack controlled with medications. In a severe attack, the airways may become completely blocked leading to respiratory failure. This condition is a medical emergency and requires immediate attention. It is important for asthmatics to learn to recognize severe episodes and how to prevent them. Some physicians blame the dramatic increase in asthma related deaths to an over-reliance on drugs designed to open obstructed airways. It appears more likely, however, that deaths are due to the delay in administering therapy to relieve the attack. Tips for parents of asthmatic children - Above all else, learn everything you can about asthma; - Learn what triggers your child's attacks and avoid them as best you can; - Recognize the signs of an oncoming attack and learn to judge its severity; - Provide preventive care so that your child has the least amount of difficulty with his or her asthma; - Teach your child how to care for him or herself. Summary Although no cure exists for asthma, excellent treatment is available. We learn more about asthma every year and newer, more effective and safer drugs are always being developed. As a result, most asthmatics live normal, productive lives. Research is continuing and the outlook is bright. For more information about asthma, contact your allergist. For more information, please contact: American College of Allergy, Asthma and Immunology 85 West Algonquin Road, Suite 550 Arlington Heights, IL 60005 (708) 427-1200 ! * ASTHMA AND ALLERGIC DISEASES Research for the Future National Institute of Allergy and Infectious Diseases National Institutes of Health FOREWORD More than 40 years ago, the United States Congress recognized the importance of studying allergic diseases and changed the name of the National Microbiological Institute to the new National Institute of Allergy and Infectious Diseases (NIAID), reflecting the growing importance of allergic diseases. Since then, NIAID has been a leader in biomedical research on allergic diseases and asthma. Allergies are the sixth leading cause of chronic disease in the United States. Major scientific discoveries by NIAID scientists and those supported by NIAID have contributed significantly to our understanding of allergic diseases, including asthma, and have led to substantially better methods of diagnosing and treating them. The Institute is especially concerned about the increasing asthma morbidity and mortality rates in the United States, particularly in minority populations. The seven-year-old boy pictured in this booklet represents the thousands of American inner-city minority children who have asthma, and who run a high risk of suffering from the most serious consequences of this treatable and controllable disease. To help these children, NIAID has launched a major study in eight research institutions around the country. The scientists who are conducting the National Cooperative Inner-City Asthma Study are looking at many possible reasons why asthma is increasing and causing severe illness and death in inner-city minority children. In this creative and innovative study, they will be evaluating interventions that might be used to reverse this trend. In this booklet, we examine the challenges faced by scientists studying asthma and allergic diseases and present some of the exciting research programs that are under way to meet these challenges. We also look down the road at how research for the future may help us reach the Institute's ultimate goal-to prevent asthma and allergic diseases. Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases INTRODUCTION Allergic diseases were once brushed off as "just allergies," but we are now realizing the significant role that they play in the health and quality of life of people in this country and around the world. Among the major causes of chronic illness and disability in the United States ,allergic diseases, including asthma, may affect as many as 50 million Americans, of one in five people. The economic burden of these diseases is staggering. For example, asthma was estimated to cost more than 6.2 billion health care dollars in 1990. The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, stands at the forefront of scientific research on allergic and immunologic diseases. NIAID scientists and those supported by NIAID are working to prevent a broad spectrum of disorders of the immune system, including asthma and allergies. Until prevention is possible, an intermediate goal of the Institute's research programs is to determine how allergic diseases develop and to improve diagnosis and treatment. Achieving this goal will help reduce the impact these diseases have on health and quality of life as well as reduce the economic burden imposed on individuals, families, and the health care system. At NIAID laboratories in Bethesda, Maryland, scientists are conducting basic and clinical investigations on asthma and allergic diseases. NIAID's Division of Allergy, Immunology, and Transplantation provides research grant, contract, and cooperative agreement support to scientists at universities and other research institutions throughout the United States. ASTHMA Asthma is a serious respiratory disorder that affects an estimated 10 to 15 million people and claims more than 4,000 lives in the United States each year. Despite our increased knowledge about asthma, the epidemiology of this disease in the United States presents a dismal picture. During the last decade, the prevalence of asthma cases, hospitalizations, and deaths has been increasing. For example, in 1 987 twice as many children and adults, ages 5 to 34, died from asthma than in 1969. The statistics are particularly grim in minority populations in the United States. Non-whites are almost three times as likely as whites to die from asthma. A higher percentage of African Americans have asthma than do whites. Minorities living in the inner cities seem to be at particular risk for developing asthma. For example, the rates of asthma among Puerto Rican children living in the New York City area are among the highest in the United States. (see aaad.gif file) SOCIOECONOMICS Of the $6.2 billion spent by Americans in 1990 on asthma-related care, almost $1.6 billion was for hospital care. Another $1 billion was spent on medications to treat and control asthma symptoms. Americans also lose billions of dollars in wages because of asthma-related problems. A recent study found that school absenteeism costs an estimated $1 billion in lost pay for parents who stayed home to care for asthmatic children. Adult asthmatics who stayed home from work because of illness lost wages amounting to $850 million. Social factors influence the rising incidence of asthma, although the magnitude of these influences has not yet been determined. Certain factors, including poverty, family problems, inadequate treatment, and lack of access to health care, probably increase an asthma patient's risk of having a severe asthma attack or, more tragically, of dying from asthma. Although good, consistent medical attention can reduce asthma-related hospitalizations, there are 500,000 asthma-related hospital admissions each year in the United States, with a higher percentage of african Americans and Hispanics being hospitalized than whites. In New York City, for example, asthma-related hospitalizations and deaths cluster in poor, predominantly minority neighborhoods where there is often a lack of adequate primary health care. Environmental factors can also adversely affect people with asthma. An example is indoor tobacco smoke, a well-known respiratory irritant that can cause serious problems for asthma patients. Asthmatic children with parents who smoke are at particular risk of suffering from the effects of inhaling second-hand tobacco smoke. The percentage of Americans who smoke cigarettes has been steadily decreasing, but smoking continues to remain highest among individuals who often have the least access to good health care. ALLERGIC DISEASES In the United States, an estimated 40 to 50 million people suffer from allergies. An estimated 33 million people have chronic sinusitis, the most prevalent allergy-related disease. Pollen allergy, commonly called hay fever, affects an estimated 19 million Americans and prompts 8 million office visits to physicians. Food allergies are believed to occur in 8 percent of children younger than 3 years old. In addition, each year billions of dollars are spent on treating allergic diseases in the United States. When an allergic person comes in contact with an allergen (allergy-provoking substances) cells of the immune system produce an unusual class of antibody (disease-fighting protein). This class of antibody is called immunoglobulin E, or IgE, and it starts the classic allergic response. Among allergic individuals, how and to what extent their immune systems respond to a particular allergen is influenced by genetic as well as environmental factors. While allergic reactions to airborne allergens such as pollen, mold, or dust usually cause relatively minor discomfort, sensitivity to substances such as penicillin, insect venom, or peanuts can cause anaphylaxis, a serious and potentially fatal allergic reaction. Anaphylactic reactions to penicillin are responsible for an estimated 1 to 8 deaths per million population. An estimated 1 to 2 million people experience severe allergic reactions to insect stings each year. Moreover, severe, life-threatening allergic reactions to food may occur as frequently as those to insect stings. RESEARCH Although a variety of therapies have been developed to treat asthma and allergies, we still do not fully understand certain critical aspects of these diseases. To develop more effective therapies and devise methods for preventing these illnesses, researchers are attempting to discern how the immune system recognizes an allergen, why people respond differently to allergens, as well as what environmental, genetic, and other factors might he responsible for allergic diseases. Allergy to latex has become an increasingly important health problem, especially among medical personnel who wear latex gloves to reduce exposure to human immunodeficiency virus, which causes AIDS, and hepatitis B virus. Although we know proteins derived from latex cause allergic reactions, better understanding of the structure and immunologic function of these proteins would help scientists devise ways to eliminate the cause of these potentially dangerous reactions. NIAID-funded scientists have been at the forefront of discoveries and advances in the field of allergy. They were the first to identity the IgE antibody that is the key to the allergic response. NIAID intramural investigators and NIAID supported investigators have now identified the complete structure of the IgE receptor, the molecule on tho surface of mast cells and basophils to which IgE antibodies attach. (Mast cells in the tissues and basophils in the blood are cells that together cause allergy symptoms.) Blocking the function of the IgE receptor may eventually lead to a new therapy for allergies. Investigators have studied the events that occur after allergic reactions are initiated by allergen binding to IgE antibody on mast cells and basophils. Perhaps the most important breakthrough in studying allergic reactions is the identification by NIAID investigators of the biologic events responsible for the late phase reaction (LPR). LPR usually occurs 4 to 6 hours after an allergen has entered the body. The discovery that these late reactions involve inflammatory cells and that they resemble a allergic reactions has led to the recent recognition that inflammation is a central feature of allergic diseases and asthma. This knowledge has provided a significant focus to asthma research-how the inflammation is produced, how it is regulated, and how it can be prevented. In addition, NIAID investigators discovered that inhaled corticosterolds inhibit LPR. That discovery contributed to the growing use of these drugs to successfully treat both allergy and asthma. The inflammatory process is highly complex, but the insights that have emerged highlight and expand this exciting area of research. One major key to this process is a group of powerful chemicals called cytokines, which are produced by certain cells of the immune system and which help regulate cell growth and function, including IgE antibody production and allergic and asthmatic inflammation. Substantial progress has been made recently in understanding how these chemicals are involved in most aspects of the development and function of inflammation. Research studies have opened the door for developing promising alternative and innovative therapies such as now anti-inflammatory drugs and agents that block the actions of cytokines. RESEARCH AND THE COMMUNITY The NIAID-supported National Cooperative Inner-City Asthma Study (NCICAS) is composed of eight units in seven cities that are studying the unusually high morbidity rates of asthma in inner city children. The objective of NCICAS phase I is to identify modifiable factors determining asthma severity and morbidity among inner-city children. A number of interesting findings have emerged from pilot studies. For example, allergen surveys of more than 80 inner-city homes revealed that cockroaches may he a more important trigger of asthma in this population than are house dust mites. NCICAS is also evaluating the use of peak flow meters, plastic devices that can be used by patients at home to monitor their breathing. (Because of airflow obstruction in the lungs, asthmatics have trouble breathing air out.) From the patient's monitoring records, the doctor can tell when a person is doing well and when to take action, such as increasing medication to forestall trouble. The peak flow meter pilot studies showed that a two-week monitoring of the variability of peak air flow can he successfully and accurately carried out. In addition, an innovative technique has been developed to measure the quality of asthma care delivered in inner-city emergency rooms. To reduce asthma morbidity, Demonstration and Education (D & E) projects develop innovative ways to apply existing knowledge and programs. The main objectives of the projects are to teach better self-management skills to those with asthma and to increase asthma Knowledge among health care providers. Two school-based D 8 E projects involve now self-management skills. One project, carried out by investigators at Scripps Clinic in San Diego, California, is concerned with developing asthma intervention protocols in fourth through sixth graders in a predominantly Hispanic school district. The other, based at The Johns Hopkins University in Baltimore, Maryland, is studying new evaluation tools for asthma in 13- to 18 year-olds in a predominantly African-American school district. In addition, a clinic-based project, a computer-driven asthma education aid for children, is in the final stages of development at Children's Hospital in Boston, Massachusetts. This program will teach asthma management skills to African-American asthma patients under age 15. NIAID established the Asthma, Allergy, and Immunologic Diseases Cooperative Research Centers (AAIDCRCS) to promote Interaction among basic and clinical researchers and to enhance outreach and demonstration activities. These centers encourage close coordination between scientists studying fundamental concepts of Immunology, genetics, biochemistry, and pharmacology and clinical investigators who treat allergic individuals. This approach will lead to both a better understanding of the complex mechanisms underlying asthma and allergies and the clinical application of this knowledge. Various allergic problems are under investigation at the AAIDCBCS: asthma; skin diseases, such as atopic dermatitis; urticaria; angioedema; and allergic reactions caused by insect stings, foods, drugs, and airborne allergens. Studies also focus on the basic mechanisms involved in immune system function and reactions, including research on antibodies, particularly IgE, and on the inflammation-inducing chemicals released during an allergic attack. FUTURE The remarkable advances during the last 10 years in our understanding of the structure and functions of the immune system are paving the way to an exciting and hopeful future for diagnosing, treating, and preventing asthma and allergic diseases. Recent discoveries using modern molecular technology are providing a stimulus for allergic disease research. For example, scientists have developed a genetically altered mouse that produces large amounts of the cytokine interleukin-4 (IL-4). Such mice express an inflammatory response in several tissues that resembles human allergic inflammation, and they also can produce large amounts of lgE antibody. This type of approach will lead to a clearer understanding of which genes are responsible for allergic responses. We are now beginning to understand how cytokines regulate the production of adhesion molecules that bind inflammatory cells to the sites of allergic disease, such as the nose, skin, and lungs. These and other findings suggest that molecules directed against critical targets in the allergic process such as cytokines and adhesion molecules-may lead to a new means of therapy to better treat asthma and allergic diseases. One of the most exciting areas of research involves unraveling the genetic mysteries of asthma and allergic diseases in conjunction with studying how allergens and other environmental factors induce these diseases. By identifying the genes responsible for them, prenatal diagnostic tests could he developed to identify persons at risk for allergic disease. This early diagnostic knowledge could he used to manipulate the environment or to start early intervention therapy, thereby eliminating or altering the severity of the disease process in these individuals. Thus, the overall quality of life would be greatly improved for these patients. Recent studies in understanding how and why the immune systems of allergic individuals produce IgE ant bodies to allergens may lead to innovative vaccine therapy. In preliminary clinical trials, scientists are evaluating an approach that could stop the immune system from responding to allergens. Called peptide induced allergy, this process could be the "allergy shot" of the future. Finally, researchers are working to better understand the actions of the cells and molecules associated with the inflammatory process in asthma and allergic diseases. Knowing more precisely how these cells travel to the site of inflammation in the lungs, nose, gastrointestinal tract, or skin should pave the way for new drugs that block this cascade of events. With the quickening pace of research on asthma and allergic diseases and on the immune system, we may be able to cure-or even prevent-these chronic, often severe, and sometimes life-threatening diseases by the end of the decade. INFORMATION RESOURCES Allergy and Asthma Network/ Mothers of Asthmatics, Inc. 3554 Chain Bridge Road, Suite 200 Fairfax, VA 22030 1-800-878-4403 American Academy of Allergy and Immunology GI 1 East Wells Street Milwaukee, WI 53202 1-800-822-ASMA American College of Allergy and Immunology 800 E. Northwest Highway Suite 1080 Palatine, IL 60067 708-359-2800 American College of Chest Physici 3300 Dundee Road Northbrook, IL 60062-2340 708-498-1400 American Lung Association American Thoracic Society 1740 Broadway New York, NY 10019-4374 212-315-8700 Asthma and Allergy Foundation of America II 25 ]5th Street, N.W., Suite 502 Washington, DC 20005 1-800-7-ASTHMA National Asthma Education Program Information Center P.O. Box 30105 Bethesda, MD 20824-0105 301-251-1222 ! * ASTHMA The one characteristic all asthmatics share is a hypersensitive airway system. When an asthma attack is triggered, these hypersensitive airways become narrow and fill up with mucus, making it difficult to breathe. Although mild asthma is sometimes more of a nuisance than a life-threatening condition, prompt treatment is necessary to avoid potential complications. Three percent of the United States population, including both children and adults, suffers from asthma. However, thanks to extensive research and the introduction of new medications, this condition is indeed treatable, and there is no reason why an asthmatic should not lead a full and productive life. What happens during an attack? Picture the human respiratory system as an upside-down tree. Air is taken in through the windpipe, or trachea (the trunk of the tree), which divides into two main branches called bronchi. The bronchi further divide into smaller branches called bronchioles. The bronchioles end in clusters of air sacs, or alveoli. Within the alveoli oxygen-laden air is exchanged for deoxygenated air (air that has already been used by the body). During an asthma attack the smooth muscles that wrap around the bronchioles tighten, shutting off the flow of air to and from the alveoli. In addition, because of irritation the soft membranes that line the bronchioles become inflamed, and the secretion of mucus increases. Because this bronchial mucus is unusually sticky, coughing fails to expel it. The mucus plugs up the bronchioles, making it extremely difficult to exhale, and causes the wheezing sound characteristic of an asthma attack. Because greater difficulty is experienced in breathing out than in breathing in, increasing amounts of stale air are retained in the lungs with each breath. In a severe attack, this can lead to a feeling of near suffocation. Causes A variety of stimuli can trigger an asthmatic attack in a susceptible individual. When asthma runs in the family (particularly if it begins in childhood) the stimulus is often found to be an allergen (a substance that produces an allergic reaction). The asthma is part of the allergic response. Common allergens include pollen, mold spores, house dust, pet dander and dairy products, especially eggs and milk. An asthma attack may also be triggered by an irritating substance in the air (not necessarily an allergen) such as chemical fumes, excessive air pollution, insecticides, chalk dust, tobacco smoke and other environmental pollutants. Many people suffer from asthma caused by substances to which they are exposed on the job. Sometimes asthma becomes worse as a result of a respiratory infection. Asthma may also be provoked by strenuous exercise or exposure to cold air. Scientific opinion is divided as to whether emotional factors play an important part in causing asthma in either children or adults. However, one thing is certain: the emotional complications resulting from the frustration and fear of being an asthmatic should be taken as seriously as the disease itself. Prevention If a particular allergen has been pinpointed, every effort should be made to avoid contact with it. For instance, if the allergen is house dust, the asthma victim's room should be kept as free as possible of dust by frequent cleaning. Objects that collect dust, such as heavy drapes, thick rugs, wool blankets and knickknacks should be removed. Someone other than the asthmatic should do the cleaning, and the asthmatic should stay out of the room until at least an hour after the cleaning has been completed. If the asthma has been found to be caused by animal dander from a pet, the animal may have to be given away, or at least kept out of the asthmatic's bedroom. Often, however, especially if the allergen is present year-round (as is true of house dust and pet dander), it is very difficult to keep from coming into contact with it. In this case, the asthmatic may sometimes be helped by a process called immunotherapy. Over a period of several weeks, the asthmatic is given a series of injections containing increasing amounts of the allergen so that tolerance is built up to it. These injections are usually given by an allergist. Another form of preventive therapy is the use of a medication that will suppress an asthma attack before it begins. This type of treatment is particularly effective for exercise-induced asthma. Treatment The most widely used preparations for treating asthmatic attacks are bronchodilators. Bronchodilators relax the muscles that tighten around the bronchioles during an asthmatic episode, reducing swelling of the mucous membranes and loosening the plugs of mucus that have collected in the bronchioles. Bronchodilators are available in oral, injectable and aerosol form. The oral preparations take somewhat longer to work than the aerosol forms, but they also last longer. An adaptor is available for people who have trouble timing actuation of the aerosol spray with inspiration. Inhalant bronchodilators should be used only as directed in order to avoid side effects. Consult your doctor promptly if the inhaler seems to be becoming less effective. If bronchodilators do not succeed in stopping asthmatic attacks, oral or inhalant corticosteroids may be prescribed. Steroids must be used under close medical supervision because they potentially can have more serious side effects than other antiasthmatic preparations. Some asthmatics are "steroid dependent" and require long-term steroid therapy. There are also some other methods that can prevent, ease or shorten asthmatic attacks. One of these is getting into a position where the mucus can drain from the lungs - for example, by lying on your back on a bed with your head hanging over the side. Other techniques include special breathing exercises and biofeedback methods. In general, try to stay healthy and particularly avoid getting a cold or the flu. Drink plenty of fluids (six to eight glasses of water daily) to loosen and break up mucus in the bronchial passages. If you smoke, it is extremely important to stop. Complications Untreated asthma can lead to serious complications. The continued stretching of the alveoli by accumulations of stale air can eventually damage the delicate tissues to the point where they lose their elasticity and cease to function. Self-treatment is inadvisable and especially dangerous for older people, who may attribute their chronic shortness of breath to asthma, when in fact they may be suffering from progressive heart failure. Anyone who experiences breathing difficulties should consult a doctor. Summing up Asthma, if left untreated, can be a disabling disease. Every effort should be made to identify the factors responsible for the attacks, because prevention is the foundation of effective treatment. A variety of therapeutic approaches may be tried to control asthma; effective therapy usually involves a combination of treatments that may include drugs, avoidance of allergens, and immunotherapy. Although many people believe that asthma is an emotional disorder, this does not seem to be the case; however, asthma - like any chronic disease - can produce emotional problems that involve not only the victim but other family members as well. Emotional support is an important element is the overall treatment of asthma. ! * National Institutes of Health EMBARGOED FOR RELEASE 6:00 p.m. EDT Thursday, June 22, 1995 Patricia Newman NCI Press Office (301) 496-6641 Questions and Answers: Ataxia Telangiectasia 1. What is ataxia telangiectasia? Ataxia telangiectasia (A-T) is a rare, recessive genetic disorder of childhood that occurs in about 1/40,000 and 1/100,000 persons worldwide. The ailment is progressive. By their teens, patients with A-T are frequently wheelchair-bound. The disease is characterized by neurologic problems, particularly abnormalities of balance, recurrent serious sinus and respiratory infections, and dilated blood vessels in the eyes and on the surface of the skin. Patients usually have immune system abnormalities and are very sensitive to the effects of radiation treatments. In the United States, where recurrent infections typical of the disorder are usually controlled by antibiotics, patients are at high risk of developing and dying of cancer, particularly leukemias and lymphomas. 2. Is the disorder curable? There is no cure for A-T at the present time. With the cloning and eventual sequencing of the gene (named ATM), several avenues of research to develop better treatment become possible, including: (1) gene therapy; (2) rational drug design; and (3) direct replacement of the functional protein. 3. What does it mean that the disorder is recessive? A disease is recessive when a person inherits the predisposing gene from both parents, each of whom transmits one copy of the abnormal gene to their child. 4. What is a carrier? A carrier is a person with one normal and one altered copy of a gene that is linked to a particular disease. These individuals usually do not realize they are carriers, because the disease is not present, or its signs and symptoms are very mild. 5. How many A-T carriers are there in the United States? An estimated one percent, or 2 1/2 million, of the U.S. population may be carriers for A-T. 6. How do I know if I am a carrier? In the past, carriers have been identified chiefly because they are parents of a child with A-T. In a small number of cases, carriers have been identified through extensive laboratory and clinical studies of families where A-T has occurred. With the cloning of the ATM gene, however, scientists will be able to devise a test to detect A-T carri- ers. To do this, they take advantage of what they know about alter- ations to the gene in a particular family. Because different carriers will have different mutations in the gene, devising a diagnostic gene test may be difficult. 7. What cancers are increased in A-T patients? At least 10 percent of A-T patients develop cancer. Most of these are cancers of the lymphoid tissues (leukemias and lymphomas), but one-fifth of the cancers occur in the stomach, brain, ovary, skin, liver, larynx, parotid gland, and breast. 8. What cancers are increased in A-T carriers? Definitive information does not yet exist to answer this question, and must await the development of a test to identify ATM gene carriers. Some studies of the families of A-T patients have reported a 3-4 fold increased risk of cancer, including breast cancer; this finding is controversial. Current estimates of risk are based on studies of selected families of A-T patients. The cloning of the ATM gene now allows scientists worldwide to evaluate suggestions of increased risk for cancer, and NCI is collaborating on several studies that combine epidemiology with molecu- lar analysis to address this question. 9. Are A-T patients sensitive to radiation? A-T patients have an increased sensitivity to ionizing radiation, the type found in X-rays. When cultured in the laboratory, the blood and skin cells of these patients have markedly reduced ability to replicate and form cell colonies after X-ray exposure. Scientists believe that the ATM gene is one of at least three genes, (ATM, p53 and GADD45) involved in this cell cycle arrest. 10. Are ATM gene carriers also sensitive to the effects of radiation? This is a question needing further study, and the cloning of the ATM gene will make new studies of carriers possible. When cultured in the laboratory, the blood and skin cells of known ATM gene carriers are intermediate in their sensitivity to X-rays, compared to A-T patients and the general public. 11. Does their increased sensitivity to radiation, compared to the general public, make it dangerous for carriers to have diagnostic X-rays? There is no evidence to support this. At the dosages of radiation delivered by today's technology, diagnostic tests are not considered harmful to carriers. 12. Are X-rays harmful to A-T patients? A-T patients are sensitive to the effects of radiation and should be monitored for adverse effects. However, they do receive diagnostic X- rays when necessary. The information about radiation sensitivity in A-T comes largely from observations of A-T patients who undergo radiation treatments, especial- ly for cancer, and also from laboratory studies on skin and blood cells. Physicians who treat A-T patients limit X-ray exposures by using the most modern equipment and techniques available, but they do recommend these diagnostic tests when they are needed. Now that the ATM gene has been isolated, scientists will be able to study the nature of the radiation sensitivity observed in cells from A-T patients, as well as any intermediate level of radiation sensitivity observed in cells from known carriers. 13. Suppose I learn I am an A-T carrier. Will mammography increase my chances of getting breast cancer? There is no definitive evidence that A-T carriers of any age have increased sensitivity to X-rays from mammograms or other diagnostic tests. For women 50 and older, th benefits of mammography have been demonstrated clearly. For younger women, those 40-49, NCI continues to recommend discussing individual risk issues with your physician. The influence, if any, of X-rays on the breast cells of premenopausal women is theoretical and will be studied further, now that the ATM gene is cloned. 14. Are there any alternatives to mammography on the horizon? Recent technological modifications to mammography result in delivery of lower radiation doses than 20 years ago. In addition, NCI is sponsoring the development and clinical testing of non-ionizing breast imaging technologies, such as magnetic resonance imaging, ultrasound and PET. 15. What about environmental sources of radiation, such as cellular phones. Should A-T carriers avoid these exposures? To date, there have been no definitive studies linking non-ionizing radiation, such as that from cellular phones, to cancer. NCI currently is evaluating non-ionizing radiation from a variety of sources to assess thoroughly any potential cancer risks. 16. What studies does NCI have under way or planned to answer these ques- tions more definitively? NCI is sponsoring a wide variety of research on DNA repair, radiation sensitivity and resistance, and A-T. Clinical scientists at the NCI have over 30 years of experience with A-T, and are continuing research to develop better diagnostic tests, immune dysfunction analyses, and treatments. In addition, NCI epidemiologists are collaborating in several studies of A-T, including population-based studies of the risk of cancer in A-T patients and their relatives in Denmark that are being expanded to other Scandinavian countries; a study of early-onset breast cancer among X-ray technologists, whose blood samples are being examined for mutations in the BRCA1 and ATM genes; and ongoing studies for over 20 years of radiation-induced breast cancer. These latter studies include analysis of scoliosis patients who as young girls received intense spinal X-rays to monitor the growth spurt; women with tuberculosis who received hundreds of chest fluoroscopic X-rays to monitor lung collapse; survivors of the atomic bombings in Hiroshima and Nagasaki; women with breast cancer who developed secondary breast cancer in the contralateral breast; women with Hodgkin's disease treated with radiotherapy, and others. In a number of these studies, blood and tumor samples are being evaluated for the influence of genes such as p53 and BRCA1 on radiation-induced breast cancer risk, and ATM gene studies will be possible in the near future. # # # ! * Athlete's Foot THIS IS A HEALTH-LINE MESSAGE FROM THE UNIVERSITY OF WISCONSIN-MADISON. Athlete's foot is a very common skin condition caused by a fungus which must have at least a 95% humidity environment in order to multiply. Signs that you may have this infection could include cracking, scaling, peeling, itching, redness and blisters on the soles of your feet or between your toes. Your toenails may have become yellowish and thickened if you have had the condition for a long time. If you suspect that you have athlete's foot try the following method of control. First, wash your feet carefully in soap and water, rinse well and dry all areas thoroughly. Powder your feet heavily, especially between your toes, and put on clean socks. While indoors, go around in your stocking feet or bare feet when at all possible. This will reduce moisture from perspiration. You may wish to purchase a special powder to use. You will find your pharmacist helpful in guiding you in your choice. Many people with mild athlete's foot find they can treat themselves very effectively. It may take a while for all signs of the infection to disappear completely but it will quickly improve if you keep the areas dry. If your condition should become more severe, more uncomfortable, look very red and angry, and last more than two weeks after beginning treatment, you may have another type of skin problem. In this case, you should consult a physician. Other skin ailments can mimic athlete's foot. You may be allergic to the synthetic material of your socks and a change to the 100% cotton variety plus general good foot hygiene may bring relief. Frequently, people are allergic to the strong laundry detergents in which socks are washed. Giving your socks an extra rinse after laundering may help your condition. In general, we can say that any condition present on the tops or your feet or between the great toe and first toe is NOT likely athlete's foot. If an inflammation seems to be related to an open blister or other wound and does not improve after two or three days of hot water soaks, see your physician. You can help prevent, as well as cure, athlete's foot if you keep all areas of your feet dry at all times. If you work outside and wear heavy boots and socks, at lunchtime you may be able to change to clean socks into which you have previously placed a goodly amount of foot powder. After putting on the clean, dry socks, spread your toes and puff the powder around. Wearing overshoes all day or wearing tennis shoes without socks will help your feet perspire and become a perfect environment in which the athlete's foot fungus can flourish. Athlete's foot cannot be just "wished" away. Face up to the situation and remember that control and cure as much easier when the problem has just begun. ! * FOOD AND WATER BORNE BACTERIAL DISEASES CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 FOOD AND WATER BORNE BACTERIAL DISEASES FOODBORNE BACTERIAL DISEASES - GENERAL INFORMATION More than 250 different diseases have been described that can be caused by contaminated food or drink. The most common foodborne diseases are infections caused by bacteria, such as Salmonella and Campylobacter, or by the Norwalk family of viruses. A foodborne disease outbreak is defined as a group of people developing the same illnesses after ingesting the same food. Most cases of foodborne disease are single cases not associated with a recognized outbreak. The great majority of food items which cause foodborne diseases are raw or undercooked foods of animal origin such as meat, milk, eggs, cheese, fish, or shellfish. In 1983, it was estimated that there were approximately 6 million cases of infectious foodborne diseases which caused 9,000 deaths. Some foodborne diseases such as botulism and trichinosis are becoming less common, while others such as salmonellosis are becoming more common. Thus, the spectrum of foodborne disease is changing. New infections not previously known to be foodborne diseases are emerging. Approximately 400-500 foodborne disease outbreaks are reported each year. Not all outbreaks or diseases are equally likely to be reported, and many cases of foodborne diseases are sporadic. To prevent contracting foodborne diseases, the consumer can do the following: 1) Make sure that food from animal sources (meat, diary, eggs) is thoroughly cooked or pasteurized. Avoid eating such foods raw or undercooked. 2) Be careful to keep juices or drippings from raw meat, poultry, shellfish or eggs, from contaminating other foods. 3) Do not leave potentially contaminated foods for extended periods of time at temperatures that permit bacteria to grow. Promptly refrigerate leftovers and food prepared in advance. Thorough cooking kills almost all foodborne bacteria, viruses and parasites, and is the single most important step in preventing foodborne disease. Preventing spread of contamination from raw foods in the kitchen is also important. Washing one's hands, cutting board, and knife with soap and water immediately after handling raw meat, raw poultry, raw seafood or raw eggs will help keep the foodhandler from contaminating any other foods in the kitchen. Persons who are ill with diarrhea or vomiting should not prepare food for others. Special care is needed in the preparation of food for infants, the elderly, and persons whose immune systems are compromised by underlying illness or medical treatment of illness. While foodborne diseases, their causes and effects are better understood today, emerging risks need to be monitored for several reasons. First, the food supply of the United States is changing dramatically, The conditions under which food animals are raised have changed greatly. We now import 30 billion tons of food a year, including fruit, vegetables, seafoods, and canned goods; these imported foods are an increasing proportion of the diet, and often come from developing countries where food hygiene and basic sanitation is less advanced. Food processing technologies are constantly evolving. The centralization of the food industry means that a single contaminated product may appear in many different foods and many different forms, and infect a considerable number of people before it is identified. Second, consumers are changing; there are increasing numbers of elderly or immunosuppressed persons who are at higher risk of severe illness; consumers spend less time cooking than before, and may have received less instruction in food handling in home or school than before. Finally, new and emerging foodborne pathogens have been identified, which can cause diseases unrecognized 50 years ago. These include bacteria, parasites, and viruses, along with toxic causes of foodborne illnesses. Constant vigilance is necessary to identify new problems requiring new solutions as they emerge. However, despite these new risks, the food supply of the United States is probably safer now than ever. ADDITIONAL SOURCES OF INFORMATION More detailed information on foodborne disease can be found in encyclopedias, in medical and public health textbooks, and in textbooks on food microbiology. CDC Surveillance summaries on foodborne diseases and their outbreaks are published as supplements to the Morbidity and Mortality Weekly Report, the MMWR, and are available at many public libraries, and all medical libraries. These Surveillance summaries include information on salmonellosis, campylobacteriosis, trichinosis, and viral hepatitis, as well as on foodborne disease outbreaks. They can also be obtained by writing this office: Public Inquires, Office of Public Affairs, Centers for Disease Control, 1600 Clifton Road, Atlanta, Georgia, 30333. Questions about the safe handling of food can be addressed to your County Health Department or County Extension Home Economist. Questions about the safety of a specific food can be answered by the FDA Consumer Hotline: 1-301-443-1240. Questions specifically about meat and poultry can be answered by the USDA Meat and Poultry Hotline: 1-800-535-4555. ! * DEAR DOCTOR COLUMNS ARE WRITTEN BY UAB UNIVERSITY OF ALABAMA AT BIRMINGHAM) EXPERTS AND PUBLISHED WEEKLY IN THE BIRMINGHAM NEWS BOILS Source: Ed Varner, M.D. Writer: Susan O. Brown QUESTION: I have recurrent boils on my buttocks and the back of my thighs. Although they eventually go away, they are often painful, becoming red, tender, and filled with pus. Sometimes I try to squeeze them to relieve the pressure, but it usually makes them worse. What causes boils and what should I do when I get one? ANSWER: Boils, also called furuncles, are an infection of a hair follicle (a tiny pit in the skin from which a hair grows) by certain bacteria, usually Staphylococcus aureus, commonly found on the skin. When there are multiple boils anywhere on the body, the condition is called furunculosis. In contrast, a carbuncle is either an unusually large, severe boil or a group of boils joined together by small tunnels in the skin. Boils are very common, and virtually everybody is affected with one at some time. Staph bacteria can enter the body through cuts, sores, puncture wounds, skin ulcers, or irritated skin, causing infection. They also can be the result of poor resistance to infection or poor hygiene. Although they can occur anywhere on your skin, they are most likely to appear on your face, neck, armpits, buttocks, or thighs. As a hair follicle becomes inflamed and painful, white blood cells, which form part of the body's defense system against bacteria, collect at the site to combat the infection. Starting as a red, tender lump, which may throb, a boil becomes larger and painful over the course of a few days. As pus collects, it develops a white or yellow head, or center. The pus is under pressure, which increases the pain and tenderness. Occasionally fever develops. Eventually, the boil bursts through the skin, the pain is relieved, and the boil heals. This process usually takes about two weeks. However, the boil may recur later near the same site and go through the same cycle. When boils occur on the upper lip or near the nose, infections can spread to the sinus cavity. Rarely, the bacteria can enter the bloodstream and cause more serious problems. Physicians warn that boils should not be touched or squeezed. Squeezing can force the infection into deeper tissues. Permanent scarring can occur from a boil, especially if it is improperly treated. Boils are sometimes signs of a system-wide problem. For example, people who have diabetes or kidney disease are more susceptible to boils and other infections than people without these conditions. Whatever the cause, large boils need to be evaluated and treated by your physician. Moist heat helps boils come to a head so they'll drain. Application of a warm, tap-water compress to the boil every 30 minutes for a few hours will help it burst and drain much sooner. Occasionally, a physician may have to lance the boil to allow the pus to drain away. Depending on the severity of the boil, an antibiotic pill or injection, or an antibiotic ointment may be prescribed to kill the bacteria. Skin cleansers that kill germs can be used to keep the area scrupulously clean during healing. Washcloths and towels should be laundered after each use. Underwear and bedclothes should be laundered after contact with the lesion. If dressings are changed at home, discard them in a plastic bag and seal it to prevent spread of infection. If you have boils, it's best to take showers instead of baths to reduce the chance of spreading the infection to other parts of your body and to others. If boils are a recurring problem, physicians recommend a complete medical evaluation to determine if a system-wide problem is the cause. ! * NIH Healthline--October/November 1994 National Institutes of Health, Office of Communications (301) 496-1766, (301) 402-0395 Compuserve 74201,1057 PREMATURE GRAYING MAY BE A SIGN OF BONE DISEASE--by Judy Folkenberg Premature graying may be a marker that an individual is at risk for osteoporosis, according to research supported by NIH's National Center for Research Resources. In this study, researchers led by Clifford J. Rosen, M.D., at the Maine Center for Osteoporosis Research and Education, picked 63 individuals who met the study's criteria out of a sample of nearly 1,000 patients from a bone clinic in Bangor. The clinic serves as a referral center for about 300,000 people in eastern Maine. Osteopenia--the term used to describe thinning bones--was measured by x-rays which scanned the spine. The scientists found those persons with premature graying were over 4 times more likely to have varying degrees of osteopenia when compared to the control group--those individuals without premature gray hair. "Premature graying" meant that an individual's hair had turned more than 50 percent gray before the age of 40. The earlier one's hair turned gray, say the researchers, the greater the chance of a history of osteoporosis in the family. For example, individuals with premature graying in their teens and twenties had a stronger family history of the disorder than those who had premature graying in their thirties. The scientists aren't sure why premature graying and increased risk for osteoporosis are linked. "But we think that perhaps the gene that controls premature graying is next to the gene that regulates bone density (genes in close proximity sometimes act together); or perhaps one gene influences the other," said Rosen. This research was published in the Journal of Clinical Endocrinology and Metabolism (Vol. 79, No. 3, 1994). --An NIH Healthline report October/November 1994 Contact: Dr. Clifford Rosen (207) 942-2466 Judy Folkenberg (301) 496-1766 ! * BOTULISM CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 FOOD AND WATER BORNE BACTERIAL DISEASES BOTULISM Botulism is a rare but serious foodborne disease. It is caused by contamination of certain foods by the botulism bacterium commonly found in the soil. There are two different illnesses: adult botulism and infant botulism. An adult may become ill by eating spoiled food containing the botulism toxin. This toxin is produced when the bacteria grow in improperly canned foods and occasionally in contaminated fish. Infant botulism is caused by eating the spores of the botulinum bacterium. For infants one source of these spores is honey. When contaminated food is eaten by adults, toxin is absorbed from the intestines and attaches to the nerves causing the signs and symptoms of botulism. Early symptoms include blurred vision, dry mouth, difficulty in swallowing or speaking, general weakness, and shortness of breath. The illness may progress to complete paralysis, respiratory failure, and death. When infants eat contaminated food, the spores grow in the intestines and release toxin. Diagnosis is made by the presence of appropriate neurologic symptoms and by laboratory tests that detect toxin or by culture of Clostridium botulinum bacterium from the patient's stool. Although there are very few cases of botulism poisoning each year, prevention is extremely important. Home canning should follow strict hygienic recommendations to reduce contamination of foods. In addition, because the botulism toxin is destroyed by boiling for 10 minutes, people who eat home- canned foods should consider boiling the food before eating it to ensure safety. A county extension home economist can provide specific instructions on safe home canning techniques. To help prevent infant botulism, infants less than 12 months old should not be fed honey. Treatment for adults requires care in an intensive care unit; botulism antitoxin can be helpful if given soon after symptoms begin. Treatment for infants requires hospitalization and possibly care in an intensive care unit. Antitoxin is not recommended for infants. In 1989, 23 adult and 75 infant botulism cases were reported to CDC from 23 states. ! * NEW YORK STATE DEPARTMENT OF HEALTH Botulism (food-borne botulism and infant botulism) What is botulism? Botulism is a food poisoning caused by a toxin produced by the bacteria, Clostridium botulinum. Only a few cases are reported in New York State each year. Who gets botulism? Food-borne botulism is due to ingestion of a toxin formed in food. It often involves improperly processed home canned foods. Botulism in infants under one year of age has been associated with the ingestion of contaminated honey. How is botulism spread? Person to person spread does not occur. A person must ingest contaminated food that has not been properly cooked or reheated after the toxin has been produced by the bacteria. With infant botulism, an infant must ingest bacterial spores and then produce the toxin in his/her gastrointestinal tract. What are the symptoms of botulism? Food-borne and infant botulism produce symptoms that affect the nervous system. The symptoms of food-borne botulism include blurred or double vision, general weakness, poor reflexes, difficulty swallowing and sometimes death. Infant botulism has a wide range of symptoms including difficulty breathing, visual disturbances, poor feeding and poor reflexes. How soon do symptoms appear? Symptoms of food-borne botulism usually appear 12-36 hours after ingestion, but may take several days. The incubation period for infant botulism is unknown. What is the treatment for botulism? Hospital care is necessary. Antitoxin is given in certain cases of food-borne botulism, but not in cases of infant botulism. What happens if botulism is not treated? Untreated botulism may result in death. How can botulism be prevented? Identified sources of infant botulism, such as honey, should not be fed to infants. All canned and preserved foods should be properly processed and prepared. Bulging containers should not be opened and foods with off-odors should not be eaten or even tasted. Commercial cans with bulging lids should be returned unopened to the vendor. ! * DEAR DOCTOR COLUMNS ARE WRITTEN BY UAB (UNIVERSITY OF ALABAMA AT BIRMINGHAM) EXPERTS AND APPEAR WEEKLY IN THE "BIRMINGHAM NEWS." QUESTION: Lately, I've been waking myself up during the night grinding my teeth. Sometimes I grind so hard my jaw is sore the next morning. Why do I do this and what can I do to prevent damaging my teeth? ANSWER: What you've been experiencing is not uncommon. In fact, an estimated 95 percent of the U.S. population, including children, will clinch and grind their teeth, called bruxism, at some point in their life. But because it occurs during sleep, only a fraction of people are aware they have this annoying and potentially harmful problem. Because bruxism often results in excessive wear or damage to your teeth, particularly the eye teeth, your dentist is often the first to suspect a problem. The first thing that may alert that you're busy grinding during the night is a stiff jaw or sore chewing muscles in the morning. Other symptoms and signs that point to bruxism include achy or painful facial muscles or jaw (temporomandibular) joints, cracked teeth, and destruction of dental work. In severe cases, people can even wake up with their jaw locked either open or closed. Once thought to be caused by problems in occlusion (the way the upper and lower teeth fit together when the jaws are closed), recent studies have pinpointed stress as the culprit. The side effects of certain medications and being physically exhausted also can cause or aggravate bruxism. Researchers, using sensors to detect tooth grinding during sleep, found that grinding increases during stressful periods of people's lives such as during school exams or divorces. However, when antianxiety medications were given, the grinding decreased. But medications are only a short-term solution. The long- term solution to bruxism is learning how to handle the stress in your life. Stress management programs used to treat bruxism include biofeedback, counseling, hypnosis, and progressive relaxation. In addition, your dentist may recommend bite splints or nightguards, which fit between the biting surfaces of the teeth to protect them from injury and to keep the jaw relaxed. If left untreated, bruxism may contribute to the premature loss of teeth and inflamed gums. Since you're aware of your problem, see your dentist right away. oblem, see your dentist right away. ! * First Aid For Burns THIS IS A HEALTH-LINE MESSAGE FROM THE UNIVERSITY OF WISCONSIN-MADISON. The proper treatment for burns is based upon a knowledge of the depth, the locations, the cause, and the extent of the burn. Burns vary in size and severity from local redness to extensive destruction of the skin and underlying tissues. The first degree burn is like a mild sunburn which produces redness, warmth, swelling, and pain. The pain of a small, first degree burn may be relieved by quickly immersing the area in cold water or by applying a cold water or ice poultice. A simple, non-greasy, water soluble burn ointment, available at most drug stores, may be placed over the washed skin. Do not use vaseline, grease, or other greasy products on burns as these can be very difficult and painful to remove should the burn become infected or be deeper than first degree. After a first degree burn, the skin may peel and itch as it heals. A second degree burn is one that blisters, a sign that the injury has killed some of the surface skin cells. The second degree burn usually heals by itself and leaves little scarring. Small second degree burns should be gently cleaned with mild soap and running , moderately warm water and covered with a simple water soluble burn ointment plus a soft sterile dressing which is left in place for four to five days. If possible, the blisters should not be broken. If the burn is likely to get dirty, some doctors like to give a tetanus booster shot. If you have a burn with blistering and haven't had a recent tetanus shot, you should call your doctor for his opinion. A third degree burn kills the full thickness of the skin and therefore heals slowly and results in a scar. Very small third degree burns are treated with an antibiotic ointment and a sterile dressing. Healing takes a number of months and the dressing therefore needs to be changed. Again, some doctors give a tetanus booster shot. All third degree burns are best treated by a health professional rather than at home. Sunburn is a common injury which everyone knows something about. Sunburns over large areas of the body require medical attention as do burns caused by sunlamps. If you are using a sunlamp, cover your eyes completely and use an automatic timing device attached to the lamp so it will turn off in case you fall asleep. Sunburns of the eyes often happen when you are skiing and can be avoided by wearing special goggles. Burns form caustic agents such as lye or acids should be washed with high quantities of moderately warm water and examined by a physician. Electrical burns are serious since they frequently cause wider injury than is first believed. The location of a burn is an important consideration. A small burn of the eyelid is much worse than a similar one on the arm. The larger the burn, the more serious the injury. Indeed, a large burn represents the most serious injury of man. Large burns, whether first, second or third degree, should be treated by a physician. In addition to infections and the need for special treatments, serious burns can cause shock. Any patient with a serious burn should be brought to a doctor's office, clinic, or emergency room as soon as possible after the occurrence of the injury so that shock can be avoided or treated. The best treatment for a burn is prevention. Every open flame is a danger. Flame retardant fabrics can prevent the tragic injuries which occur when clothing catches fire. Scalding burns are also common and all homemakers should habitually use back burners and turn pot handles so that a child CANNOT reach them. Finally, anyone working around flammable agents must obey simple rules of safety if serious and fatal accidents are to be avoided. Remember, fat or grease fires must be extinguished with foam, not water. In the kitchen, the grease fires can be suffocated with damp towels or a pan lid. If you are concerned about the treatment of a burn, the safest course of action is to consult your physician or call a local emergency health service. Thank you. ! * NEW YORK STATE DEPARTMENT OF HEALTH Campylobacteriosis What is campylobacteriosis? Campylobacteriosis is a bacterial infection that affects the intestinal tract and, rarely, the bloodstream. It is probably the most common cause of bacterial diarrhea in New York State. Most cases are seen in the summer months and occur assingle cases or outbreaks. Is this a new disease? No. Campylobacteriosis has probably been in existence for many years but has only recently been recognized as a common infection due to improved laboratory methods. Who gets campylobacteriosis? Anyone can get campylobacter infection. How is the germ spread? Campylobacter are generally spread by eating or drinking contaminated food or water and, occasionally, by contact with infected people or animals. What are the symptoms of campylobacteriosis? Campylobacteriosis may cause mild or severe diarrhea, often with fever and traces of blood in the stool. How soon after exposure do symptoms appear? The symptoms generally appear two to five days after the exposure. Where are the campylobacter germs found? Many animals including swine, cattle dogs and birds (particularly poultry) carry the germ in their intestines. These sources in turn may contaminate meat products (particularly poultry), water supplies, milk and other items in the food chain. For how long can a person carry the campylobacter germ? Generally, infected people will continue to pass the germ in their feces for a few days to a week or more. Certain antibiotics may shorten the carrier phase. Do infected people need to be isolated or excluded from school or work? Since the organism is passed in the feces, only people with active diarrhea who are unable to control their bowel habits (infants, young children, certain handicapped individuals, for example) should be isolated. Most infected people may return to work or school when their stools become formed provided that they carefully wash their hands after toilet visits. Food handlers, children in day care and health care workers must obtain the approval of the local or state health department before returning to their routine activities. What is the treatment for campylobacteriosis? Most people infected with campylobacter will recover on their own or require fluids to prevent dehydration. Antibiotics are occasionally used to treat severe cases or to shorten the carrier phase, which may be important for food handlers, children in day care and health care workers. Since relapses occasionally occur, some physicians might treat mild cases with antibiotics to prevent a recurrence of symptoms. How can campylobacteriosis be prevented? 1. Always treat raw poultry, beef and pork as if they are contaminated and handle accordingly: - Wrap fresh meats in plastic bags at the market to prevent blood from dripping on other foods. - Refrigerate foods promptly; minimize holding at room temperature. - Cutting boards and counters used for preparation should be washed immediately after use to prevent cross contamination with other foods. - Avoid eating raw or undercooked meats. - Ensure that the correct internal cooking temperature is reached-particularly when using a microwave. 2. Avoid eating raw eggs or undercooking foods containing raw eggs. 3. Avoid using raw milk. 4. Encourage careful handwashing before and after food preparation. 5. Make sure children, particularly those who handle pets, wash their hands carefully. ! * CARPAL TUNNEL SYNDROME CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 CARPAL TUNNEL SYNDROME In recent years, reports of repetitive motion injuries have risen dramatically in workplaces across the country. These problems, frequently termed "Cumulative Trauma Disorders" are being reported at alarming rates in all types of workplaces - from meatpacking plants to newspaper pressrooms. Of all these disorders, carpal tunnel syndrome is the condition most frequently reported. What is Carpal Tunnel Syndrome (CTS)? The carpal tunnel receives its name from the 8 bones in the wrist, called carpals, that form a tunnel-like structure. The tunnel is filled with flexor tendons which control finger movement. It also provides a pathway for the median nerve to reach sensory cells in the hand. Repetitive flexing and extension of the wrist may cause a thickening of the protective sheaths which surround each of the tendons. The swollen tendon sheaths, or tenosynovitis, apply increased pressure on the median nerve and produce Carpal Tunnel Syndrome (CTS). What are the Symptoms of CTS? The symptoms of CTS often first appear as painful tingling in one or both hands during the night, frequently painful enough to disturb sleep. Accompanying this is a feeling of uselessness in the fingers, which are sometimes described as feeling swollen, even though little or no swelling is apparent. As symptoms increase, tingling may develop during the day, commonly in the thumb, index, and ring fingers. A decreased ability and power to squeeze things may follow. In advanced cases, the thenar muscle at the base of the thumb atrophies, and strength is lost. Many patients with CTS are unable to differentiate hot from cold by touch, and experience an apparent loss of strength in their fingers. They appear clumsy in that they have trouble performing simple tasks such as tying their shoes or picking up small objects. What Causes CTS? As stated earlier, swelling of the tendons that line the carpal tunnel causes CTS. Although there are many reasons for developing this swelling of the tendon, it can result from repetitive and forceful movements of the wrist during work and leisure activities. NIOSH research indicates that job tasks involving highly repetitive manual acts, or necessitating wrist bending or other stressful wrist postures, are connected with incidents of CTS or related problems. Moreover, it is apparent that this hazard is not confined to a single industry or job but occurs in many occupations--especially those in the manufacturing sector. Indeed, jobs involving cutting, small parts assembly, finishing, sewing, and cleaning seem predominantly associated with the syndrome. The factor common in these jobs is the repetitive use of small hand tools. How Large of a Problem is CTS? In the past ten years, more and more cases of workers afflicted with CTS have been reported in medical literature. One reason for this increase may be that automation and job specialization have fragmented workers' tasks to the point where a given job may involve only a few manipulations performed thousands of times per workday. Increased public awareness of work related risk factors has led to an increased number of requests for NIOSH health hazard evaluations (HHEs) to investigate suspected problems. The increased awareness of work tasks as a factor in the onset of CTS is reflected in the growing number of requests for health hazard evaluations (HHEs) received by NIOSH to investigate such suspected problems. NIOSH received about three times as many HHE requests related to hand and wrist pain in 1992 as compared to 1982. While no nationwide statistics on incidence and cost are available, the Wisconsin Workers' Compensation Division shows the number of compensated CTS cases in Wisconsin grew from 230 in 1983 to 1,937 in 1988. Additionally, the Bureau of National Affairs reports that a case of CTS can cost as much as $30,000. Prevention NIOSH recommendations for controlling carpal tunnel syndrome have focused on ways to relieve awkward wrist positions and forceful arm and hand movements. NIOSH recommends redesigning tools or tool handles to enable the user's wrist to maintain a more natural position during work. Other recommendations have involved modified layouts of work stations. Still other approaches include altering the existing method for performing the job task, providing more frequent rest breaks, and rotating workers across jobs. Tool and process redesign are preferable to administrative means, such as job rotation, as a means of prevention. The incidence and severity of CTS can be minimized through training programs that increase worker awareness of symptoms and prevention methods, and through proper medical management of injured workers. Treatment Treatment of CTS may involve surgery to release the compression on the median nerve and/or use of anti-inflammatory drugs and hand splinting to reduce tendon swelling in the carpal tunnel. Such medical interventions have met with mixed success especially when an affected person must return to the same working conditions. Current NIOSH Research In 1992, NIOSH continued to investigate cumulative trauma disorders (CTD's), such as CTS, among workers using keyboards in the news and telecommunications industries, direct mail order processors, and grocery store workers using laser scanning devices. NIOSH is also developing projects to study the ergonomic design of keyboards to reduce CTS, the ergonomics of powered hand tools in the automotive industry, and possibilities for ergonomic intervention in the beverage container delivery industry. In addition, NIOSH analyzed the 1988 National Health Interview Survey Data to estimate the prevalence of CTS in the adult population of the U.S. The findings show 2.8 million people self-reported CTS in 1988. White females between ages 45 to 54 were at the highest risk of self-reported CTS. A projected prevalence of "medically-diagnosed" carpal tunnel syndrome was about 0.7 million among "recent workers" (72% of U.S. adults). To improve the surveillance of CTS, NIOSH is assisting health departments in California, Massachusetts, and Wisconsin to develop pilot state-based strategies using voluntary reporting from health care providers. ! * Cataracts U.S. Department of Health and Human Services Public Health Service National Institutes of Health What is a cataract? A cataract is a cloudy or opaque area in the lens of the eye. The lens is located behind the pupil and iris. It helps focus light onto the retina, the light-sensitive tissue that lines the inside of the back of the eye. Usually, the lens is transparent. But if it becomes clouded, the passage of light is obstructed and vision may be impaired. What causes a cataract? When a cataract forms, there is a change in the chemical composition of the lens, but scientists do not know exactly what causes these chemical changes. The most common form of cataract is related to aging, although this type can occur at age 50 or even earlier. Cataracts also may be associated with diabetes, other systemic diseases, drugs, and eye injuries. Sometimes babies are born with congenital cataracts or develop them during the early years of life. What are the symptoms of a cataract? Cataracts usually develop gradually, without pain, redness, or tearing in the eye. Some cataracts never progress to the point where they seriously impair vision, whereas others eventually block most or all vision in the affected eye. The effect of a cataract on vision depends on several things: 1) its size, 2) its density, 3) its location within the lens. Among the signs that a cataract may be forming are: o Hazy, fuzzy, or blurred vision. Double vision sometimes occurs, but this usually goes away as the cataract worsens. o The need for frequent changes in eyeglass prescriptions. When the cataract progresses beyond a certain point, these changes no longer improve vision. o A feeling of having a film over the eyes, or of looking through veils or a waterfall. The person with a cataract may blink a lot in an effort to see better. o Changes in the color of the pupil, which is usually black. When the eye is examined, the pupil may look grey, yellow, or white, but color changes are not always noticeable. o Problems with light. For example, night driving becomes harder because the cloudy part of the lens scatters the light from oncoming headlights, making these lights appear double or dazzling. Also, the person with a cataract may have trouble finding the right amount of light for reading or close work. o "Second sight"-a temporary improvement in reading vision experienced by some people when their cataract reaches a certain stage of development. As the cataract progresses, vision again worsens. None of these symptoms necessarily means that a person has a cataract, or if a cataract is present that it must be removed. However, people who have any of these symptoms should see an eye doctor. When should a cataract be removed? A cataract should be removed surgically when it has progressed to the point where resulting vision problems interfere with one's daily activities. A second reason for cataract surgery, more urgent but less common than the first, is that the cataract has become completely opaque (mature). It is possible for a mature cataract to swell and even disintegrate inside the eye. Such changes can permanently endanger vision. With congenital cataracts, it used to be standard practice to postpone surgery until the child was at least 6 months old. Recently, however, cataracts have been removed from the eyes of newborn infants with good results. Early removal of severe congenital cataracts is an important advance because it reduces the risk of visual loss resulting from the disuse of one or both eyes during childhood. How are cataracts treated? Treating cataracts really involves two steps. The first is removal of the clouded lens by an ophthalmologist. Surgery is the only method proven effective for removing cataracts. The second is finding an appropriate substitute for the natural lens. The decision about which substitute lens to use is usually made before surgery. There are two general methods of removing a cataract: intracapsular and extracapsular extraction of the lens. Intracapsular extraction is sometimes used to remove senile cataracts. In this method, the entire lens, including its capsule, is removed. Extracapsular extraction involves removal of most lens tissue but the back part of the lens capsule is left in place. In infants and young children, whose lenses are relatively soft, the lens tissue may be withdrawn through a hollow needle, a procedure called aspiration. A variety of extracapsular techniques are also used to remove the lens in adults. One technique is called phacoemulsification. High-frequency sound vibrations (ultrasound) are used to soften and liquefy the lens so it can be aspirated through the needle. Phacoemulsification should not be confused with another form of eye surgery, photocoagulation, in which laser light-not ultra- sound-is used to treat some eye disorders other than cataract. A laser cannot remove a cloudy lens or make it dear again. However, some doctors may use a laser to open the front part of the lens capsule before removing the lens or to help patients who develop 66 after-cataract." (See "What happens after surgery?") How safe is cataract surgery? Cataract surgery is one of the most successful operations done today-more than 90 percent of the people who have this surgery find that they can see better. Complications may occur, but most are treatable. Serious complications that threaten vision are rare. Certain people may not benefit much from cataract surgery. They include people whose cataracts are not advanced enough to impair vision seriously and those whose vision is impaired by another eye disease as well. In summary, each cataract patient should discuss the possibility of surgery with the doctor who examines his or her eyes to determine whether the potential benefits of cataract surgery outweigh the risks. It is also very important to decide in advance, with the help of the doctor, what form of substitute lens would be most suitable. Patients may want to get a second opinion on the advisability of surgery and on the most appropriate substitute lens to use after surgery. What are the choices for a substitute lens? There are three options for replacing the natural lens removed,in cataract surgery: eyeglasses, contact lenses, or an intraocular lens implant. Each has advantages and drawbacks. Eyeglasses. This is a safe and time-proven solution to the problem of seeing without a natural lens. But cataract eyeglasses can have some unpleasant effects. Patients may be bothered by the fact that these glasses magnify objects 20-35 percent, affect depth perception until the person relearns how to judge distances, and limit side vision. If only one eye requires cataract surgery, eyeglasses may well cause problems because the person is unable to fuse the different-sized images formed by the operated and unoperated eyes. Such patients are often advised before surgery that it would be best to use a contact lens, or have a lens implant. Contact lenses. These usually provide better vision than eyeglasses and also are quite safe if handled and maintained properly. A contact lens may be especially helpful after cata- ract extraction in one eye. With a contact lens in the operated eye, the difference in the size of the images seen by the two eyes is much smaller. Soft contact lenses are commonly used for cataract patients. Another option is the extended-wear contact lens. These lenses can be left in the eye for a longer period of time without being removed, even for sleep. They may be especially useful for people who have trouble inserting and removing a contact lens, because an eye care specialist can remove and clean them period- ically. However, extended-wear lenses have some disadvantages: They are very fragile; some serious infections have been reported; their long-term safety is still being assessed; and they do require periodic removal, cleaning, and reinserting. Intraocular lenses. These devices, sometimes called IOLS, are clear plastic lenses that are implanted in the eye during the cataract operation. Lens implants have certain advantages: They usually eliminate or minimize the problems with image size, side vision, and depth perception noted by people who wear cataract eyeglasses. Also, because lens implants remain in the eye and do not have to be removed, cleaned, and reinserted, they are more convenient than contact lenses. This is particularly true for people who have physical problems that would make it difficult for them to carry out the procedures involved in using contact lenses. Because of these advantages, lens implants have been used with increasing frequency in recent years. About three-fourths of all people now undergoing cataract surgery have an IOL inserted at the same time, and the vast majority are very pleased with the results. Of course ophthalmologists will continue to study IOLs for many years in an effort to assess the long-term effects of implantation on the eye as well as the short-term complications. What happens after surgery? Most people who undergo cataract surgery are treated as outpatients and can go home the same day. For others, a stay in the hospital of 1-3 days may be required. In either case, during the early stages of recovery, patients need to take special care to avoid strenuous physical activity. Sometimes people whose cataract surgery was performed by the extracapsular method develop a problem called "after-cataract." After the operation, the back part of the lens capsule left in the eye may become cloudy and interfere with passage of light to the retina. The cloudy material must be cleared away, if possible, so that full vision can be restored. Ophthalmologists often treat after- cataract with an ophthalmic laser called the neodymium-YAG or "cold" laser. When this procedure is successful, the patient's vision is restored without additional eye surgery. What research is being done on cataracts? The National Eye Institute supports and conducts research on the eye and its disorders, including cataracts. The major goals of this research are to learn more about how and why cataracts develop, to find ways of preventing cataracts or slowing their progress, to evaluate the safety and effectiveness of techniques for treating cataracts, and to devise better methods of correcting vision after cataract surgery. This brochure was prepared by the National Eye Institute, NIH, Building 31, Room 6A31, Bethesda, MD 20893. The telephone number is: (301) 496-5248. NIH Publication No. 93-201 ! * What are Cataracts? by Bruce Tizes Cataracts affect the young and old and have been documented for longer than 5,000 years. From the ancient writings of the Egyptians and Chinese through the earliest portion of the seventeenth century we have known that cataracts interfere with vision and occur most frequently in older persons. In some countries of the world they are the leading cause of blindness. Anatomically the actual description of a cataract was precisely developed only as late at the eighteenth century, and the marvelous microsurgical techniques for visual rehabilitation have only been developed over the past few decades. Cataracts are nothing more or less than a clouding of the natural lens in each of our eyes. When one approaches the eye anatomically, from front to back, the structures encountered are the eye lids, the cornea (a clear dome), the anterior (front) chamber, the iris (colored part of the eye), and the pupil (the circular black hole in the center of the iris). Behind the pupil, and not very deep into the eye, is the lens, a discus shaped crystalline clear object. Just behind the lens, occupying the balance of the hollow eyeball is the vitreous (a clear jello-like substance), then the retina (nerve cells which pick up the light information much as a movie screen picks up the light from a movie projector) and the balance of the structural elements. The optic nerve transmits the visual information from the eye to the brain, and is roughly analogous to a telephone cord in it's transmission of information. Thus, light enters the eye through the open lids, passes through the cornea, the anterior chamber, the pupillary space in the iris, the lens, the vitreous cavity, and finally arrives at the retina and is sent to the brain via the optic nerve. If anything interferes with the proper functioning of any part of this system deterioration of visual quality will result. Functionally the lens serves as the fine focusing system of the eye, much as a magnifying glass when held in proper position will focus the sun's light rays to a fine point capable of burning a paper. The lens of the eye is susceptible to many difficulties, many of which result in clouding. It is easy to understand why it is difficult to see clearly through ground glass or a dirty automobile windshield, and it is equally easy to understand why it is difficult to see clearly through a cloudy lens of the eye. Medically the clouding of the lens is called a cataract; many causes for cataracts exist, and they range from trauma, aging, systemic diseases such as diabetes, and some cataracts can even be present at birth. Irrespective of the cause, the functional result of a clouding of the lens is the same, namely deterioration of the quality of the visual image. Several parameters to evaluate the seriousness of a cataract are commonly employed; they include: the vision of the eye, the amount of glare the eye suffers, the possibility of damage to the eye by the cataract, and the particular visual requirements that an individual patient. Treatment of cataracts is clearly linked with the seriousness of the problem. If one person has a small cataract, is not suffering much visual loss or life activity difficulty, and has no other reason for intervention, then that person should probably refrain from a surgical intervention. The person with substantial visual loss, inconvenience and disability has an equally clear choice, the rehabilitation of vision by cataract surgery. The correction of vision is a complicated topic, and much evolution of the techniques and procedures used is progressing even as you read these words. Generally, surgery is required and the person must have the benefit of a skilled ophthalmic surgeon. The surgical procedure, called a "cataract extraction," usually lasts under one hour, is performed under a microscope, in a hospital or out-patient surgical center, and is virtually painless. It is usually performed under local anesthesia (i.e. the patient does not go to sleep) and generally the patient returns home the same day. Technically the operation consists of an incision at the juncture of the sclera (white part of the eye) and the cornea. The lens is removed after careful manipulation, and any residual lens material is carefully removed. An intraocular lens implant is placed, if appropriate, and the eye is closed with fine sutures approximately one half of the thickness of a typical hair. Post-operatively the patient is patched for one or more days, which is followed by the use of an eye shield to protect the eye from trauma, and various types of eye drops and medications to properly govern the course of recovery. Visual rehabilitations may occur immediately, and is progressive over the weeks following surgery; the overwhelming majority of patients have substantial visual improvement. Intraocular lens implants ("implants") are plastic innert lenses that the surgeon insert during the surgery to improve the visual result. Although implants will generally avoid the need for thick glasses after surgery they are not appropriate for every patient. Final visual correction is usually achieved by approximately eight weeks after the surgery. ! * Cerebral Palsy (aka C.P.) is a nonspecific condition in which brain damage before or at birth leads to partial paralysis. The most common cause of the disorder is traumatic delivery due to either a small maternal pelvis, large fetal head, forceps compression of the head, umbilical cord strangulation, or the partial separation of the placenta from the uterus before delivery. Other causes include oxygen deprivation in the newborn due to excessive anesthesia, delayed spontaneous respiration, or severe cardiac malformations. Certain infections during pregnancy may also increase the risk of cerebral palsy. These infections include toxoplasmosis, measles, mumps, cytomegalicinclusion disease, and syphilis, all of which may affect brain tissue. Bacterial meningitis or encephalitis may occur as a result of nonsterile delivery and cause brain damage. Similarly, a fetus subjected to radiation or toxic chemicals, including alcohol, is also a candidate for cerebral palsy. As a result of the above, the infant may have a small brain, hydrocephalus, or focal lesions in the brain. The child's appearance ranges from the demented and deformed to the bright, alert, and happy, with one wasted and and spastic limb. Physical Therapy (aka P.T.) may provide some benefit, but the frequency of cerebral palsy will diminish only with improved prenatal care and delivery techniques. A.W. DUDLEY, MD. Taken from Cruickshank, William M., ed., Cerebral Palsy: A Developmental Disability, rev. 3rd ed 1976. ________________________________________________________________ General Information about CEREBRAL PALSY Fact Sheet Number 2 (FS2), 1993 ______________________________________________________________________________ NICHCY National Information Center for Children and Youth with Disabilities P.O. Box 1492 Washington, DC 20013 (703) 893-6061 (Local) (703) 893-8614 (TT) 1-800-999-5599 (Toll-free) SpecialNet User Name: NICHCY SCAN User Name: NICHCY ______________________________________________________________________________ General Information about CEREBRAL PALSY Fact Sheet Number 2 (FS2), 1993 ______________________________________________________________________________ NICHCY National Information Center for Children and Youth with Disabilities P.O. Box 1492 Washington, DC 20013 (703) 893-6061 (Local) (703) 893-8614 (TT) 1-800-999-5599 (Toll-free) SpecialNet User Name: NICHCY SCAN User Name: NICHCY ______________________________________________________________________________ DEFINITION OF CEREBRAL PALSY Cerebral palsy is a condition caused by damage to the brain, usually occurring before, during or shortly following birth. "Cerebral" refers to the brain and "palsy" to a disorder of movement or posture. It is neither progressive nor communicable. It is also not "curable" in the accepted sense, although education, therapy and applied technology can help persons with cerebral palsy lead productive lives. It is not a disease and should never be referred to as such. It can range from mild to severe. The causes of cerebral palsy include illness during pregnancy, premature delivery, or lack of oxygen supply to the baby; or it may occur early in life as a result of an accident, lead poisoning, viral infection, child abuse, or other factors. Chief among the causes is an insufficient amount of oxygen or poor flow of blood reaching the fetal or newborn brain. This can be caused by premature separation of the placenta, an awkward birth position, labor that goes on too long or is too abrupt, or interference with the umbilical cord. Other causes may be associated with premature birth, RH or A-B-O blood type incompatibility between parents, infection of the mother with German measles or other viral diseases in early pregnancy, and microorganisms that attack the newborn╒s central nervous system. Lack of good prenatal care may also be a factor. A less common type is acquired cerebral palsy: head injury is the most frequent cause, usually the result of motor vehicle accidents, falls, or child abuse. INCIDENCE Between 500,000 - 700,000 Americans have some degree of cerebral palsy. About 3,000 babies are born with the disorder each year, and another 500 or so acquire it in the early years of life. CHARACTERISTICS There are three main types of cerebral palsy: spastic -- stiff and difficult movement; athetoid -- involuntary and uncontrolled m ovement; and ataxic -- disturbed sense of balance and depth perception. There may be a combination of these types for any one individual. Other types do occur, although infrequently. Cerebral palsy is characterized by an inability to fully control motor function. Depending on which part of the brain has been damaged and the degree of involvement of the central nervous system, one or more of the following may occur: spasms; tonal problems; involuntary movement; disturbance in gait and mobility; seizures; abnormal sensation and perception; impairment of sight, hearing or speech; and mental retardation. DEVELOPMENTAL, EDUCATIONAL, AND EMPLOYMENT IMPLICATIONS Early identification of cerebral palsy can lessen developmental problems and lead to appropriate intervention when it helps the most. Early intervention programs are family-centered in which professionals and families work together with the child in specific activities. Educators, physical and occupational therapists, social workers, speech- language pathologists, psychologists and physicians can assist families by providing information and education. Activities for children with cerebral palsy may include: - speech and language therapy; - occupational therapy; - physical therapy; - medical intervention; - family support services; - early education; and - assistive technology. As a child gets older and begins formal schooling, the intensity of services will vary from individual to individual. Persons with cerebral palsy are usually able to attain a substantial degree of independence but, in some cases, may need considerable assistance. Services for the school age child may include continuing therapy, regular or special education, counseling, technical support, community integration opportunities, recreation and possible personal attendants. A key factor seems to be a supportive family. People extensively affected by cerebral palsy can still be highly functional and independent. The HEATH Resource Center, the clearinghouse on postsecondary education for individuals with disabilities, states that a significant number of students with cerebral palsy are enrolled in colleges and universities. Important advances have taken place in the last 15 years which have had a great effect on the long-term well-being of children born with cerebral palsy. Advanced technology, including computers and engineering devices, has been applied to the needs of persons with cerebral palsy. Technological innovations have been developed in the areas of speech and communication, self-care, and adapting living arrangements and work sites. The future may bring even more significant applications. Another important development has been the increased ability of persons with disabilities, including those who have cerebral palsy and other severe disabilities, to live independently in the community. Adults with cerebral palsy are now living, with or without assistance, in their own apartments or townhouses. Independent Living Centers have also proven to be important resources for persons with disabilities. RESOURCES Schleichkorn, J. (1983). Coping with Cerebral Palsy: Answers to Questions Parents Often Ask. Austin, TX: Pro-Ed, Inc. (Contact Pro-Ed, 8700 Shoal Creek Boulevard, Austin, TX 78758. Telephone: (512) 451-3246.) Geralis, E. (1991). Children with Cerebral Palsy, A Parent's Guide. Rockville, MD: Woodbine House. (Contact Woodbine House, 5615 Fishers Lane, Rockville, MD 20852. Telephone: Outside of the DC metropolitan area, call 1-800-843-7323; call (301) 468-8800 in DC metropolitan area.) Weiss, S. (1993). Each of Us Remembers: Parents of Children with Cerebral Palsy Answer Your Questions. Washington, DC: United Cerebral Palsy Associations, Inc. (See address and telephone number below.) ORGANIZATIONS American Academy for Cerebral Palsy and Developmental Medicine 1910 Byrd Avenue, Suite 100 P.O. Box 11086 Richmond, VA 23230-1086 (804) 282-0036 (For physician referral) Independent Living Residential Utilization Project (ILRU) The Institute for Rehabilitation and Research 2323 South Sheppard, Suite 1000 Houston, TX 77019 (713)520-0232; (713) 520-5136 (TT) National Easter Seal Society, Inc. 70 East Lake Street Chicago, IL 60601 (312) 726-6200; (312) 726-4258 (TT) (800) 221-6827 (Outside IL) National Rehabilitation Information Center (NARIC) 8455 Colesville Road Suite 935 Silver Spring, MD 20910-3319 (301) 588-9284 (TT/Voice); (800) 346-2742 United Cerebral Palsy Associations, Inc. 1522 K Street, N.W., Suite 1112 Washington, D.C. 20005 (202) 842-1266 (V/TT); (800) 872-5827 (V/TT) ! * CHICKEN POX (VARICELLA) CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 CHICKEN POX (VARICELLA) DISEASE INFO Chickenpox is a common, highly contagious disease of childhood. Most Americans will have been infected by the virus by age 15, and it is estimated that approximately 4 million cases occur each year. Children between 5 and 9 years of age account for the majority of all cases, with more cases occurring during the winter and spring than during other times of the year. Chickenpox is easily transmitted between household members or classmates at schools or day-care centers through the drainage from the open sores, respiratory droplets, or airborne particles. The virus can also be transmitted indirectly through contact with articles containing fresh drainage from the sores. Persons are most contagious from 1 to 2 days before the rash appears through the first 5 to 6 days after the rash. Generally, patients are no longer contagious after the sores have crusted over. Persons exposed to chickenpox are most likely to develop symptoms 14 to 16 days after exposure. However, for normal individuals, symptoms may appear any time after 10 days and up to 21 days. Chickenpox is characterized by 1 to 2 days of fever up to 102 degrees, general body weakness, and a rash, which in many children is the first sign of the disease. Only rarely will a person have chickenpox without a rash. Often, the rash begins on the scalp, moves to the trunk, and then to the arms and legs. The chickenpox rash usually is generalized, itchy, and progresses to blisters, which become open sores before crusting. The blisters contain a clear fluid that can transmit the virus to others. Successive crops of blisters appear over several days. In normal children, chickenpox is generally a mild disease although the following complications do occur. Sometimes bacterial skin infections will develop from the open sores associated with chickenpox. Other complications that are more rare but serious include pneumonia, infection of the brain (encephalitis), infections of the covering of the brain (meningitis), Reye syndrome, and death. Serious chickenpox disease and complications are more likely to occur in the following types of patients: 1. Those whose immune systems are not functioning normally, such as persons with certain leukemias or cancers, persons with AIDS, or persons taking drugs, including steroids, which suppress their immune systems; 2. Newborn infants whose mother developed the chickenpox rash close to the time of delivery; and 3. To a lesser degree, normal adults. After a chickenpox infection, persons generally have lifelong immunity to chickenpox and do not have a second episode of chickenpox. However, the virus can reactivate later in life as a different problem - zoster or shingles. This is particularly likely to happen if a person has a problem with their immune system such as can occur with older age, disease, or drugs. CHICKEN POX (VARICELLA) - PREGNANCY AND INFANTS More than 90% of the adult U.S. population is immune to chickenpox because of an infection during childhood. Therefore, for the vast majority of pregnant women, being exposed to chickenpox should pose little concern to either the pregnant woman or the unborn child. Pregnant women who are not immune to chickenpox, and who have been significantly exposed may be at increased risk. Both the pregnant woman and the unborn child have risks including: 1. A pregnant woman has an increased risk of complications associated with a chickenpox illness. However, remember that while chickenpox is usually a mild infection with few complications for normal children, for normal adults the infection can be more severe, and complications are a little more frequent. Therefore, normal adults, including pregnant women, may have an infection with symptoms somewhat more severe than children, and these adults are also at increased risk of complications. Pregnant women who are not immune to chickenpox and who have significant exposure to a person with chickenpox can be evaluated by their doctor for possible treatment with Varicella-Zoster Immune Globulin, also known as VZIG. Treatment with VZIG, if given within 96 hours of exposure, can prevent or moderate a chickenpox infection in the pregnant women. There is, however, no evidence that VZIG can prevent or moderate a chickenpox infection in the unborn child. A treatment dose of VZIG costs between $400 and $500 and physicians can obtain VZIG from The American Red Cross. 2. The unborn child is at a low risk of birth defects if the pregnant woman is infected with chickenpox during the first 16 weeks of pregnancy. Infants whose mother was infected with chickenpox during the first 16 weeks of pregnancy rarely develop congenital varicella syndrome, which can include eye, skin, or limb defects in the child. The risk of having congenital varicella is low (around 2 to 3 percent), and is similar to the risk of developing birth defects in general. Unborn children whose mother is infected with chickenpox after the first 16 weeks do not appear to develop congenital varicella syndrome. 3. The newborn child is at increased risk of serious infection if the pregnant woman is infected with chickenpox close to the time of delivery. If the mother develops chickenpox between 5 days before delivery and 48 hours after delivery, the newborn infant may develop serious infection. Infants whose mothers develop chickenpox outside the "5 days before to 48 hours after delivery" window do not appear to be at increased risk of serious illness. 4. Premature infants who have significant exposure after birth may be at increased risk for serious illness, especially those infants born before 28 weeks of gestation, or whose mothers are not immune to chickenpox. If there is concern that a pregnant woman has been exposed to chicken pox, there are 3 ways to figure out if she ia already immune to chickenpox: 1. By asking her parents or relatives if they remember whether she had chickenpox. 2. Check the medical records of her family or pediatric physician. 3. Have a laboratory test performed that would indicate whether she was already infected and thus is immune. If the pregnant woman is not known to be immune to chickenpox, it is important to figure out whether she was significantly exposed to a person with chickenpox. Significant exposure means being in the presence or having prolonged contact with someone who is developing or currently has a chickenpox infection. For example, significant exposure to chickenpox can include: (a)continuous household contact. (b)playmate contact of greater than one hour. (c)hospital contact involving the same bedroom, or adjacent beds in a large ward, or (d)prolonged face-to-face contact. If a woman is pregnant and had a significant exposure to chickenpox, she should consult with her physician about the risk to herself and her unborn child. CHICKEN POX (VARICELLA) - EXPOSED Since 3 to 4 million cases of chickenpox occur each year, exposure is very difficult to prevent, especially in children. More than 90% of the adult U.S. population are already immune to chickenpox because they were infected during childhood. Therefore, for the vast majority of normal adults, being exposed to chickenpox should pose little or no concern. For a person to become infected with chickenpox, they must be both susceptible to infection (that is, not immune) and have significant exposure to an infected person. Individuals who want to know if they have had chickenpox can do one of the following: 1. Ask relatives if anyone remembers them having chickenpox. 2. Check the medical records of their family or pediatric physician. 3. Have a laboratory test performed that would indicate whether they have been infected previously and therefore are immune. Significant exposure to chickenpox can include: (a)continuous household contact. (b)playmate contact of greater than one hour. (c)hospital contact involving the same bedroom, or adjacent beds in a large ward or (d) prolonged face-to-face contact. Remember that chickenpox is a mild infection with few complications in normal children. However, certain groups of people are at greater risk for more serious infection and complications. These groups include the following: high- risk newborn infants, which are those newborn infants whose mother developed chickenpox between 5 days before delivery to 48 hours after delivery, and persons with a defective immune system, such as cancer and leukemia patients, persons with AIDS, or persons taking drugs, including steroids, which suppress their immune system. Normal adults are at a greater risk of developing serious illness or complications, than children, but most do not have serious illness. Complications of chickenpox include skin infections, pneumonia, brain inflammations, infections of other body organs, Reye syndrome, and death. Because Reye syndrome, a serious brain and liver disease, may occur after using aspirin during an episode of chicken pox or flu, aspirin is not recommended for treatment of symptoms of chickenpox or flu. In fact, never give aspirin to children without first consulting a physician. There is currently no licensed vaccine for chickenpox in the United States. Persons at high risk of serious chickenpox illness who are not immune to chickenpox should be evaluated by their doctor for treatment with Varicella- Zoster Immune Globulin, also known as VZIG, if they have significant exposure to infection. In some cases, treatment with VZIG, if given within 96 hours of exposure, can prevent or moderate a chickenpox infection. A treatment dose of VZIG costs between $400 and $500 and physicians can obtain VZIG from The American Red Cross. There is no evidence that VZIG can prevent or moderate a chickenpox infection in an unborn child. CHICKEN POX (VARICELLA) - VZIG (Varicella-Zoster Immune Globulin) Varicella-Zoster Immune Globulin, also know as VZIG, can be used to modify or prevent chickenpox in susceptible individuals who have had recent significant exposure to the disease. To be effective, VZIG should be administered within 96 hours of exposure. Treatment with VZIG may lengthen the incubation period of chickenpox to as long as 28 days. VZIG is normally used to treat individuals who have a high risk of serious disease or complications, including immunocompromised children, high risk newborn children, premature infants with significant exposure, and immunocompromised adults. Normal adults, including pregnant women, should be evaluated on a case by case basis. Because there is no evidence that VZIG can prevent or modify a chickenpox infection in the unborn child, the decision to administer VZIG to a pregnant woman is based on the benefits to the woman alone. The duration of protection after VZIG administration is unknown, but VZIG is probably effective for at lease three weeks. VZIG is not known to be useful in treating clinical chickenpox or shingles after the infection has developed, or in preventing disseminated shingles, and VZIG is not recommended for these uses. VZIG costs between $400 and $500 for an adult dose. It is available from the American Red Cross through its regional offices. CHICKEN POX (VARICELLA) - PREVENTION Because chickenpox is highly contagious even before symptoms appear, prevention is difficult. Susceptible persons who have been exposed to chickenpox and may be developing the disease should be kept from contact with persons at high risk for serious chickenpox infection, such as patients with defective immune systems, from 10 days until 21 days after exposure. Isolating infected persons for 1 week after eruption of sores is prudent and somewhat effective in limiting the spread of chickenpox. Varicella-Zoster Immune Globulin, also know as VZIG, can be used to prevent or modify chickenpox in susceptible individuals with significant exposure to the disease. Ordinarily, VZIG is reserved for use with persons who are at high risk for serious chickenpox disease or complications. To be effective VZIG should be administered within 96 hours of exposure. Persons who develop mild chickenpox after receipt of VZIG may still be infectious. A vaccine to prevent chickenpox has been developed by Merck Sharp Dohme Research Laboratories and is being tested for use in normal children and adults; it may become available within a couple of years. TREATMENT Once a person develops chickenpox, treatment may include bedrest and medication for fever, headache, and itching. Your local physician familiar with your child is best suited to recommend treatment for chickenpox. In all cases, contact your physician before using any treatment because some preparations are harmful if not used in the correct dose, especially in children. Remember that aspirin should not be given to children to control fever, pain, or headache associated with chickenpox. In fact, never give aspirin to children without first consulting a physician. Instead, acetaminophen products (like Tylenol), may be used to treat mild complaints. Also, do not use skin treatments containing diphenhydramine without first consulting a physician. Acyclovir and Arabinoside-A are antiviral drugs used to treat individuals with serious chickenpox disease and complications. These drugs are sometimes used to treat patients with defective immune systems and high-risk newborn infants. These drugs are not usually used to treat chickenpox in normal healthy children with a routine chickenpox illness. CHICKEN POX (VARICELLA) - STATISTICS Chickenpox is a common, highly contagious disease of childhood that occurs usually during late winter and early spring. Most Americans will have been infected by the virus by age 15, and it is estimated that approximately 3.5 to 4 million cases occur each year. Not all states require that health care workers report chickenpox cases. Some cases of chickenpox are so mild that medical attention is never sought. Therefore, only an average of 225,000 cases of chickenpox are reported to the CDC annually. Even though most cases of chickenpox are mild with few complications, between 40 and 90 chickenpox- related deaths occur annually. About half these deaths occur in normal individuals, and half in persons whose immune systems are not functioning normally. A few other deaths are from Reye Syndrome, which can occur in children following the use of aspirin during an episode of chickenpox. During the past few years, the deaths due to chickenpox have been decreasing. The decrease in the death rate may be due to both improved treatment and to a decrease in Reye Syndrome. ! * Chlamydia CHLAMYDIA (Chlamydia trachomatis) One of the most prevalent and problematic sexually transmitted diseases (STDs) is Chlamydia. This bacterial disease causes infections affecting 3-4 million people each year. Chlamydia may occur alone, but can also occur simultaneously with other sexually transmitted diseases. For women, it is the most frequent cause of pelvic inflammatory disease (PID), an infection of the internal reproductive organs which may result in infertility if left untreated. For men, Chlamydia is the most frequent cause of NGU, or Nongonococcal Urethritis, and can also cause sterility. Symptoms/Transmission ---------------------- Chlamydia is transmitted through sexual contact, most often intercourse. The infection causes symptoms for some people, while others have no symptoms at all. Women are more likely than men to have Chlamydia without symptoms. In many cases, the infection is first noticed during a routine pelvic examination. Examination is recommended for the presence of any of the following symptoms: vaginal itching or discharge; burning on urination; pain in the abdomen or pelvis; pain with intercourse; or swollen glands in the groin. Men may have mild burning with urination and for some men, this symptom may resolve without treatment. However, many times the infection is still present without any evident symptoms and can cause permanent damage. Examination is recommended if symptoms such as a discharge, painful or burning urination or swollen glands are noticed. Diagnosis ---------- If the clinician who examines you suspects the presence of Chlamydia or other infections, testing will be recommended. The test involves a painless procedure in which a swab is used to take a sample of cells from the cervix (for women) or from the urethra (for men). This test sample is sent to the McKinley Health Center Laboratory for evaluation and the results are available within a few days. During this waiting period, it is recommended that you refrain from sexual intercourse. ! * DEAR DOCTOR COLUMNS ARE WRITTEN BY UAB (UNIVERSITY OF ALABAMA AT BIRMINGHAM) EXPERTS AND APPEAR WEEKLY IN "THE BIRMINGHAM NEWS" QUESTION: My daughter is on her high school's swim team. She is very fair skinned with light blonde hair. Her beautiful hair has turned green, and others tell me it's the chlorine in the pool. Her hair is also dry. Is there anything she can do to protect her hair? ANSWER: It's somewhat misleading to say that chlorine used to keep swimming pools free of germs turns hair green. Actually, it's chlorine's oxidation of dissolved metals such as copper in the pool water that causes blonde and grey hair to take on a greenish tint. As a bleach, chlorine does lighten hair. But it also eats away at the cuticle -- the protective outer protein layer of the hair shaft -- causing hair to become split, dry, and brittle. Damaged cuticle also allows the hair shaft to absorb dissolved metals in pool water. Permed and color-treated hair intensifies the drying effects of chlorine. Wearing a bathing cap will help protect your daughter's hair against pool chemicals. And many competitive swimmers use a cap to streamline their movements through water by cutting down on drag. Running some protein conditioner or oil treatment through her hair before putting on a bathing cap, will coat the hair shaft for extra protection. Your daughter should wash her hair immediately after getting out of the pool and avoid letting her hair dry without at least rinsing the pool water out of her hair. ! * CHOLERA CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 FOOD AND WATER BORNE BACTERIAL DISEASES CHOLERA CDC has detailed information to help people understand foodborne diseases. This information is referenced on the Disease Information Directory. Cholera is an acute intestinal infection. Cholera occurs in many of the developing countries of Africa, and Asia, where sanitary conditions are less than optimal. Most recently, cholera outbreaks have occurred in parts of Latin America. Most infected persons have no symptoms or only mild diarrhea. However, persons with severe disease can die within a few hours after onset due to loss of fluid and salts through profuse diarrhea and, to a lesser extent, through vomiting. Only a few cases of cholera have occurred in the United States since 1973. Even with foreign travel, the risk of infection to the U. S. traveler is very low, especially for those who are follow the usual tourist itineraries and stay in standard accommodations. Worldwide cholera activity is characterized by occasional epidemics in developing countries. The organism that causes the illness is named Vibrio cholerae type O:1. During epidemics, it is spread by ingestion of food or water contaminated directly or indirectly by feces or vomitus from infected persons. Diagnosis is made by culturing the bacteria from the stool of a patient and confirming that the organism produces toxin. The best protection is to avoid consuming food or water that may be contaminated with feces or vomitus from infected persons. The organism can grow well in some foods, such as rice, but it will not grow or survive in very acidic foods, including carbonated beverages, and is killed by heat. A cholera vaccine is available, but normally is not recommended. Only 50% of those who take the vaccine develop immunity to cholera, and this immunity lasts only a few months. Treatment for cholera involves rehydration with oral rehydration solution or, in the most severe cases, with intravenous solutions until the patient is able to ingest fluids. Treatment with antibiotics (usually tetracycline or doxycycline) will decrease the duration of illness and the excretion of live cholera bacteria, and will decrease the volume of fluid lost, but is not necessary for successful treatment. CHOLERA VACCINE INFORMATION A cholera vaccine is available, but normally is not recommended. Only 50% of those who take the vaccine develop immunity to cholera, and this immunity lasts only a few months. No country currently requires the cholera vaccine for entry if arriving from cholera-infected countries. Consult the International Travelers Hotline for specific recommendations. The complete vaccination schedule includes 2 doses of vaccine spaced 1 to 4 or more weeks apart. Dosages are age specific. For infants 0-6 months of age; the vaccine is not recommended. Data indicate that simultaneous administration of cholera and yellow fever vaccines produces less-than-normal antibody responses to both vaccines. A three week minimum interval between cholera and yellow fever vaccines is recommended. In cases where both vaccines are required and time constraints exist, then administer simultaneously or as far apart as possible. Reactions to the vaccine are: 1-2 days of pain, erythema, and induration at the site of injection; fever, malaise, and headache. Serious reactions are rare, but if experienced, re-vaccination is not advisable. No specific information on the safety of cholera vaccine in pregnancy is available, therefore vaccination should be avoided. ! * CHOLESTEROL: THE NUMBERS Cholesterol is an essential substance in animal cells. However, when present in excess in susceptible animals, it can accumulate in damaged blood vessel walls. This can lead to stoppage of blood flow in the blood vessel. If the vessel involved is a coronary artery, a heart attack results. If a brain artery is involved, the result is a stroke. While factors other than high cholesterol are necessary for atherosclerosis to occur, high blood cholesterol is a major modifiable factor. Smoking and high blood pressure are the other two factors. The presence of any one of these factors doubles the risk of heart disease. Having two of these factors increases the risk more than four times. Having all three factors increases the risk of heart disease and stroke more than eight times normal. A goal of modern preventive medicine is to identify those individuals with high cholesterol and to provide them with the means to reduce this to a normal or low level. Here are the recommended maximum levels for total cholesterol. AGE RECOMMENDED MODERATE RISK HIGH RISK 20-29 Under 180 200-220 220+ 30+ Under 200 201-239 240+ The total cholesterol level, however, can be misleading. Cholesterol in the body is attached to molecules called lipoproteins which transport it. Some lipoproteins (called LDL and VLDL) lead to an over accumulation of cholesterol and a risk of atherosclerosis. Other lipoproteins (HDL) transport cholesterol out of the body and thus reduce the risk of atherosclerosis. Total cholesterol is a quantitative measurement of all the cholesterol bound to all of the lipoprotein, both the "good" and the "bad". Thus, to better evaluate one's risk, we need to separately measure the protective and the dangerous lipoprotein. A simplified way to do this is to independently measure the total cholesterol level and the HDL cholesterol level. We then divide the total cholesterol by the HDL cholesterol to give the Cholesterol/HDL Cholesterol Ratio. This ratio is a much better predictor of atherosclerosis because it looks at the balance between the "good" and "bad" cholesterol which is not possible with only the total cholesterol value. Complete cholesterol testing is available for a small fee through the Student Health Service for students. Faculty & staff can obtain cholesterol testing through their private physician or the Wellness Program. Following is a list of recommended reading for diet and exercise. GOOD FAT, BAD FAT: HOW TO LOWER YOUR CHOLESTEROL & BEAT THE ODDS OF HEART ATTACK, Glenn Griffin & William Castelli (ed. by Bill Fisher), Fisher Books, 1988. NEW AMERICAN DIET, Conner, Simon and Schuster, 1986 PHYSIOLOGY OF FITNESS, 2nd edition. Dr. Brian J. Sharkey: Human Kinetics Publishers, Inc., Illinois, 1984. ROCKPORT WALKING PROGRAM, Dr. James Rippe & Ann Ward, PhD., Prentice Hall PRess, New York, 1988. THE AEROBICS PROGRAM FOR TOTAL WELLBEING. Dr. Kenneth Cooper, Bantam Books, New York, 1962. ! * American Heart Association Cholesterol and Your Health Know Your Numbers A routine visit to a physician by a healthy American adult might include having a blood sample drawn and analyzed. Usually the lab work is completed, the results are reported to the physician, and the numbers are recorded on the patient's chart. The American Heart Association suggests that patients ask their physicians to discuss these results when they are available and understand what the tests are for and what the numbers mean. One report the physician generally requests is cholesterol level. Cholesterol is a fat- like substance carried in the blood which comes from two sources. "Blood cholesterol" is produced primarily by the liver, while "dietary cholesterol" is found in foods from animals. These foods include egg yolks, meat, fish, poultry and whole milk dairy products such as ice cream and cheese. A certain amount of cholesterol is needed to generate hormones and cells. However, when the blood cholesterol climbs above the desirable level, cholesterol can build up over a period of time with some other substances on the inner lining of blood vessels like rust in water pipes. During that time, the buildup can narrow those vessels, keeping sufficient oxygen-carrying blood from getting to the heart or brain. It is easy for a clot to form that will clog the vessels, cutting off the flow of blood. The result can be heart attack or stroke. To understand what the numbers resulting from a blood cholesterol test mean, first know that cholesterol is measured in milligrams per deciliter of blood, expressed as "mg/dl." Also be aware that the level varies depending on age, sex, and the presence of certain disease. If other risk factors are present-smoking, high blood pressure, diabetes, glucose imbalances, excess weight or a history of heart disease in the patient's family, the probability of having a heart attack increases regardless of cholesterol level. The American Heart Association considers a healthy American adult, 20 years or older, at "low risk" for cardiovascular disease when cholesterol measures 200 mg/dl or lower, if no other phase of cardiovasculardisease or any other cardiovascular risk factors are present. The same adult is at "moderate risk" if cholesterol level is between 200 and 239 mg/dl, and at "high risk" with a reading of 240 mg/dl or higher. If it is determined that a patient has a high cholesterol level, the AHA recommends that the physician determine the appropriate treatment. This will usually include a low-fat, low-cholesterol diet. The physician should also address other major risk factors, including smoking and high blood pressure. More than 50 percent of middle-aged Americans have cholesterol levels 200 mg/dl and above. It is prudent for all adults to follow a heart-healthy, low-fat, low- cholesterol diet as a preventive measure. Have your cholesterol checked regularly by a physician and know your numbers. ! * So You Have High Blood Cholesterol... U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health NIH Publication No. 92-2922 Reprinted April 1992 [Graphic Omitted] National Cholesterol Education Program National Heart, Lung, and Blood Institute National Institutes of Health Know Your Cholesterol Level Lowering your high blood cholesterol is an important step to reducing your risk of coronary heart disease, Remember to ask your doctor to tell you your total cholesterol, LDL-cholesterol, and HDL-cholesterol levels. Use the charts below to record your progress. Date _________________________ Date _________________________ Total Cholesterol ____________ Total Cholesterol ____________ HDL __________________________ HDL __________________________ LDL __________________________ LDL __________________________ Date _________________________ Date _________________________ Total Cholesterol ____________ Total Cholesterol ____________ HDL __________________________ HDL __________________________ LDL __________________________ LDL __________________________ Date _________________________ Date _________________________ Total Cholesterol ____________ Total Cholesterol ____________ HDL __________________________ HDL __________________________ LDL __________________________ LDL __________________________ Table of Contents So You Have High Blood Cholesterol High Blood Cholesterol: What It Means How high does your blood cholesterol level have to be to affect your health? How does high blood cholesterol lead to coronary heart disease? What will lowering your high blood cholesterol level do? What factors influence your blood cholesterol level? Blood Cholesterol and Lipoproteins: What They Are Is there "good" and "bad" cholesterol? How are LDL and HDL levels determined? What do your LDL and HDL levels mean? How To Lower Your High Blood Cholesterol What foods contain fat and cholesterol? What are some practical guidelines for changing your diet? What You Can Expect How soon and how much can you expect your blood cholesterol levels to change? How long do you need to follow this diet? What should your blood cholesterol goal be? How do you check your progress? How often should you have your blood cholesterol levels checked? Can you eat before your test? Other Steps You Can Take Do you need to take special medications along with your diet? What are these medications? Do you need to make other changes to lower your blood cholesterol level? What else can you do to lower your risk for coronary head disease? Where You Can Go For Help What other health professionals, in addition to your doctor, can give you help? How can you get more materials about high blood cholesterol? Glossary So You Have High Blood Cholesterol... [Graphic Omitted] Anyone can develop high blood cholesterol regardless of age, sex, race, or ethnic background. But, because there are no warning symptoms or signs, you are likely to be surprised at such a diagnosis. Don't be alarmed, but do take it seriously. Like high blood pressure, most people are unaware that their blood cholesterol levels are high until they learn it from their doctor. And, like high blood pressure, it is a potential threat to your health that you can do something about. If you have just learned that you have high blood cholesterol, there are some important facts you need to know to protect your health. First, you need to find out what high blood cholesterol is, how high your level is, and what you can do to lower it. Then prepare to make some changes. Although these changes will depend on many factors considered by your doctor, modifying your diet is the preferred way to lower blood cholesterol. This brochure will answer many of the questions you may have about your blood cholesterol level. The glossary will help you become familiar with the terms used in this brochure and in other information about cholesterol. High Blood Cholesterol: What It Means High blood cholesterol is one of the three major risk factors for coronary heart disease (cigarette smoking and high blood pressure are the other two). In other words, high blood cholesterol can significantly increase your risk of developing heart disease. Fortunately all three risk factors are "modifiable"; that is, you can do something about them. You can take steps to lower your cholesterol level and thus lower your risk for coronary heart disease. High blood cholesterol occurs when there is too much cholesterol in your blood. Your cholesterol level is determined partly by your genetic makeup and the saturated fat and cholesterol in the foods you eat. Even if you didn't eat any cholesterol, your body would manufacture enough for its needs. How High Does Your Blood Cholesterol Level Have To Be To Affect Your Health? The risk of developing coronary heart disease increases as your blood cholesterol level rises. This is why it is so important that you have your blood cholesterol level measured. Currently, more than half of all adult Americans have blood cholesterol levels of 200 mg/dl or greater, which places them at an increased risk for coronary heart disease. Approximately 25 percent of the adult population 20 years of age or older has blood cholesterol levels that are considered "high," that is, 240 mg/dl or greater. [Graphic Omitted] Your doctor will measure your level with a blood sample taken from your finger or your arm and will confirm this result with a second test if it is greater than 200 mg/dl. The following table can help you see how the results of your total blood cholesterol tests relate to your risk of developing coronary heart disease. Does Your Total Blood Cholesterol Increase Your Risk For Developing Coronary Heart Disease? Desirable Borderline-High High Blood Cholesterol Blood Cholesterol Blood Cholesterol Less than 200 mg/dl 200 to 239 mg/dl 240 mg/dl and above Note: These categories apply to anyone 20 years of age or older. A blood cholesterol level of 240 mg/dl or greater is considered "high" blood cholesterol. But any level above 200 mg/dl, even in the "borderline-high" category, increases your risk for heart disease. If your blood cholesterol is 240 mg/dl or greater, you have more than twice the risk of someone whose cholesterol is 200 mg/dl, and you need medical attention and further testing. [Graphic Omitted] When your high blood cholesterol level is combined with another major risk factor (either high blood pressure or cigarette smoking), your risk for coronary head disease increases even further. For example, if your cholesterol level is in the "high" category and you have high blood pressure, your risk for coronary head disease increases six times. If you also smoke, your risk increases more than 20 fold. Other factors that increase your risk for coronary head disease include a family history of coronary heart disease before the age of 55, diabetes, vascular (blood vessel) disease, obesity, and being male. Whether your total blood cholesterol is in the "borderline-high" category or "high" category, you should make some changes in your diet to lower your level. More specifically, if your level is in the "borderline-high" category and you have coronary head disease or two other risk factors for coronary heart disease or is in the "high" category, your physician will prescribe more aggressive treatment and follow your cholesterol levels more closely. If your cholesterol level is desirable, you should have your level checked again in 5 years and take steps to prevent it from rising. Risk Factors for Coronary Hearth disease High blood cholesterol High blood pressure Cigarette smoking Family history of coronary hearth disease before the age of 55 Diabetes Vascular disease Obesity Being male How Does High Blood Cholesterol Lead to Coronary Heart Disease? Most coronary heart disease is caused by atherosclerosis, which occurs when cholesterol, fat, and other substances build up in the walls of the arteries that supply blood to the heart. These deposits narrow the arteries and can slow or block the flow of blood. Among many things, blood carries a constant supply of oxygen to the heart. Without oxygen, heart muscle weakens, resulting in chest pain (angina), a heart attack (myocardial infarction), or even death. Atherosclerosis is a slow progressive disease that may start very early in life yet might not produce symptoms for many years. [Graphic Omitted] What Will Lowering Your High Blood Cholesterol Level Do? Lowering your high blood cholesterol level will slow fatty buildup in the walls of the arteries and reduce your risk of a heart attack and death caused by a heart attack. In fact, some studies have shown that, in adults with "high" blood cholesterol levels, for each 1 percent reduction in total cholesterol levels, there is a 2 percent reduction in the number of heart attacks. In other words, if you reduce your cholesterol level 15 percent, your risk of coronary heart disease could drop by 30 percent. What Factors Influence Your Blood Cholesterol Level? * Diet. Among the factors you can do something about, diet has the largest effect on your blood cholesterol level. Saturated fat raises your blood cholesterol level more than anything else you eat. Dietary cholesterol also increases your blood cholesterol level. If you have high blood cholesterol, changing your diet will be a very important step to lower it. * Weight. Being overweight may also increase your blood cholesterol level. Most overweight patients with high levels of cholesterol can help lower their levels by weight reduction. * Physical activity/exercise. Although it is not clear whether physical activity can prevent atherosclerosis, regular exercise may help you control weight, lower your blood pressure, and increase your level of HDL cholesterol, the "good" type of blood cholesterol. (HDL cholesterol is explained in a later section.) * Genetic factors. Genetic factors play a major role in determining your blood cholesterol level and can determine your ability to lower your level by diet. A small number of people have an inherited tendency to have a high blood cholesterol level. If you have a genetic disorder contributing to a high blood cholesterol level, then your parents, children, brothers, and sisters should also have their blood cholesterol levels measured. * Sex/age. Coronary heart disease is the leading cause of death and disability for both men and women in the United States. Estimates are that 1 out of 5 men and 1 out of 17 women will have symptoms of heart disease before the age of 60. This means that men have two to three times the risk of developing heart disease as women. However, in women as in men, cholesterol levels are predictive of coronary heart disease. [Graphic Omitted] In the United States, blood cholesterol levels in men and women start to rise at about age 20. Women's blood cholesterol levels prior to menopause (45-60 years) are lower than those of men of the same age. After menopause, however, the cholesterol level of women usually increases to a level higher than that of men. In men, blood cholesterol levels off around age 50 and the average blood cholesterol level declines slightly after age 50. Since the risk of coronary head disease is especially high in the later decades of life, reducing blood cholesterol levels may be important in the elderly. In addition, oral contraceptives and pregnancy can increase blood cholesterol levels in some women. For pregnant women, blood cholesterol levels should return to normal 20 weeks after delivery. [Graphic Omitted] * Alcohol. You may have heard that modest amounts of alcohol can improve your cholesterol profile by increasing your HDL-cholesterol level. However, it is not known whether the higher level produced by alcohol protects against coronary head disease. With this in mind and because drinking can have serious adverse effects, alcohol is not recommended in the prevention of coronary head disease. * Stress. Although stress has been reported to raise blood cholesterol levels, there may be other explanations for this effect. For example, during periods of stress, people may eat more foods that are high in saturated fat and cholesterol, which may increase their blood cholesterol levels -- rather than the stress itself. While all of these factors can influence your blood cholesterol level, clearly you can do something about a number of them. In fact, most people are able to lower their blood cholesterol levels with diet alone. Blood Cholesterol and Lipoproteins: What They Are Cholesterol is an odorless, soft, waxy substance. Your body needs cholesterol to function normally (for example, as a component of cell membranes and for the production of many hormones, vitamin D, and bile acids -- which are important for the absorption of fat). Cholesterol is present in all parts of the body, including the brain and nervous system, muscle, skin, liver, intestines, heart, skeleton, etc. The cholesterol level of your blood is affected by: * The cholesterol your body produces and * The saturated fat and cholesterol in your diet. [Graphic Omitted] Your blood cholesterol level is affected not only by the saturated fat and cholesterol in your diet, but also by the cholesterol your body produces. As a matter of fact, your body produces all the cholesterol it needs, and the saturated fat and cholesterol in your diet only serve to increase your blood cholesterol level. Is There "Good" and "Bad" Blood Cholesterol? Cholesterol travels in the blood in packages called lipoproteins. All lipoproteins are formed in the liver and carry cholesterol through the body. Blood cholesterol packaged in low density lipoproteins (LDLs) is transported from the liver to other parts of the body where it can be used. LDLs carry most of the cholesterol in the blood, and if not removed from the blood, cholesterol and fat can build up in the arteries contributing to atherosclerosis. This is why LDL-cholesterol is often called "bad cholesterol." Cholesterol is also packaged in high density lipoproteins (HDLs). HDLs carry cholesterol back to the liver for processing or removal from the body. HDLs therefore help remove cholesterol from the blood, preventing the accumulation of cholesterol in the walls of the arteries. Thus they are often referred to as "good cholesterol." How are LDL and HDL Levels Determined? If your total cholesterol level is either in the "high" category or in the "borderline-high" category and you have coronary head disease or two other risk factors for coronary heart disease, your doctor will want a more complete "cholesterol profile" that includes LDL-cholesterol, HDL cholesterol levels, and triglyceride levels. A blood test provides this information: you will have to fast for 12 hours prior to the test. (You may notice that your LDL -- and HDL cholesterol values do not add up to your total blood cholesterol level. LDLs usually carry about 60-70 percent and HDLs about 25 percent of the total cholesterol in your blood. Other lipoproteins carry the rest.) Some laboratories may calculate your cholesterol ratio. This measurement is actually just your total cholesterol or LDL-cholesterol divided by your HDL-cholesterol. For example, if your LDL-cholesterol level is 140 mg/dl and your HDL-cholesterol level is 35 mg/dl, your cholesterol ratio is 1 40/35, or 4. However, HDL-, LDL-, and total cholesterol levels are independent predictors of your risk for coronary heart disease. Because combining these values into a ratio can conceal information useful to you and your physician, it is more important to know each value separately. What Do Your LDL and HDL Levels Mean? Along with your total blood cholesterol level, your LDL and HDL levels provide more information on your risk of developing coronary heart disease. A high LDL-cholesterol level or a low HDL-cholesterol level puts you at increased risk. LDL- and HDL-cholesterol levels more accurately predict your risk for coronary heart disease than a total cholesterol level alone. If your doctor measured your LDL-cholesterol level, use the chart below to see how your LDL-cholesterol level measures up. Does Your Total Blood Cholesterol Increase Your Risk For Developing Coronary Heart Disease? Desirable Borderline-High Risk High Risk Less than 130 mg/gl 130 to 159 mg/dl 160 mg/dl and above If your LDL-cholesterol level is in the "desirable" category, you are at an acceptable level of risk. If your LDL level is in the "borderline-high risk" category, you could benefit from lowering your blood cholesterol level by making some dietary changes. If your LDL level is in the "borderline-high risk" category and you have coronary heart disease or two risk factors for coronary head disease, you should begin diet treatment under your physician's supervision, as should a person in the "high risk" category. In general, this means you will be paying closer attention to your cholesterol level and making more dietary changes than a person at lower risk. [Graphic Omitted] HDL-cholesterol will also be measured if your total blood cholesterol puts you in a high risk category. The lower your HDL-cholesterol level, the greater your risk for coronary head disease. Any HDL-cholesterol level lower than 35 mg/dl is considered too low. Quitting smoking, losing weight, and becoming physically active may help raise your HDL-cholesterol level. Although it is not known for certain that raising HDL levels in this way will reduce the risk of coronary heart disease, these measures are likely to be good for your heart in any case. Sample Lab Report Patient Sex Age Account ID Recieved Reported Kevin Stone M 38 01300542 2944 25-Oct-87 26-Oct-87 Test Name Result Ranges CHOL 250 <200 mg/dl (desirable) 200-239 mg/dl (borderline-high) >240 mg/dl (high) HDL CHOL 43 <35 mg/dl (increased risk) >35 mg/dl (acceptable) LDL CHOL 171 <130 mg/dl (desirable) 130-159 mg/dl (borderline-risk) >160 mg/dl (high risk) How To Lower Your High Blood Cholesterol The primary treatment for high blood cholesterol is a diet that is low in saturated fat and low in cholesterol. This new way of eating is also nutritious, with all the protein, carbohydrate, fat, vitamins, and minerals your body needs. To lower your blood cholesterol, you will: * Eat less high-fat food (especially those high in saturated fat); * Replace part of the saturated fat in your diet with unsaturated fat; * Eat less high-cholesterol food; * Choose foods high in complex carbohydrates (starch and fiber); and * Reduce your weight, if you are overweight. Saturated fats raise your cholesterol level more than anything else in your diet. Dietary cholesterol also raises blood cholesterol levels. Instead of eating foods rich in saturated fat and cholesterol, try more breads, cereals, and other foods high in complex carbohydrates as well as more fruits and vegetables. Using unsaturated fats in place of saturated fats can also help lower your blood cholesterol. Fortunately, these dietary changes work together. For example, eating less saturated fat may also help you decrease the amount of cholesterol you eat and may help you lose weight. This is because foods high in saturated fat are often high in cholesterol as well and are high in calories. In fact, all fats have more than twice as many calories as either carbohydrate or protein. And, by losing weight if you are overweight, you can help lower your LDL-cholesterol level and increase your HDL-cholesterol level. What Foods Contain Fat and Cholesterol? Saturated fats are found primarily in animal products, particularly fatty meats and many dairy products. [Graphic Omitted] Coconut oil, palm kernel oil, and palm oil are also very saturated. [Graphic Omitted] Some of the unsaturated fats in vegetable oils are also made more saturated by a process called hydrogenation. [Graphic Omitted] Commercially prepared and processed foods made with these vegetable oils or with saturated fats like butter and lard can also be high in saturated fat. [Graphic Omitted] There are two kinds of unsaturated fat: polyunsaturated and monounsaturated. You should substitute both of these for saturated fat in your diet. polyunsaturated fats are found primarily in plant products -- including safflower, sunflower, corn, soybean, and cottonseed oils; nuts; and seeds -- and in fatty fish. Major vegetable oil sources of monounsaturated fats are primarily olive oil and canola oil. Cholesterol is found only in foods of animal origin, both high-fat foods (like hotdogs and cheddar cheese) and lowfat foods (like liver and other organ meats). And the amount of cholesterol in these foods varies. A daily intake of less than 300 mg is recommended. A 3-ounce piece of meat, fish, or poultry has 60-90 mg of cholesterol; one egg yolk contains about 270 mg; and a 3-ounce serving of liver has about 390 mg of cholesterol. What Are Some Practical Guidelines for Changing Your Diet? Again, to reduce your blood cholesterol level, your diet should be low in fat, particularly saturated fat, and low in cholesterol. Use the following guidelines as you plan your new diet. 1. To cut back on saturated fats: [Graphic omitted] * Choose poultry, fish and lean cuts of meat more often; remove the skin from chicken and trim the fat from the meat. * Drink skim milk or 1% milk instead of 2% milk or whole milk. And eat cheeses with no more than 2-6 gram of fat per ounce (like low-fat cottage or low-fat farmer cheese) instead of processed, natural, and hard cheeses (like American, brie, and cheddar). * Use tub margarines or liquid vegetable oils that are high in unsaturated fat (like sunflower, corn, and olive oil) instead of butter, lard, and hydrogenated vegetable shortening that are high in saturated fat. Choose products that list more unsaturated fat than saturated fat on the label. * Cut down on commercially prepared and processed foods made with saturated fats or oils. Read labels to choose those low in saturated fats. 2. To cut back on dietary cholesterol: * Eat less organ meat such as liver, brain, and kidney. * Eat fewer egg yolks; try substituting two egg whites for each whole egg in recipes. 3. To increase complex carbohydrates (starch and fiber): * Eat more whole grain breads and cereals, pasta, rice, and dried peas and beans. * Eat vegetables and fruits more often. [Graphic omitted] 4. To lose weight: * Eat fewer daily calories (cutting back on fat in your diet will really help): * Burn extra calories by exercising regularly. What You Can Expect How Soon and How Much Can You Expect Your Blood Cholesterol Levels to Change? Remember, by closely following your diet and monitoring your progress with regular checkups, you can lower your blood cholesterol level and greatly reduce your risk of developing coronary heart disease. Generally, both your total and LDL-cholesterol levels will begin to drop 2-3 weeks after you begin your cholesterol lowering diet. Over time, you may reduce your cholesterol levels by 30-55 mg/dl or even more. The more you reduce your level, the more you will reduce your risk of developing coronary heart disease. [Graphic Omitted] How much you reduce your blood cholesterol levels depends on how much fat, specifically saturated fat, and how much cholesterol you were eating before starting your cholesterol-lowering diet; how well you follow your new diet; and how responsive your body is to the diet. Also, the higher your blood cholesterol level is to begin with, the greater or more dramatic reduction you can expect with your new diet. How Long Do You Need to Follow This Diet? Your new cholesterol-lowering diet should be continued for life. While eating some foods high in saturated fat and cholesterol for 1 day or at one meal will not raise blood cholesterol levels, resuming old eating patterns will. Surprisingly, after a while your new way of eating won't seem like a "diet" at all, but simply like your regular routine--full of appealing and appetizing foods. What Should Your Blood Cholesterol Goal Be? Before starting your cholesterol-lowering diet, your physician will determine your blood cholesterol goal, specifically the LDL-cholesterol level, that is right for you. This goal will vary depending on whether you have coronary heart disease or any of the other risk factors for coronary head disease. Even though achieving your LDL-cholesterol goal is more important that the total cholesterol goal, your physician can check your progress by measuring your total cholesterol level because it is a good deal simpler and because you do not have to fast before its measurement. Remember, a total cholesterol level below 200 mg/dl and an LDL-cholesterol below 130 mg/dl are desirable. How Do You Check your progress? To get your blood cholesterol measured, see your doctor or local clinic. They will take a blood sample and send it to a laboratory. There may be differences in your blood cholesterol level from day to day. Cholesterol measurements may also differ somewhat from one laboratory to the next. Your doctor will consider these factors when you return to check your progress. It is important that you have your cholesterol level measured at the same place each time. How Often Should You Have Your Blood Cholesterol Levels Checked? Your physician will probably want to measure your cholesterol level after you have been on the diet for 4-6 weeks and again after 3 months. If the total cholesterol goal is met after 3 months, measuring your LDL-cholesterol level will confirm that the LDL-cholesterol goal has been met. If your response to the diet has been satisfactory (both total cholesterol and LDL-cholesterol goals have been met), you will enter a phase of long-term monitoring. Long-term monitoring may involve remeasuring total cholesterol twice a year and LDL-cholesterol once a year. If you have not met your blood cholesterol goal in 3 months, your doctor may further restrict the saturated fat and cholesterol in your diet and enlist the help of a dietitian. Then, after 4-6 weeks more and again after 3 months, your doctor may measure your cholesterol level. If you have attained your goal, long-term monitoring can begin. If not, your doctor may decide you need medication along with your dietary changes. [Graphic Omitted] Can You Eat Before Your Test? Since total cholesterol levels do not change much after a meal, total cholesterol can be measured at any time of day, whether or not you have just eaten. Therefore, you do not need to fast. However, you should not eat or drink anything except water or black coffee for at least 12 hours before having your lipoprotein levels determined (LDL, HDL, triglycerides). Therefore, it may be convenient to eat your last meal at about 9 p.m. and have your test the next day before breakfast. Other Steps You Can Take While dietary change is the first and most important action you will be taking to lower your blood cholesterol level, your doctor may suggest other steps you can take. These will depend on how well the diet lowers your blood cholesterol level and whether or not you have any other risk factors for coronary head disease. Do You Need to Take Special Medications Along With Your Diet?. In most cases, a blood cholesterol-lowering diet is the only step necessary to lower blood cholesterol levels. However, if your LDL-cholesterol level is still too high after you've been on your diet for 6 months, your doctor may decide to include medication as part of your treatment. In addition, if your cholesterol level is unusually high or if you have other major risk factors for coronary heart disease, your doctor may prescribe medications to lower blood cholesterol even sooner. If your doctor does prescribe medications, you must continue your cholesterol-lowering diet since the combination may allow you to take less medication to lower your levels. And, because diet is still the safest treatment, you should always try to lower your levels with diet alone before adding medication. What Are These Medications? There are several medications your physician can prescribe to help you lower your blood cholesterol levels. The report issued by the National Cholesterol Education Program cited the bile acid sequestrants--cholestyramine and colestipol--and nicotinic acid as the drugs of first choice, The report underscored the effectiveness and the long-term safety of these drugs as demonstrated in research studies. The report also cited a new class of drug--HMG CoA reductase--which has demonstrated considerable effectiveness in lowering cholesterol levels. One drug in this class--lovastatin--has been approved for use by the Food and Drug Administration. Because of its newness, long-term safety data has not yet been established. Other drugs cited in the report which were not considered as efficacious in lowering LDL-cholesterol as those mentioned above include gemfibrozil and probucol. All cholesterol-lowering medications should be taken only with the advice of and under the supervision of your physician. Do You Need to Make Other Changes to Lower Your Blood Cholesterol Level? The key changes you need to make are the ones discussed above. To review: * Follow a diet that is low in saturated fat and cholesterol. This is the most important step you will take to reduce your high blood cholesterol level. * Maintain a desirable weight. If you need to lose weight, your new diet will help since it is likely to be lower in calories than your current diet. * Finally, exercise to help you lose weight and improve overall physical fitness. Exercise may also help you raise your HDL level. Unless your doctor prescribes a cholesterol-lowering medication, these are the only steps you will need to take to lower your blood cholesterol level. What Else Can You Do to Lower Your Risk for Coronary Heart Disease? Fortunately, you can do something about all three of the major risk factors for coronary head disease-high blood cholesterol, cigarette smoking, and high blood pressure. Thus, in addition to lowering your blood cholesterol level, it's a good idea to quit smoking and control your blood pressure. Maintaining your desirable weight will also help you lower your risk for coronary head disease. And all of these steps will help you to feel better. Where You Can Go for Help Need more help? Want to know more? There are many places you can go to get information about your new diet, your diagnosis, and the latest findings about treatment and medications for high blood cholesterol. What Other Health Professionals, in Addition to Your Doctor, Can Give You Help? [Graphic Omitted] If you want some help following your recommended diet, talk to a registered dietitian or qualified nutritionist. They can explain the diet to you in greater detail and show you ways to follow it. They can give you advice on shopping and preparing foods, eating away from home, and changing your eating habits to help you stay on your new diet. They will also help you set goals for dietary change so that you can successfully lower your high blood cholesterol levels without drastically changing your eating pattern and overall lifestyle all at one time. The Division of Practice of the American Dietetic Association [(312) 899-0040] can help you find a registered dietitian in your area. State and local branches of the American Dietetic Association,your local hospital, or your doctor can recommend a dietitian for you. There are also other resources. The nurse in your doctor's office can answer questions you may have about your high blood cholesterol or your new diet. If your blood cholesterol level is not lowered by diet and medication, your doctor may refer you to a physician who is a lipid specialist. Lipid specialists are experts in the management of high blood cholesterol and other lipid disorders. If you have questions about drug therapy or the medication your doctor is prescribing, ask your doctor. Finally, pharmacists are also aware of the best ways to take medication, of ways to minimize side effects, and of the latest research about specific drugs. How Can You Get More Materials About High Blood Cholesterol? If you would like more information to help you start your new approach to healthy eating, contact the National Cholesterol Education Program (NCEP) of the National Heart, Lung, and Blood Institute, Another NCEP pamphlet that can help you, Eating to Lower Your High Blood Cholesterol, provides more specific information on how to lower your blood cholesterol levels through diet. NCEP also has developed a resource list of agencies and organizations that can answer your questions. These and other materials can be requested by writing: National Cholesterol Education Program National Head, Lung, and Blood Institute C-200 Bethesda, MD 20892 Glossary 1. Atherosclerosis -- A type of "hardening of the arteries" in which cholesterol, fat, and other blood components build up in the walls of arteries. As atherosclerosis progresses, the arteries to the heart may narrow so that oxygen-rich blood and nutrients have difficulty reaching the heart. 2. Bile acid sequestrants -- One type of cholesterol lowering medication, including cholestyramine and colestipol. The sequestrants bind with cholesterol containing bile acids in the intestine and remove them in bowel movements. 3. Carbohydrate -- One of the three nutrients that supply calories (energy) to the body. Carbohydrate provides 4 calories per gram -- the same number of calories as pure protein and less than half the calories of fat. Carbohydrate is essential for normal body function. There are two basic kinds of carbohydrate -- simple carbohydrate (or sugars) and complex carbohydrate (starches and fiber). In nature, both the simple sugars and the complex starches come packaged in foods like oranges, apples, corn, wheat, and milk. Refined or processed carbohydrates are found in cookies, cakes, and pies. * Complex carbohydrate -- Starch and fiber. Complex carbohydrate comes from plants. When complex carbohydrate is substituted for saturated fat, the saturated fat reduction lowers blood cholesterol. Foods high in starch include breads, cereals, pasta, rice, dried beans and peas, corn, and lima beans. * Fiber -- A nondigestible type of complex carbohydrate. High-fiber foods are usually low in calories. Foods high in fiber include whole grain breads and cereals, whole fruits, and dried beans. The type of fiber found in foods such as oat and barley bran, some fruits like apples and oranges, and some dried beans may help reduce blood cholesterol. 4. Cholesterol -- A soft, waxy substance. It is made in sufficient quantity by the body for normal body function, including the manufacture of hormones, bile acid, and vitamin D. It is present in all pads of the body, including the nervous system, muscle, skin, liver, intestines, head, etc. * Blood cholesterol -- Cholesterol that is manufactured in the liver and absorbed from the food you eat and is carried in the blood for use by all parts of the body. A high level of blood cholesterol leads to atherosclerosis and coronary heart disease. * Dietary cholesterol -- Cholesterol that is in the food you eat. It is present only in foods of animal origin, not in foods of plant origin. Dietary cholesterol, like dietary saturated fat, tends to raise blood cholesterol, which increases the risk for heart disease. 5. Coronary head disease -- Heart ailment caused by narrowing of the coronary arteries (arteries that supply oxygen and nutrients directly to the head muscle). Coronary heart disease is caused by atherosclerosis, which decreases the blood supply to the head muscle. The inadequate supply of oxygen-rich blood and nutrients damages the head muscle and can lead to chest pain, heart attack, and death. 6. Fat -- One of the three nutrients that supply calories to the body. Fat provides 9 calories per gram, more than twice the number provided by carbohydrate or protein. In addition to providing calories, fat helps in the absorption of certain vitamins. Small amounts of fat are necessary for normal body function. * Total fat -- The sum of the saturated, monounsaturated, and polyunsaturated fats present in food. A mixture of all three in varying amounts is found in most foods. * Saturated fat -- A type of fat found in greatest amounts in foods from animals such as meat, poultry, and whole-milk dairy products like cream, milk, ice cream, and cheese. Other examples of saturated fat include butter, the marbling and fat along the edges of meat, and lard and the saturated fat content is high in some vegetable oils-like coconut, palm kernel, and palm oils. Saturated fat raises blood cholesterol more than anything else in the diet. * Unsaturated fat -- A type of fat that is usually liquid at refrigerator temperature. Monounsaturated fat and polyunsaturated fat are two kinds of unsaturated fat. * Monounsatumted fat -- A slightly unsaturated fat that is found in greatest amounts in foods from plants, including olive and canola (rapeseed) oil. When substituted for saturated fat, monounsaturated fat helps reduce blood cholesterol. * Polyunsaturated fat -- An highly unsaturated fat that is found in greatest amounts in foods from plants, including safflower, sunflower, corn, and soybean oils. When substituted for saturated fat, polyunsaturated fat helps reduce blood cholesterol. 7. Gram (g) -- A unit of weight. There are about 28 g in 1 ounce. Dietary fat, protein, and carbohydrate are measured in grams. 8. Hydrogenation -- A chemical process that changes liquid vegetable oils (unsaturated fat)into a more solid saturated fat. This process improves the shelf life of the product -- but also increases the saturated fat content. Many commercial food products contain hydrogenated vegetable oil. Selection should be made based on information found on the label. 9. Lipids -- Fatty substances, including cholesterol and triglycerides, that are present in blood and body tissues. 10. Lipoproteins -- Protein-coated packages that carry fat and cholesterol through the blood. Lipoproteins are classified according to their density. * High density lipoproteins (HDL) -- Lipoproteins that contain a small amount of cholesterol and carry cholesterol away from body cells and tissues to the liver for excretion from the body. Low levels of HDL are associated with an increased risk of coronary head disease. Therefore the higher the HDL level, the better. * Low density lipoproteins (LDL) -- Lipoproteins that contain the largest amount of cholesterol in the blood. LDL is responsible for depositing cholesterol in the artery walls. High levels of LDL are associated with an increased risk of coronary head disease and are therefore referred to as "bad cholesterol." 11. Milligram (mg) -- A unit of weight equal to one thousandth of a gram. There are about 28,350 mg in 1 ounce. Dietary cholesterol is measured in milligrams. 12. Milligrams/deciliter (mg/dl) -- A way of expressing concentration: in blood cholesterol measurements, the weight of cholesterol (in milligrams)in a deciliter of blood. A deciliter is about one-tenth of a quart. 13. Niacin -- A B vitamin essential for energy production in cells. The recommended daily allowance is about 14 mg for adult females and about 18 mg for adult males. When used in massive quantities under a physician's guidance, niacin is considered a cholesterol-lowering medication. 14. Protein -- One of the three nutrients that supply calories to the body. Protein provides 4 calories per gram, which is less than half the calories of fat. Protein is an essential nutrient that becomes a component of many parts of the body, including muscle, bone, skin, and blood. 15. Risk factor -- A habit, trait, or condition in a person that is associated with an increased chance (or risk) of developing a disease. 16. Triglycerides -- Lipids (fat-like substances) carried through the bloodstream to the tissues. The bulk of the body's fat tissue is in the form of triglycerides, stored for later use as energy. We get triglycerides primarily from the fat in our diet. 17. Vascular disease -- An ailment of the blood vessels often caused by atherosclerosis. Vascular disease may occur in the arteries to the brain and the major leg arteries. Limited quantities of this brochure are available free of charge. National Cholesterol Education Program National Heart, Lung, and Blood Institute C-200 Bethesda, Maryland 20892 ! * Study confirms lowering cholesterol can save lives By Craig M. Walker, M.D. Medical Director, Cardiocascular Institute of the South A Scandinavian study has confirmed that bringing the cholesterol levels of heart patients under control could prolong their lives. We've known for a long time that there was a statistical link between high blood levels of cholesterol and the accumulation of cholesterol plaque in the coronary arteries -- the cause of most heart pain and heart attacks. About one-fourth of heart patients in this country take one of four similar drugs to control the problem. However, some physicians have been reluctant to prescribe them because there was little independent research to prove that these fairly expensive medications really had much effect. The study by doctors at 94 hospitals in Denmark, Finland, Iceland, Norway and Sweden appears to provide that proof. The study involved 4,444 men and women who had heart-related chest pain (angina) or who had previously suffered heart attacks. They were randomly assigned to receive either the drug simvastatin or a placebo -- an identical-looking pill containing no medication. After five years, it was found that the overall death rate among those receiving the cholesterol-fighting drug was 30 percent lower and the death rate from heart disease was 42 percent lower than it was among those receiving the placebo. Those receiving simvastatin also needed 37 percent fewer coronary bypass surgeries or angioplasties than those in the placebo group. It's estimated that nine out of every 100 heart attack and angina patients will die over a six-year period. The physicians who conducted the Scandinavian study estimate that the use of cholesterol-controlling drugs could prevent four of those deaths. One of the study's authors went so far as to say that controlling cholesterol could be as important as stopping smoking in preventing further heart attacks. While these medications aren't cheap, they are far less expensive than bypass surgery or balloon angioplasty required to clear the blockages they can prevent. So their appropriate use should help reduce medical costs. The study does not address whether these medications have a similar benefit for patients who have high cholesterol, but who have not had heart attacks or angina. So the effectiveness -- or, at least, the cost-effectiveness -- of their use in such patients still might be debated. Nevertheless, the study underscores for all of us the importance of controlling cholesterol -- by diet and exercise or medication -- before a heart attack or other manifestation of coronary artery disease compels us to do so. ! * You can control high cholesterol, and the sooner, the better By Craig M. Walker, M.D. Medical Director, Cardiocascular Institute of the South Here's the problem with cholesterol: you're feeding cheeseburgers to a body that thinks you're a caveman living on roots, nuts and berries, with just the occasional mastodon steak thrown in. It still behaves as if obtaining cholesterol -- a vital nutrient -- is a much bigger problem than getting rid of it. In our prosperous society with its fat and cholesterol-rich diet, the reverse is actually true, and it is a concern for everyone, not just for the middle-aged and elderly. Vietnam War era studies found that a significant number of physically fit American men in their late teens and early 20s had already developed advanced levels of atherosclerosis -- the buildup of waxy cholesterol plaque in arteries that ultimately leads to heart attacks. We're more aware today of the risks posed by excessive cholesterol, a form of fat which comes entirely from animal products, and saturated fats, which have both animal and vegetable sources. Most people have even heard that there is a "good cholesterol" (HDL) and a "bad cholesterol" (LDL). Unfortunately, that effort to provide a simple explanation of cholesterol measurement actually misrepresents it. HDL and LDL aren't cholesterol, and both are vital to our survival. They are lipoproteins, a low-density form (LDL), which transports cholesterol to the body's cells, and a high-density form (HDL), which carries away excess cholesterol the cells don't use. Chemically, they are detergents -- molecules which have one fat-soluble (lipo) end and one water-soluble (protein) end that allow them to hold fats in suspension in a water-based medium -- blood -- which, by itself, couldn't dissolve or transport them. What we call cholesterol measurement actually measures the levels of these two transporting detergents, not the cholesterol itself. Theoretically, the higher the level of HDL, which carries away excess cholesterol, compared to LDL, which carries it to the cells, the less likely there will be excess cholesterol left around to start building up plaque accumulations in our arteries. You can, with some effort, actually improve your own HDL-to-LDL ratio. Aerobic exercise -- jogging, walking or any other regimen which features lots of motion against little resistance -- can be one of the biggest factors in shifting your body's LDL /HDL ratio in your favor. Losing weight can also have a positive effect. And, yes, there is evidence that alcohol, in moderation, can have some small beneficial effect in raising HDL levels. But the important word in this regard is moderation. If your alcohol consumption exceeds one or two drinks a day, you can raise your blood pressure and increase the levels of fatty triglycerides in your blood stream, thus undoing the benefit of more restrained consumption. It has been learned recently that a third lipoprotein, called LP(a), figures in the type of high cholesterol that runs in some families with a high incidence of atherosclerotic cardiovascular disease and in some ethnic groups, including African-Americans. If you fall into one of these high-risk groups, it would be worthwhile for you to schedule a special test, called a vertical analytical profile, which can detect elevated LP(a) levels.. LP(a)-related high cholesterol can be controlled by physician-monitored administration of niacin, one of the B-complex vitamins. If none of these remedies suffice to bring your cholesterol level into the "safe" zone, there are a number of medications your doctor can prescribe that are effective in controlling the condition. I almost hesitate to mention that a sufficiently high level of HDL can even slightly reduce plaque accumulation in arteries, because so many patients make too much of the fact. HDL isn't some sort of biological Drano that can clear out badly clogged arteries. And you can't administer it like a drug. You have to make your own -- the hard way. ! * Chronic Pain: Hope Through Research U.S. Department of Health and Human Services Public Health Service National Institutes of Health National Institute of Neurological Disorders and Stroke What was the worst pain you can remember? Was it the time you scratched the cornea of your eye? Was it a kidney stone? Childbirth? Rare is the person who has not experienced some beyond-belief episode of pain and misery. Mercifully, relief finally came. Your eye healed, the stone was passed, the baby born. In each of those cases pain flared up in response to a known cause. With treatment, or with the body's healing powers alone, you got better and the pain went away. Doctors call that kind of pain acute pain. It is a normal sensation triggered in the nervous system to alert you to possible injury and the need to take care of yourself. Chronic pain is different. Chronic pain persists. Fiendishly, uselessly, pain signals keep firing in the nervous system for weeks, months, even years. There may have been an initial mishap-a sprained back, a serious infection-from which you've long since recovered. There may be an ongoing cause of pain-arthritis, cancer, ear infection. But some people suffer chronic pain in the absence of any past injury or evidence of body damage. Whatever the matter may be, chronic pain is real, unremitting, and demoralizing-the kind of pain New England poet Emily Dickinson had in mind when she wrote: Pain-has an Element of Blank- It cannot recollect When it begun-or if there were A time when it was not The terrible triad Pain of such proportions overwhelms all other symptoms and becomes the problem. People so afflicted often cannot work. Their appetite falls off. Physical activity of any kind is exhausting and may aggravate the pain. Soon the person becomes the victim of a vicious circle in which total preoccupation with pain leads to irritability and depression. The sufferer can't sleep at night and the next day's weariness compounds the problem-leading to more irritability, depression, and pain. Specialists call that unhappy state the "terrible triad" of suffering, sleeplessness, and sadness, a calamity that is as hard on the family as it is on the victim. The urge to do something-anything-to stop the pain makes some patients drug dependent, drives others to undergo repeated operations or worse, resort to questionable practitioners who promise quick and permanent "cures." "Chronic pain is the most costly health problem in America," says one of the world's authorities on pain. He and others estimate annual costs, including direct medical expenses, lost income, lost productivity, compensation payments and legal charges, at close to $50 billion. Here's how that adds up: * Headache. At least 40 million Americans suffer chronic recurrent headaches and spend $4 billion a year on medications. Migraine sufferers alone account for 65 million workdays lost annually. * Low back pain. Fifteen percent of the adult U.S. population have had persistent low back pain at some time in their lives. Five million Americans are partially disabled by back problems, and another 2 million are so severely disabled they cannot work. Low back pain accounts for 93 million workdays lost every year and costs over $5 billion in health care. * Cancer pain. The majority of patients in intermediate or advanced stages of cancer suffer moderate to severe pain. More than 800,000 new cases of cancer are diagnosed each year in the U.S., and some 430,000 people die. * Arthritis pain. The great crippler affects 20 million Americans and costs over $4 billion in lost income, productivity and health care. Other pain disorders like the neuralgias and neuropathies that affect nerves throughout the body, pain due to damage to the central nervous system (the brain and spinal cord), as well as pain where no physical cause can be found-psychogenic pain-swell the total to that $50 billion figure. Many chronic pain conditions affect older adults. Arthritis, cancer, angina-the chest-binding, breath-catching spasms of pain associated with coronary artery disease-commonly take their greatest toll among the middle-aged and elderly. Tic douloureux (trigeminal neuralgia) is a recurrent, stabbing facial pain that is rare among young adults. But ask any resident of housing for retired persons if there are any tic sufferers around and you are sure to hear of cases. So the fact that Americans are living longer contributes to a widespread and growing concern about pain. Neuroscientists share that concern. At a time when people are living longer and painful conditions abound, the scientists who study the brain have made landmark discoveries that are leading to a better understanding of pain and more effective treatments. In the forefront of pain research are scientists supported by the National Institute of Neurological Disorders and Stroke (NINDS), the leading Federal agency supporting research on pain. Other Federal agencies important in pain research include the National Institute of Mental Health (NIMH), the National Institute of Dental Research (NIDR) and the National Cancer Institute (NCI). Within the last decade both the International Association for the Study of Pain and the American Pain Society have been established and grown into flourishing professional organizations attracting young as well as established research investigators and practicing physicians. Sounding the pain alarm Part of the inspiration for the new groups has come from a deeper understanding of pain made possible by advances in research techniques. Not long ago neuroscientists debated whether pain was a separate sense at all, supplied with its own nerve cells and brain centers like the senses of hearing or taste or touch. Maybe you hurt, the scientists reasoned, because nerve endings sensitive to touch are pressed very hard. To some extent, that is true: Some nerve fibers in your skin will be stimulated by a painful pinch as well as a gentle touch. But neuroscientists now know that there are many small nerve cells with extremely fine nerve fibers that are excited exclusively by intense, potentially harmful stimulation. Scientists call the nerve cells nociceptors, from the word noxious, meaning physically harmful or destructive. Some nociceptors sound off to several kinds of painful stimulations hammer blow that hits your thumb instead of a nail; a drop of acid; a flaming match. Other nociceptors are more selective. They are excited by a pinprick but ignore painful heat or chemical stimulation. It's as though nature had sprinkled your skin and your insides with a variety of pain-sensitive cells, not only to report what kind of damage you're experiencing, but to make sure the message gets through on at least one channel. Broadcasting the news That same dispersion of forces continues once pain messages reach the central nervous system. Suppose you touch a hot stove. Some incoming pain signals are immediately routed to nerve cells that signal muscles to contract, so you pull your hand back. That streamlined pathway is a reflex, one of many protective circuits wired into your nervous system at birth. Meanwhile the message informing you that you've touched the stove travels along other pathways to higher centers in the brain. One path is an express route that reports the facts: where it hurts; how bad it is; whether the pain is sharp or burning. Other pain pathways plod along more slowly, the nerve fibers branching to make connections with many nerve cells (neurons) en route. Scientists think that these more meandering pathways act as warning systems alerting you of impending damage and in other ways filling out the pain picture. All the pathways combined contribute to the emotional impact of pain-whether you feel frightened, anxious, angry, annoyed. Experts called those feelings the "suffering" component of pain. Still other branches of the pain news network are alerting another major division of the nervous system, the autonomic nervous system. That division handles the body's vital functions like breathing, blood flow, pulse rate, digestion, elimination. Pain can sound a general alarm in that system, causing you to sweat or stop digesting your food, increasing your pulse rate and blood pressure, dilating the pupils of your eye, and signaling the release of hormones like epinephrine (adrenaline). Epinephrine aids and abets all those responses as well as triggering the release of sugar stored in the liver to provide an extra boost of energy in an emergency. Censoring the news Obviously not every source of pain creates a full-blown emergency with adrenaline-surging, sweat-pouring, pulse-racing responses. Moreover, observers are well aware of times and places when excruciating pain is ignored. Think of the quarterback's ability to finish a game oblivious of a torn ligament, or a fakir sitting on a bed of spikes. One of the foremost pioneers in pain research adds his personal tale, too, of the time he landed a salmon after a long and hearty struggle, only then to discover the deep blood-dripping gash on his leg. Acknowledging such events, neuroscientists have long suspected that there are built-in nervous system mechanisms that can block pain messages. Now it seems that just as there is more than one way to spread the news of pain, there is more than one way to censor the news. These control systems involve pathways that come down from the brain to prevent pain signals from getting through. The gate theory of pain Interestingly, a pair of Canadian and English investigators speculated that such pain-suppressing pathways must exist when they devised a new "gate theory of pain" in the midsixties. Their idea was that when pain signals first reach the nervous system they excite activity in a group of small neurons that form a kind of pain "pool." When the total activity of these neurons reaches a certain minimal level, a hypothetical "gate" opens up that allows the pain signals to be sent to higher brain centers. But nearby neurons in contact with the pain cells can suppress activity in the pain pool so that the gate stays closed. The gate-closing cells include large neurons that are stimulated by nonpainful touching or pressing of your skin. The gate could also be closed from above, by brain cells activating a descending pathway to block pain. The theory explained such everyday behavior as scratching a scab, or rubbing a sprained ankle: the scratching and rubbing excite just those nerve cells sensitive to touch and pressure that can suppress the pain pool cells. The scientists conjectured that brain-based pain control systems were activated when people behaved heroically-ignoring pain to finish a football game, or to help a more severely wounded soldier on the battlefield. The gate theory aroused both interest and controversy when it was first announced. Most importantly, it stimulated research to find the conjectured pathways and mechanisms. Pain studies got an added boost when investigators made the surprising discovery that the brain itself produces chemicals that can control pain. The landmark discovery of the pain-suppressing chemicals came about because scientists in Aberdeen, Scotland, and at the Johns Hopkins University Hospital in Baltimore were curious about how morphine and other opium-derived painkillers, or analgesics, work. For some time neuroscientists had known that chemicals were important in conducting nerve signals (small bursts of electric current) from cell to cell. In order for the signal from one cell to reach the next in line, the first cell secretes a chemical "neurotransmitter" from the tip of a long fiber that extends from the cell body. The transmitter molecules cross the gap separating the two cells and attach to special receptor sites on the neighboring cell surface. Some neurotransmitters excite the second cell-allowing it to generate an electrical signal. Others inhibit the second cell--preventing it from generating a signal. When investigators in Scotland and at Johns Hopkins injected morphine into experimental animals, they found that the morphine molecules fitted snugly into receptors on certain brain and spinal cord neurons. Why, the scientists wondered, should the human brain-the product of millions of years of evolution-come equipped with receptors for a man-made drug? Perhaps there were naturally occurring brain chemicals that behaved exactly like morphine. The brain's own opiates Both groups of scientists found not just one pain-suppressing chemical in the brain, but a whole family of such proteins. The Aberdeen investigators called the smaller members of the family enkephalins (meaning "in the head"). In time, the larger proteins were isolated and called endorphins, meaning the "morphine within." The term endorphins is now often used to describe the group as a whole. The discovery of the endorphins lent weight to the general concept of the gate theory. Endorphins released from brain nerve cells might inhibit spinal cord pain cells through pathways descending from the brain to the spinal cord. Endorphins might also be activated when you rub or scratch your itching skin or aching joints. Laboratory experiments subsequently confirmed that painful stimulation led to the release of endorphins from nerve cells. Some of these chemicals then turned up in cerebrospinal fluid, the liquid that circulates in the spinal cord and brain. Laced with endorphins, the fluid could bring a soothing balm to quiet nerve cells. A new look at pain treatments Further evidence that endorphins figure importantly in pain control comes from a new look at some of the oldest and newest pain treatments. The new look frequently involves the use of a drug that prevents endorphins and morphine from working. Injections of this drug, naloxone, can result in a return of pain which had been relieved by morphine and certain other treatments. But, interestingly, some pain treatments are not affected by naloxone: Their success in controlling pain apparently does not depend on endorphins. Thus nature has provided us with more than one means of achieving pain relief. * Acupuncture. Probably no therapy for pain has stirred more controversy in recent years than acupuncture, the 2,000-year-old Chinese technique of inserting fine needles under the skin at selected points in the body. The needles are agitated by the practitioner to produce pain relief which some individuals report lasts for hours, or even days. Does acupuncture really work? Opinion is divided. Many specialists agree that patients report benefit when the needles are placed near where it hurts, not at the body points indicated on traditional Chinese acupuncture charts. The case for acupuncture has been made by investigators who argue that local needling of the skin excites endorphin systems of pain control. Wiring the needles to stimulate nerve endings electrically (electroacupuncture) also activates endorphin systems, they believe. Further, some experiments have shown that there are higher levels of endorphins in cerebrospinal fluid following acupuncture. Those same investigators note that naloxone injections can block pain relief produced by acupuncture. Others have not been able to repeat those findings. Skeptics also cite long-term studies of chronic pain patients that showed no lasting benefit from acupuncture treatments. Current opinion is that more controlled trials are needed to define which pain conditions might be helped by acupuncture and which patients are most likely to benefit. * Local electrical stimulation. Applying brief pulses of electricity to nerve endings under the skin, a procedure called transcutaneous electrical nerve stimulation (TENS), yields excellent pain relief in some chronic pain patients. The stimulation works best when applied to the skin near where the pain is felt and where other sensibilities like touch or pressure have not been damaged. Both the frequency and voltage of the electrical stimulation are important in obtaining pain relief. * Brain stimulation. Another electrical method for controlling pain, especially the widespread and severe pain of advanced cancer, is through surgically implanted electrodes in the brain. The patient determines when and how much stimulation is needed by operating an external transmitter that beams electronic signals to a receiver under the skin that is connected to the electrodes. The brain sites where the electrodes are placed are areas known to be rich in opiate receptors and in endorphin-containing cells or fibers. Stimulation-produced analgesia (SPA) is a costly procedure that involves the risk of brain surgery. However, patients who have used this technique report that their pain "seems to melt away." The pain relief is also remarkably specific: The other senses remain intact, and there is no mental confusion or cloudiness as with opiate drugs. NINDS is currently supporting research on how SPA works and is also investigating problems of tolerance: Pain may return after repeated stimulation. * Placebo effects. For years doctors have known that a harmless sugar pill or an injection of salt water can make many a patient feel better-even after major surgery. The placebo effect, as it has been called, has been thought to be due to suggestion, distraction, the patient's optimism that something is being done, or the desire to please the doctor (placebo means "I will please" in Latin). Now experiments suggest that the placebo effect may be neurochemical, and that people who respond to a placebo for pain relief-a remarkably consistent 35 percent in any experiment using placebos-are able to tap into their brains' endorphin systems. To evaluate it, two NINDS- and NIDR-supported investigators at the University of California at San Francisco designed an ingenious experiment. They asked adults scheduled for wisdom teeth removal to volunteer in a pain experiment. Following surgery, some patients were given morphine, some naloxone, and some a placebo. As expected, about a third of those given the placebo reported pain relief. The investigators then gave these people naloxone. All reported a return of pain. How people who benefit from placebos gain access to pain control systems in the brain is not known. Scientists cannot even predict whether someone who responds to a placebo in one situation will respond in another. The San Francisco investigators suspect that stress may be a factor. Patients who are very anxious or under stress are more likely to react to a placebo for pain than those who are more calm, cool, and collected. But dental surgery itself may be sufficiently stressful to trigger the release of endorphins-with or without the effects of placebo. For that reason, many specialists believe further studies are indicated to analyze the placebo effect. As research continues to reveal the role of endorphins in the brain, neuroscientists have been able to draw more detailed brain maps of the areas and pathways important in pain perception and control. They have even found new members of the endorphin family: Dynorphin, the newest endorphin, is reported to be 10 times more potent a painkiller than morphine. At the same time, clinical investigators have tested chronic pain patients and found that they often have lower-than-normal levels of endorphins in their spinal fluid. If you could just boost their stores with man-made endorphins, perhaps the problems of chronic pain patients could be solved. Not so easy. Some endorphins are quickly broken down after release from nerve cells. Other endorphins are longer lasting, but there are problems in manufacturing the compounds in quantity and getting them into the right places in the brain or spinal cord. In a few promising studies, clinical investigators have injected an endorphin called beta-endorphin under the membranes surrounding the spinal cord. Patients reported excellent pain relief lasting for many hours. Morphine compounds injected in the same area are similarly effective in producing long-lasting pain relief. But spinal cord injections or other techniques designed to raise the level of endorphins circulating in the brain require surgery and hospitalization. And even if less,drastic means of getting endorphins into the nervous system could be found, they are probably not the ideal answer to chronic pain. Endorphins are also involved in other nervous system activities such as controlling blood flow. Increasing the amount of endorphins might have undesirable effects on these other body activities. Endorphins also appear to share with morphine a potential for addiction or tolerance. Meanwhile, chemists are synthesizing new analgesics and discovering painkilling virtues in drugs not normally prescribed for pain. Much of the drug research is aimed at developing nonnarcotic painkillers. The motivation for the research is not only to avoid introducing potentially addictive drugs on the market, but is based on the observation that narcotic drugs are simply not effective in treating a variety of chronic pain conditions. Developments in nondrug treatments are also progressing, ranging from new surgical techniques to physical and psychological therapies like exercise, hypnosis, and biofeedback. New and old drugs for pain When you complain of headache or low back pain and the doctor says take two aspirins every 4 hours and stay in bed, you may think your pain is being dismissed lightly. Not at all. Aspirin, one of the most universally used medications is an excellent painkiller. Scientists still cannot explain all the ways aspirin works, but they do know that it interferes with pain signals where they usually originate, at the nociceptive nerve endings outside the brain and spinal cord: peripheral nerves. Aspirin also inhibits the production of chemicals manufactured in the blood to promote blood clotting and wound healing: Prostaglandins. Unfortunately, prostaglandins, released from cells at the site of injury, are pain-causing substances. They actually sensitize nerve endings, making them-and you-feel more pain Along with increasing the blood supply to the area, the chemicals contribute to inflammation-the pain, heat, redness and swelling of tissue damage. Some investigators now think that the continued release of pain-causing substances in chronic pain conditions may lead to long-term nervous system changes in some patients that make them hypersensitive to pain. People suffering such hyperalgesia can cry out in pain at the gentlest touch, or even when a soft breeze blows over the affected area. In addition to the prostaglandins, blister fluid and certain insect and snake venoms also contain pain-causing substances. Presumably these chemicals alert you to the need for care-a fine reaction in an emergency, but not in chronic pain. There are several prescription drugs that usually can provide stronger pain relief than aspirin. These include the opiate-related compounds codeine, propoxyphene (Darvon), morphine, and meperidine (Demerol). All these drugs have some potential for abuse, and may have unpleasant and even harmful side effects. In combination with other medications or alcohol, some can be dangerous. Used wisely, however, they are important recruits in the chemical fight against pain. In the search for effective analgesics physicians have discovered pain-relieving benefits from drugs not normally prescribed for pain. Certain antidepressants as well as antiepileptic drugs are used to treat several particularly severe pain conditions, notably the pain of shingles and of facial neuralgias like tic douloureux. Interestingly, pain patients who benefit from anti-depressants report pain relief before any uplift in mood. Pain specialists think that the antidepressant works because it increases the supply of a naturally produced neurotransmitter, serotonin. (Doctors have long associated decreased amounts of serotonin with severe depression.) But now scientists have evidence that cells using serotonin are also an integral part of a pain-controlling pathway that starts with endorphin-rich nerve cells high up in the brain and ends with inhibition of pain-conducting nerve cells lower in the brain or spinal cord. Antidepressant drugs have been used successfully in treating the excruciating pain that can follow an attack of shingles. Antiepileptic drugs have been used successfully in treating tic douloureux, the riveting attacks of facial pain that affect older adults. The rationale for the use of the antiepileptic drugs (principally carbamazepine-Tegreto) does not involve the endorphin system. It is based on the theory that a healthy nervous system depends on a proper balance of incoming and outgoing nerve signals. Tic and other facial pains or neuralgias are thought to result from damage to facial nerves. That means that the normal flow of messages to and from the brain is disturbed. The nervous system may react by becoming hypersensitive: It may create its own powerful discharge of nerve signals, as though screaming to the outside world "Why aren't you contacting me?" Antiepileptic drugs-used to quiet the excessive brain discharges associated with epileptic seizures-quiet the distress signals associated with tic and may relieve pain that way. Psychological methods Psychological treatment for pain can range from psychoanalysis and other forms of psychotherapy to relaxation training, meditation, hypnosis, biofeedback, or behavior modification. The philosophy common to all these varied approaches is the belief that patients can do something on their own to control their pain. That something may mean changing attitudes, feelings, or behaviors associated with pain, or understanding how unconscious forces and past events have contributed to the present painful predicament. * Psychotherapy. Freud was celebrated for demonstrating that for some individuals physical pain symbolizes real or imagined emotional hurts. He also noted that some individuals develop pain or paralysis as a form of self-punishment for what they consider to be past sins or bad behavior. Sometimes, too, pain may be a way of punishing others. This doesn't mean that the pain is any less real; it does mean that some pain patients may benefit from psychoanalysis or individual or group psychotherapy to gain insights into the meaning of their pain. * Relaxation and meditation therapies. These forms of training enable people to relax tense muscles, reduce anxiety, and alter mental state. Both physical and mental tension can make any pain worse, and in conditions such as headache or back pain, tension may be at the root of the problem. Meditation, which aims at producing a state of relaxed but alert awareness, is sometimes combined with therapies that encourage people to think of pain as something remote and apart from them. The methods promote a sense of detachment so that the patient thinks of the pain as confined to a particular body part over which he or she has marvelous control. The approach may be particularly helpful when pain is associated with fear and dread, as in cancer. * Hypnosis. No longer considered magic, hypnosis is a technique in which an individual's susceptibility to suggestion is heightened. Normal volunteers who prove to be excellent subjects for hypnosis often report a marked reduction or obliteration of experimentally induced pain, such as that produced by a mild electric shock. The hypnotic state does not lower the volunteer's heart rate, respiration, or other autonomic responses. These physical reactions show the expected increases normally associated with painful stimulation. The role of hypnosis in treating chronic pain patients is uncertain. Some studies have shown that 15 to 20 percent of hypnotizable patients with moderate to severe pain can achieve total relief with hypnosis. Other studies report that hypnosis reduces anxiety and depression. By lowering the burden of emotional suffering, pain may become more bearable. * Biofeedback. Some individuals can learn voluntary control over certain body activities if they are provided with information about how the system is working-how fast their heart is beating, how tense are their head or neck muscles, how cold are their hands. The information is usually supplied through visual or auditory cues that code the body activity in some obvious way-a louder sound meaning an increase in muscle tension, for example. How people use this "biofeed-back" to learn control is not understood, but some masters of the art report that imagery helps: They may think of a warm tropical beach, for example, when they want to raise the temperature of their hands. Biofeed-back may be a logical approach in pain conditions that involve tense muscles, like tension headache or low back pain. But results are mixed. * Behavior modification. This psychological technique (sometimes called operant conditioning) is aimed at changing habits, behaviors, and attitudes that can develop in chronic pain patients. Some patients become dependent, anxious, and homebound-if not bedridden. For some, too, chronic pain may be a welcome friend, relieving them of the boredom of a dull job or the burden of family responsibilities. These psychological rewards-sometimes combined with financial gains from compensation payments or insurance-work against improvements in the patient's condition, and can encourage increased drug dependency, repeated surgery, and multiple doctor and clinic visits. There is no question that the patient feels pain. The hope of behavior modification is that pain relief can be obtained from a program aimed at changing the individual's lifestyle. The program begins with a complete assessment of the painful condition and a thorough explanation of how the program works. It is essential to enlist the full cooperation of both the patient and family members. The treatment is aimed at reducing pain medication and increasing mobility and independence through a graduated program of exercise, diet, and other activities. The patient is rewarded for positive efforts with praise and attention. Rewards are withheld when the patient retreats into negative attitudes or demanding and dependent behavior. How effective are any of these psychological treatments? Are some superior to others? Who is most likely to benefit? Do the benefits last? The answers are not yet in hand. Patient selection and patient cooperation are all-important. Analysis of individuals who have improved dramatically with one or another of these approaches is helping to pinpoint what factors are likely to lead to successful treatment. Surgery to relieve pain Surgery is often considered the court of last resort for pain: When all else fails, cut the nerve endings. Surgery can bring about instant, almost magical release from pain. But surgery may also destroy other sensations as well, or, inadvertently, become the source of new pain. Further, relief is not necessarily permanent. After 6 months or a year, pain may return. For all those reasons, the decision for surgery must always involve a careful weighing of the patient's condition and the outlook for the future. If surgery can mean the difference between a pain-wracked existence ending in death, versus a pain-free time in which to compose one's life and see friends and family, then surgery is clearly a humane and compassionate choice. There are a variety of operations to relieve pain. The most common is cordotomy: severing the nerve fibers on one or both sides of the spinal cord that travel the express routes to the brain. Cordotomy affects the sense of temperature as well as pain, since the fibers travel together in the express route. Besides cordotomy, surgery within the brain or spinal cord to relieve pain includes severing connections at major junctions in pain pathways, such as at the places where pain fibers cross from one side of the cord to the other, or destroying parts of important relay stations in the brain like the thalamus, an egg-shaped cluster of nerve cells near the center of the brain. In addition, surgeons sometimes can relieve pain by destroying nerve fibers or their parent cell bodies outside the brain or spinal cord. A case in point is the destruction of sympathetic nerves (a part of the autonomic nervous system) to relieve the severe pain that sometimes follows a penetrating wound from a sharp instrument or bullet. When pain affects the upper extremities, or is widespread, the surgeon has fewer options and surgery may not be as effective. Still, skilled neurosurgeons have achieved excellent results with upper spinal cord or brain surgery to treat severe intractable pain. These procedures may employ chemicals or use heat or freezing treatments to destroy tissue, as well as the more traditional use of the scalpel. Recently, Harvard Medical School surgeons reported success with a new brain operation called cingulotomy to relieve intractable pain in patients with severe psychiatric problems. The nerve fibers destroyed are part of a pathway important in emotions and motivation. The surgery appears to eliminate the discomfort and suffering the patient feels, but does not interfere with other mental faculties such as thinking and memory. Prior to operating, physicians can often test the effectiveness of surgery by using anesthetic drugs to block like the pain from a penetrating wound-these temporary blocks can in themselves be beneficial, promoting repair of nerve damage. How do these current treatments apply to the more common chronic pain conditions? What follows is a brief survey of major pain disorders and the treatments most in use today. The major pains * Headache. Tension headache, involving continued contractions of head and neck muscles, is one of the most common forms of headache. The other common variety is the vascular headache involving changes in the pressure of blood vessels serving the head. Migraine headaches are of the vascular type, associated with throbbing pain on one side of the head. Genetic factors play a role in determining who will be a victim of migraine, but many other factors are important as well. A major difficulty in treating migraine headache is that changes occur throughout the course of the headache. Blood vessels may first constrict and then dilate. Changing levels of neurotransmitters have also been noted. While a number of drugs can relieve migraine pain, their usefulness often depends on when they are taken. Some are only effective if taken at the onset. Drugs are also the most common treatment for tension headache, although attempts to use biofeedback to control muscle tension have had some success. Physical methods such as heat or cold applications often provide additional if only temporary relief. * Low back pain. The combination of aspirin, bed rest, and modest amounts of a muscle relaxant are usually prescribed for the first-time low back pain patient. At the initial examination, the physician will also note if the patient is overweight or works at an occupation such as truck-driving or a desk job that offers little opportunity for exercise. Some authorities believe that low back pain is particularly prevalent in Western society because of the combination of overweight, bad posture (made worse if there is added weight up front), and infrequent exercise. Not surprisingly, then, when the patient begins to feel better, the suggestion is made to take off pounds and take on physical exercise. In some cases, a full neurological examination may be necessary, including an x-ray of the spinal cord called a myelogram, to see if there may be a ruptured disc or other source of pressure on the cord or nerve roots. Sometimes x-rays will show a disc problem which can be helped by surgery. But neither the myelogram nor disc surgery is foolproof. Milder analgesics (aspirin or stronger nonnarcotic medications) and electrical stimulation-using TENS or implanted brain electrodes-can be very effective. What is not effective is long-term use of the muscle-relaxant tranquilizers. Many specialists are convinced that chronic use of these drugs is detrimental to the back patient, adding to depression and increasing pain. Massage or manipulative therapy are used by some clinicians but other than individual patient reports their usefulness is still undocumented. * Cancerpain. The pain of cancer can result from the pressure of a growing tumor or the infiltration of tumor cells into other organs. Or the pain can come about as the result of radiation or chemotherapy. These treatments can cause fluid accumulation and swelling (edema), irritate or destroy healthy tissue causing pain and inflammation, and possibly sensitize nerve endings. Ideally, the treatment for cancer pain is to remove the cancerous tissue. When that is not possible, pain can be treated by any or all of the currently available therapies: electrical stimulation, psychological methods, surgery, and strong painkillers. * Arthritis pain. Arthritis is a general descriptive term meaning an affliction of the joints. The two most common forms are osteoarthritis that typically affects the fingers and may spread to important weight-bearing joints in the spine or hips, and rheumatoid arthritis, an inflammatory joint disease associated with swelling, congestion, and thickening of the soft tissue around joints. Recently, a distinguished panel of pain experts commenting on arthritis reported that "in all probability aspirin remains the most widely used ... and important drug ... although it may cause serious side effects." In the 1950's the steroid drugs were introduced and hailed as lifesavers-important anti-inflammatory agents modeled after the body's own chemicals produced in the adrenal glands. But the long-term use of steroids has serious consequences, among them the lowering of resistance to infection, hemorrhaging, and facial puffiness-producing the so-called "moonface." Besides aspirin, current treatments for arthritis include several nonsteroid anti-inflammatory drugs like indomethacin and ibuprofen. But these drugs, too, may have serious side effects. TENS and acupuncture have been tried with mixed results. In cases where tissue has been destroyed, surgery to replace a diseased joint with an artificial part has been very successful. The "total hip replacement" operation is an example. Arthritis is best treated early, say the experts. A modest program of drugs combined with exercise can do much to restore full function and forestall long-term degenerative changes. Exercise in warm water is especially good since the water is both relaxing and provides buoyancy that makes exercises easier to perform. Physical treatments with warm or cold compresses are helpful sources of temporary pain relief. * Neurogenic pain. The most difficult pains to treat are those that result from damage to the peripheral nerves or to the central nervous system itself. We have mentioned tic douloureux and shingles as examples of extraordinarily searing pain, along with several drugs that can help. In addition, tic sufferers can benefit from surgery to destroy the nerve cells that supply pain-sensation fibers to the face. "Thermocoagulation"-which uses heat supplied by an electrical current to destroy nerve cells-has the advantage that pain fibers are more sensitive to the treatment resulting in less destruction of other sensations (touch and temperature). Sometimes specialists treating tic find that certain blood vessels in the brain lie near the group of nerve cells supplying sensory fibers to the face, exerting pressure that causes pain. The surgical insertion of a small sponge between the blood vessels and the nerve cells can relieve the pressure and eliminate pain. Among other notoriously painful neurogenic disorders is pain from an amputated or paralyzed limb-so called "phantom" pain-that affects up to 10 percent of amputees and paraplegia patients. Various combinations of antidepressants and weak narcotics like Darvon are sometimes effective. Surgery, too, is occasionally successful. Many experts now think that the electrical stimulating techniques hold the greatest promise for relieving these pains. * Psychogenic pain. Some cases of pain are not due to past disease or injury, nor is there any detectable sign of damage inside or outside the nervous system. Such pain may benefit from any of the psychological pain therapies listed earlier. It is also possible that some new methods used to diagnose pain may be useful. One method gaining in popularity is thermography, which measures the temperature of surface tissue as a reflection of blood flow. A color-coded "thermogram" of a person with a headache or other painful condition often shows an altered blood supply to the painful area, appearing as a darker or lighter shade than the surrounding areas or the corresponding part on the other side of the body. Thus an abnormal thermogram in a patient who complains of pain in the absence of any other evidence may provide a valuable clue that can lead to a diagnosis and treatment. Where to go for help People with chronic pain have usually seen a family doctor and several other specialists as well. Eventually they are referred to neurologists, orthopedists, or neurosurgeons. The patient/doctor relationship is extremely important in dealing with chronic pain. Both patients and family members should seek out knowledgeable specialists who neither dismiss nor indulge the patient; physicians who understand full well how pain has come to dominate the patient's life and the lives of everyone else in the family. Many specialists today refer chronic pain patients to pain clinics for treatment. Over 800 such clinics have opened their doors in the United States since a world leader in pain therapy established a pain clinic at the University of Washington in Seattle in 1960. Pain clinics differ in their approaches. Generally speaking, clinics employ a group of specialists who review each patient's medical history and conduct further tests when necessary. If the applicant is admitted, the clinic staff designs a personal treatment program that may include individual and group psychotherapy, exercise, diet, ice massage for pain (especially before bedtime), electrical stimulation techniques, and the use of a variety of analgesic but nonnarcotic drugs. The aim is to reduce pain medication and so improve the patient's pain problem that when he or she leaves the hospital it is with the prospect of resuming more normal activities with a minimal requirement for analgesics and a positive self-image. Contrary to what many people think, pain clinic patients are not malingerers or hypochondriacs. They are men and women of all ages, education, and social background, suffering a wide variety of painful conditions. Patients with low back pain are frequent, and so are people with the complications of diabetes, stroke, brain trauma, headache, arthritis, or any of the rarer pain conditions. The majority of patients participate for 2 or 3 weeks and usually report substantial improvement at discharge. One young man who had suffered painful chest injury as a result of a factory accident said he literally "felt taller" after his pain clinic experience. Followup at 3- and 6-month intervals, and at lengthier intervals thereafter, is an essential part of the program, both to evaluate the long-term effectiveness of treatment and to initiate a further course of treatment or counseling if necessary. Pain clinics have the virtue that they bring together people with pain problems that have left them feeling isolated, helpless, and hopeless. But not everyone with a pain problem may need the support of a group or residence in a hospital. The important factors are that the pain patient-and the family-understand all the ramifications of pain, and the many and varied steps that can now be taken to undo what chronic pain has done. As a result of the strides neuroscience has made in tracking down pain in the brain-and in the mind-we can expect more and better treatments in the years to come. The days when patients were told "I'm sorry, but you'll have to learn to live with the pain" will be gone forever. Voluntary health organizations Several lay organizations are directly concerned with pain problems. They are excellent sources of additional information, research updates, and specific help and referrals: American Chronic Pain Association, Inc. 257 Old Haymaker Road Monroeville, PA 15146 (412) 856-9676 National Chronic Pain Outreach Association, Inc. 4922 Hampden Lane, Dept. P Bethesda, MD 20814 (301) 652-4948 National Headache Foundation 5252 N. Western Avenue Chicago, IL 60625 (312) 878-7715 (800) 843-2256 (Toll free) (800) 523-8858 (Toll free in Illinois) In addition, many organizations concerned with specific diseases, such as arthritis or heart disease, provide information and advice about attendant pain problems. Pain clinics While there is no official certifying agency accrediting pain clinics throughout the country, there are many excellent clinics, often affiliated with university-associated medical centers. Your family doctor or university medical center may be able to refer you to reputable clinics nearby. If not, physicians can write to the American Society of Anesthesiologists, 515 Busse Highway, Park Ridge, IL 60068, which publishes a worldwide pain clinic directory. NINDS information For additional information concerning NINDS research on pain write: Office of Scientific and Health Reports National Institute of Neurological Disorders and Stroke Building 31, Room 8AO6 National Institutes of Health 9000 Rockville Pike Bethesda, MD 20892 (301) 496-5751 Prepared by the Office of Scientific and Health Reports National Institute of Neurological Disorders and Stroke NATIONAL INSTITUTES OF HEALTH Bethesda, Maryland 20892 This file scanned from NIH Publication No. 90-2406 November 1989 ! * COCHLEAR IMPLANTS IN ADULTS AND CHILDREN National Institutes of Health Consensus Development Conference Statement May 15-17, 1995 This statement will be published as: Cochlear Implants in Adults and Children. NIH Consens Statement 1995 May 15-17; 13(2):1-__. For making bibliographic reference to consensus statement no. 100 in the electronic form displayed here, it is recommended that the following format be used: Cochlear Implants in Adults and Children. NIH Consens Statement Online 1995 May 15-17 [cited year month day]; 13(2):1- __. Introduction Cochlear implants are now firmly established as effective options in the habilitation and rehabilitation of individuals with profound hearing impairment. Worldwide, more than 12,000 people have attained some degree of sound perception with cochlear implants, and the multichannel cochlear implant has become a widely accepted auditory prosthesis for both adults and children. The vast majority of adults who are deaf and have cochlear implants derive substantial benefit from them when they are used in conjunction with speechreading. Many of these individuals are able to understand some speech without speechreading, and some of these individuals are able to communicate by telephone. Benefits have also been observed in children, including those who lost their hearing prelingually; moreover, there is evidence that the benefits derived improve with continued use. New speech-sound processing techniques have improved the effectiveness of cochlear implants, increasing user performance levels to ones previously unseen. The NIH sponsored a Consensus Development Conference on Cochlear Implants in 1988. Since then, implant technology has been continually improved. Questions unanswered at that time have now been resolved. New issues have emerged that must be addressed. For example, the performance of some severely to profoundly hearing-impaired adults using hearing aids is poorer than that of even more severely hearing-impaired individuals using cochlear implants with advanced speech- processing strategies. It is possible that cochlear implants could be beneficial for some of these individuals. Therefore, the criteria for implantation should be re-examined. The ability to predict preoperatively the level of performance at which an individual implant recipient will function is highly desirable. Currently, the limited prediction of implant efficacy in a specific individual remains a pressing problem. Agreement does not exist on the definition of a successful implant user. What are the appropriate expectations for individuals using cochlear implants? How is benefit defined and measured? What are the audiological, educational, and psychosocial impacts of this intervention and is it cost-effective? Advancing technology will allow for the modification of existing devices or the development of new devices. It is therefore important to know what risks and benefits are associated with device explantation/reimplantation. Surgical and other risks and possible long-term effects of cochlear implants require evaluation. Implantation of individuals with multiple disabilities, the elderly, and children, particularly children who are prelingually deaf, engenders special questions. Longitudinal studies are providing information on the development of auditory speech perception and production and language skills in children who are deaf and have a cochlear implant. What educational setting is best for the development of speech and language in these children? Are cochlear implants efficacious in children who are prelingually deaf? To address these new issues since the 1988 Consensus Development Conference (CDC) on Cochlear Implants, the National Institute on Deafness and Other Communication Disorders, together with the NIH Office of Medical Applications of Research, convened a Consensus Development Conference on Cochlear Implants in Adults and Children, May 15-17, 1995. The conference was cosponsored by the National Institute on Aging, the National Institute of Child Health and Human Development, the National Institute of Neurological Disorders and Stroke, and the Department of Veterans Affairs. The conference was convened to summarize current knowledge about the range of benefits and limitations of cochlear implantation that have accrued to date. Such knowledge is an important basis for informed choices for individuals and their families whose philosophy of communication is dedicated to spoken discourse. Issues related to the acquisition of sign language were not directly addressed by the panel, because the focus of the conference was to synthesize thoughtfully the new information on cochlear implant technology and its use. The panel acknowledges the value and contributions of bilingual-bicultural approaches to deafness. This conference brought together specialists in auditory anatomy and physiology, otolaryngology, audiology, aural rehabilitation, education, speech-language pathology, bioengineering, and other related disciplines as well as representatives from the public. After 1-1/2 days of presentations and audience discussion, an independent, non- Federal consensus panel weighed the scientific evidence and developed a draft statement that addressed the following five questions: 1. What Factors Affect the Auditory Performance of Cochlear Implant Recipients? Subject Factors Auditory performance, defined as the ability to detect, discriminate, recognize, or identify acoustic signals, including speech, is highly variable among individuals using cochlear implants. Since the 1988 CDC on Cochlear Implants, however, some factors associated with outcome variability are now better understood. Etiology Because of a larger subject sample, the effects of etiology can now be distinguished from other factors such as the duration of deafness and the age of onset. Meningitic deafness does not necessarily limit the benefit of cochlear implantation in the absence of central nervous system complications, cochlear ossification, or cochlear occlusion. Children with congenital deafness and children with prelingually acquired meningitic deafness, for example, achieve similar auditory performance if the cochlear implant is received before age 6 years. In general, etiology does not appear to impact auditory performance in either children or adults. Age of Onset of Deafness The age of onset continues to have important implications for cochlear implantation, depending on whether the hearing impairment occurred before (prelingual), during (perilingual), or after (postlingual) learning speech and language. At the time of the last CDC, data on cochlear implantation suggested that children or adults with postlingual onset of deafness had better auditory performance than children or adults with prelingual or perilingual onsets. On average, current data following auditory performance in children over a longer period of time support this finding. However, the difference between children with postlingual and prelingual-perilingual onsets appears to lessen with time. Large individual differences remain within each group. Age at Implantation Previous data suggested that prelingually or perilingually deafened persons who were implanted in adolescence or adulthood did not achieve as good auditory performance as those implanted during childhood, although individual differences were recognized. Current data continue to support the importance of early detection of hearing loss and implantation for maximal auditory performance. However, it is still unclear whether implantation at age 2, for example, ultimately results in better auditory performance than implantation at age 3. Duration of Deafness As deafness endures, even in postlingually deafened individuals, some acquired skills and knowledge may decline and some behaviors that work against successful adaptation to a sensory device may develop. Individuals with shorter durations of auditory deprivation tend to achieve better auditory performance from any type of sensory aid, including cochlear implants, than individuals with longer durations of auditory deprivation. Residual Hearing Cochlear implants tend to give people with profound deafness a level of auditory performance that is similar to, or better than, the performance of people with severe hearing impairment who use hearing aids. These data raise the issue of whether cochlear implants might give persons with severe hearing impairment and some residual hearing even better auditory performance than they can attain with a hearing aid. No residual hearing is typically defined as profound hearing loss and no open-set speech recognition. However, the degree of preimplantation residual hearing does not predict postimplantation auditory performance. Research is now addressing the critical distinction between the importance of residual pure tone sensitivity compared with that of overall residual auditory capacities and functional communication status. Electrophysiological Factors Some surviving spiral ganglion cells are necessary for auditory performance with a cochlear implant. Degenerative changes occur in both ganglion cells and central auditory neurons following sensorineural deafening. Although a relationship between the number of surviving ganglion cells and psychophysical performance has been demonstrated in animals, a direct relationship between ganglion cell survival and level of auditory performance in humans has not been shown. Animal studies also suggest that electrical stimulation increases ganglion cell survival and also modifies the functional organization of the central auditory system. The implications of these new findings remain to be determined. Device Factors The task of representing speech stimuli as electrical stimuli is central to the design of cochlear implants. Designs vary according to (1) the placement, number, and relationship among the electrodes; (2) the way in which stimulus information is conveyed from an external processor to the electrodes; and (3) how the electrical stimuli are derived from the speech input (and other signals). Changes in cochlear implant design/processing strategies and their effects on auditory performance are discussed in Section 3. 2. What Are the Benefits and Limitations of Cochlear Implantation? Impact on Speech Perception in Adults Cochlear implantation has a profound impact on hearing and speech reception in postlingually deafened adults. Most individuals demonstrate significantly enhanced speech-reading capabilities, attaining scores of 90-100 percent correct on everyday sentence materials. Speech recognition afforded by the cochlear implant effectively supplements the information least favorably cued through speech-reading. A majority of those individuals with the latest speech processors for their implants will score above 80-percent correct on high-context sentences without visual cues. Performance on single-word testing in these individuals is notably poorer, although even these scores have been significantly improved with newer speech-processing strategies. Recognition of environmental sounds and even appreciation of music have been repeatedly observed in adult implant recipients. Noisy environments remain a problem for cochlear-implanted adults, significantly detracting from speech-perception abilities. Prelingually deafened adults have generally shown little improvement in speech perception scores after cochlear implantation, but many of these individuals derive satisfaction from hearing environmental sounds and continue to use their implants. Speech Perception, Speech Production, and Language Acquisition in Children Improvements in the speech perception and speech production of children following cochlear implantation are often reported as primary benefits. Variability across children is substantial. Factors such as age of onset, age of implantation, the nature and intensity of (re)habilitation, and mode of communication contribute to this variability. Using tests commonly applied to children and adults with hearing impairments (e.g., pattern perception, closed-set word identification, and open-set perception), perceptual performance increases on average with each succeeding year post implantation. Shortly after implantation, performance may be broadly comparable to that of some children with hearing aids and over time may improve to match that of children who are highly successful hearing aid users. Children implanted at younger ages are on average more accurate in their production of consonants, vowels, intonation, and rhythm. Speech produced by children with implants is more accurate than speech produced by children with comparable hearing losses using vibro-tactile or hearing aids. One year after implantation, speech intelligibility is twice that typically reported for children with profound hearing impairments and continues to improve. Oral-aural communication training appears to result in substantially greater speech intelligibility than manually based total communication. The language outcomes in children with cochlear implants have received less attention. Reports involving small numbers of children suggest that implantation in conjunction with education plus habilitation leads to advances in oral language acquisition. The nature and pace of language acquisition may be influenced by the age of onset, age at implantation, nature and intensity of habilitation, and mode of communication. One current limitation is that children are typically implanted at no earlier than age 2 years, which is beyond what may be critical periods of auditory input for the acquisition of oral language. Benefits are not realized immediately, but rather are manifested over time, with some children continuing to show improvement over several years. Few studies have used language as an outcome measure. The assessment of speech perception, language production, and language comprehension in young children is particularly challenging. Furthermore, all results in children have been reported for single-channel or feature-based devices only, despite the relatively rapid evolution of alternatives in speech-coding strategies. Oral language development in deaf children, including those with cochlear implants, remains a slow, training-intensive process, and results will typically be delayed in comparison with normally hearing peers. Psychologic and Social Issues in Adults and Children Although psychological evaluation has previously been a part of the preimplant evaluation process, comparatively little research has been conducted on the long-term psychological and social effects of electing for implantation. Still, the psychological and social impact for adults is generally quite positive, and there appears to be agreement between preimplantation expectations and later benefit. This benefit is expressed as a decline in loneliness, depression and social isolation and an increase in self-esteem, independence, social integration, and vocational prospects. Many adults report being able to function socially or vocationally in ways comparable to those with moderate hearing loss. Furthermore, they describe a new or renewed curiosity about the experience of hearing and the phenomena of sound. In some cases the experience of implantation becomes an integral part of the individual's identity, leading implant users to participate and share experiences in self-interest and advocacy groups. Negative psychological and social impact is less frequently observed and is often related to concerns about the maintenance and/or malfunction of the implant and external hardware. Other social insecurities may result from the difficulty of hearing amidst background noise, and from unreasonable expectations of aural-only benefit on the part of the implant user or his/her family and friends. The assessment of psychological impact in children with implants lags behind that for the adult population, in part because psychological outcome is a factor of audiological benefit, which is realized more slowly in children. Additionally, such assessment must consider the child's family setting. Because language acquisition is closely associated with identity, social development, and social integration, the impact of implantation on a child's development in these areas deserves more study in order to produce useful indicators that can bear upon parental decision-making processes. Rehabilitation and Educational Issues Although a cochlear implant can provide dramatic augmentation of the auditory information perceived by deaf children and adults, it is clear that training and educational intervention play a fundamental role in optimizing postimplant benefit. Access to postimplant rehabilitation involving professionals familiar with cochlear implants must be provided to ensure successful outcomes for implant recipients. Rehabilitation efforts must be tailored to meet individual needs, and protocols should be developed to reflect therapies effective for various types of individuals receiving implants. Therapeutic intervention with prelingually deaf adults may differ significantly in both time and content from that of postlingually deaf recipients. Pediatric cochlear implantation requires a multidisciplinary team composed of physicians, audiologists, speech-language pathologists, rehabilitation specialists, and educators familiar with cochlear implants. These professionals must work together in a long-term relationship to support the child's auditory and oral development. Although the effects of communication mode in implantation habilitation have not been sufficiently documented, it is clear that the educational programs for children with cochlear implants must include auditory and speech instruction using the auditory information offered by the implant. Cost-Utility The cost-benefit or cost-utility of cochlear implantation must be calculated for children and adults separately. For adults, the cost of cochlear implantation includes the initial costs of assessment, the device, implantation, rehabilitation, system overhead, and maintenance. The benefit or utility is estimated as a function of quality of life over time. On this basis, cochlear implantation whether at age 45 years or 70 years compares quite favorably to many medical procedures now commonly in use (e.g., implantable defibrillator insertion). Although it appears that the cost-utility estimates for children are also quite favorable, we are still in the early stages of cochlear implant application and cannot yet estimate the cost or potential cost savings that will accrue in the area of (re)habilitation and education. 3. What Are the Technical and Safety Considerations of Cochlear Implantation? Cochlear Implant Design Issues A cochlear implant works by providing direct electrical stimulation to the auditory nerve, bypassing the usual transducer cells that are absent or nonfunctional in a deaf cochlea. Over the past 10 years, significant improvements have been made in the technology used to accomplish auditory stimulation. The best performance in speech recognition occurs with intracochlear electrodes that are close to the nerves to be stimulated, thus minimizing undesirable side effects. Early implants used only a single electrode; it has been found that these single-channel implants rarely provide open-set speech perception. Most recent implants have used multielectrode arrays that provide a number of independent channels of stimulation. Such devices provide more information about the acoustic signal and give better performance on speech recognition. No agreement exists on the optimum number of channels, although at least 4-6 channels seem to be necessary. Much of the recent progress in implant performance has involved improvements in the speech processors, which convert sound into the electrical stimulus. The best performance comes with speech processors that attempt to preserve the normal frequency code or spectral representation of the cochlea. These are distinguished from feature-based processors, which attempt to analyze certain features known to be important to speech perception and present only those features through the electrodes. A major problem in multichannel implants is channel interaction, in which two electrodes stimulate overlapping populations of nerves. Channel interaction has now been minimized with speech processors that activate the electrodes in a nonsimultaneous or interleaved fashion, which has been shown to improve speech recognition significantly. A final design issue is the means by which the stimulus information is passed through the skin from the speech processor to the electrodes. In a transcutaneous system, the skin is intact and the coupling is done electromagnetically to an implanted antenna. In a percutaneous system, the leads are passed directly through the skin. The two systems have slightly different surgical complications, which are discussed below. The percutaneous system (1) provides a more flexible connection to the electrodes in case a change in speech processor is desired, (2) is easier to troubleshoot in case of electrode problems, and (3) is magnetic resonance imaging (MRI) compatible. Currently, percutaneous systems are not commercially available. Issues Related to Magnetic Resonance Imaging Magnetic Resonance Imaging (MRI) is increasingly the diagnostic tool of choice for a variety of medical conditions. Implants that use transcutaneous connectors contain an implanted magnet and some ferrous materials that are incompatible with the high magnetic fields of an MRI scanner. Implant manufacturers are redesigning their devices to circumvent this problem. Potential MRI risks should be part of the informed consent procedure for persons considering an implant. The external speech processor cannot be made MRI compatible and should not be taken into the scanner. Surgical Issues Cochlear implantation entails risks common to most surgical procedures, e.g., general anesthetic exposure, as well as unique risks that are influenced by device design, individual anatomy and pathology, and surgical technique. Comparative data of major complications incurred in adult implantation show a halving of the complication rate to approximately 5 percent in 1993. The complication rate in pediatric implantation is less than that currently seen in adults. Overall, the complication rate compares favorably to the 10 percent rate seen with pacemaker/defibrillator implantation. Major complications, i.e., those requiring revision surgery, include flap problems, device migration or extrusion, and device failure. Facial palsy is also considered a major complication but is distinctly uncommon and rarely permanent. Notably, no mortalities have been attributed to cochlear implantation. Alterations in surgical technique, especially flap design, have led to a considerable reduction in the flap complication rate, which is particularly relevant to transcutaneous devices. Alterations in surgical technique, particularly in methods used to anchor the device, have contributed to a decrease in device migration/extrusion. All implants are potentially prone to failure--either because of manufacturing defects or use- related trauma. Pedestal fracture is a problem unique to the percutaneous device, but occurs rarely. Manufacturer redesign has produced electrode arrays that are smaller but sturdier. For the most commonly implanted device, 95 percent of implants are still functioning after 9 years. Most current implants with transcutaneous connectors do not provide self-test capability for the implanted portion, making it cumbersome to test for simple electrode failure, such as open and short circuits. Failure detection is particularly problematic in young children. Device manufacturers should include self-test circuity in future implant designs. Minor complications are those that resolve without surgical intervention. The most common is unwanted facial nerve stimulation with electrode activation, which is readily rectified by device reprogramming. In percutaneous devices, pedestal infections are uncommon and can be treated successfully with antibiotics, but on rare occasions may require explantation. Reimplantation is necessary in approximately 5 percent of cases because of improper electrode insertion or migration, device failure, serious flap complication, or loss of manufacturer support. In general, reimplantation in the same ear is usually possible, and thus far individual auditory performance after reimplantation equals or exceeds that seen with the original implant. Long-term complications of implantation relate to flap breakdown, electrode migration and receiver/stimulator migration. Particularly in the child, the potential consequences of otitis media have been of concern, but as the implanted electrode becomes ensheathed in a fibrous envelope, it appears protected from the consequences of local infection. 4. Who Is a Candidate for Cochlear Implantation? Adults Cochlear implants are often highly successful in postlingually deafened adults with severe/profound hearing loss with no speech perception benefit from hearing aids. Previously, individuals receiving marginal benefit from hearing aids were not considered implant candidates. Ironically, such individuals often have less speech perception than more severely deafened persons who receive implants. Recent data show that most marginally successful hearing aid users implanted with a cochlear implant will have improved speech perception performance. It is therefore reasonable to extend cochlear implants to postlingually deafened adult individuals currently obtaining marginal benefit from other amplification systems. Prelingually deafened adults may also be suitable for implantation, although these candidates must be counseled regarding realistic expectations. Existing data indicate that these individuals achieve minimal improvement in speech recognition skills. However, there may be other basic benefits such as improved sound awareness that correlate with psychological satisfaction and safety needs. Because of the wide variability in speech perception and recognition in persons with similar hearing impairments, all candidates require indepth counseling of the surgery, its risks and benefits, rehabilitation, and alternatives to cochlear implantation. To give adequate informed consent, adult candidates should understand that large variability in individual audiologic performance precludes preoperative prediction of success. Determining implant candidacy requires consideration of both objective audiological variables as well as the subjective needs and wishes of individual candidates. Specific characteristics of potential adult cochlear implant recipients are provided below. Audiologic Criteria Indications in favor of an implant are a severe-to-profound sensorineural hearing loss bilaterally and open-set sentence recognition scores less than or equal to 30 percent under best aided conditions. Duration of deafness and age of onset have been shown to influence auditory performance with cochlear implants and should be discussed with potential candidates. In general, when there is no residual hearing in either ear, the ear with better closed-set performance, more sensitive electrical thresholds, shorter period of auditory deprivation, or better radiologic characteristics is implanted. However, when there is residual hearing, the poorer ear should be chosen, provided that there is radiologic evidence of cochlear patency. Medical and Surgical Criteria Traditionally, implantation candidacy was limited to healthy persons. Although there may be specific medical contraindications to surgery and implantation such as poor anesthetic risk, severe mental retardation, severe psychiatric disorders, and organic brain syndromes, cochlear implantation should be offered to a wider population of individuals. In some circumstances, such as in individuals with low vision, implantation may be a tool to promote independence and other quality-of-life goals. The medical history, physical examination, and laboratory tests are important tools in candidacy evaluation. Individuals with active ear pathology require treatment and re-evaluation prior to implantation. The standard evaluation includes high-resolution computed tomography (CT) scans that serve to detect mixed fibrous and bony occlusions and anatomical abnormalities. MRI provides better resolution of soft tissue structures and should supplement the CT scan when indicated. These imaging techniques should be used to identify abnormalities that may compromise or impede implant surgery or device use. The results of electrophysiologic tests do not predict implant success. However, in selected individuals, such as those with cochlear obliteration or in decisions regarding ear of implantation, the results of promontory stimulation may be useful. Children Cochlear implants have also been shown to result in successful speech perception in children. Currently, the earliest age of implantation is 24 months, but there are reasons to reassess this age threshold. A younger age of implantation may limit the negative consequences of auditory deprivation and may allow more efficient acquisition of speech and language. Determining whether cochlear implant benefits are greater in children implanted at age 2-3 years as compared to those implanted at age 4-5 years might resolve this issue, but sufficient data are unavailable. It is also not clear that the benefits of implantation before age 2 years would offset potential liabilities associated with the increased difficulty in obtaining reliable and valid characterization of hearing and functional communication status at the younger age. A number of children under age 2 years have received implants, both internationally and in the United States, when it was thought that bone growth associated with meningitis would preclude implantation at a later date. Speech/language data obtained on such children will be helpful in determining the potential benefits of early implantation and therefore may help to guide future policy. Audiologic Criteria Children age 2 years or older with profound (greater than 90 dBHL) sensorineural hearing loss bilaterally and minimal speech perception under best aided conditions may be considered for cochlear implantation. In the young child, auditory brainstem response, stapedial reflex testing, and/or otoacoustic emission testing may be useful when combined with auditory behavioral responses to determine hearing status. Prior to implantation, a trial period with appropriate amplification combined with intensive auditory training should have been attempted to ensure that maximal benefit has been achieved. When the validity of behavioral test results is compromised by maturational factors, the above criteria should be applied in the most stringent manner (i.e., worse hearing sensitivity, longer trial periods, and so on). Current research may broaden audiometric criteria for candidacy to better reflect functional auditory capacity. Medical and Surgical Criteria Children should undergo a complete medical evaluation to rule out the presence of active disease, which would be a contraindication to surgery. The child must be otologically stable and free of active middle ear disease prior to cochlear implantation. The radiologic imaging criteria used in adult candidates can be applied to children. Psychosocial Criteria Preoperative assessment should entail evaluation of the child in the context of the home and social and educational milieu to assure that implantation is the proper intervention. In some instances psychosocial factors may be used as exclusionary criteria; however, in most cases it should serve only as baseline data for tracking cochlear implant outcomes. Informed Consent The parents of a deaf child are responsible for deciding whether to elect cochlear implantation. The informed consent process should be used to empower parents in their decision-making. The parents must understand that cochlear implants do not restore normal hearing and that auditory and speech outcomes are highly variable and unpredictable. They must be informed of the advantages, disadvantages, and risks associated with implantation to establish realistic expectations. Furthermore, the importance of long-term rehabilitation to success with cochlear implants must be stressed. As part of the process of informed consent, parents must be told that alternative approaches to habilitation are available. All children should be included in the informed consent process to the extent that they are able, as their active participation is crucial to (re)habilitative success. 5. What Are the Directions for Future Research on Cochlear Implantation? * Research must attempt to explain the wide variation in performance across individual cochlear implant users. New tools, such as functional imaging of the brain, might be applied to unexplored variables such as the ability of the implant to activate the central auditory system. Investigations of the role of higher level cognitive processes in cochlear implant performance are needed. * The strides that have been made in improving speech perception of cochlear implant users should continue through improvements in electrode design and signal processing strategies. Noise-reduction technologies and enhancement of performance using binaural implants are promising areas. * Studies of the effects of cochlear stimulation on auditory neurons have provided clear evidence of plasticity in both the survival of neural elements and in receptive field organization. Comparisons of neural plasticity in animal experiments and of adaptation to cochlear implant electrical stimulation by humans provide a unique opportunity to study the relationships between neural activity and auditory perception. * Comparative research on language development in children with normal hearing, children with hearing impairment who use hearing aids, deaf children with cochlear implants, and deaf children using American Sign Language should be conducted. These studies should be longitudinal and reflect current theoretical and empirical advances in neurolinguistics and psycholinguistics. * Studies of the relationship between the development of speech perception and speech production in cochlear implant users must continue. Implanted deaf children provide a unique opportunity to examine these developmental processes and their relationship to the acquisition of aural/oral language. Such information is crucial to understanding and enhancing the performance of implanted prelingual children and may help define optimal age for implantation. * Adequate tools for the assessment of nonspeech benefits of implantation should be applied to gain a better understanding of the full effects of implantation on the quality of life of implant recipients. This may be particularly useful for implant recipients who do not realize significant speech-perception benefit. Such data will help in evaluating the cost-utility of cochlear implantation. * Identifying the components of successful (re)habilitation approaches will facilitate extension of these services to all children and adults receiving cochlear implants, as will comparison of model and routine service programs. Conclusions * Cochlear implantation improves communication ability in most adults with deafness and frequently leads to positive psychological and social benefits as well. The greatest benefits seen to date have occurred in postlingually deafened adults. Cochlear implantation in prelingually deafened adults provides more limited improvement in speech perception, but offers important environmental sound awareness. Cochlear implantation outcomes are more variable in children. Nonetheless, gradual, steady improvement in speech perception, speech production, and language does occur. There is substantial unexplained variability in the performance of implant users of all ages, and implants are not appropriate for all individuals. * Currently children at least 2 years old and adults with profound deafness are candidates for implantation. Cochlear implant candidacy should be extended to adults with severe hearing impairment and poor open-set sentence discrimination, i.e., less than or equal to 30 percent in the best aided condition. Although there are theoretical reasons to lower the age of implantation in children, data are too scarce to justify a change in criteria. Additional data may justify a change in age and audiologic criteria. * Auditory performance with a cochlear implant varies among individuals. The data indicate that performance is better in individuals who (1) have shorter durations of deafness, (2) were implanted before age 6 years, and (3) acquired language before their hearing loss occurred. Auditory performance is not affected by etiology of hearing loss. * Access to optimal educational and (re)habilitation services is important to adults and is critical to children to maximize the benefits available from cochlear implantation. * The current generation of intracochlear, multichannel implants with spectrally based speech processors provides a substantial improvement over the previous generation of devices, especially when nonsimultaneous electrode activation is used. * The low complication rate and high reliability for cochlear implants compares favorably with other implanted electronic devices, and continues to improve. * Current devices are not MRI compatible, and users and physicians should be acutely aware of this problem. Implant manufacturers should include MRI compatibility and internal self-test systems in future devices. * Percutaneous connectors offer many research and clinical opportunities, including MRI compatibility, ease of electrode testing, and processor upgrades, and they should not be abandoned. Consensus Development Panel George A. Gates, M.D. Conference and Panel Chairperson Professor of Otolaryngology-Head and Neck Surgery Director Virginia Merrill Bloedel Hearing Research Center University of Washington Seattle, Washington Kathleen Daly, Ph.D. Assistant Professor Department of Otolaryngology University of Minnesota Minneapolis, Minnesota William J. Dichtel, M.D. Otolaryngologist Roanoke, Virginia Robert J. Dooling, Ph.D. Professor Department of Psychology University of Maryland College Park, Maryland Aina Julianna Gulya, M.D. Professor Department of Otolaryngology Head and Neck Surgery Georgetown University Washington, District of Columbia Joseph W. Hall III, Ph.D. Professor Department of Surgery Division of Otolaryngology University of North Carolina at Chapel Hill Chapel Hill, North Carolina Susan W. Jerger, Ph.D. Professor and Director Children's Special Hearing Section Department of Otorhinolaryngology Baylor College of Medicine Houston, Texas Jacqueline E. Jones, M.D. Assistant Professor Department of Otolaryngology Cornell University Medical College New York Hospital New York, New York Margaret H. Mayer, Ed.D. Coordinator for Teacher Education and Research Northwest School for Hearing-Impaired Children Seattle, Washington Michael Pierschalla Cambridge, Massachusetts Lainie Friedman Ross, M.D., M.Phil. Assistant Professor Department of Pediatrics and MacLean Center for Clinical Medical Ethics University of Chicago Chicago, Illinois Richard G. Schwartz, Ph.D. Professor Ph.D. Program in Speech and Hearing Sciences City University of New York New York, New York Barbara E. Weinstein, Ph.D. Associate Professor of Audiology Director, Audiology Program Lehman College City University of New York New York, New York Eric D. Young, Ph.D. Professor Department of Biomedical Engineering Johns Hopkins University Baltimore, Maryland Speakers Paul J. Abbas, Ph.D. "Factors Affecting Auditory Performance: Electrophysiologic Measures" Professor Department of Speech Pathology and Audiology Department of Otolaryngology Head and Neck Surgery University of Iowa Iowa City, Iowa Peter Blamey, Ph.D. "Factors Affecting Auditory Performance of Postlinguistically Deaf Adults Using Cochlear Implants: Etiology, Age, and Duration of Deafness" Principal Research Fellow Department of Otolaryngology University of Melbourne East Melbourne, Victoria, Australia Derald E. Brackmann, M.D., F.A.C.S. "Percutaneous Connectors in Cochlear Implantation" Clinical Professor of Otolaryngology-Head and Neck Surgery/Neurosurgery University of Southern California School of Medicine President House Ear Clinic and Institute Los Angeles, California Judith A. Brimacombe, M.A. "Multichannel Cochlear Implants in Adults With Residual Hearing" Vice President Clinical and Regulatory Affairs Cochlear Corporation Englewood, Colorado Patricia M. Chute, Ed.D. "Residual Hearing in Children" Director, Cochlear Implant Center Manhattan Eye, Ear, and Throat Hospital New York, New York Noel L. Cohen, M.D. "Surgical Complications and Considerations" Professor and Chairman Department of Otolaryngology New York University School of Medicine New York, New York Michael F. Dorman, Ph.D. "Speech Perception by Adults" Professor Department of Speech and Hearing Science Arizona State University Tempe, Arizona Adjunct Professor Division of Otolaryngology University of Utah Health Sciences Center Salt Lake City, Utah Donald K. Eddington, Ph.D. "Introduction and Overview" Cochlear Implant Research Laboratory Massachusetts Eye and Ear Infirmary Boston, Massachusetts Bruce J. Gantz, M.D., F.A.C.S. "Device Failure" Professor and Interim Head Department of Otolaryngology Head and Neck Surgery University of Iowa College of Medicine Iowa City, Iowa James W. Heller, P.E. "MRI Considerations" Manager of Research Cochlear Corporation Englewood, Colorado Darlene R. Ketten, Ph.D. "Radiologic Assessment" Assistant Professor Department of Otology and Laryngology Harvard Medical School Research Director Three-Dimensional Imaging Service Massachusetts Eye and Ear Infirmary Boston, Massachusetts John F. Knutson, Ph.D. "Psychological and Social Issues in Cochlear Implant Use" Professor Department of Psychology Spence Laboratories of Psychology University of Iowa Iowa City, Iowa Patricia A. Leake, Ph.D. "Long-Term Effects of Electrical Stimulation" Professor in Residence Department of Otolaryngology Research Director Epstein Hearing Research Laboratory University of California San Francisco San Francisco, California Hugh J. McDermott, Ph.D. "Speech Processing Using Selected Spectral Features" Research Fellow Department of Otolaryngology University of Melbourne East Melbourne, Victoria, Australia Richard T. Miyamoto, M.D., F.A.C.S. "Timing of Implantation in Children" Arilla Spence DeVault Professor and Chairman Department of Otolaryngology-Head and Neck Surgery Indiana University School of Medicine Indianapolis, Indiana Jean S. Moog, M.S. "Rehabilitation and Educational Issues in Children" Director of Deaf Education Central Institute for the Deaf St. Louis, Missouri Mary Joe Osberger, Ph.D. "Effect of Age at Onset of Deafness on Cochlear Implant Performance" "Speech Perception in Children" Director, Pediatric Clinical Research Advanced Bionics Corporation Sylmar, California Robert V. Shannon, Ph.D. "Information Transmission in Cochlear Implants: Analysis Channels, Number of Electrodes, and Received Channels" Auditory Implant Research House Ear Institute Los Angeles, California Margaret W. Skinner, Ph.D. "Audiologic Criteria for Cochlear Implantation in Adults and Children" Associate Professor Director of Audiology Director of Cochlear Implant Program Department of Otolaryngology-Head and Neck Surgery Washington University School of Medicine St. Louis, Missouri Quentin Summerfield, Ph.D. "Cost-Effectiveness Considerations in Cochlear Implantation" Professor Medical Research Council Institute of Hearing Research Nottingham, United Kingdom Emily A. Tobey, Ph.D. "Speech Production in Children" Professor and Nelle C. Johnston Chair in Early Childhood Communication Disorders Department of Communication Disorders Callier Center for Communication Disorders University of Texas at Dallas Dallas, Texas Susan B. Waltzman, Ph.D. "Comparison of Implant Systems" Professor Department of Otolaryngology New York University School of Medicine New York, New York Blake S. Wilson, B.S.E.E. "Continuous Interleaved Sampling and Related Strategies" Director Center for Auditory Prosthesis Research Research Triangle Institute Research Triangle Park, North Carolina Teresa A. Zwolan, Ph.D. "Factors Affecting Auditory Performance With a Cochlear Implant by Prelingually Deafened Adults" Assistant Research Scientist Director, Cochlear Implant Program Department of Otolaryngology-Head and Neck Surgery Audiology and Electrophysiology Division University of Michigan Medical Center Ann Arbor, Michigan Planning Committee Amy M. Donahue, Ph.D. Chairperson Acting Chief, Hearing and Balance/Vestibular Sciences Branch Division of Human Communication National Institute on Deafness and Other Communication Disorders National Institutes of Health Bethesda, Maryland Marin P. Allen, Ph.D. Chief Program Planning and Health Reports Branch National Institute on Deafness and Other Communication Disorders National Institutes of Health Bethesda, Maryland Lucille B. Beck, Ph.D. Associate Chief Audiology and Speech Pathology Service Department of Veterans Affairs Washington, District of Columbia Elsa A. Bray Program Analyst Office of Medical Applications of Research National Institutes of Health Bethesda, Maryland Judith A. Cooper, Ph.D. Deputy Director Division of Human Communication National Institute on Deafness and Other Communication Disorders National Institutes of Health Rockville, Maryland John H. Ferguson, M.D. Director Office of Medical Applications of Research National Institutes of Health Bethesda, Maryland Marilyn Neder Flack, M.A. Senior Scientific Reviewer/Audiologist Ear, Nose, and Throat Devices Center for Devices and Radiological Health Office of Device Evaluation Food and Drug Administration Rockville, Maryland George A. Gates, M.D. Conference and Panel Chairperson Professor of Otolaryngology-Head and Neck Surgery Director of Virginia Merrill Bloedel Hearing Research Center University of Washington Seattle, Washington William H. Hall Director of Communications Office of Medical Applications of Research National Institutes of Health Bethesda, Maryland F. Terry Hambrecht, M.D. Head, Neural Prosthesis Program National Institute of Neurological Disorders and Stroke National Institutes of Health Bethesda, Maryland Norman Krasnegor, Ph.D. Chief Human Learning and Behavior Branch Center for Research for Mothers and Children National Institute of Child Health and Human Development National Institutes of Health Bethesda, Maryland Andrew A. Monjan, Ph.D., M.P.H. Chief Neurobiology of Aging Branch Neuroscience and Neuropsychology of Aging Program National Institute on Aging National Institutes of Health Bethesda, Maryland Ralph F. Naunton, M.D. Director Division of Human Communication National Institute on Deafness and Other Communication Disorders National Institutes of Health Rockville, Maryland Conference Sponsors Office of Medical Applications of Research, NIH John H. Ferguson, M.D. Director National Institute on Deafness and Other Communication Disorders James B. Snow, Jr., M.D. Director Cosponsors National Institute on Aging Richard J. Hodes, M.D. Director National Institute of Child Health and Human Development Duane F. Alexander, M.D. Director National Institute of Neurological Disorders and Stroke Zach W. Hall, Ph.D. Director U.S. Department of Veterans Affairs Jesse Brown Secretary ABOUT THE NIH CONSENSUS DEVELOPMENT PROGRAM NIH Consensus Development Conferences are convened to evaluate available scientific information and resolve safety and efficacy issues related to a biomedical technology. The resultant NIH Consensus Statements are intended to advance understanding of the technology or issue in question and to be useful to health professionals and the public. NIH Consensus Statements are prepared by a nonadvocate, non-Federal panel of experts, based on (1) presentations by investigators working in areas relevant to the consensus questions during a 2-day public session, (2) questions and statements from conference attendees during open discussion periods that are part of the public session, and (3) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government. Statement Availability Preparation and distribution of this statement is the responsibility of the Office of Medical Applications of Research of the National Institutes of Health. Free copies of this statement and bibliographies prepared by the National Library of Medicine are available from the Office of Medical Applications of Research, National Institutes of Health, or the NIH Consensus Program Information Service by 24-hour voice mail. In addition, free copies of all other available NIH Consensus Statements and NIH Technology Assessment Statements may be obtained from the following resources: NIH Consensus Program Information Service P.O. Box 2577 Kensington, MD 20891 Telephone 1-800-NIH-OMAR (644-6627) Fax (301) 816-2494 NIH Office of Medical Applications of Research Federal Building, Room 618 7550 Wisconsin Avenue MSC 9120 Bethesda, MD 20892-9120 ! * THE "COMMON" COLD: (So named because we all seem to get it) Usually colds occur in the Fall and Winter. The "cold" is caused by a number of different viruses which infect the upper respiratory system: nose, throat, and trachea (windpipe) and sometimes lower into the lungs. The influenza (flu) virus is one of many types of viruses which can cause a "common cold". The typical "cold" lasts 7-10 days, but may last up to 2-4 weeks. Symptoms include: fever (99-101), runny or stuffy nose, sore throat, cough, headache, muscle aches, weakness and hoarseness. The common cold is not curable with antibotics. Your body's defenses will eventually cure the infection. Your recovery will be helped by adequate rest, good nutrition, avoiding excessive physical activity, not smoking, and using alcohol only in moderation. Your doctor will often recommend medicine to alleviate specific symptoms. Headache, fever and muscle ache can be helped by acetaminophen (Tylenol) or ibuprofen. Tylenol is preferred to aspirin because aspirin has been associated with an illness called Reyes Syndrome. Runny nose or stuffiness is helped by decongestants or antihistamines or a combination. Normally it is best to avoid the antihistamines which may cause sedation and dry out secretions. Coughing can be suppressed by cough medicine containing Dextromethorphan or a codeine preparation. Studies have shown that 500 mg. of Vitamin C taken every 4-6 hours will shorten the course of a cold by 36-48 hours. Vitamin C has a mild antihistamine effect that will not cause excessive drying. A stuffy, plugged nose can be helped by saline (salt water) nose drops. Other nose drops such as Afrin can be used to a lesser degree (no more than 3 days). In general, the common cold can be treated in the dorm room or home. High fever, severe headache, prolonged cough or sore throat more than 2-3 days, cough or runny nose productive of yellow or green colored mucous or shortness of breath do warrant a visit to the Health Service. A flu shot, given before the flu season, may help decrease the incidence or severity of an influenza infection. This vaccine is recommended primarily for the elderly or those with chronic diseases such as diabetes. Amantadine, an antiviral drug, can be useful in the treatment of influenza but needs to be started in the first 24-48 hours to be effective. ! * While this article was written specifically for the teachers of students with Crohn's Disease and Ulcerative Colitis, the information will be helpful to families and friends of persons with one of these disorders. Many ideas are applicable to other health problems as well. For more information, please contact: National Foundation for Ileitis & Colitis, Inc. 444 Park Avenue South New York, NY 10016 (212) 685-3440 A TEACHER'S GUIDE TO CROHN'S DISEASE & ULCERATIVE COLITIS Some Facts You Should Know: 1. Crohn's disease and ulcerative colitis are lifelong illnesses. Medications often alleviate inflammation and discomfort, but do not cure the diseases. 2. Crohn's disease and ulcerative colitis are NOT caused by emotional stress. Young people with these illnesses need the support of teachers as well as family and friends in order to cope. 3. Crohn's disease and ulcerative colitis are NOT contagious. Researchers feel the diseases may be caused by an unknown bacterium or virus, or by a defect in the body's immune system. 4. Most children do NOT need special diets. They can generally eat what their classmates eat, although they may avoid certain foods which cause them discomfort. However, when the disease is active, they may be more selective in their food intake. 5. Young people with Crohn's disease and ulcerative colitis need ready access to a bathroom. Diarrhea is often a severe problem for these youngsters, and getting to a bathroom in time can be a great source of anxiety. Young people with Crohn's disease and ulcerative colitis need our understanding and support in order to develop their full academic and social potential. It would be wonderful if all young people could enjoy good health and smooth adjustment during their elementary and high school years. Unfortunately, some children are plagued with chronic illnesses such as Crohn's disease and ulcerative colitis. Just getting through the school day can be an extremely difficult task without the support and encouragement of teachers who understand their illness. ABOUT THE DISEASES Crohn's disease is a condition in which the wall of the small or large intestine becomes sore, inflamed, and swollen. This causes abdominal pain, diarrhea, fever, and loss of weight. Some young people experience pain in their knees, ankles, and other joints. Crohn's disease is called ileitis when it affects the lower small intestine, Crohn's colitis when it affects the large intestine (colon), and ileocolitis when both small and large intestines are involved. Ulcerative colitis causes inflammation of the inner lining of the large intestine. For this reason, diarrhea is often mixed with blood and may occur with great urgency to the point of incontinence. There may also be abdominal pain and pain in the joints. Crohn's disease and ulcerative colitis may occur at any age, even in children under 10 years of age. Boys and girls appear to be affected equally. These diseases are NOT to be confused with "spastic colon," or irritable bowel syndrome, a far less serious, unrelated condition. COPING WITH THE DISEASE AND ITS TREATMENT "The hardest thing for me to cope with was the fact that I was different." "My disease sort of isolates me from other kids. So it is hard for me to make friends. Deep down I really want to be like everyone else." Young people with Crohn's disease or ulcerative colitis must cope with attacks of pain and diarrhea, episodes of fever and nausea, and lack of appetite. Because many of these children eat less than their bodies require, they often grow at a slower rate and may appear younger and smaller than their classmates. These combined problems often cause them to withdraw and become depressed or angry, especially during the pre-adolescent or adolescent years. Treatment can cause problems, too. Cortisone-like drugs are effective in controlling, but not curing, the inflammation caused by Crohn's disease and ulcerative colitis. But these drugs often cause youngsters to gain weight, to develop a rounded puffy appearance, to have worsening of acne, and to become moody and restless. This change in appearance further isolates them from their classmates, who may not be aware of their illness and may ridicule or make fun of them. ABSENCE FROM SCHOOL "My biggest problem is that most of my teachers don't think I look sick!" Not all young people with Crohn's disease or ulcerative colitis are small or have side effects of medication. They may APPEAR quite well but actually FEEL too ill to attend school. They might also feel well one day and sick the next. The disease and medications cause either fatigue or sleeplessness, making it difficult for the child to keep alert during the school day, and keep up with assignments. An understanding of these patterns helps the child to cope with missed assignments and lost school days. Many young people with Crohn's disease or ulcerative colitis require hospitalization from time to time, sometimes for several weeks or even longer. Surgery may be necessary to remove diseased intestine or alleviate a complication. While in the hospital, they appreciate hearing from classmates and teachers and frequently can keep up with schoolwork and assignments. LEAVING THE CLASSROOM "Sometimes when I have to leave the classroom, some teachers give me a hard time, and this forces me into explaining my situation. Meanwhile, I am in pain and do not feel I have to explain my condition." Young people with these illnesses tell us that their most difficult problem in school is their need to use the bathroom. Unfortunately for them, attacks of pain and diarrhea may occur suddenly and without warning. Children with Crohn's disease or ulcerative colitis MUST be able to leave the classroom quickly and without attracting attention. Questions about their need in front of classmates will only cause intense embarrassment and shame, and even a short delay may cause an accident. When treated like adults, young persons will usually respond maturely and will not abuse the privilege of leaving the classroom to use the bathroom. In some schools, bathrooms are locked for long periods during the day to encourage students to remain in the classroom; in many schools, the stalls in the bathrooms do not have doors. These situations present further obstacles to students needing a bathroom urgently. One solution might be to provide a key or a special pass to be used at any time during the school day; another might be to have the student use the bathroom in the nurse's office. these solutions acknowledge the reality of the problem and show respect for the student's feelings. CLASS TRIPS "I was never sure what to do about field trips because I never knew in advance how I was going to feel that day. The problem was that the money had to be collected in advance with no refunds." Participation in class trips and outings can present problems for the student with Crohn's disease or ulcerative colitis. Attacks of pain, gas, or diarrhea during long bus trips, for example, can cause intense anxiety even in the most secure student. Since few young people are willing to impose their requirements for frequent bathroom stops on the whole group, a child whose disease is causing problems may decide to skip the trip altogether. TAKING MEDICATION DURING SCHOOL HOURS Students with these conditions often need to take medications during the school day to help control their diarrhea or pain. Schools generally require that these medications be dispensed by the school nurse. This often means that the student must take time from a lunch period or may be late to class as a result. Ongoing communication between the school nurse and the teachers will make this routine easier for the student. PARTICIPATION IN SPORTS Young people with these illnesses should be as active as they would like to be. They can participate in sports if they feel well enough. However, some strenuous sports may cause fatigue or aggravate abdominal or joint pains. If this happens, a modified gym program may be the answer. Teachers or guidance personnel can usually work closely with parents and the child's physician in developing an individualized program. If the student has had recent surgery, his or her surgeon will make the determination when it is safe to resume activity. (For more information on these two disorders, choose "Crohn" and "Ulcerative Colitis" as your search terms in the Rare Disease Database.) ! * CONGENITAL HEART DEFECTS COMMON CHARACTERISTICS A congenital abnormality is a defect that is present at birth. It is estimated that eight out of every one thousand babies are born with some type of congenital heart defect. The abnormality may be minor, requiring no treatment or restriction of activity. On the other hand, it may be so severe that no effective treatment is available and the infant will die. Between these extremes, there is a range of congenital heart defects of various degrees of severity. Some have become increasingly amenable to surgical treatment, offering new hope to families. CAUSES The fetal heart begins to develop early in pregnancy. By about the fourth week, it starts to twitch and then to beat; by the sixth week, the four heart chambers are recognizable; by the end of the third month, its development is complete. Any abnormality of development during these weeks may cause a congenital heart defect. When a baby is born with a heart defect, parents are often distressed about their own possible role in causing the disorder. However, it is seldom that anything parents do--or fail to do--has any causal relationship to the baby's problem. In fact, in 90 percent of cases, the causes of congenital heart defects remain unknown. Some congenital heart defects are known to be associated with disturbances in oxygen supply to the mother, or with infections such as German measles (rubella), or with specific injuries or nutritional deficiencies. Sometimes a defective chromosome is associated with the problem, as in Down's syndrome. Several drugs, when taken early in pregnancy, have been shown to lead to heart abnormalities in babies. Therefore, no woman who is pregnant or thinks she may be pregnant should take any medication unless it has been approved by a physician. Finally, there is a tendency for congenital heart defects to run in families. If either parent has or has had a congenital heart defect, the risk that a child will be affected is about one in twenty. Thus, if you or any of your immediate family members has such a problem, you might wish to consult a genetic counselor before starting a pregnancy. SYMPTOMS Frequently, a baby with a congenital heart defect has no symptoms, and the abnormality is discovered during a routine examination. In other cases, the symptoms are marked at birth--or may become severe in early infancy. The presence of symptoms is not necessarily related to the need for treatment; many children with no symptoms at all require surgery to prevent later problems, while others who have symptoms may outgrow the problem without treatment. A classic indication of a congenital heart defect is cyanosis, a blueness of the skin and mucous membranes caused by an excess of underoxygenated blood in the circulatory system. The birth of such a "blue baby" may be a medical emergency. More often, the symptoms are less obvious. For example, an infant with mild heart failure--a less than normal output of blood from the heart--may have problems feeding, because sucking is difficult, and may therefore be underweight. Infants with severe heart failure may have rapid and distressed breathing. Many children with congenital heart defects become breathless on exertion, or even at rest. Their physical development is often below average. DIAGNOSIS The physician may detect the presence of a congenital abnormality through the simple use of a stethoscope, which picks up normal heart sounds and abnormal ones such as murmurs. (Murmurs do not necessarily signal heart abnormalities: "innocent murmurs" are heard in about 60 percent of normal infants.) Different congenital abnormalities generally produce recognizably different and characteristic murmurs, and in most cases the doctor can detect which abnormality is present. A clearer picture may be derived from diagnostic tests. These include chest X-rays, which show the shape and size of the heart; electrocardiograms, which show electrical impulses produced by the heart and can reveal thickening of its chambers; and ultrasound examinations, which show the thickness of the heart chamber walls, the size of the chambers and the condition of the valves. Sometimes cardiac catheterization, an examination in which a catheter is passed along a blood vessel until it reaches the heart, is required. TYPES OF DEFECTS Eight types of defects are most common in infants. CONGENITAL AORTIC STENOSIS is a narrowing of the aortic valve and sometimes of the aorta itself. This restricts the flow of blood to the body generally. CONGENITAL PULMONARY STENOSIS is a narrowing of the pulmonary valve--or, less frequently, of the pulmonary artery or the upper right ventricle--that restricts the flow of blood to the lungs. In VENTRICULAR SEPTAL DEFECTS and ATRIAL SEPTAL DEFECTS, there are holes in the wall within the heart that separates the left and right chambers. These holes disturb normal flow within the chambers, leading to an excess of blood circulating in the lungs, which, in turn, leads to fibrosis of the pulmonary vessels. While about a quarter of all ventricular holes close spontaneously, such closure is less common for atrial defects. COARCTATION OF THE AORTA is a constriction that limits the blood supply to the lower parts of the body. PATENT DUCTUS ARTERIOSUS involves a failure of the ductus to close after birth. In the womb, the ductus prevents circulation of blood through the fetus's lungs, which are not needed since oxygen is supplied through the placenta. After birth, the ductus normally closes. If it does not, blood from the aorta flows through the open ductus into the pulmonary artery and results in excess blood passing through the lungs. In FALLOT'S TETRALOGY, four abnormalities occur together: a hole between the ventricles, aortic displacement, a narrowed pulmonary valve, and a thickening of the wall of the right ventricle. In the defect known as TRANSPOSITION OF THE GREAT ARTERIES, the locations of the aorta and pulmonary arteries are switched. Here, oxygenated blood coming from the lungs returns to the pulmonary arteries instead of passing through the aorta to the peripheral tissues. There is usually a hole in the septum, allowing some oxygenated blood to reach the aorta. TREATMENT Except in the case of very small holes in the heart, or when patent ductus arteriosus is detected early and occasionally closed with drug treatment, most congenital heart defects require surgery to correct the abnormality. If the disorder is not so severe as to demand immediate surgery, the operation may be delayed until the child is five years old or older, when he or she is larger and better able to withstand the stress of open heart surgery. SUMMING UP In most cases of congenital heart defects, the cause of the abnormality is not known. Drugs, infections such as rubella, and hereditary factors are implicated in about 10 percent of the cases. With modern surgical techniques, the success rate for heart operations in children is very high. Most children who have effective surgical treatment for a congenital heart defect can expect to live normal lives. ! * Conjunctivitis CONJUNCTIVITIS Introduction ------------- Conjunctivitis, commonly known as "pink eye", is an inflammation of the membrane (conjunctiva) that covers the eye and lines the inner surface of the eyelid. There are three main causes of conjunctivitis. One cause involves the introduction of either bacterial or viral microorganisms into the eye. These may be transmitted to the eye by contaminated hands, washcloths or towels, cosmetics (particularly eye makeup), false eyelashes or extended wear contacts. It is not uncommon for a minor conjunctivitis to accompany a viral cold or flu. Although bacterial and some of the viral infections (particularly herpes) are not very common, they are potentially serious. Both types of infection are contagious. Irritants are another cause of conjunctivitis. Offenders of this type include air pollutants, smoke, soap, hairspray, makeup, chlorine, cleaning fluids, etc. Lastly, some individuals acquire conjunctivitis due to a seasonal allergic response to grass and other pollens. Symptoms --------- Various combinations of the following symptoms may be present: itching, redness, photophobia (sensitivity to light), swelling of the lids and/or discharge from the eyes. The consistency of possible discharge may range from watery to purulent (pus-like), depending on the specific cause of the conjunctivitis. Duration -------- It usually takes from a few days to 2 weeks for most types of conjunctivitis to clear. Conjunctivitis due to an allergy may continue as long as the offending pollen is present. With such conditions, symptoms are likely to recur each year. Diagnosis ---------- Diagnosis consists of physical examination of the eye by the clinician. If a discharge is present, a culture for bacteria may be warranted. Treatment --------- Treatment varies depending on the cause. Medications in the form of ointments, drops or pills may be recommended to either help kill the germ infecting the eye, relieve allergic symptoms and/or decrease discomfort. In the case of conjunctivitis due to a viral cold or flu, the practitioner may recommend that you be patient and let it run its course. Other measures that should be followed: * Apply cool compresses to the eye(s) 3-4 times per day for 10-15 minutes using a clean washcloth each time. This should help reduce itching and swelling and provide some comfort. * Wash your hands frequently and keep them away from your eyes in order to reduce or prevent recontamination. * Avoid rubbing your eyes to decrease irritation of the area. * Wear sunglasses if your eyes are sensitive to the light. * Avoid exposure to the irritants which may be causing the conjunctivitis. * Dispose of old eye makeup if the culture for bacteria is positive. * Use a clean pillow case each night. (Pillow case can be changed every other day and turned over nightly). * Avoid wearing contact lenses while you are using medications or if your eyes are uncomfortable. Prevention ----------- Although many kinds of conjunctivitis are hard to prevent, there are measures which can be taken to decrease your risk of reacquiring or spreading it to someone else. These are listed below: * Do not share eye makeup or cosmetics of any kind with someone else. * Avoid sharing washcloths or towels. * Wash hands frequently and keep away from the eyes. * Wear protective goggles (i.e., for swimming or working) if you must be exposed to chemicals which are irritating. * Do not use medication (eye drops, ointment, etc.) which has been prescribed for someone else. * Avoid swimming in nonchlorinated pools or stagnant lakes or ponds. Concerns --------- If any of the following problems should occur, notify your clinician: * Visual changes * Severe eye pain * Pain when moving eyes * Fever * No improvement with medication within 48-72 hours * Drainage continues after you have completed full course of medication * Roommates or other family members develop symptoms * Eyes become very sensitive to light Directions for using eye drops or ointment ------------------------------------------- 1. Wash your hands before touching your eyes or your medications. 2. Gently, pull your lower lid down with your finger. 3. Look up toward the ceiling. 4. To instill drops: Drop medicine inside center of your lower lid. Do not drop it on your eyeball. Close your eyes gently without squeezing the lids shut. Blink to distribute medication over the eye. To instill ointment: Starting in the corner of your eye closest to the nose, squeeze a thin ribbon of ointment along the inside of the lower lid. Close eyes gently without squeezing the lids shut. Roll eyes to distribute the medication over them. 5. Remove excess solution or ointment outside your eye with a clean tissue, using a separate tissue for each eye. 6. Wash hands after you have finished your medication, to avoid transmitting the infection to others. If you are concerned about any difference in your treatment plan and the information in this handout, you are advised to contact your health care provider. References: ----------- Boyd-Monk, H. (1983). Conjunctivitis. In H. K. Hamilton (Ed.), Diseases (pp. 1184-1186). Springhouse, PA: Intermed Communications. Trepeta, J. (1984). Conjunctivitis. In S. L. Shamansky, M. C. Cecere, and E. Shellenberger (Eds.), Primary Health Care Handbook (p. 132). Boston, MA: Little, Brown. Vickery, D. M. and Fries, J. F. (1986). Eye burning, itching, and discharge. Take Care of Yourself: A Consumer's Guide to Medical Care (pp. 310-311). Reading, MA: Addison-Wesley. ! * COPROPORPHYRIA RESEARCH REQUEST: COPROPORPHYRIA October 8, 1995 General Information ------------------ Hereditary Coproporphyria is an autosomal dominant form of hepatic porphyria that is very similar to Acute Intermittent Porphyria, although it is usually a less severe disease. It is caused by an enzyme deficiency. Some patients develop skin photosensitivity, and must avoid sunlight. The diagnosis is established by finding excess coproporphyrin in urine and stool (other types of porphyrins show little or no increase). Urinary ALA and PBG are increased during acute attacks, but may become normal on recovery. The Porphyrias are a group of at least seven disorders. The common feature in all porphyrias is the excess accumulation in the body of "porphyrins" or "porphyrin precursors." These are natural chemicals that normally do not accumulate in the body. Precisely which one of these porphyrin chemicals builds up depends upon the type of porphyria that a patient has. Porphyrias can also be classified into two groups: the "hepatic" and "erythropoietic" types. Porphyrins and related substances originate in excess amounts from the liver in the hepatic types, and mostly from the bone marrow in the erythropoietic types. The porphyrias with skin manifestations are sometimes called "cutaneous porphyrias." The "acute porphyrias" are characterized by sudden attacks of pain and other neurological manifestations. These "acute symptoms can be both rapidly-appearing and severe. An individual may be considered in a "latent" condition if he or she has the characteristic enzyme deficiency, but has never developed symptoms. There can be a wide spectrum of severity between the "latent" and "active" cases of any particular type of this disorder. The symptoms and treatments of the different types of porphyrias are not the same. Symptoms -------- The large amount of coproporphyrin present in Hereditary Coproporphyria (HCP) makes the patient sensitive to sunlight, but skin disease is rarely severe in this type or porphyria. Clinically, it resembles variegate porphyria and acute intermittent porphyria. Symptoms may include abdominal pain, arm and/or leg pain, generalized weakness, vomiting, confusion, constipation, increased heart rate, fluctuating blood pressure, urinary retention, psychosis, hallucinations, and seizures. The muscle weakness may progress to respiratory paralysis, necessitating artificial respiration. The symptoms of porphyria generally arise from effects on the nervous system and/or the skin. Sometimes, the cause of the nervous system symptoms is not clear, and proper diagnosis is delayed. Skin manifestations can include burning, blistering and scarring of sun-exposed areas. Porphyria Cutanea Tarda is the only type of porphyria that can be either acquired or inherited. All other types of Porphyria are caused by genetic factors. Environmental factors such as drugs, chemicals, diet and sun exposure can, depending on the type of the disorder, greatly influence the severity of symptoms. The terms "porphyrin" and "porphyria" are derived from the Greek word "porphyrus," meaning purple. Urine from some porphyria patients may be reddish in color due to the presence of excess porphyrins and related substances, and the urine may darken after being exposed to the light. Because this disease can mimic a host of other more common conditions, its presence is often not suspected. On the other hand, the diagnosis of this and other types of porphyria is sometimes made incorrectly in patients who do not have porphyria, particularly if improper laboratory tests are carried out. The finding of increased levels of delta-aminolevulinic acid (ALA) in urine establishes that one of the "acute" porphyrias is present. When a patient is diagnosed as having HCP, relatives should be examined as well. Latent cases so identified can then avoid agents known to cause attacks. Causes ------ Hereditary Coproporphyria is a genetic, non-x-linked disorder inherited as an autosomal dominant trait. (In autosomal dominant disorders, a single abnormal gene, contributed by either parent, "overrides" the normal gene contributed by the other parent causing disease. Individuals with one affected parent have a 50% chance of inheriting the disorder. Males and females will be affected in equal numbers.) Drugs such as barbiturates, tranquilizers, anticonvulsants, and estrogens may precipitate attacks. Environmental factors may include drugs, chemicals, diet and sun exposure. Depending on the type of porphyria, these factors can greatly influence the severity of symptoms. Because all porphyrias are uncommon, it is very unlikely that more than one type will occur in the same family, or that someone with one type of porphyria will go on to develop another. Affected Population ------------------- Hereditary Coproporphyria may have its onset at any age, and may affect males and females in equal numbers. It is the least common of the "hepatic" porphyrias. Related Disorders ----------------- The Porphyrias are a group of related disorders. For more information on each of the following types of the disease, choose "porphyria" as your search term in the Rare Disease Database. ALA-D Porphyria is a recently-described form of acute porphyria inherited as an autosomal recessive trait. It is apparently extremely rare. There is a deficiency of the enzyme delta-aminolevulinic acid dehydratase (ALA-D) and increased excretion of ALA in the urine of patients with this type or porphyria. Acute Intermittent Porphyria is a hereditary, possibly metabolic, usuallyasymptomatic disorder (latent). It may possibly be provoked into active disease by the administration of certain drugs, notably barbiturates, sulfonamides, and estrogenic compounds. Congenital Erythropoietic Porphyria (CEP) is a hereditary disorder due to an inborn error of metabolism, and manifested in infancy. Faulty conversion of the enzyme PBG to uroporphyrinogen in erythroid cells of bone marrow, and red blood cells leads to this type of Porphyria. Increased porphyrins also may be found in plasma, urine, feces, teeth and bones. Porphyria Cutanea Tarda (PCT) can be either an acquired or inherited type of Porphyria. It may become acute due to exposure to chronic alcoholism, barbiturates or other chemicals, cirrhosis of the liver, or a hepatic tumor. It may also stem from a nutritional disorder. Variegate Porphyria (VP) is a hereditary type of Porphyria due to an inborn error of metabolism. Precipitating or aggravating factors may include exposure to barbiturates, sulfonamides, general anesthetics, excessive amounts of ethanol, and estrogens. Erythropoietic Protoporphyria (EPP) is a hereditary type of Porphyria marked by an accumulation of protoporphyrin in the bone marrow, red blood cells and sometimes the liver. Excess protoporphyrin is excreted by the liver into the bile, which in turn enters the intestine and is excreted in the feces. There are no urinary abnormalities. The diagnosis is established by finding increased protoporphyrin in red blood cells, plasma and feces. Therapies: Standard -------------------- The orphan drug Hematin (an intravenous drug) is very potent in suppressing acute attacks of the disease. It is usually given only after a trial of glucose therapy. Attention should be given to salt and water balance during treatment. Many types of drugs such as aspirin and certain antibiotics are believed to be safe in patients with some types of porphyria. Recommendations about drugs for certain types of the disorder are based on experience with the porphyria patients in whom attacks have been caused by drugs and by tests in animals. Since many commonly used drugs have not been tested, they should be avoided if at all possible. If a question of drug safety arises, a physician or medical center specializing in porphyria should be contacted. A list of these institutions may be procured from the American Porphyria Foundation (see Resources). Pregnancy is tolerated much better than was formerly believed. Many patients have a few reservations about family planning. For those who do, genetic counseling may be useful. Wearing a Medic Alert bracelet is advisable in patients who have had attacks, but is probably not warranted in most latent cases. Therapies: Investigational --------------------------- New treatments for several types of porphyria are under investigation. For the most updated information on research, please contact the organizations listed in the Resources section. Dr. Karl E. Anderson of the University of Texas Medical Branch, Galveston, TX, 77550, has received orphan drug designation for Histrelin, a drug to treat various types of Porphyria. Research is underway on the Finnish product Normasang (heme arginate). Dr. Karl Anderson of The University of Texas Medical Branch will be directing clinical studies in the United States. Patients are needed to participate in this research. People interested in this study should have their physician contact: Dr. Karl Anderson Ewing Hall (J-09) University of Texas Medical Branch 700 Strand St. Galveston, TX 77555 (409) 772-4661 The Orphan product Hemin and Zinc Mesoporphyrin (HEMEX) is being used for treatment of Acute Prophyric Syndromes. For more information, contact: Herbert L. Bonkovsky, MD University of Massachusetts Medical Ctrl Worchester, MA 01655 Resources --------- For more information on Hereditary Coproporphyria, please contact: American Porphyria Foundation P.O. Box 22712 Houston, TX 77227 (713) 266-9617 Porphyria Support Group 4 Eve Road Leytonstone, London, England E11 3JE Tel: 01-519-7868 NIH/National Digestive Diseases Information Clearinghouse (NDDIC) 9000 Rockville Pike Bethesda, MD 20892 (301) 654-3810 For information on genetics and genetic counseling referrals, please contact: March of Dimes Birth Defects Foundation 1275 Mamaroneck Avenue White Plains, NY 10605 (914) 428-7100 Alliance of Genetic Support Groups 35 Wisconsin Circle, Suite 440 Chevy Chase, MD 20815 (800) 336-GENE (301) 652-5553 References ---------- American Porphyria Foundation brochure, "Common Questions About Porphyria." ! * CROHN'S DISEASE Fact Sheet DD Clearinghouse Inflammatory bowel disease (IBD) is a group of chronic disorders that cause inflammation or ulceration in the small and large intestines. Most often IBD is classified as ulcerative colitis or Crohn's disease but may be referred to as colitis, enteritis, ileitis, and proctitis. Ulcerative colitis causes ulceration and inflammation of the inner lining of the colon and rectum, while Crohn's disease is an inflammation that extends into the deeper layers of the intestinal wall. Ulcerative colitis and Crohn's disease cause similar symptoms that often resemble other conditions such as irritable bowel syndrome (spastic colitis). The correct diagnosis may take some time. Crohn's disease usually involves the small intestine, most often the lower part (the ileum). In some cases, both the small and large intestine (colon) are affected. In other cases, only the colon is involved. Sometimes, inflammation also may affect the mouth, esophagus, stomach, duodenum, appendix, or anus. Crohn's disease is a chronic condition and may recur at various times over a lifetime. Some people have long periods of remission, sometimes for years, when they are free of symptoms. There is no way to predict when a remission may occur or when symptoms will return. What Are the Symptoms? The most common symptoms of Crohn's disease are abdominal pain, often in the lower right area, and diarrhea. There also may be rectal bleeding, weight loss, and fever. Bleeding may be serious and persistent, leading to anemia (low red blood cell count). Children may suffer delayed development and stunted growth. What Causes Crohn's Disease and Who Gets It? There are many theories about what causes Crohn's disease, but none has been proven. One theory is that some agent, perhaps a virus or a bacterium, affects the body's immune system to trigger an inflammatory reaction in the intestinal wall. Although there is a lot of evidence that patients with this disease have abnormalities of the immune system, doctors do not know whether the immune problems are a cause or a result of the disease. Doctors believe, however, that there is little proof that Crohn's disease is caused by emotional distress or by an unhappy childhood. Crohn's disease affects males and females equally and appears to run in some families. About 20 percent of people with Crohn's disease have a blood relative with some form of inflammatory bowel disease, most often a brother or sister and sometimes a parent or child. How Does Crohn's Disease Affect Children? Women with Crohn's disease who are considering having children can be comforted to know that the vast majority of such pregnancies will result in normal children. Research has shown that the course of pregnancy and delivery is usually not impaired in women with Crohn's disease. Even so, it is a good idea for women with Crohn's disease to discuss the matter with their doctors before pregnancy. Children who do get the disease are sometimes more severely affected than adults, with slowed growth and delayed sexual development in some cases. How Is Crohn's Disease Diagnosed? If you have experienced chronic abdominal pain, diarrhea, fever, weight loss, and anemia, the doctor will examine you for signs of Crohn's disease. The doctor will take a history and give you a thorough physical exam. This exam will include blood tests to find out if you are anemic as a result of blood loss, or if there is an increased number of white blood cells, suggesting an inflammatory process in your body. Examination of a stool sample can tell the doctor if there is blood loss, or if an infection by a parasite or bacteria is causing the symptoms. The doctor may look inside your rectum and colon through a flexible tube (endoscope) that is inserted through the anus. During the exam, the doctor may take a sample of tissue (biopsy) from the lining of the colon to look at under the microscope. Later, you also may receive x-ray examinations of the digestive tract to determine the nature and extent of disease. These exams may include an upper gastrointestinal (GI) series, a small intestinal study, and a barium enema intestinal x-ray. These procedures are done by putting the barium, a chalky solution, into the upper or lower intestines. The barium shows up white on x-ray film, revealing inflammation or ulceration and other abnormalities in the intestine. If you have Crohn's disease, you may need medical care for a long time. Your doctor also will want to test you regularly to check on your condition. What Is the Treatment? Several drugs are helpful in controlling Crohn's disease, but at this time there is no cure. The usual goals of therapy are to correct nutritional deficiencies; to control inflammation; and to relieve abdominal pain, diarrhea, and rectal bleeding. Abdominal cramps and diarrhea may be helped by drugs. The drug sulfasalazine often lessens the inflammation, especially in the colon. This drug can be used for as long as needed, and it can be used along with other drugs. Side effects such as nausea, vomiting, weight loss, heartburn, diarrhea, and headache occur in a small percentage of cases. Patients who do not do well on sulfasalazine often do very well on related drugs known as mesalamine or 5-ASA agents. More serious cases may require steroid drugs, antibiotics, or drugs that affect the body's immune system such as azathioprine or 6-mercaptopurine (6-MP). Can Diet Control Crohn's Disease? No special diet has been proven effective for preventing or treating this disease. Some people find their symptoms are made worse by milk, alcohol, hot spices, or fiber. But there are no hard and fast rules for most people. Follow a good nutritious diet and try to avoid any foods that seem to make your symptoms worse. Large doses of vitamins are useless and may even cause harmful side effects. Your doctor may recommend nutritional supplements, especially for children with growth retardation. Special high-calorie liquid formulas are sometimes used for this purpose. A small number of patients may need periods of feeding by vein. This can help patients who temporarily need extra nutrition, those whose bowels need to rest, or those whose bowels cannot absorb enough nourishment from food taken by mouth. What Are the Complications of Crohn's Disease? The most common complication is blockage (obstruction) of the intestine. Blockage occurs because the disease tends to thicken the bowel wall with swelling and fibrous scar tissue, narrowing the passage. Crohn's disease also may cause deep ulcer tracts that burrow all the way through the bowel wall into surrounding tissues, into adjacent segments of intestine, into other nearby organs such as the urinary bladder or vagina, or into the skin. These tunnels are called fistulas. They are a common complication and often are associated with pockets of infection or abscesses (infected areas of pus). The areas around the anus and rectum often are involved. Sometimes fistulas can be treated with medicine, but in many cases they must be treated surgically. Crohn's disease also can lead to complications that affect other parts of the body. These systemic complications include various forms of arthritis, skin problems, inflammation in the eyes or mouth, kidney stones, gallstones, or other diseases of the liver and biliary system. Some of these problems respond to the same treatment as the bowel symptoms, but others must be treated separately. Is Surgery Often Necessary? Crohn's disease can be helped by surgery, but it cannot be cured by surgery. The inflammation tends to return in areas of the intestine next to the area that has been removed. Many Crohn's disease patients require surgery, either to relieve chronic symptoms of active disease that does not respond to medical therapy or to correct complications such as intestinal blockage, perforation, abscess. or bleeding. Drainage of abscesses or resection (removal of a section of bowel) due to blockage are common surgical procedures. Sometimes the diseased section of bowel is removed. In this operation, the bowel is cut above and below the diseased area and reconnected. Infrequently some people must have their colons removed (colectomy) and an ileostomy created. In an ileostomy, a small opening is made in the front of the abdominal wall, and the tip of the lower small intestine (ileum) is brought to the skin's surface. This opening, called a stoma, is about the size of a quarter or a 50-cent piece. It usually is located in the right lower corner of the abdomen in the area of the beltline. A bag is worn over the opening to collect waste, and the patient empties the bag periodically. The majority of patients go on to live normal, active lives with an ostomy. The fact that Crohn's disease often recurs after surgery makes it very important for the patient and doctor to consider carefully the benefits and risks of surgery compared with other treatments. Remember, most people with this disease continue to lead useful and productive lives. Between periods of disease activity, patients may feel quite well and be free of symptoms. Even though there may be long-term needs for medicine and even periods of hospitalization, most patients are able to hold productive jobs, marry, raise families, and function successfully at home and in society. Addition Readings Brandt, LJ, Steiner-Grossman, P, eds. Treating IBD: A Patient's Guide to the Medical and Surgical Management of Inflammatory Bowel Disease. New York: Raven Press, 1989. General guide for patients with sections on treatment and descriptions and drawings of surgical procedures. Available from the Crohn's & Colitis Foundation of America. Clayman, CB, ed. The American Medical Association Encyclopedia of Medicine. New York: Random House, 1989. Reference guide for patients with sections on Crohn's disease and other intestinal disorders. Available in libraries and bookstores. Lipshutz, WH. Exploring the causes of IBD and Crohn's disease. Contemporary Gastroenterology 1991; 4(4): 10-14. Review article for physicians. Available in medical and university libraries. Steiner-Grossman, P, Banks PA, Present, DH, eds. The New People Not Patients: A Source Book for Living with IBD. Dubuque, Iowa: Kendall/Hunt Publishing Company, 1992. Authoritative book for patients with sections on diagnostic tests, medications, nutrition, coping with employment and health insurance problems, and IBD in children and teenagers, older adults, and during pregnancy. Available from the Crohn's & Colitis Foundation of America. Tapley, DF, et al., eds. ne Columbia University College of Physicians and Surgeons Complete Home Medical Guide. New York: Crown Publishers, Inc., 1989. General medical guide with sections on Crohn's disease and other intestinal disorders. Available in libraries and bookstores. Addition Resources Crohn's & Colitis Foundation of America, Inc., 444 Park Avenue South, 11th floor, New York, NY 10016-7374; (800) 932-2423 or (212) 685-3440. Ileitis and Colitis Educational Foundation, Central DuPage Hospital, 24 North Winfield Road, Winfield, IL 60190; (708) 682-1600, Ext. 649 Wound Ostomy and Continence Nurses Society, 2755 Bristol Street, Suite 110, Costa Mesa, CA 92626; (714) 476-0268. United Ostomy, Association, 36 Executive Park, Suite 120, Irvine, CA 92714; (714) 660-8624. National Digestive Diseases Information Clearinghouse Box NDDIC, 9000 Rockville Pike, Bethesda, MD 20892 (301) 468-6344 The National Digestive. Diseases Information Clearinghouse is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, under the U.S. Public Health Service. The clearinghouse was authorized by Congress to focus a national effort on providing information to the public, patients and their families, and doctors and other health care professionals. The clearinghouse works with organizations to educate people about digestive health and disease. The clearinghouse answers inquiries; develops, reviews, and distributes publications; and coordinates informational resources about digestive diseases. Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, appropriateness of content, and readability. Publications produced by sources other than the clearinghouse also are reviewed for scientific accuracy and are used, along with clearinghouse publications, to answer requests. This publication is not copyrighted. The clearinghouse urges users of this fact sheet to duplicate and distribute as many copies as desired. National Institutes of Health NATIONAL INSTITUTES OF DIABETES & DIGESTIVE & KIDNEY DISEASES U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICE Public Health Service National Institutes of Health This file scanned from NIH Publication No. 92-3410 October 1992 ! * CROHN'S DISEASE Like ulcerative colitis, Crohn's Disease affects young people primarily, and is a disease which causes inflammation of the colon. In this disease, however, the small intestine is also commonly affected, and the farthest reaches of the colon, rectum, and anal regions are less common targets. Crohn's disease is of unknown cause, and seems to be less common than ulcerative colitis. Current theories revolve around a combination of an autoimmune reaction of the body directed toward the intestinal tissue, perhaps triggered by one or more infectious or environmental factors. Around 30 out of 100,000 Americans have the disease, which is more frequent in Jews for unknown reasons. Some inconsistent familial tendencies have been identified, but the genetic component is poorly understood. Under the microscope, the inflammation of Crohn's Disease is distinct, and resembles the body's reaction to certain types of infection such as tuberculosis, although no such germs are associated. If the colon is the main area affected, which happens occasionally if not often, the microscopic picture can be the only way to separate it from ulcerative colitis in some cases. SYMPTOMS Typically, a teenager or young adult experiences a period of weeks or months of "the blahs," with fatigue, weight loss, and depression. Then ther occur a progressive combination of abdominal cramping and diarrhea, usually in the lower right abdomen. A low grade fever may be present, and eventually, medical attention is sought. The disease may also cause fistulae; these are small tunnels or tracts within the intestine, and may result in communicating infections or abscesses between areas of intestine, or even between intestine and bladder, skin, or other organs. Extra-intestinal symptoms of the disease include joint pains, rashes, eye inflammation, and kidney and gall bladder stones. The disease may come on at any age, not rarely in the 40's and 50's. Delay in diagnosis is not rare, since so many diseases can cause similar symptoms. DIAGNOSIS When the history suggests the diagnosis, this is usually confirmed with upper and lower digestive x-rays, and occasionally with a biopsy of tissue when necessary; this can sometimes be done through a special viewing tube swallowed by the patient as an outpatient procedure (endoscopy) or through the proctoscope if the colon is involved. Evaluation of the extent and complications usually includes special blood tests. If enough of the last part of the small intestine is inflamed, it becomes unable to absorb certain nutrients, especially vitamin B 12, fats, and dairy sugar. This can lead to anemia, malnutrition, and calcium deficiency. Special care must be taken to rule out alternative diagnoses including intestinal lymph node cancers like Hodgkin's Disease, appendicitis in the acute cases, tuberculosis of the intestine, and other rare diseases. TREATMENT The approach to treatment of this disease includes a careful combination of medical and surgical modalities. General measures include careful nutritional measures such as a high protein and ample calorie diet. Activity and rest should be carefully combined, and undue fatigue will contribute to the symptoms of the disease. Foods such as dairy products and concentrated fats are often poorly tolerated, and should be taken in moderation. Sulfasalazine (Azulfidine and others) is a useful agent for the treatment of mild flares and prevention of future attacks. It is metabolized in the intestine to chemicals which have both anti-inflammatory and anti-microbial actions, but its exact mechanism of action in not known. In more severe worsenings, corticosteroids (cortisone-like drugs) are often used, despite their well-recognized side effects. It is questionable whether these drugs alter the long-term outcome of the disease but the do seem to control symptoms of acute attacks, especially when organs outside the intestine are involved, such as eye, skin, and joints. When possible, their use should be kept as brief as possible. When even corticosteroids are not useful in the seriously ill patient, immunosuppressive drugs, such as those used in the treatment of some cancers, may be cautiously added. These are serious agents with potentially fatal side effects, and only should be used in expert hands with careful monitoring. The role of surgery in this disease is important. Unfortunately, recurrences in regions adjacent to the surgery, or even distant areas, is very common. If too much surgery is done, the patient may be left with insufficient intestine to absorb nutrients (see malabsorption). Nonethless, selective surgery can reduce symptoms, and in the more serious complications of obstruction or internal fistulae, it may be the only alternative. PROGNOSIS The course is highly variable, and generalizations are of little use. There is some increased mortality in patients compared to those without the disease, but this is often in the few patients with fulminant, unremitting disease. For most patients, the disease presents a recurrent source of illness, the need for long-term medication, and a significant burden. Optimal care, patient cooperation, and attitude adjustment can keep these intrusions to a minimum during the frequent remissions. ! * CROHN'S DISEASE COMMON CHARACTERISTICS Crohn's disease is a chronic, or long-term, inflammation of part of the digestive tract. The part most commonly affected is the final section of the small intestine, although patchy inflammation can occur anywhere in the intestines. The cause of the disease is not known, but it does not seem to be either hereditary or infectious. It begins with the development of patches of inflammation in the intestinal wall, which sometimes grow or spread from one part of the digestive system to another, and sometimes develop in only one place. Some of the spots heal, but they may leave scar tissue that thickens intestinal walls and narrows the passageways. SYMPTOMS Crohn's disease usually appears as periodic attacks of cramps, abdominal pain (especially after eating), diarrhea, and a general sense of feeling ill. You may also have a slight fever. Attacks tend to begin when you are in your twenties and to recur, sometimes every few months, sometimes every few years, for the rest of your life. In about one-quarter of cases, the symptoms only appear once or twice, and the disease does not recur. RISKS This has been a rare disorder in the Western world, but it is gradually becoming more common. There are about twice as many cases of it today as there were 20 years ago. If Crohn's disease continues for years, it causes a gradual deterioration of bowel functioning. Sometimes the inflamed intestinal wall may leak, and cause peritonitis (see Peritonitis). There is a risk of poor absorption of nutrients, with the associated loss of appetite and weight, or of intestinal obstruction. Severe bleeding that causes iron-deficiency anemia can also occur. There is also a slight chance that Crohn's disease, if it is not treated, can increase your susceptibility to cancer of the intestine. TREATMENT If your symptoms suggest the possibility of Crohn's disease, consult your physician, who, after examining you, will probably want X-rays of your digestive tract, for which you will need a barium swallow and perhaps a barium enema. You may also have to undergo endoscopy of the intestines in order to locate the inflamed areas. Blood and bowel movement samples may be required to see if you show signs of internal bleeding such as bloody bowel movements or anemia. In most cases treatment by drugs eases attacks of Crohn's disease. Among the drugs used are analgesics, antidiarrhea tablets, vitamin supplements to ensure adequate nutrition, and a drug that reduces inflammation. Your physician may also recommend certain foods and warn against others, and may suggest that you modify your daily routine to relieve tension that may affect your nervous and digestive systems. To guard against further attacks, long-term treatment with steroids may be prescribed. Another drug that helps, especially if your colon is affected, is an antibacterial medication. Initial high doses of such drugs may be decreased gradually. Such treatment should reduce the severity of the attacks. If repeated attacks have scarred and narrowed your intestines so badly that the inflammation does not respond to drug treatment, you will probably need surgery to remove the section of intestine that is most affected. Surgery cannot cure Crohn's disease, but it can provide dramatic improvement and postpone further progress of the disease for many years. ! * CUSHING'S SYNDROME Cushing's syndrome is an endocrine, or hormonal, disorder. Although symptoms vary from person to person, most patients have upper-body obesity, severe fatigue and muscle weakness, high blood pressure, backache, elevated blood sugar, easy bruising, and bluish-red stretch marks on the skin. In women, there may be increased growth of facial and body hair, and menstrual periods may become irregular or stop completely. Cushing's syndrome is caused by prolonged exposure of the body's tissues to high levels of the hormone cortisol. For this reason, the disorder is sometimes called "hypercortisolism." Cortisol is normally produced by the adrenal glands, located just above the kidneys. It belongs to a class of hormones called glucocorticoids, which affect almost every organ and tissue in the body. Scientists think that cortisol has possibly hundreds of effects in the body. Among its vital tasks, cortisol: * helps maintain blood pressure and cardiovascular function; * helps slow the immune system's inflammatory response; * helps balance the effects of insulin in breaking down sugar for energy; and * helps regulate the metabolism of proteins, carbohydrates, and fats. One of cortisone's most important jobs is to help the body respond to stress. In fact, the adrenal glands naturally produce more cortisol during stress. High levels of the hormone normally occur in women during the last 3 months of pregnancy and in highly trained athletes. Increased cortisol levels also are found in people suffering from depression, alcoholism, malnutrition, and panic disorders. To understand the different ways that cortisol production can go wrong, it helps to look at how hormones normally do their work. Endocrine glands differ from other organs in the body because they release hormones into the bloodstream. Hormones travel through the blood, instructing cells in other parts of the body to release another hormone or to perform a specific function. Among the major endocrine glands are the thyroid, parathyroid, thymus, pituitary, and adrenals. Together, they play a major role in growth, metabolism, reproduction, and overall health.The leaders in this carefully balanced performance are the brain's hypothalamus and the pituitary gland, a bean-sized organ at the base of the brain. First, the hypothalamus sends "releasing hormones" to the pituitary gland. The pituitary responds by secreting other hormones that regulate growth, thyroid function, and sex hormones such as estrogen and testosterone. One of the pituitary's main duties is to secrete ACTH (adrenocorticotropin), a hormone that stimulates the adrenal glands. When the adrenals receive the pituitary's signal in the form of ACTH, they respond by producing cortisol. Completing the cycle, cortisol then signals the pituitary to lower secretion of ACTH. Normally, the amount of cortisol released by the adrenals is precisely balanced to meet the body's daily needs. If something goes wrong during this process -- for example, with the adrenals, or their regulating switches in the brain (the pituitary gland or the hypothalamus) -- cortisol production can go awry. Cause Exposure to too much cortisol can occur for different reasons. A common cause of elevated cortisol is the long-term use of glucocorticoid hormones such as prednisone for the treatment of inflammatory illnesses like rheumatoid arthritis. People who have taken these hormones for a long time may develop the symptoms of Cushing's syndrome, for example, the rounded or "moon face" and muscle weakness. Elevated levels of cortisol also can be traced to abnormalities of the pituitary gland or the adrenal glands. High cortisol production also can be caused by tumor cells that release ACTH, in turn signaling the adrenals to overproduce cortisol. Each of these causes is discussed in more detail below. PITUITARY ADENOMAS Most cases of Cushing's syndrome are caused by benign, or noncancerous tumors of the pituitary gland called adenomas, which secrete increased amounts of ACTH. Most patients have a single adenoma. This form of the syndrome, known as "Cushing's disease," afflicts more women than men. Adenomas are unlikely to spread; rarely, however, some pituitary tumors have the features of cancer, including the ability to spread. ECTOPIC ACTH SYNDROME About 17 percent of Cushing's syndrome cases are due to the production of ACTH by various types of potentially malignant tumors that arise in different parts of the body. By far, the most common form of ACTH-producing tumor is oat cell, or small cell, lung cancer, which accounts for about 25 percent of all lung cancer cases. Other, less common types of cancer that can produce ACTH are thymomas, carcinoid tumors, pancreatic islet cell tumors, and medullary carcinomas of the thyroid. ADRENAL TUMORS In about 15 percent of patients with Cushing's syndrome, the cause can be traced to an abnormality of the adrenal glands, most often an adrenal tumor. In about one-half of these cases, the tumors are noncancerous growths of adrenal tissue, called adrenal adenomas, which release excess cortisol into the blood. Adrenocortical carcinomas, or adrenal cancers, are the least common cause of Cushing's syndrome, accounting for about 7 percent of cases. They tend to occur in children. Cancer cells secrete excess levels of several adrenal cortical hormones, causing cortisol and adrenal androgen levels to remain elevated. Adrenal carcinomas also can be marked by very high hormone levels and rapid development of symptoms. Incidence Cushing's syndrome is relatively rare. It affects about 10 people per million population every year, or approximately 1 in 5,000 hospital admissions, with most cases occurring between the ages of 20 and 50 years. About 70 percent of reported cases are diagnosed with pituitary adenomas that overproduce ACTH (Cushing's disease). This form of the syndrome affects more women than men at a ratio of 5:1. The ectopic ACTH syndrome, caused by ACTH-producing tumors, is responsible for about 17 percent of the cases of Cushing's syndrome. Of these, over 50 percent are due to lung tumors, with a 3:1 ratio of males to female. Adrenal tumors account for the remainder of cases, occurring in about two per million population annually. The average age of onset is about 40 years. Symptoms There is no single symptom shared by all patients with Cushing's syndrome, although some features of the disorder occur more often than others. OBESITY The most common symptom is weight gain, with rounding of the face and increased fat in the neck and above the collar bone, while the arms and legs tend to stay thin. Obesity associated with poor growth is most common in children. SKIN Skin changes also are common in Cushing's syndrome. The cheeks redden as the skin becomes thin, making the blood vessels more visible. The thin, fragile skin breaks easily, and ulcers may arise from minor injury. The ulcers may persist for a long time because of poor wound healing. Easy bruising and bluish-red stretch marks, which often appear on the abdomen, thighs, buttocks, arms, armpits, and breasts, result from weakened connective tissue. Connective tissue not only provides the supportive framework of the body and its internal organs, but it is a major structural component of arteries and veins as well as the skin. Cushing's Syndrome EXCESS HAIR GROWTH In women, excess hair growth, or hirsutism, often appears on the face, neck, chest, abdomen, and thighs. It occurs in about 80 percent of women with Cushing's syndrome. MENSTRUAL DISORDERS Menstrual disorders are common. Periods become irregular and often stop. In men, there is decreased fertility with diminished or absent libido. HIGH BLOOD PRESSURE Blood pressure above the normal range, or hypertension, occurs in 85 percent of Cushing's patients. More than 50 percent of patients have elevated diastolic pressure, and practically all patients have elevated systolic pressure. High blood pressure is associated with increased atherosclerosis, a buildup of fat in the arteries. MUSCLE AND BONE WEAKNESS Severe fatigue and weak, fragile muscles are characteristic of Cushing's syndrome. Backache is common due to osteoporosis, a weakening of the bones resulting from decreased bone mass. In Cushing's syndrome, rib fractures are frequent, and vertebral (spinal column) compression fractures may occur during routine activities such as bending, lifting, or rising from a chair. HIGH BLOOD SUGAR High blood sugar, or hyperglycemia, is seen in 80 percent of patients with Cushing's syndrome following the oral glucose tolerance test. However, diabetes mellitus occurs in less than 20 percent of people with Cushing's syndrome, and usually only in those with a family history of the disorder. Diagnosis The diagnosis of Cushing's syndrome is based on a review of the patient's medical history, physical examination, laboratory tests, and often x-ray exams of the adrenal or pituitary glands. The aim of these tests is first to determine whether excess levels of cortisol are present and then to establish the cause. 24-HOUR URINARY FREE CORTISOL LEVEL This is the most specific test for diagnosing Cushing's syndrome. The patient's urine is collected over a 24-hour period and- then tested for the amount of cortisol. Levels higher than 100 micrograms a day for an adult suggest Cushing's syndrome. (Persons suffering from depression or alcoholism, who tend to produce higher than normal levels of cortisol, may need further testing to confirm a diagnosis of Cushing's syndrome.) Once Cushing's syndrome has been diagnosed, it is important to determine its cause. Various other tests are used to find the abnormality that leads to excess cortisol production. The choice of test depends in part on the preference of the endocrinologist or the center where the test is performed. Two very specialized tests that may be used are described below. DEXAMETHASONE SUPPRESSION TEST In this test, dexamethasone, a synthetic cortisol, is given by mouth every 6 hours for a period of 4 days. For the first 2 days, low doses of dexamethasone are given, and for the last 2 days, higher doses are given. The normal response after taking dexamethasone is a drop in blood and urine cortisol levels. Depending on the cause of Cushing's syndrome, different responses of cortisol to dexamethasone are obtained. The dexamethasone suppression test helps to distinguish patients with pituitary adenomas from those with ACTH- or cortisol-producing tumors. The dexamethasone test can produce false-positive results in response to depression, alcohol abuse, high estrogen levels, acute illness, and stress. Conversely, drugs such as phenytoin and phenobarbital may cause false results in response to dexamethasone suppression. For this reason, patients should stop taking these drugs for at least 1 week before the test is performed. CRH STIMULATION TEST The corticotropinreleasing hormone (CRH) stimulation test is a relatively new diagnostic tool that also may be used to identify the cause of Cushing's syndrome. Patients with pituitary adenomas, after receiving an injection of CRH, usually have a rise in blood levels of ACTH and cortisol. This response is rarely seen in patients with ectopic ACTH syndrome and practically never in patients with cortisol-secreting adrenal tumors. DIRECT VISUALIZATION OF ENDOCRINE GLANDS Doctors use different imaging tools to reveal the size and shape of the pituitary and adrenal glands. The most common are the CT (computerized tomography) scan and MRI (magnetic resonance imaging). A CT scan produces a series of x-ray pictures giving a cross-sectional image of a body part. MRI also produces images of the internal organs of the body but without exposing the patient to ionizing radiation. A CT scan or MRI of the pituitary gland may help determine if a tumor is present, causing an overproduction of ACTH. Occasionally, doctors use a special radioisotope procedure, known as the iodocholesterol scan, to view the adrenal glands. If these tests do not establish the source of ACTH, some centers are experienced in performing catheterization procedures that sample the blood leaving the pituitary gland to determine if the pituitary is the source of high ACTH. Treatment Treatment of Cushing's syndrome depends on the specific reason for cortisol overproduction. If the cause is long-term use of glucocorticoid hormones to treat another disorder, the doctor will gradually reduce the dosage until the symptoms are under control. Once control is established, the daily dose will be doubled and given on alternate days. PITUITARY ADENOMAS Several therapies are available to treat the ACTH-secreting pituitary adenomas of Cushing's disease. The most widely used treatment is removal of the tumor by surgery, known as transsphenoidal adenomectomy. Using a special microscope and very fine instruments, the surgeon approaches the pituitary gland through a nostril or an opening made in the bridge of the nose. Because this is an extremely delicate procedure, patients are often referred to centers specializing in this type of surgery. The success, or cure, rate of this procedure is over 80 percent. When surgery fails, it is usually because the CT scan or MRI is unable to identify the small adenoma. After pituitary surgery, there is a natural but temporary drop in the production of ACTH, so patients must be given a synthetic glucocorticoid hormone called hydrocortisone. Most patients can stop this replacement therapy in less than 1 year. For patients in whom transsphenoidal surgery has failed or who are not suitable candidates for surgery, radiotherapy is another possible treatment. Radiation to the pituitary gland is given over a period of 6 weeks, with improvement occurring in 40 to 50 percent of adults and up to 80 percent of children. It may take several months before patients feel better from radiation treatment alone. However, the combination of radiation and the drug mitotane (Lysodren) can help speed recovery. Mitotane suppresses cortisol production and lowers plasma and urine hormone levels. Treatment with mitotane alone can be successful in 30 to 40 percent of patients. Other drugs used alone or in combination to control the production of excess cortisol are aminoglutethimide, metyrapone, and ketoconazole. Like all drugs, each has its own set of side effects that doctors consider when prescribing therapy for individual patients. ECTOPIC ACTH SYNDROME To cure the overproduction of cortisol caused by ectopic ACTH syndrome, it is necessary to eliminate all of the cancerous tissue that is secreting ACTH. The choice of cancer treatment -- surgery, radiotherapy, chemotherapy, immunotherapy, or a combination of these treatments -- depends on the type of cancer and how far it has spread. Since ACTH-secreting tumors (for example, small cell lung cancer) may be very small or widespread at the time of diagnosis, rtisol-inhibiting drugs like mitotane form an important part of treatment. In some cases, if pituitary surgery is not successful surgical removal of the adrenal glands (bilateral adrenalectomy) may take the place of drug therapy. Recently, researchers have found that a glucocorticoid antagonist, RU 486, is effective in fighting the excessive effects of cortisol that cause Cushing's syndrome. RU 486 is still an investigational drug however, and its use is limited to clinical trials. ADRENAL TUMORS Surgery is the mainstay of treatment for benign as well as cancerous tumors of the adrenal glands. Research in Cushing's Syndrome The National Institutes of Health (NIH) is the biomedical research arm of the Federal Government. It is one of seven health agencies of the Public Health Service, which is part of the U.S. Department of Health and Human Services. Several components of NIH-the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Child Health and Human Development (NICHD), the National Institute of Neurological Disorders and Stroke, and the National Cancer Institute-conduct and support research on Cushing's syndrome and other disorders of the endocrine system. NIH-supported scientists are conducting intensive research into the normal and abnormal function of the major endocrine glands and the many hormones of the endocrine system. One important NIDDK-supported study by Dr. Wylie W. Vale and colleagues at the Salk Institute for Biological Studies in La Jolla, California, led to the identification of corticotropinreleasing hormone (CRH), which instructs the pituitary gland to release ACTH. This finding enabled Dr. George P. Chrousos and coworkers at the NICHD to develop the CRH stimulation test, which is increasingly being used to identify the cause of Cushing's syndrome. Using the dexamethasone suppression test, doctors are able to diagnose the cause of Cushing's syndrome in 80 percent of patients. With the CRH stimulation test alone, they can accurately diagnose the cause in 85 percent of cases. By using the dexamethasone suppression test and CRH stimulation test together, they are able to diagnose Cushing's syndrome with 98 percent accuracy, according to a recent NIH study. NIH scientists are continuing their efforts to improve the diagnosis and treatment of Cushing's syndrome. Current research is targeted not only at identifying new hormones, but also understanding their precise functions. Researchers also are focusing on the role of receptors, which are large complex molecules either on the surface of or within target cells to which hormones must attach to be effective. One goal of future research is to find ways to cure Cushing's syndrome without surgery. For example, it may be possible to destroy pituitary tumors selectively by binding a hormone like CRH, which precisely targets pituitary tissue, with a tumor-killing toxin or monoclonal antibody. Current NIH Studies Scientists are treating patients with Cushing's syndrome at the NIH Warren Grant Magnuson Clinical Center in Bethesda, Maryland. Physicians who are interested in referring a patient with Cushing's syndrome may contact Dr. George P. Chrousos, Developmental Endocrinology Branch, NICHD, Building 10, Room 10N262, Bethesda, Maryland 20892, telephone (301) 496-4686. Suggested Reading The following materials can be found in medical libraries, many college and university libraries, and through interlibrary loan in most public libraries. Forsham, Peter H. and Tyrrell, J. Blake, "Cushing's Syndrome," in Current Diagnosis, edited by Rex B. Conn. Philadelphia, W.B. Saunders Company, 1985, pp 863-867. Chrousos, George P., "Cushing's Syndrome," in Conn's Current Therapy, edited by Robert E. Rakel. Philadelphia, W.B. Saunders Company, Philadelphia, 1987, pp 495-498. Kohler, Peter O., ed. Clinical Endocrinology, New York, John Wiley & Sons, 1986. Braunwald, Eugene et al., eds. Harrison's Principles of Internal Medicine, 11th edition, New York, McGraw-Hill Book Company, 1987, pp 1760-1764. NCI Research Report: Cancer of the Lung. Prepared by the Office of Cancer Communications, National Cancer Institute, NIH Publication No. 86-526. Other Resources National Cushing's Association 4620l/2 Van Nuys Boulevard Sherman Oaks, California 91403 (818) 788-9235 or (818) 788-9239 This epub was written by Eileen K. Corrigan of NIDDK's Office of Health Research Reports. The draft was reviewed by Dr. George F. Chrousos, National Institute of Child Health and Human Development, and by Dr. Richard Horton, University of Southern California Medical Center. This epub is not copyrighted. Readers are encouraged to duplicate and distribute as many copies as needed. Printed single copies may be obtained from the Office of Health Research Reports, NIDDK, Building 31, Room 9A04, Bethesda, Maryland 20892. NIH Publication No. 89-3007 April 1989 ! * Cystic Fibrosis: Tests, Treatments Improve Survival by Ricki Lewis, Ph.D. Alex Deford had been ill almost from the moment of her birth on Oct. 30, 1971. Her frequent colds and ear infections coupled with her small size, despite a healthy appetite, prompted doctors to vaguely diagnose "failure to thrive." When Alex developed double pneumonia at 4 months, it was clear that something was very wrong. That something turned out to be cystic fibrosis, the most common inherited illness among white people of Northern and Western European ancestry, although it is seen in all ethnic groups. Symptoms include thick, sticky mucus clogging the lungs, impairing breathing and attracting infection; a blocked pancreas that cannot release digestive enzymes, causing pain after eating; stubbed fingers from poor circulation; infertility; salty sweat; and other problems. Patients may have any or all of these symptoms--Alex had quite a list. When she was diagnosed at Boston Children's Hospital early in 1972, Alex was so ill that she was expected to live only days. She survived eight years, but not easily. Alex began each day by inhaling a decongestant. Then her parents took turns providing "postural drainage," a 30- to 60- minute pounding and pressing on each of 11 segments of the lungs, to loosen the mucus, which she coughed up. Alex would then take drugs--antibiotics to prevent lung infection and powdered digestive enzymes mixed into applesauce. Despite this daily regimen, Alex died in January 1980. Her father, sportswriter and commentator Frank Deford, tells her story in his book, Alex, the Life of a Child. Cystic fibrosis (CF) is inherited and affects 30,000 Americans. In 1989, scientists discovered the gene that causes cystic fibrosis (see accompanying article.) This discovery is enabling researchers to develop new diagnostic tests that will help identify those who can benefit from traditional as well as several new treatment approaches being evaluated by FDA. How CF Is Inherited CF is typically passed from parents who each carry the gene, to children of either sex. Carriers have one faulty copy of the gene, which is responsible for the illness, plus one normal copy, which prevents symptoms. Each child of carrier parents has a 1 in 4 chance of inheriting CF; a 1 in 4 chance of being completely free of the mutant gene; and a chance of 1 in 2 of being a carrier, like the parents. Couples usually learn that they carry CF when they have an affected child. By 1985, individuals who had a sibling with CF could find out if they carried the gene by taking a "genetic marker" (linkage analysis) test that spots a particular family's CF-carrying chromosome, but not the gene itself. Finding the CF gene makes it possible to detect most carriers, even if there are no affected relatives. The Office of Technology Assessment estimates that 100 million to 200 million people in the United States might want to take a CF carrier test. About 8 million people in the United States, or 1 in 25 whites, may be carriers. Diagnosing CF The same gene discovery that has led to development of carrier tests is expected to help to more quickly diagnose CF, whose symptoms resemble those of other illnesses. The most widely used and best-known CF test is the electrolyte sweat test. It detects the excess sodium, potassium and chloride (charged chemicals called electrolytes) found on the skin of many people with CF. A physician would perform a sweat test in a child with unexplained failure to gain weight, or with very frequent respiratory infections. The sweat test evolved from the observations made by a physician, Dr. Paul di Sant'Agnese, during a 1953 heat wave in New York City. He was curious why so many children with CF were being brought to Babies and Children's Hospital, where he worked, with heat prostration. The youngsters were unable to cope with the heat because too much salt exited their bodies in sweat. The fact that the sweat of a person with CF contains two to six times as much salt as normal sweat gave him the idea for the sweat test. The sweat test became widely used by the mid-1950s, and is the only CF test cleared by FDA for marketing. (A forerunner of the sweat test was the observation that a child's brow was salty when kissed. At the turn of the century, this is how midwives identified babies with cystic fibrosis.) Although the sweat test is a critical part of a CF diagnostic work-up, salty sweat can indicate any of several disorders. Other tests help focus the diagnosis. Some of these tests are based on methodologies developed by reference laboratories, which perform medical tests and send the results to physicians. According to Freda Yoder of FDA's Center for Devices and Radiological Health, methodologies developed in- house have not traditionally been regulated by the agency. Explains Tom Tsakeris, director of the division of clinical laboratory devices at FDA, "FDA regulates products, not laboratories. As long as they are not marketing the test itself, we do not regulate the lab." However, he adds, the Clinical Laboratory Improvement Act, signed into law in 1988 but not yet fully implemented, will regulate reference laboratories. One test developed by reference labs measures the amount of the protein trypsinogen in a newborn's blood. Trypsinogen is manufactured by the pancreas and sent to the intestine, where it is snipped to a shorter form, trypsin, which helps digest proteins. If the pancreas is clogged by the sticky mucus of CF, trypsinogen levels are elevated, because the longer protein cannot be cut down to size. In one study conducted by researchers at the University of Colorado School of Medicine and Children's Hospital in Denver, the trypsinogen test identified 95.2 percent of infants with CF who did not have the earliest sign, a greenish discharge called meconium ileus indicating intestinal blockage. But in the study there were many false positives--of 96 infants who tested high for trypsinogen on two tests, only 31 had CF. So, although the trypsinogen test alone is not perfect, combined with a sweat test and observing symptoms, it can begin to paint a portrait of CF. Another test detects the level of certain fetal intestinal enzymes in the amniotic fluid (the liquid surrounding the fetus). Amniotic fluid is collected for testing by a procedure called amniocentesis (see "Genetic Screening: Fetal Signposts on a Journey of Discovery" in the December 1990 FDA Consumer). In a fetus with CF, these enzymes are decreased. Again, however, other disorders besides CF can produce this finding, and therefore it is not a specific disease marker. Researchers have turned to the genetic material to develop a definitive CF test. Enter Genetic Testing Developing a test to detect the gene that causes CF would provide a definitive diagnosis, because this mutant gene is the only cause of the disorder. The first step was to find out where the gene behind CF lies among the 23 pairs of chromosomes. By 1985, several research teams had narrowed the search to a part of chromosome 7 (the seventh largest chromosome). Until the CF gene itself was isolated and characterized in 1989, relatives of patients could take an indirect test that uses linkage analysis. Because of the complexity of test interpretation, these tests are primarily performed at academic centers. A genetic linkage test tracks a known DNA sequence (a genetic marker) that, within a family, always occurs in people with CF, and never in those who do not have the illness. A genetic marker and the gene responsible for the disorder behave like two inseparable friends. If you see one at a party, you know the other is nearby. Genetic linkage testing is based on the observation that genes carried close together on the same chromosome tend to be inherited together. Ray White at the Howard Hughes Medical Institute at the University of Utah in Salt Lake City and Robert Williamson of St. Mary's Hospital Medical School in London each found a marker, one on either side of the CF gene. Using these two markers, a couple who already had a child with CF could have fetal chromosomes tested in a subsequent pregnancy. If the two markers on the two chromosome 7's in the fetus matched those of the affected child, then it, too, has likely inherited the disease. A major limitation of linkage tests is that they only work on families known to have CF. Because people can carry CF without having symptoms, a disease-causing gene can be in a family without anyone in recent memory being ill. Finding the CF gene itself, however, may make possible a test useful on anyone, so that carriers could be detected in families where no one has CF. Like other genetic tests, CF tests can be performed on any type of tissue, because all human cells (except red blood cells) contain two copies of all of the genes, and sperm and egg have one copy of each. The first CF tests used white blood cells. Then Williamson's group in London came up with a pleasanter alternative--a mouthwash! After swishing a saltwater solution in the mouth, the person spits into a bottle. The CF gene can be spotted in cells dislodged from the inside of the cheek. Taking a cue from London, Genzyme Corp. (Cambridge, Mass.) developed a cheekbrush test for CF, which is investigational. A patient swabs cheek cells onto a brush, and the physician sends the sample to Genzyme. The presence of both normal and mutant CF genes indicates carrier status. If only mutant genes are there, CF is indicated. To Test or Not To Test? A carrier test provides information to couples who are not ill but whose children are at high risk of inheriting the condition. Many experts predict that the day of universal CF screening is approaching, with several companies developing CF tests that simultaneously screen for several CF mutations. Two factors contribute to the sensitivity of a CF carrier test. The first is the number of mutations that can be detected. The more mutations tested for, the more carriers will be spotted. Ethnic background is the other important factor, says Marisa Ladoulis, a genetic counselor at Collaborative Diagnostic Services in Waltham, Mass. For example, a 12- mutation test that spots 84 percent of whites with a Northern or Western European background will detect 92 to 95 percent of Ashkenazi Jews, and the 16-mutation test finds 96 to 98 percent of them. All CF Mutations Are Not Equal Checking for an errant CF gene may be easy, but interpreting the results may not be. Researchers are finding that different CF mutations cause different degrees of sickness. Alex Deford probably had two copies of delta F508, the most common and one of the more serious mutations that can cause CF. But a researcher in the laboratory of Francis Collins, the co-discoverer of the CF gene, has a milder case of CF because he inherited the delta F508 mutation as well as a different one. This young man must perform postural drainage on himself and take antibiotics and digestive enzymes, but he also plays the trumpet, bikes, and sings. Still, a respiratory infection can send him to the hospital for a week or longer. Clinicians are finding that some people who have frequent bouts of pneumonia and other respiratory infections actually have CF. Some people with CF may not even have lung or digestive symptoms. Aubrey Milunsky, D.Sc., Director of the Center for Human Genetics at the Boston University School of Medicine, found that some men who were referred to him because they were having difficulty fathering a child actually had CF. In examining x-rays that had been taken as part of a standard fertility work-up, Milunsky noticed the men lacked the vas deferens, the paired tubes that deliver sperm from the body. Knowing this is a symptom in 90 percent of men with CF, Milunsky tested their genes and found they had inherited CF. "Cystic fibrosis is not a simple single mutation to look for," says Margaret Wallace, Ph.D., assistant professor in the division of genetics in the department of pediatrics at the University of Florida in Gainesville. "There will be a lot of problems in doing the diagnosis and giving an idea of what it means," she adds. Treating CF CF symptoms are controlled with a number of drugs. Antibiotic drugs combat infections to which CF patients are prone, including Pseudomonas aeruginosa bacteria, a type of microbe that is attracted to the sticky mucus in the lungs. The combination of animal enzymes, called Viokase, that Alex Deford took regularly is still used today by CF patients. It is approved as a prescription digestive aid for CF patients and others with pancreatic insufficiencies. Combined with a high-calorie diet, this enzyme preparation aids digestion, helping the patient to maintain weight. Many patients also take anti-inflammatory prescription drugs, such as ibuprofen (Motrin and others), prednisone (Deltasone, Winpred, Orason, and others), and naproxen (Anaprox, Naprosyn and others). The drug amiloride (Midamor, Moduretic), introduced in 1967 and approved as an adjunct to treatment with some diuretic drugs, is now being tested as a treatment for CF. Scientists believe amiloride thins lung secretions by blocking sodium uptake by lung cells. Clinical studies are under way to assess amiloride as a CF treatment alone, and in combination with the biological products adenosine triphosphate (ATP) and uridine triphosphate (UTP). (ATP and UTP are components of the nucleic acids DNA and RNA.) Other investigational products are aimed at tempering the body's immune response to lung infection, which can be excessive. One such product is deoxyribonuclease. The March 19, 1992, New England Journal of Medicine reported that in a pilot study, this protein biologic given in an aerosol helped clear the lungs of 16 adult CF patients. It is being tested in 900 CF patients at 50 medical centers in the United States. Gene Therapy FDA has designated recombinant cystic fibrosis transmembrane conductance regulator (the gene's protein product, abbreviated CFTR) as well as gene therapy as orphan products. This gives their sponsors special incentives because they are developing products for a condition affecting relatively few people. The first human gene therapy study of CF got under way last April 17 at the National Heart, Lung, and Blood Institute after FDA gave the go-ahead the previous day. An engineered cold virus (adenovirus) was introduced into the cells lining the nose and airways of a 23-year-old man with CF. The virus was altered to carry the normal CFTR gene and lacks the genes to cause a cold and to replicate. The research was the first use of gene therapy for a common genetic disorder and the first use of a cold virus to transport genes. The study includes 10 patients age 21 or older who have mild to moderate CF symptoms. Previous experiments in rats indicated that replacing the CF genes in just 10 percent of the lung lining cells improves lung function. However, because the genes go to the patients' lungs but not their sex cells, CF can still be passed to the patients' children. New knowledge of CF is coming so fast that the goals of carrier screening may change even before the tests are cleared for marketing. Soon, detecting the gene for CF may be a way of finding who needs treatment, as early as possible, just as is presently done for high blood pressure and elevated blood cholesterol. Says Wallace, "CF research is moving so quickly, with a lot of hope for treatment in the near future. It will be treatable, and possibly easily." Ricki Lewis is a genetic counselor and is the author of textbooks on biology and human genetics. Box: For more information, contact The Cystic Fibrosis Foundation, 6000 Executive Blvd., Suite 510, Rockville, MD 20852; telephone (1-800) FIGHTCS. Advances and Stumbling Blocks The symptoms of CF were first described in medical journals in 1938. The malady was attributed to a defect in the channels leading from certain glands--a remarkably accurate description, it would turn out. But the disorder was recognized before it was given a name, as illustrated by the 17th century English saying, "A child that is salty to taste will die shortly after birth." In 1960, a CF patient rarely lived past the age of 12. By 1970, only half lived to see their 18th birthdays. In the 1970s, when postural drainage began to be implemented and FDA approved enzyme replacement and antibiotic therapy, the average lifespan began to creep upwards. Today, it is 29 years, according to the Cystic Fibrosis Foundation. New, more targeted therapies may raise survival age higher. Cystic fibrosis researchers marked a medical milestone on Oct. 8, 1989, when Science magazine published a report by Francis Collins and his co-workers at the University of Michigan at Ann Arbor and Lap-chee Tsui at the Hospital for Sick Children in Toronto on precisely how a specific gene disrupts a certain protein to cause CF. The researchers named the protein the "cystic fibrosis transmembrane conductance regulator," or CFTR for short. CFTR is normally manufactured inside cells lining glands in the respiratory passages, small intestine, pancreas, and sweat glands. The protein travels to the cell's surface, where it controls the flow of salt in and out of the cell like a gateway in the cell membrane. In the disorder, CFTR protein is abnormal in a way that prevents it from reaching the cell's surface. Without the gateway in the membrane, salt is trapped inside cells. Following a natural chemical tendency to try to dilute the salty interiors of cells, moisture is drawn inside them through other gateways. This dries out the surrounding secretions, causing symptoms. In most people with CF, the protein is missing just one amino acid building block out of 1,480--a tiny, but devastating, glitch. Almost as soon as Collins and Tsui described the mutation that causes CF, dubbed delta F508, a difficulty arose. Delta F508 was not the only way that the gene could be altered. (A gene consists of sequences of four types of building blocks. Just as a sentence can have an error in any of its letters, a gene can be altered in many ways. A person with CF inherits two abnormal forms.) But within days of the publication of the Science report, several biotechnology firms were already devising carrier tests for delta F508. A test for the disease-causing gene variant became available on an investigational basis by November 1989. But on Feb. 1, 1990, Collins, Tsui, and several others reported in The New England Journal of Medicine that only 75.9 percent of white CF patients of Northern and Western European backgrounds had the delta F508 variant. How useful would a test for delta F508 be, researchers worried, if this wasn't the only variant responsible for CF? At current count, more than 200 variants of the gene are known. The multiple guises of the CF gene meant that a test to spot delta F508 would miss about 24 percent of Northern or Western European descended whites in the United States who do carry a CF gene. This, in turn, meant that the test would find only about half the couples in the United States who risk passing CF to a child (this figure is derived by multiplying the chances of each parent having delta F508). But it would be too costly to develop a test for more than 200 different mutations, when only a few of them are common. Adding to the complexity is that different populations have different proportions of the CF gene variants. For example, delta F508 occurs in only 35 percent of African- Americans and Jews of Central and Eastern European ancestry (called Ashkenazi) who carry CF, making the test for this mutation even less valuable than it is for non-Jewish whites. For Hispanics and Italians, the frequency of delta F508 is 50 percent. The potential powder keg of a carrier test for a common genetic disease that would, at best, only work three-quarters of the time set off a flurry of statements by professional medical organizations. On Nov. 13, 1989, the American Society of Human Genetics urged caution in carrier testing until a greater percentage of the CF-carrying population could be identified, calling for pilot programs to test the tests. Meanwhile, they suggested the test only for those with a close affected relative. In early March 1990, a panel of physicians, geneticists, genetic counselors, and attorneys met at the National Institutes of Health in Bethesda, Md., to develop guidelines for CF carrier testing. This group echoed the earlier call for pilot programs, adding that widespread testing should wait until tests could detect 90 to 95 percent of carriers. In December 1992, the American Society of Human Genetics reevaluated their 1989 statement, in light of the ability to detect many CF mutations. Their advice remains unchanged--for now, CF testing should be offered only to those with a relative who has the disorder. The organization also calls for informed consent and genetic counseling, confidentiality of results, and quality control of the laboratory performing the test. --R.L. ! * Diabetic Retinopathy U.S. Department of Health and Human Services Public Health Service National Institutes of Health Why is it important to know how diabetes affects the eyes? If you are among the 10 million people in the United States who have diabetes-or if someone close to you has this disease-you should know that diabetes can affect the eyes and cause visual impairment. Fortunately, there are ways to prevent or lessen the eye damage caused by diabetes. That is why it is so important for people with this disease to have a professional eye examination as soon as their diabetes is diagnosed, and at least once a year thereafter. Regular eye examinations are especially important for people who have had diabetes 5 years or longer, for those who have difficulty controlling the level of sugar in their blood, and for diabetic women who are pregnant. All of these people are at increased risk for diabetes-associated eye problems. What is diabetic retinopathy? Diabetic retinopathy is a potentially serious eye disease caused by diabetes. It affects the retina-the light-sensitive tissue at the back of the eye that transmits visual messages to the brain. Damage to this delicate tissue may result in visual impairment or blindness. Diabetic retinopathy begins with a slight deterioration in the small blood vessels of the retina. Portions of the vessel walls balloon outward and fluid starts to leak from the vessels into the surrounding retinal tissue. Generally, these initial changes in the retina cause no visual symptoms. However, they can be detected by an eye specialist who is trained to recognize subtle signs of retinal disease. In many people with diabetic retinopathy, the disease remains mild and never causes visual problems. But in some individuals, continued leakage from the retinal blood vessels leads to macular edema. This is a build-up of fluid in the macula-the part of the retina responsible for the sharp, clear vision used in reading and driving. When critical areas of the macula become swollen with excess fluid, vision may be so badly blurred that these activities become difficult or impossible. Some people with diabetes develop an even more sight-threatening condition called proliferative retinopathy. It may occur in people who have macular edema, but also can develop in those who don't. In proliferative retinopathy, abnormal new blood vessels grow on the surface of the retina. These fragile new vessels can easily rupture and bleed into the middle of the eye, blocking vision. Scar tissue also may form near the retina, ultimately detaching it from the back of the eye. Severe visual loss, even permanent blindness, may result. But this happens in only a small minority of people with diabetes. How many diabetics are affected? Approximately 40 percent of all people with diabetes have at least mild signs of diabetic retinopathy. About 3 percent have suffered severe visual loss because of this disease. In general, the longer one has had diabetes, the greater one's chances of developing diabetic retinopathy. What are the symptoms of diabetic retinopathy? As already indicated, diabetic retinopathy generally causes no symptoms in its earliest stages. For the person who develops macular edema, blurring of vision may provide a clue that something is wrong. But proliferative retinopathy can progress a long way without any warning signs. That is why a person with diabetes should make regular visits to an eye specialist, so any eye problems can be detected and treated if necessary. How is diabetic retinopathy treated? Recently, scientists have found that laser treatment can prevent visual loss in many people with diabetic macular edema. In this treatment, called photocoagulation, powerful beams of light from a laser are aimed at leaking retinal blood vessels in the macula. The goal of treatment is to seal the vessels and prevent further leakage. In many patients, this treatment halts the decline in vision or even reverses it. Research also has shown that laser photocoagulation can dramatically reduce the risk of blindness in people who have proliferative retinopathy. For these patients, the laser is used in a different way: It is not directed at the macula but is aimed at hundreds of spots in other parts of the retina. The purpose of the treatment is to destroy diseased tissue and stop the retinopathy from getting worse. In fact, the treatment can reduce the risk of severe visual loss by 60 percent. The studies which proved the value of laser treatment for people with diabetic retinopathy were supported by the National Eye Institute. It is part of the National Institutes of Health, a component of the U.S. Department of Health and Human Services. These studies also have helped ophthalmologists determine which diabetic patients need laser treatment and when to begin it. Who should have laser treatment? An ophthalmologist (a medical doctor who specializes in the care of eye conditions) usually will consider laser treatment when a person with diabetes has proliferative retinopathy or retinal signs that suggest this condition may soon develop. Also, people with a significant degree of macular edema would now be considered for laser treatment. When deciding whether to recommend laser treatment to a particular patient, the ophthalmologist weighs the potential benefits-pre- venting or delaying severe visual loss against the risk of unwanted side effects. These may include some loss of central or side vision. Unfortunately, laser treatment cannot restore sight to the person who has already suffered severe retinal damage from diabetic retinopathy. Also, the laser generally is not used when bleeding inside the eye has made it difficult or impossible for the ophthalmologist to see the areas that need treatment. What is vitrectomy? A few diabetic retinopathy patients-including some who have had photocoagulation go blind from massive bleeding inside the eye. Now, ophthalmologists can remove the blood and scar tissue from the center of the eye. This procedure is known as vitrectomy. Following vitrectomy, patients can often see well enough to move around on their own. Occasionally, vision in the operated eye recovers enough for the patient to resume reading or driving. What research is being done on diabetic retinopathy? The National Eye Institute is supporting a nationwide study to determine whether photocoagulation-used alone or in combination with aspirin-can benefit people who are still in the early stages of diabetic retinopathy. Almost 4,000 patients are enrolled in this S-year clinical trial. It already has proven the value of photocoagulation for macular edema (see "How is diabetic retinop- athy treated?"), and is expected to yield further valuable findings in the future. Another clinical trial sponsored by the Institute and Pfizer, Inc., is evaluating a new drug called sorbinil to see if it can prevent eye and nerve damage in people with diabetes. In addition to these clinical trials, the Institute is supporting an extensive program of research on the causes, detection, and treatment of diabetic retinopathy. Who can refer you to an eye care specialist? If you know you have diabetes, you are probably under the care of a physician who can refer you to an eye doctor for regular examinations and treatment, if needed. You may also request the name of an appropriate eye doctor from eye care centers affiliated with academic institutions, from a hospital, or from a diabetes clinic at a medical center. You may obtain information on diabetes from the American Diabetes Association, 1660 Duke Street, Alexandria, Virginia 22314, telephone (703) 549-1500; and the Juvenile Diabetes Foundation, 432 Park Avenue South, 16th Floor, New York, New York 10016, telephone (212) 889-7575. Check your local telephone directory for their affiliates or chapters near you. What help is available to the person who has already lost vision from diabetic retinopathy? There are many useful devices that can help a partially sighted person to make the most of his or her remaining vision. Called low vision aids, these devices have special lenses or electronic systems that produce enlarged images of nearby objects. If you need low vision aids, your eye care specialist can generally prescribe them. Often, he or she will be able to suggest further sources you might contact to get information about counseling, training and other special services for people with low vision. These may include a nearby school of medicine or optometry. This brochure was prepared by the National Eye institute, NIH, Building 31, Room 6A32, Bethesda, MD 20892. The telephone number is (301) 496-5248. ! * WHEN YOUR DIAGNOSIS IS CYSTITIS ...it simply means you have an inflammation of the bladder. (Cystitis comes from "kystis", the Greek word for bladder.) The usual cause of this inflammation is a bacterial infection. This is a very common infection in females...more so in younger than older females. It clears rapidly in most uncomplicated cases with oral medication taken faithfully by the patient. How did you get it? The bladder drains through a tube called the urethra. The opening is close to the vagina, and not far from the anus (rectal opening). The germ involved in many bladder infections is an erstwhile peaceful and necessary resident of the human colon which is inadvertently introduced into the bladder (urethral) opening. Once in the bladder these germs act like pathogens (disease-producers) and infect the bladder lining, producing the characteristic symptoms. Cystitis can follow or accompany systemic illnesses, excessive irritation of the tissues in the genital area, such as from intercourse or repeated trauma as in horseback riding, excessive generalized dehydration or seeding from infections elsewhere in the genito-urinary tract (e.g. kidneys). The symptoms are quite characteristic -- burning sensation on urination, the often urgent feeling of having to urinate frequently (though not much urine may be passed), pressure sensation and distress in the pelvic area and not infrequently blood in the urine. Is it serious? Many cases would gradually go away if untreated, but a high enough percent of infections become chronic, recur frequently, spread to other organs such as the kidney, etc. so that proper medical treatment is by far the wisest course to pursue. Treatment is usually simple. Nearly all cases can be treated with oral antibacterial medications. While under treatment, increasing fluid intake enough so you urinate at least four times daily, avoiding strenuous physical activity in severe cases, abstinence from alcohol and sexual intercourse, rest and when the lower abdominal symptoms are marked, applying heat to the lower abdomen - all help to gain quicker relief. Symptoms are usually relieved within 24-72 hours, BUT THAT DOES NOT MEAN THE INFECTION IS GONE. It is important to take all the medication to insure the best chance for complete eradication of the infection. If you have persistent symptoms after treatment, return to clinic for follow-up. Can cystitis be prevented? Simple hygiene is important - bathing and showering. Incorrect "back to front" or careless wiping after bowel movements should be avoided - it can smear colon germs into the urethra. Sometimes "dry", excessive, or prolonged sexual intercourse will irritate the tissues enough to "kick off" cystitis. (The condition is not, however, considered a venereal disease under most circumstances.) Bacteria in the bladder reproduce approximately every twenty minutes. One becomes a million in seven hours. If the bladder is kept flushed out by adequate fluid input, this rapid bacterial replication is inhibited and symptomatic infections eliminated. Since sexual activity is so commonly linked to bladder infections, it is a good idea to empty your bladder after sex. Then drink a large glass of water. You may need to get up at 3 AM to urinate, but when you do you will flush out bacteria which were earlier introduced. If you are a sparing consumer of fluids, increase your intake so that at least once a day the urine is colorless or very pale, urinating at least four times daily. So...for best results take your medication faithfully and be sure to follow-up with the doctor after finishing the course of treatment. ! * End-Stage Renal Disease Choosing A Treatment That's Right For You U.S. Department of Health and Human Services Public Health Service National Institutes of Health Contents Introduction When Your Kidneys Fail Treatment Choices Hemodialysis Peritoneal Dialysis Kidney Transplantation Conclusion Paying for Treatment Other Sources of Information Introduction This booklet is for people whose kidneys fails to work. This condition is called end-stage renal disease (ESRD). Today, there are new and better treatments for ESRD that replace the work of healthy kidneys. By learning about your treatment choices, you can work with your doctor to pick the one that's best for you. No matter which type of treatment you choose, there will be some changes in your life. But with the help of your health care team, family, and friends, you may be able to lead a full, active life. This booklet describes the choices for treatment: hemodialysis, peritoneal dialysis, and kidney transplantation. It gives the pros and cons of each. It also discusses diet and paying for treatment. It gives tips for working with your doctor, nurses, and others who make up your health care team. It provides a list of groups that offer information and services to kidney patients. It also lists magazines, books, and brochures that you can read for more information about treatment. You and your doctor will work together to choose a treatment what's best for you. This booklet can help you make that choice. When Your Kidneys Fails Healthy kidneys clean the blood by filtering out extra water and wastes. They also make hormones that keep your bones strong and blood healthy. When both of your kidneys fail, your body holds fluid. Your blood pressure rises. Harmful wastes build up in your body. Your body doesn't make enough red blood cells. When this happens, you need treatment to replace the work of your failed kidneys. Treatment Choice Hemodialysis Purpose Hemodialysis is a procedure that cleans and filters your blood. It rids your body of harmful wastes and extra salt and fluids. It also controls blood pressure and helps your body keep the proper balance chemicals such as potassium, sodium, and chloride. How It Works Hemodialysis uses a dialyzer, or special filter, to clean your blood. The dialyzer connects to a machine. During treatment, your blood travels through tubes into the dialyzer. The dialyzer filters out wastes and extra fluids. Then the newly cleaned blood flows through another set of tubes and back into your body. Getting Ready Before your first treatment, an access to your bloodstream must be made. The access provides a way for blood to be carried from your body to the dialysis machine and then back into your body. The access can be internal (inside the body --usually under your skin) or external (outside the body). Who Performs It Hemodialysis can be done at home or at a center. At a center, nurses or trained technicians perform the treatment. At home, you perform hemodialysis with the help of a family member or friend. If you decide to do home dialysis, you and your partner will receive special training. The Time It Takes Hemodialysis usually is done three times a week. Each treatment lasts from 2 to 4 hours. During treatment, you can read, write, sleep, talk, or watch TV. Possible Complications Side effects can be caused by rapid changes in your body's fluid and chemical balance during treatment. Muscle cramps and hypotension are two common side effects. Hypotension, a sudden drop in blood pressure, can make you feel weak, dizzy, or sick to your stomach. It usually take a few months to adjust to hemodialysis. You can avoid many of the side effects if you follow the proper diet and take your medicines as directed. You should always report side effects to your doctor. They often can be treated quickly and easily. Your Diet Hemodialysis and a proper diet help reduce the wastes that build up in your blood. A dietitian can help you plan meals according to your doctor's orders. When choosing foods, you should remember to: ■Eat balanced amounts of foods high in protein such as meat and chicken. Animal protein is better used by your body than the protein found in vegetables and grains. ■Watch the amount of potassium you eat. Potassium is a mineral found in salt substitutes, some fruits, vegetable, milk, chocolate, and nuts. Too much or too little potassium can be harmful to your heart. ■Limit how much you drink. Fluids build up quickly in your body when your kidneys aren't working. To much fluid makes your tissues swell. It also can cause high blood pressure and heart trouble. ■Avoid salt. Salty foods make you thirsty and cause your body to hold water. ■Limit foods such as milk, cheese, nuts, dried beans, and soft drinks. These foods contain the mineral phosphorus. Too much phosphorus in your blood causes calcium to be pulled from you bones. Calcium helps keep bones strong and healthy. To prevent bone problems, your doctor may give you special medicines. You must take these medicines everyday as directed. Pros and Cons Each person responds differently to similar situations. What may be a negative factor for one person may be positive for another. However, in general, the following are pros and cons for each type of hemodialysis. In-Center Hemodialysis Pros ■You have trained professionals with you at all times. ■You can get to know other patients. Cons ■Treatments are scheduled by the center. ■You must travel to the center for treatment. Home Hemodialysis Pros ■You can do it at the hours you choose. (But you still must do it as often as your doctor orders.) ■You don't have to travel to a center. ■You gain a sense of independence and control over your treatment. Cons ■Helping with treatments may be stressful to your family. ■You need training. ■You need space for storing the machine and supplies at home. Working With Your Health Care Team Questions You May Want To Ask: ■Is hemodialysis the best treatment choice for me? Why or why not? ■If I am treated at a center, can I go to the center of my choice? ■What does hemodialysis feel like? Does it hurt? ■What is self-care dialysis? ■How long does it take to learn home hemodialysis? Who will train my partner and me? ■What kind of blood access is best for me? ■As a hemodialysis patient, will I be able to keep working? Can I have treatments at night if I plan to keep working? ■How much should I exercise? ■Who will be on my health care team? How can they help me? ■Who can I talk with about sexuality, family problems, or mane concerns? ■How/where can I talk to other people who have faced this decision? Write Other Questions You May Have Here: Treatment Choice Peritoneal Dialysis Purpose Peritoneal dialysis is another procedure that replaces the work of your kidneys. It removes extra water, wastes, and chemicals from your body. This type of dialysis uses the lining of your abdomen to filter your blood. This lining is called the peritoneal membrane. How I Works A cleansing solution, called dialysate, travels through a special tube into your abdomen. Fluid, wastes, and chemicals pass from tiny blood vessels in the peritoneal membrane into the dialysate. After several hours, the dialysate gets drained from your abdomen, taking the wastes from your blood with it. Then you fill your abdomen with fresh dialysate and the cleaning process begins again. Getting Ready Before your first treatment, a surgeon places a small, soft tube called a catheter into your abdomen. This catheter always stays there. It helps transport the dialysate to and from your peritoneal membrane. Types of Peritoneal Dialysis There are three types of peritoneal dialysis. 1. Continuous Ambulatory Peritoneal Dialysis (CAPD) CAPD is the most common type of peritoneal dialysis. It needs no machine. It can be done in any clean, well-lip place. With CAPD, your blood is always being cleaned. The dialysate passes from a plastic bag through the catheter and into your abdomen. The dialysate stays in your abdomen with the catheter sealed. After several hours, you drain the solution back into the bag. Then you refill your abdomen with fresh solution through the same catheter. Now the cleaning process begins again. While the solution is in your body, you may fold the empty plastic bag and hide it under your clothes, around your waist, or in a pocket. 2. Continuous Cyclic Peritoneal Dialysis (CCPD) CCPD is like CAPD except that a machine, which connects to your catheter, automatically fills and drains the dialysate from your abdomen. The machine does this at night while you sleep. 3. Intermittent Peritoneal Dialysis (IPD) IPD uses the same type of machine as CCPD to add and drain the dialysate. IPD can be done at home, but it's usually done in the hospital. IPD treatments take longer than CCPD. Who Performs It CAPD is a form of self-treatment. It needs no machine and no partner. However, with IPD and CCPD, you need a machine and the help of a partner (family member, friend, or health professional). The Time It Takes With CAPD, the dialysate stays in your abdomen for about 4 to 6 hours. The process of draining the dialysate and replacing fresh solution takes 30 to 40 minutes. Most people change the solution four times a day. With CCPD, treatments are done several times a week, for a total of 36 to 42 hours per week. Sessions may last up to 24 hours. Possible Complications Peritonitis, or infection of the peritoneum, can occur if the opening where the catheter enters your body gets infected. You can also get it if there is a problem connecting or disconnecting the catheter from the bags. Peritonitis can make you feel sick. It can cause a fever and stomach pain. To avoid peritonitis, you must be careful to follow the procedure exactly. You must know the early signs of peritonitis. Look for reddening or swelling around the catheter. You should also note if your dialysate looks cloudy. It is important to report these signs to your doctor so that the peritonitis can be treated quickly to avoid serious problems. Your Diet Diet for peritoneal dialysis is slightly different than diet for hemodialysis. ■You may be able to have more salt and fluids. ■You may eat more protein. ■You may have different potassium restrictions. ■You may need to cut back on the number of calories you eat. This limitation is because the sugar in the dialysate may cause you to gain weight. Pros and Cons There are pros and cons to each type of peritoneal dialysis. Pros ■You can perform treatment alone ■You can do it at times you choose. ■You can do it in many locations. ■You don't need a machine. Cons ■It disrupts your daily schedule. CCPD Pros ■You can do it at night, mainly while you sleep. Cons ■You need a machine and help from a partner. IPD Pros ■Health professionals usually perform treatments Cons ■You may need to go to a hospital. ■It takes a lot of time. ■You need a machine. Working With Your Health Care Team Questions You May Want To Ask: ■Is peritoneal dialysis the best treatment choice for me? Why or why not? Which type? ■How long will it take me to learn peritoneal dialysis? ■What does peritoneal dialysis feel like? Does it hurt? ■How will peritoneal dialysis affect my blood pressure? ■How do I know if I have peritonitis? How is peritonitis treated? ■As a peritoneal dialysis patient, will I be able to continue working? ■How much should I exercise? ■Who will be on my health care team? How can they help me? ■Who can I talk with about sexuality, finances, or family concerns? ■How/where can I talk to other people who have faced this decision? Write Other Questions You May Have Here: Dialysis Is Not a Cure Hemodialysis and peritoneal dialysis are treatments that try to replace your failed kidneys. These treatments help you feel better and live longer, but they are not cures for ESRD. While patients with ESRD are now living longer than ever, ESRD can cause problems over the years. Some problems are bone disease, high blood pressure, nerve damage, and anemia (having to few red blood cells). Although these problems won't go away with dialysis, doctors now have new and better ways to treat or prevent them. You should discuss these treatments with your doctor. Treatment Choice Kidney Transplantation Purpose Kidney transplantation is a procedure that places a health kidney from another person into your body. This one new kidney does all the work that your two failed kidneys cannot do. How It Works A surgeon places the new kidney inside your body between your upper thigh and abdomen. The surgeon connects the artery and vein of the new kidney to your artery and vein. Your blood flows through the new kidney and makes urine, just like your own kidneys did when they were healthy. The new kidney may start working right away or may take up to a few weeks to make urine. Your own kidneys are left where they are, unless they are causing infection or high blood pressure. Getting Ready You may receive a kidney from a member of your family. This kind of donor is called a living-related donor. You may receive a kidney from a person who has recently died. This type of donor is called a cadaver donor. Sometimes a spouse or very close friend may donate a kidney. This kind of donor is called a living- unrelated donor. It is very important for the donor's blood and tissues to closely match yours. This match will help prevent your body's immune system from fighting off, or rejecting, the new kidney. A lab will do special tests on blood cells to find out if your body will accept the new kidney. The Time It Takes The time it takes to get a kidney varies. There are not enough cadaver donors for every person who needs a transplant. Because of this, you must be placed on a waiting list to receive a cadaver donor kidney. However, if a relative gives you a kidney, the transplant operation can be done sooner. The surgery takes from 3 to 6 hours. The usual hospital stay may last from 10 to 14 days. After you leave the hospital, you will go to the clinic for regular followup visits. If a relative or close friend gives you a kidney, he or she will probably stay in the hospital for one week or less. Possible Complications Transplantation is not a cure. There is always a chance that your body will reject your new kidney, no matter how good the match. The chance of your body accepting the new kidney depends on your age, race, and medical condition. Normally, 75 to 80 percent of transplants from cadaver donors are working one year after surgery. However, transplants from living relatives often work better than transplants from cadaver donors. This fact is because they are usually a closer match. Your doctor will give you special drugs to help prevent rejection. These are called immunosuppressants. You will need to take these drugs every day for the rest of your life. Sometimes these drugs cannot stop your body from rejecting the new kidney. If this happens, you will go back to some form of dialysis and possibly wait for another transplant. Treatment with these drugs may cause side effects. The most serious is that they weaken your immune system, making it easier for you to get infections. Some drugs also cause changes in how you look. Your face may get fuller. You may gain weight or develop acne or facial hair. Not all patients have these problems, and makeup and diet can help. Some of these drugs may cause problems such as cataracts, extra stomach acid, and hip disease. In a smaller number of patients, these drugs also may cause liver or kidney damage when used for a long period of time. Your Diet Diet for transplant patients is less limiting than it is for dialysis patients. You may still have to cut back on some foods, though. Your diet probably will change as your medicines, blood values, weight, and blood pressure change. ■You may need to count calories. Your medicine may give you a bigger appetite and cause you to gain weight. ■You may have to limit eating salty foods. Your medications may cause salt to be held in your body, leading to high blood pressure. ■You may need to eat less protein. Some medications cause a higher level of wastes to build up in your bloodstream. Pros and Cons There are pros and cons to kidney transplantation. Pros ■It works like a normal kidney. ■It helps you feel healthier. ■You have fewer diet restrictions. ■There's no need for dialysis. Cons ■It requires major surgery. ■You may need to wait for a donor. ■One transplant may not last a lifetime. Your body may reject the new kidney. ■You will have to take drugs for the rest of your life. Working With Your Health Care Team Questions You May Want To Ask: ■Is transplantation the best treatment choice for me? Why or why not? ■What are my chances of having a successful transplant? ■How do I find out if a family member or friend can donate? ■What are the risks to a family member or friend if he or she donates? ■If a family member or friend doesn't donate, how do I get placed on a waiting list for a kidney? How long will I have to wait? ■What are the symptoms of rejection? ■Who will be on my health care team? How can they help me? ■Who can I talk to about sexuality, finances, or family concerns? ■How/where can I talk to other people who have faced this decision? Write Other Questions You May Have Here: Conclusion It's not always easy to decide which type of treatment is best for you. Your decision depends on your medical condition, lifestyle, and personal likes and dislikes. Discuss the pros and cons of each with your health care team. If you start one form of treatment and decide you'd like to try another, talk it over with your doctor. The key is to learn as much as you can about your choices. With that knowledge, you and your doctor will choose a treatment that suits you best. Paying for Treatment Treatment for ESRD is expensive, but the Federal Government helps pay for much of the cost. Often, private insurance or state programs pay the rest. Medicare Medicare pays for 80 percent of the cost of your dialysis treatments or transplant, no matter how old you are. To qualify, ■you must have worked long enough to be insured under Social Security (or be the child of someone who has) or ■you already must be receiving Social Security benefits. You should apply for Medicare as soon as possible after beginning dialysis. Often, a social worker at your hospital or dialysis center will help you apply. Private Insurance Private insurance often pays for the entire cost or treatment. Or it may pay for the 20 percent that Medicare does not cover. Private insurance also may pay for your prescription drugs. Medicaid Medicaid is a state program. Your income must be below a certain level to receive Medicaid funds. Medicaid may pay for your treatments if you cannot receive Medicare. In some states, it also pays the 20 percent that Medicare does not cover. It also may pay for some of your medicines. To apply for Medicaid, talk with your social worker or contact your local health department. Veterans Administration (VA) Benefits If you are veteran, the VA can help pay for treatment. Contact your local VA office for more information. Social Security Income (SSI) and Social Security Disability Income (SSDI) These benefits are available from the Social Security Administration. They assist you with the costs of daily living. To find out if you qualify, talk to your social worker or call your local Social Security office. Organizations That Can Help There are several groups that offer information and services to kidney patients. You may wish to contact the following: ■American Kidney Fund Suite 1010 6110 Executive Boulevard Rockville, MD 20852 (800) 638-8299 ■American Association of Kidney Patients Suite LL1 1 Davis Boulevard Tampa, FL 33606 (813) 251-0725 ■National Kidney Foundation, Inc. 30 East 33rd Street New York, NY 10016 (800) 622-9010 ■National Kidney and Urologic Diseases Information Clearinghouse Box NKUDIC 9000 Rockville Pike Bethesda, MD 20892 (301) 654-4415 Additional Reading If you would like to learn more about ESRD and its treatment, you may be interested in reading: Your New Life With Dialysis--A Patient Guide for Physical and Psychological Adjustment Edith T. Oberley, M.A., and Terry D. Oberley, M.D., Ph.D. Fourth edition, 1991 Charles C. Thomas Publishers 2600 South First Street Springfield, IL 62794-9265 Understanding Kidney Transplantation Edith T. Oberley, M.A., and Neal R. Glass, M.D., F.A.C.S. Charles C. Thomas Publishers, 1987 2600 South First Street Springfield, IL 62794-9265 Kidney Disease: A Guide for Patients and Their Families American Kidney Fund Suite 1010 6610 Executive Boulevard Rockville, MD 20852 National Kidney Foundation Patient Education Brochures Includes information on treatment, diet, work, and exercise. National Kidney Foundation, Inc. 30 East 33rd Street New York, NY 10016 (800) 622-9010 Medicare Coverage of Kidney Dialysis and Kidney Transplant Services: A Supplement to Your Medicare Handbook Publication Number HCGA-02183 U.S. Department of Health and Human Services Health Care Financing Administration Suite 500 1331 H Street, NW Washington, DC 20005 (301) 966-7843 Renalife Magazine American Association of Kidney Patients (AAKP) Suite LL1 1 Davis Boulevard Tampa, FL 33606 (813) 251-0725 Published quarterly. Family Focus Newsletter National Kidney Foundation, Inc. 30 East 33rd Street New York, NY 10016 (800) 622-9010 For Patients Only Magazine Suite 400 20335 Ventura Boulevard Woodland Hills, CA 91364 (800) 704-5555 Published six times per year. ! * Diverticulitis Although once felt to be similar to left-sided "appendicitis," in fact diverticulitis is probably quite distinct in its nature and cause. A diverticulum is generally an acquired outpouching of the colon, although there are occasional congenital varieties, and some can occur elsewhere in the digestive tract. The predisposing abnormality is diverticulosis, the occurrence of the puches with no apparent disease. This condition is found in over half of all people over age 60, although very few (1%) of these develop diverticulitis. It is generally believed that the far reaches of the colon near the rectum (the sigmoid colon) are exposed repeatedly to the very high pressures of contraction in some individuals. Since the stool in the area must be propelled forward for final removal through a bowel movement, when the fecal matter is hard or compacted, the contractions become increasingly forceful. Ultimately, like the inner tube of an old tire, the weaker areas of the colon wall bulge as described, sometimes forming hundreds of diverticula. The factors responsible are believed by many to be dietary. High fiber foods generally retain water as they; move through the colon, leaving the stool soft and easy to expel. With no fiber the bolus is hard and inflexible. Poor fluid intake may play the same role. Chronic laxatives may cause forceful contractions as well. Diverticulitis is caused when factors weaken the wall of the diverticulum so much that the wall microscopically perforates into the surrounding abdominal cavity. From there on, a process similar to appendicitis may occur. Symptoms Pain in the left lower abdominal area, often with fever, is typical. The patient is usually older than 50 years. A tender mass in the abdomen may be felt by the physician, sometimes representing an abscess near the site of perforation. Sometimes, the diverticulum may wear its way into the bladder, causing urinary symptoms. Differential considerations include those discussed under appendicitis, but in addition one must consider cancer of the colon, and other diseases common to the older population seen with this disease. Certain blood test results, judicious plain and barium x-rays, and careful judgment are most important. Treatment Unlike appendicitis, diverticulitis only occasionally requires surgical treatment. Generally, the digestive system is placed at total rest with elimination of oral intake, stomach suction and replacement of fluids by vein. Antibiotics are given to counter the abdominal infection. If there is no improvement in 24 to 48 hours (there usually is), or if things worsen despite treatment, surgery may be necessary, with removal of large portions of the colon sometimes necessary.. Recurrences may also warrant surgery. It is essential that a coexistent tumor be ruled out at some point, usually with x-rays and a proctosigmoidoscopy. Almost all deaths occur in older patients, under conditions of emergency surgery. Thus, when possible, many surgeons prefer to wait until the patient has stabilized before operating, when this is possible. ! * Dizziness Hope Through Research For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Prepared by the Office of Scientific and Health Reports National Institute of Neurological and Communicative Disorders and Stroke NATIONAL INSTITUTES OF HEALTH Bethesda, Maryland 20892 NIH Publication No. 86-76 September 1986 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health Cover: Research has given us new ways to diagnose dizziness. Here, a technician applies electrodes to a man's face to record eye movement while the balance system in his inner ear is stimulated. Dizziness - Hope Through Research Most of us can remember feeling dizzy--after a roller coaster ride, maybe, or when looking down from a tall building, or when, as children, we would step off a spinning merry-go-round. Even superbly conditioned astronauts have had temporary trouble with dizziness while in space. In these situations, dizziness arises naturally from unusual changes that disrupt our normal feeling of stability. But dizziness can also be a sign that there is a disturbance or a disease in the system that helps people maintain balance. This system is coordinated by the brain, which reacts to nerve impulses from the ears, the eyes, the neck and limb muscles, and the joints of the arms and legs. If any of these areas fail to function normally or if the brain fails to coordinate the many nerve impulses it receives, a person may feel dizzy. The feeling of dizziness varies from person to person and, to some extent, according to its cause; it can include a feeling of unsteadiness, imbalance, or even spinning. Disease-related dizziness, whether it takes the form of unsteadiness or spinning, is fairly common in the older population. Today, both older and younger people with serious dizziness problems can be helped by a variety of techniques--from medication to surgery to balancing exercises. Such techniques have been developed and improved by scientists studying dizziness. Much of today's research on dizziness is supported by the National Institute Of Neurological and Communicative Disorders and Stroke (NINCDS). This Institute is a unit of the National Institutes of Health. It is the focal point within the Federal Government for research on the brain and central nervous system, including studies of the senses through which we interact with our surroundings. With NINCDS support, scientists are searching for better ways to diagnose and treat dizziness, and are investigating the mechanisms that help us maintain our normal sense of balance. These studies, along with basic research on how the ear, the brain, and the nerves work, hold the best hope for relief for dizziness sufferers. A delicate balancing act To understand what goes wrong when we feel dizzy, we need to know about the vestibular system by which we keep a sense of balance amid all our daily twisting and turning, starting and stopping, jumping, falling, rolling, and bending. The vestibular system is located in the inner ear and contains the following structures: vestibular labyrinth, semicircular canals, vestibule, utricle, and saccule. These structures work in tandem with the vestibular areas of the brain to help us maintain balance. [Graphic Omitted] The semicircular canals and vestibule of the inner ear contain a fluid called endolymph that moves in response to head movement. The vestibular labyrinth is located behind the eardrum. The labyrinth's most striking feature is a group of three semicircular canals or tubes that arise from a common base. At the base of the canals is a rounded chamber called the vestibule. The three canals and the vestibule are hollow and contain a fluid called endolymph which moves in response to head movement. Within the vestibule and the semicircular canals are patches of special nerve cells called hair cells. Hair cells are also found in two fluid-filled sacs, the utricle and saccule, located within the vestibule These cells are aptly named: rows of thin, flexible, hairlike fibers project from them into the endolymph. Also located in the inner ear are tiny calcium stones called otoconia. When you move your head or stand up, the hair cells are bent by the weight of the otoconia or movement of the endolymph. The bending of the hair cells transmits an electrical signal about head movement to the brain. This signal travels from the inner ear to the brain along the eighth cranial nerve--the nerve involved in balance and hearing. The brain recognizes the signal as a particular movement of the head and is able to use this information to help maintain balance. [Graphic Omitted] In the inner ear, rows of hairlike fibers project from tiny patches of nerve cells called hair cells. [Graphic Omitted] These tiny calcium stones called otoconia are part of the inner ear's balance system. A thorough exam reveals the cause of most dizziness. The senses are also important in determining balance. Sensory input from the eyes as well as from the muscles and joints is sent to the brain, alerting us that the path we are following bends to the fight or that our head is tilted as we bend to pick up a dime. The brain interprets this information--along with cues from the vestibular system--and adjusts the muscles so that balance is maintained. Dizziness can occur when sensory information is distorted. Some people feel dizzy at great heights, for instance, partly because they cannot focus on nearby objects to stabilize themselves. When one is on the ground, it is normal to sway slightly while standing. A person maintains balance by adjusting the body's position to something close by. But when someone is standing high up, objects are too far away to use to adjust balance. The result can be confusion, insecurity, and dizziness, which is sometimes resolved by sitting down. Some scientists believe that motion sickness, a malady that affects sea, car; and even space travelers, occurs when the brain receives conflicting sensory information about the body's motion and position. For example, when someone reads while riding in a car, the inner ear senses the movement of the vehicle, but the eyes gaze steadily on the book that is not moving. The resulting sensory conflict may lead to the typical symptoms of motion sickness: dizziness, nausea, vomiting, and sweating. Another form of dizziness occurs when we turn around in a circle quickly several times and then stop suddenly. Turning moves the endolymph. The moving endolymph tells us we are still rotating but our other senses say we've stopped. We feel dizzy. Diagnosing the problem The dizziness one feels after spinning around in a circle usually goes away quickly and does not require a medical evaluation. But when symptoms appear to be caused by an underlying physical problem, the prudent person will see a physician for diagnostic tests. According to a study supported by the National Institute of Neurological and Communicative Disorders and Stroke, a thorough examination can reveal the underlying cause of dizziness in about 90 percent of cases. A person experiencing dizziness may first go to a general practitioner or family physician; between 5 and 10 percent of initial visits to these physicians involve a complaint of dizziness. The patient may then be referred either to an ear specialist (otologist) or a nervous system specialist (neurologist). [Graphic Omitted] As part of a research study, this NINCDS physician tests a patient's balance. Tests that make the patient feel dizzy help establish a diagnosis. The patient will be asked to describe the exact nature of the dizziness, to give a complete history of its occurrence, and to list any other symptoms or medical problems. Patients give many descriptions of dizziness-depending to some extent on its cause. Common complaints are light-headedness, a feeling of impending faint, a hallucination of movement or motion, or a loss of balance without any strange feelings in the head. Some people also report they have vertigo--a form of dizziness in which one's surroundings appear to be spinning uncontrollably or one feels the sensation of spinning. The physician will try to determine what components of a patient's nervous system are out of kilter, looking first for changes in blood pressure, heart rhythm, or vision--all of which may contribute to the complaints. Sometimes dizziness is associated with an ear disorder. The patient may have loss of hearing, discomfort from loud sounds, or constant noise in the ear, a disorder known as tinnitus. The physician will also look for other neurological symptoms: difficulty in swallowing or talking, for example, or double vision. Tests and scans After the initial history-taking and physical examination, the physician may deliberately try to make the patient feel dizzy. The patient may be asked to repeat actions or movements that generally cause dizziness: to walk in one direction and then turn quickly in the opposite direction, or to hyperventilate by breathing deeply for 3 minutes. In another test, the patient sits upright on an examining table. The physician tilts the patient's head back and turns it partway to one side, then gently but quickly pushes the patient backward to a lying down position. The reaction to this procedure varies according to the cause of dizziness. Patients with benign positional vertigo may experience vertigo plus nystagmus. rapid, uncontrollable back-and-forth movements of the eyes. [Graphic Omitted] In a new caloric test to diagnose dizziness, air or water is injected gradually into a patient's ears. The eye movements that result are recorded. One widely used procedure, called the caloric test, involves electronic monitoring of the patient's eye movements while one ear at a time is irrigated with warm water or warm air and then with cold water or cold air. This double stimulus causes the endolymph to move in a way similar to that produced by rotation of the head. If the labyrinth is working normally, nystagmus should result. A missing nystagmus reaction is a strong argument that the balance organs are not acting correctly. NINCDS-supported scientists at The Johns Hopkins University in Baltimore observed that not all patients can tolerate the traditional caloric test. Some become sick when the ear is irrigated with the standard amount of water or air before physicians can measure their eye movements. So the scientists are designing a method of conducting the test more gradually by slowly adjusting the amount of water or air reaching the inner ear. Their goal is to reduce patient discomfort while allowing the test to proceed. Balance disorders are often accompanied by hearing loss. Some patients who cannot tolerate the caloric test are given a rotatory test. In this procedure, the patient sits in a rotating chair, head tilted slightly forward. The chair spins rapidly in one direction, then stops abruptly. Depending on the cause of dizziness, the patient may experience vertigo after this rotation. In one variation of this test, the chair is placed in a tent of striped cloth. As the chair rotates, electrodes record movements of the patient's eyes in response to the stripes. The physician evaluates these eye movements, a form of nystagmus, to determine if the patient has a disorder of the balance system. Because disorders of balance are often accompanied by hearing loss, the physician may order a hearing test. Hearing loss and associated dizziness could also be due to damaged nerve cells in the brain stem, where the hearing and balance nerve relays signals to the brain. To detect a malfunction, the physician may order a kind of computerized brain wave study called a brain stem auditory evoked response test. In this procedure, electrodes are attached to several places on the surface of the patient's scalp and a sound is transmitted to the patient's ear. The electrodes measure the time it takes nerve signals generated by the sound to travel from the ear to the brain stem. [Graphic Omitted] This patient will undergo a rotatory test. How her eyes respond to the stripes as the chair rotates will give otologists information about her balance system. [Graphic Omitted] Patients with dizziness may undergo a computed tomographic (CT) scan to see if the problem is a tumor or a cyst. If there is reason to suspect that the dizziness could stem from a tumor or cyst, the patient may undergo a computed tomographic (CT) scan. In a CT scan, x-ray pictures are taken of the brain from several different angles. These images are then combined by a computer to give a detailed view that may reveal the damaging growth. Sometimes anxiety and emotional upset cause a person to feel dizzy. Certain patients may be asked to take a psychological test, to try to find out whether the dizziness is caused or intensified by emotional stress. The many tests administered by a physician will usually point to a cause for the patient's dizziness. Disorders responsible for dizziness can be categorized as: * peripheral vestibular, or those involving a disturbance in the labyrinth. * central vestibular, or those resulting from a problem in the brain or its connecting nerves. * systemic, or those originating in nerves or organs outside the head. Confused signals When someone has vertigo but does not experience faintness or difficulty in walking, the cause is probably a peripheral vestibular disorder. In these conditions, nerve cells in the inner ear send confusing information about body movement to the brain. Ménière's disease. A well-known cause of vertigo is the peripheral vestibular disorder known as Ménière's disease. First identified in 1861 by Prosper Ménière, a French physician, the disease is thought to be caused by too much endolymph in the semicircular canals and vestibule. Some scientists think that the excess endolymph may affect the hair cells so that they do not work correctly. This explanation, however, is still under study. The vertigo of Ménière's disease comes and goes without an apparent cause; it may be made worse by a change in position and reduced by being still. In addition to vertigo, patients have hearing loss and tinnitus. Hearing loss is usually restricted at first to one ear and is often severe. Patients sometimes feel "fullness" or discomfort in the ear, and diagnostic testing may show unusual sensitivity to increasingly loud sounds. In 10 to 20 percent of patients, hearing loss and tinnitus eventually occur in the second ear. [Graphic Omitted] Patients suspected of having Ménière's disease commonly undergo electronystagmography, an electronic recording of the caloric test. Ménière's disease patients are often helped by drugs or surgery. Ménière's disease patients may undergo electronystagmography, an electrical recording of the caloric test, to determine if their labyrinth is working normally. Attacks of Ménière's disease may occur several times a month or year and can last from a few minutes to many hours. Some patients experience a spontaneous disappearance of symptoms while others may have attacks for years. Treatment of Ménière's disease includes such drugs as meclizine hydrochloride and the tranquilizer diazepam to reduce the feeling of intense motion during vertigo. To control the buildup of endolymph, the patient may also take a diuretic, a drug that reduces fluid production. A low-salt diet--which reduces water retention-is claimed to be an effective treatment of Ménière's disease. When these measures fail to help, surgery may be considered. In shunt surgery, part of the inner ear is drained to reestablish normal inner ear fluid or endolymph pressure. In another operation, called vestibular nerve section, surgeons expose and cut the vestibular part of the eighth nerve. Both vestibular nerve section and shunt surgery commonly relieve the dizziness of Ménière's disease without affecting hearing. A more drastic operation, labyrinthectomy, involves total destruction of the inner ear. This procedure is usually successful in eliminating dizziness but causes total loss of hearing in the operated ear--an important consideration since the second ear may one day be affected. Positional vertigo. People with benign positional vertigo experience vertigo after a position change. Barbara noticed the first sign of this disorder one morning when she got up out of bed. She felt the room spinning. Frightened, she quickly returned to bed and lay down. After about 30 seconds the vertigo passed. Fearing a stroke, Barbara went to the emergency room of a hospital for a medical evaluation, which failed to show a problem. She had no symptoms for several days, then the problem returned. At this point, Barbara was referred to an otoneurologist, a physician who specializes in the ear and related parts of the nervous system. Viral infections may lead to vestibular neuronitis. Like Barbara, most patients with benign positional vertigo are extremely worried about their symptoms. But the patients usually feel less threatened once the disorder is diagnosed. The cause of benign positional vertigo is not known, although some patients may recall an incident of head injury. The condition can strike at any adult age with attacks occurring periodically throughout a person's life. In one type of treatment, the patient practices the position that provokes dizziness until the balance system eventually adapts. Rarely, a physician will prescribe medication to prevent attacks. Vestibular neuronitis. In this common vestibular disorder, the patient has severe vertigo. Jack experienced his first attack of this problem at 2 a.m. when he rolled over in bed and suddenly felt the room spinning violently. He started vomiting but couldn't stand up; finally, he managed to crawl to the bathroom. When he returned to bed, he lay very still--the only way to stop the vertigo. Three days later, he was able to walk without experiencing vertigo, but he still felt unsteady. Gradually, over the next several weeks, Jack's balance improved, but it was a year before he was entirely without symptoms. Unlike Ménière's disease, vestibular neuronitis is not associated with hearing loss. Patients with vestibular neuronitis first experience an acute attack of severe vertigo lasting for hours or days, just as Jack did, with loss of balance sometimes lasting for weeks or months. About half of those who have a single attack have further episodes over a period of months to years. The cause of vestibular neuronitis is uncertain. Since the first attack often occurs after a viral illness, some scientists believe the disorder is caused by a viral infection of the nerve. Other labyrinth problems. Inner ear problems with resulting dizziness can also be caused by certain antibiotics used to fight life-threatening bacterial infections. Probably the best-known agent of this group is streptomycin. Problems usually arise when high doses of these drugs are taken for a long time, but some patients experience symptoms after short treatment with low doses, especially.if they have impaired kidneys. The first symptoms of damage to the inner ear caused by medication are usually hearing loss, tinnitus, or unsteadiness while walking. Stopping the drug can usually halt further damage to the balance mechanism, but this is not always possible: the medicine may have to be continued to treat a life-threatening infection. Patients sometimes adapt to the inner ear damage that may-occur after prolonged use of these antibiotics and recover their balance Balance can also be affected by a cholesteatoma, a clump of cells from the eardrum that grow into the middle ear and accumulate there These growths are thought to result from repeated infections such as recurrent otitis media. If unchecked, a cholesteatoma can enlarge and threaten the inner ear. But if the growth is detected early, it can be surgically removed. [Graphic Omitted] This CT scan shows a massive cholesteatoma (arrow), a tumorlike clump of cells that has grown in the middle ear, and is a likely cause of this patient's dizziness. Brain and nerve damage The vestibular nerve carries signals from the inner ear to the brain stem. If either the nerve or the brain stem is damaged, information about position and movement may be blocked or incorrectly processed, leading to dizziness. Conditions in which dizziness results from damage to the brain stem or its associated nerves are called central causes of dizziness. Acoustic neuroma. One central cause of dizziness is a tumor called an acoustic neuroma. Although the most common sign of this growth is hearing loss followed by tinnitus, some patients also experience dizziness. An acoustic neuroma usually occurs in the internal auditory canal, the bony channel through which the vestibular nerve passes as it leaves the inner ear. The growing tumor presses on the nerve, sending false messages about position and movement to the brain. The hearing nerve running alongside the vestibular nerve can also be compressed by the acoustic neuroma, with resulting tinnitus and hearing loss. Or the tumor may press on other nearby nerves, producing numbness or weakness of the face. If the neuroma is allowed to grow, it will eventually reach the brain and may affect the function of other cranial nerves. [Graphic Omitted] These benign cells from an acoustic neuroma were grown in tissue culture. If diagnosed early, acoustic neuromas can be removed completely with no neurological damage. Early treatment of acoustic neuroma helps patients regain balance. Computed tomography has revolutionized the detection of acoustic neuromas. If an early diagnosis is made, a surgeon can remove the tumor. The patient usually regains balance Stroke. Dizziness may be a sign of a "small stroke" or transient ischemic attack (TIA) in the brain stem. TIA's, which result from a temporary lack of blood supply to the brain, may also cause transient numbness, tingling, or weakness in a limb or on one side of the face. Other signs include temporary blindness and difficulty with speech. These symptoms are warning signs: one should see a physician immediately for treatment. If a TIA is ignored, a major stroke may follow. Systemic diseases: underlying illness Dizziness can be a symptom of diseases affecting body parts other than the-brain and central nervous system. Systemic conditions like anemia or high blood pressure decrease oxygen supplies to the brain; a physician eliminates the resulting dizziness by treating the underlying systemic illness. Damaged sensory nerves. We maintain balance by adjusting to information transmitted along sensory nerves from sensors in the eyes, muscles, and joints to the spinal cord or brain. When these sensory nerves are damaged by systemic disease, dizziness may result. Multiple sensory deficits, a systemic disease, is believed by some physicians to be the chief cause of vaguely described dizziness in the aged population. In this disorder several senses or sensory nerves are damaged. The result: faulty balance. People with diabetes, which can damage nerves affecting vision and touch, may develop multiple sensory deficits. So can patients with arthritis or cataracts, both of which distort how sensory information reaches the brain. The first step in treating multiple sensory deficits is to eliminate symptoms of specific disorders. Permanent contact lenses can improve vision in cataract patients, for example, and medication or surgery may ease pain and stiffness related to arthritis. Symptoms of damaged sensory nerves may be relieved by a collar to eliminate extreme head motion, balancing exercises to help compensate for sensory losses, or a cane to aid balance. Some patients are helped by the drug methylphenidate, which can increase awareness of remaining sensations. Systemic neurological disorders such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, or Creutzfeldt-Jakob disease may also cause dizziness, primarily during walking. However, dizziness is rarely the sole symptom of these nervous system diseases. Low blood pressure. One common systemic disease causing dizziness is postural or orthostatic hypotension. In this disease, the heart does not move the blood with enough force to supply the brain adequately. Symptoms include sudden feelings of faintness, light-headedness, or dizziness when standing up quickly. Because the muscles in aging blood vessels are weak and the arteries inadequate in helping convey blood to the head, older people are particularly susceptible to this condition. Older persons who do not sit or lie down at the first sensation of dizziness may actually lose consciousness. [Graphic Omitted] Postural hypotension is easily diagnosed. The patient's blood pressure is checked before standing abruptly and immediately afterward. Anxiety can trigger attacks of dizziness. People who have undetected anemia or those who are taking diuretics to eliminate excess water from their body and reduce high blood pressure are also at risk of developing postural hypotension. A physician can easily diagnose postural hypotension: the patient's blood pressure is measured before standing abruptly and immediately afterward. Treatment is designed to eliminate dizziness by reducing the patient's blood volume. A secondary symptom. Dizziness may also be a secondary symptom in many other diseases. Faintness accompanied by occasional loss of consciousness can be due to low blood sugar, especially when the faint feeling persists after the patient lies down. A common cause of mild dizziness--the kind described as light-headedness--is medicine. A number of major prescription drugs may produce light-headedness as a side effect. Two types of drugs that can cause this problem are sedatives, which are taken to induce sleep, and tranquilizers, which are used to calm anxiety. When anxiety strikes Tranquilizers may cause a type of dizziness referred to as light-headedness--but so may anxiety. Cynthia is a young woman who becomes light-headed under a variety of stressful circumstances. The light-headedness sometimes is accompanied by heart palpitations and panic. She can produce these symptoms at will by breathing rapidly and deeply for a few minutes. Cynthia's light-headedness is due to hyperventilation: rapid, prolonged deep breathing or occasional deep sighing that upsets the oxygen and carbon dioxide balance in the blood. The episodes are typically brief and often associated with tingling and numbness in the fingers and around the mouth. Hyperventilation is triggered by anxiety or depression in about 60 percent of dizziness patients. Research offers new insights into the basis of balance. Once made aware of the source of the symptoms, a patient can avoid hyperventilation or abort attacks by breath-holding or breathing into a paper bag to restore a correct balance of oxygen and carbon dioxide. If hyperventilation is due to anxiety, psychological counseling may be recommended. Some patients who report dizziness may be suffering from a psychiatric disorder. Generally these persons will say that they experience light-headedness or difficulty concentrating; they may also describe panic states when in crowded places. Tests of such patients reveal that the inner ear is working correctly. Treatment may include counseling. Demystifying dizziness through research Scientists are working to understand dizziness and its sources among the complex interactions of the labyrinth, the other sense organs, and the brain. The research is offering new insights into the basis of balance, as well as improvements in diagnosis, treatment, and prevention of dizziness. Innovative surgery. Delicate surgical instruments and operating microscopes have made possible new methods to help patients with dizziness. The symptoms of benign positional vertigo, for example, may be relieved by a microsurgical ear operation called a singular neurectomy in which a tiny portion of the vestibular nerve is divided and cut. Patients with Ménière's disease may benefit from a microsurgical operation called the cochleosacculotomy. In this procedure, a small curette or wire loop is used to reach into the vestibule of the inner ear and remove the fluid-filled saccule. An investigator at the Massachusetts Eye and Ear Institute in Boston has found that this operation relieves symptoms of vertigo in about 80 percent of patients. Space biology. Research also promises to help astronauts who suffer from dizziness or space sickness. In one study, a scientist aboard a space shuttle conducted experiments to find out why half the astronauts who have space sickness at the start of a flight overcome this problem before the end of the mission. The investigator, from the Massachusetts Institute of Technology, found that the space traveler's brain no longer relies on the gravity-sensitive inner ear structures for information about position and motion. Instead, the astronaut's brain realizes that the inner ear is sending false information and starts to depend more on the eyes to find out about the body's movements. This finding may enable space biologists to train astronauts before launch to avoid space sickness. During that same space mission, a German scientist performed experiments that raised questions about the theory behind the caloric test. According to that theory, alternate heating and cooling of the endolymph causes the fluid to form wave-like swirling patterns called convection currents. These currents make the brain think the head is moving. The result is nystagmus. In space, however, lack of gravity should prevent convection currents from forming, so the eyes were expected to remain still. Instead, they moved just as though the test was being done on Earth in normal gravity. These experiments indicate there is more than one explanation for why the caloric test works: when the endolymph is warmed, the fluid expands and moves the cupula, the top of the cochlear duct. The movement of the cupula cues the brain that the head is moving and the eyes respond. This research helps scientists interpret methods used to test vestibular function. It also promises to increase our understanding of the balance system. Currently, scientists at the Johnson Space Center in Houston and at the Good Samaritan Hospital in Portland are preparing to study space sickness and vestibular function in a microgravity (near zero gravity) laboratory. The astronauts' vestibular function will be analyzed in a series of experiments, including studies to test whether visual input becomes more important in maintaining balance as weightlessness increases. The scientists anticipate that this research will help all sufferers of motion sickness, not just astronauts. Scientists are developing better diagnostic tests for dizziness. Improved diagnosis. Back on Earth, improvements are being made in measuring precisely the eye movements of patients undergoing diagnostic tests for dizziness. Investigators at the NINCDS-funded research center at the University of California at Los Angeles have developed a computer-controlled chair in which a patient is shifted into a variety of body positions to stimulate the labyrinth. Eye responses are measured with newly designed computerized instruments. To further stimulate eye movements, a set of computer-generated visual patterns can be moved with the chair or independently. of it. These instruments will extract much information about a patient's ability to integrate information from the eyes and the inner ear, and will help distinguish patients with different disorders of the balance system. Signaling the brain. To understand dizziness, scientists must find out how stimuli to the labyrinth are translated into information that the brain can use to maintain balance. How, for example, is information from the inner ear sent to the brain and interpreted? Among the scientists studying this question is an NINCDS grantee at the University of Chicago who is looking at the different ways hair cells react to the movement of inner ear fluid. He has identified a characteristic pattern of electrical response in hair cells. The next step is to discover how these messages are interpreted by the nerve cells carrying information to the brain. [Graphic Omitted] An NINCDS grantee at the University of Minnesota adjusts the controls on an oscilloscope used to monitor patients' eye movements during vestibular testing. Another NINCDS grantee at the University of Minnesota is studying the activity of the brain when it sends balance-preserving signals from the sense organs to the muscles. In one experiment, healthy persons are rotated in the dark at a constant rate. After a few minutes they no longer think they are moving. This is because the inner ear only senses changes in the rate of movement. If the lights are turned on and both the chair and the room rotate at the same constant speed, again the person doesn't sense movement. Both the inner ear and the eyes are fooled into thinking there is no motion. But the investigator found that if the chair and the room are accelerated, the patient develops what is described as sensory conflict. The acceleration of the chair tells the inner ear that there is movement. But the eyes tell the brain that the body is stationary. How patients react in these conflict situations reveals how the brain puts together various types of sensory information to maintain balance. The results of this and related experiments will help scientists build a mathematical model of the balance system. Hope for the future For those who are healthy, equilibrium is a sense often taken. for granted. People can't see their labyrinth, even though it is as much a sense organ as the ears or the eyes. But when it is injured, an ability vital to everyday living is lost. Scientists already understand a great deal about the labyrinth's function and the way the brain maintains balance. Further research into this complex system should help those who are incapacitated by dizziness when the balance system goes awry. Voluntary health organizations The following organizations provide information on dizziness or on inner ear diseases that cause dizziness: Acoustic Neuroma Association P.O. Box 398 Carlisle, PA 17013 (717) 249-4783 American Academy of Otolaryngology-Head and Neck Surgery Suite 302 1101 Vermont Avenue, N.W. Washington, DC 20005 (202) 289-4607 Better Hearing Institute P.O. Box 1840 Washington, DC 20013 (703) 642-0580 (800) 424-8576 (Toll free) National Hearing Association 721 Enterprise Oak Brook, IL 60521 (312) 323-7200 Human tissue banks The study of ear tissue from patients with dizziness and deafness is invaluable in research. Temporal bones willed by people with balance or hearing problems and by people with normal hearing can be used to help research scientists and physicians training to be otolaryngologists. Physicians in training study the basic anatomy of the temporal bone and develop their surgical skills. Scientists use the bones for research on the inner ear and on congenital disorders that cause deafness. Middle ear bones (ossicles) and the eardrum are also used as grafts to surgically correct sound transmission problems of the middle ear. NINCDS supports four temporal bone banks that supply scientists in every state with tissue from patients who have dizziness or deafness. The donated temporal bone includes the eardrum, the entire middle and inner ear, and the nerve tissues which combine into the brain stem. For information about tissue donation and collection, write to: National Temporal Bone Bank Eastern Center Massachusetts Eye and Ear Infirmary 243 Charles Street Boston, MA 02114 (617) 523-7900, ext. 2711 National Temporal Bone Bank Midwestern Center University of Minnesota Box 396-Mayo Minneapolis, MN 55455 (612) 624-5466 National Temporal Bone Bank Southern Center Baylor College of Medicine Neurosensory Center--Room A523 Houston, TX 77030 (713) 790-5470 National Temporal Bone Bank Western Center UCLA School of Medicine 31-24 Rehabilitation Center Los Angeles, CA 90024 (213) 825-4710 Some useful definitions: acoustic neuroma: tumor of the vestibular nerve that may press on the hearing nerve causing dizziness and hearing loss. balance system: complex biological system that enables us to know where our body is in space and to keep the position we want. Proper balance depends on information from the labyrinth in the inner ear, from other senses such as sight and touch, and from muscle movement. benign positional vertigo: condition in which moving the head to one side or to a certain position brings on vertigo. brain stem auditory evoked response (BAER): diagnostic test in which electrodes are attached to the surface of the scalp to determine the time it takes inner ear electrical responses. to sound to travel from the ear to the brain. The test helps locate the cause of some types of dizziness. caloric test: diagnostic test in which warm or cold water or air is put into the ear. If a person experiences certain eye movements (nystagmus) after this procedure, the labyrinth is working correctly. cholesteatoma: a tumorlike accumulation of dead cells in the middle ear. This growth is thought to result from repeated middle ear infections. computed tomography (CT) scan: radiological examination useful for examining the inside of the ear and head. diuretic: drug that promotes water loss from the body, through the urine. Used to treat hypertension, diuretics may bring on dizziness due to postural hypotension. dizziness: feeling of physical instability with regard the outside world. endolymph: fluid filling part of the labyrinth. hair cells: specialized nerves found in the semicircular canals and vestibule. Fibers (hairs) sticking out of one end of the hair cells move when the head moves and send information to the brain that is used to maintain balance. hyperventilation: repetitive deep breathing that reduces the carbon dioxide content of the blood and brings on dizziness. Anxiety may cause hyperventilation and dizziness. inner ear: contains the organs of hearing and balance. labyrinth: the organ of balance, which is located in the inner ear. The labyrinth consists of the three semicircular canals and the vestibule. Ménière's disease: condition that causes vertigo. The disease is believed to be caused by too much endolymph in the labyrinth. Persons with this illness also experience hearing problems and tinnitus. middle ear:. the space immediately behind the eardrum. This part of the ear contains the three bones of heating: the hammer (malleus), anvil (incus), and stirrup (stapes). multiple sensory deficits: condition associated with dizziness in which damage to nerves of the eye and arms or legs reduces information about balance to the brain. neurologist: physician who specializes in disorders of the nervous system. nystagmus: rapid back-and-forth movements of the eyes. These reflex movements may occur during the caloric test and are used in the diagnosis of balance problems. orthostatic hypotension: see postural hypotension. otologist: physician who specializes in diseases of the ear. peripheral vestibulopathy: vestibular disorder in which the vestibular nerve appears inflamed and paralyzed. Patients may have one or several attacks of vertigo. postural hypotension (also called orthostatic hypotension): sudden dramatic drop in blood pressure when a person rises from a sitting, kneeling, or lying position. The prime symptom of postural hypotension, which is sometimes due to low blood volume, is dizziness or faintness. The condition can be dangerous in older persons, who may faint and injure themselves. semicircular canals: three curved hollow tubes in the inner ear that are part of the balance organ, the labyrinth. The canals are joined at their wide ends and are filled with endolymph. stroke: death of nerve cells due to a loss of blood flow in the brain. A stroke often results in permanent loss of some sensation or muscle activity. TIA: see transient ischemic attack. tinnitus: noises or ringing in the ear. transient ischemic attack (TIA): temporary interruption of blood flow to a part of the brain. Because a TIA may signal the possibility of a stroke, it requires immediate medical attention. During a TIA, a person may feel dizzy, have double vision, or feel tingling in the hands. vertigo: severe form of dizziness in which one's surroundings appear to be spinning uncontrollably. Extreme cases of vertigo may be accompanied by nausea. vestibular disorders: diseases of the inner ear that cause dizziness. vestibular nerve: nerve that carries messages about balance from the labyrinth in the inner ear to the brain. vestibular neuronitis: another name for peripheral vestibulopathy. vestibule: part of the labyrinth, located at the base of the semicircular canals. This structure contains the endolymph and patches of hair cells. [Graphic Omitted] While a patient watches a rotating drum, the otoneurologist checks his eyes for signs of any disturbance in neurological function that could cause dizziness. Photograph Credits: Bill Branson, NIH, cover 1, pages 7, 27. Howard Bartner, NIH, page 2. University of California, San Francisco, News Service Publications, page 3 (upper). House Ear Institute, Los Angeles, California, page 3 (lower). Experimental Therapeutics Branch, NINCDS, page 5. Dr. Bobby R. Alford, Baylor University, page 8. Dr. Cecil W. Hart, Northwestern University Medical School, page 10. Dr. Leonard Proctor, The Johns Hopkins University, page 13. National Heart, Lung, and Blood Institute, page 16. Dr. John H. Anderson, University of Minnesota, page 20. ! * General Information about Down Syndrome Fact Sheet Number 4 (FS4), 1993 ______________________________________________________________________________ NICHCY National Information Center for Children and Youth with Disabilities P.O. Box 1492 Washington, DC 20013 (703) 893-6061 (Local) (703) 893-8614 (TT) 1-800-999-5599 (Toll-free) ______________________________________________________________________________ DEFINITION OF Down Syndrome Down syndrome is the most common and readily identifiable chromosomal condition associated with mental retardation. It is caused by a chromosomal abnormality: for some unexplained reason, an accident in cell development results in 47 instead of the usual 46 chromosomes. This extra chromosome changes the orderly development of the body and brain. In most cases, the diagnosis of Down syndrome is made according to results from a chromosome test administered shortly after birth. INCIDENCE Approximately 4,000 children with Down syndrome are born in the U.S. each year, or about 1 in every 800 to 1,000 live births. Although parents of any age may have child with Down syndrome, the incidence is higher for women over 35. Most common forms of the syndrome do not usually occur more than once in a family. CHARACTERISTICS There are over 50 clinical signs of Down syndrome, but it is rare to find all or even most of them in one person. Some common characteristics include: - Poor muscle tone; - Slanting eyes with folds of skin at the inner corners (called epicanthal folds); - Hyperflexibility (excessive ability to extend the joints); - Short, broad hands with a single crease across the palm on one or both hands; - Broad feet with short toes; - Flat bridge of the nose; - Short, low-set ears; - Short neck; - Small head; - Small oral cavity; and/or - Short, high-pitched cries in infancy. Individuals with Down syndrome are usually smaller than their non- disabled peers, and their physical as well as intellectual development is slower. Besides having a distinct physical appearance, children with Down syndrome frequently have specific health-related problems. A lowered resistance to infection makes these children more prone to respiratory problems. Visual problems such as crossed eyes and far- or nearsightedness are higher in those with Down syndrome, as are mild to moderate hearing loss and speech difficulty. Approximately one third of babies born with Down syndrome have heart defects, most of which are now successfully correctable. Some individuals are born with gastrointestinal tract problems that can be surgically corrected. Some people with Down syndrome also may have a condition known as Atlantoaxial Instability, a misalignment of the top two vertebrae of the neck. This condition makes these individuals more prone to injury if they participate in activities which overextend or flex the neck. Parents are urged to have their child examined by a physician to determine whether or not their child should be restricted from sports and activities which place stress on the neck. Although this misalignment is a potentially serious condition, proper diagnosis can help prevent serious injury. Children with Down syndrome may have a tendency to become obese as they grow older. Besides having negative social implications, this weight gain threatens these individuals' health and longevity. A supervised diet and exercise program may help reduce this problem. EDUCATIONAL AND EMPLOYMENT IMPLICATIONS Shortly after a diagnoses of Down syndrome is confirmed, parents should be encouraged to enroll their child in an infant development/early intervention program. These programs offer parents special instruction in teaching their child language, cognitive, self-help, and social skills, and specific exercises for gross and fine motor development. Research has shown that stimulation during early developmental stages improves the child's chances of developing to his or her fullest potential. Continuing education, positive public attitudes, and a stimulating home environment have also been found to promote the child's overall development. Just as in the normal population, there is a wide variation in mental abilities, behavior, and developmental progress in individuals with Down syndrome. Their level of retardation may range from mild to severe, with the majority functioning in the mild to moderate range. Due to these individual differences, it is impossible to predict future achievements of children with Down syndrome. Because of the range of ability in children with Down syndrome it is important for families and all members of the school's education team to place few limitations on potential capabilities. It may be effective to emphasize concrete concepts rather than abstract ideas. Teaching tasks in a step-by-step manner with frequent reinforcement and consistent feedback has been proven successful. Improved public acceptance of persons with disabilities along with increased opportunities for adults with disabilities to live and work independently in the community, have expanded goals for individuals with Down syndrome. Independent Living Centers, group shared and supervised apartments and support services in the community have proven to be important resources for persons with disabilities. RESOURCES Brill, M.T. (1993). Keys to parenting a child with Down syndrome. Hauppauge, NY: Barron's Educational Series. National Down Syndrome Congress. (1988). Down syndrome (revised pamphlet). (See address below.) Stray-Gundersen, K. (1986). Babies with Down syndrome: A new parent's guide. Rockville, MD: Woodbine House. [Available from Woodbine House, 1-800-843-7323 (outside DC area) or (301) 468-8800 (in DC area).] National Down Syndrome Society. This baby needs you even more. (See address below.) ORGANIZATIONS National Down Syndrome Congress 1605 Chantilly Drive, Suite 250 Atlanta, GA 30324 (404) 633-1555 (800) 232-6372 National Down Syndrome Society 666 Broadway, Suite 810 New York, NY 10012 (212) 460-9330 (1-800) 221-4602 (Toll Free) The Arc (formerly the Association for Retarded Citizens of the United States) 500 East Border Street, Suite 300 Arlington, TX 76010 (817) 261-6003 (800) 433-5255 ! * Title: What Is Dyslexia: 1984 Digest. Personal Author: Harrie, Roger P.; Weller, Carol Clearinghouse Number: EC180908 Publication Date: 84 Accession Number: ED262500 Descriptors: *Dyslexia; *Etiology; *Reading Difficulties; *Student Characteristics Identifiers: ERIC Digests Abstract: The digest focuses on the nature of dyslexia and its characteristics. An initial section notes the variations in definitions as a function of the discipline. Diagnosis of dyslexia is said to isolate the specific difficulties associated with the problem and to suggest appropriate educational intervention. Typical characteristics of dyslexia are noted, including a family history of reading problems, predominant occurrence in males, an average or above average IQ and possibly a proficiency in math, lack of enjoyment of reading as a leisure activity, problems of letter and word reversal, and difficulty transferring information from what is heard to what is seen and vice versa. The contribution of three major factors to dyslexia is addressed: ocular problems, language problems, and visuo-spatial-motor problems. A list of references and resources concludes the digest. (CL) TA- Teachers; Practitioners Institution Name: ERIC Clearinghouse on Handicapped and Gifted Children, Reston, Va. Article Body: Dyslexia is a term that has been loosely applied to reading disabilities. Specific definitions for dyslexia vary with disciplines. Those in medicine define dyslexia as a condition resulting from neurological, maturational, and genetic causes, while those in psychology relate dyslexia on the basis of the specific reading problems evidenced and give no reference to causation. All disciplines would probably agree that dyslexia is evidenced by persons of otherwise normal intellectual capacity who have not learned to read despite exposure to adequate instruction. HOW IS DYSLEXIA DIAGNOSED? The diagnosis of dyslexia usually begins with an awareness by parents or teachers that a problem in reading exists. A physician is often the first diagnostician to explore the nature of the difficulty. The medical practitioner should investigate the cause of the reading problem by conducting a complete physical examination and obtaining a comprehensive health history. If indicated, the child should be referred for a neurological examination. If dyslexia is suspected, the physician should refer the child for further evaluation and treatment by a specialist in psychoeducational diagnosis. The major purpose of the diagnostic process is to isolate the specific difficulties associated with dyslexia and to suggest appropriate educational intervention. Usually the diagnostician will employ a battery of assessment instruments that explore the relationship of specific reading problems to the intellectual, achievement, perceptual, motoric, linguistic, and adaptive capabilities of the individual. Based on the results, an intervention plan can be implemented by a special educator or remedial reading teacher trained in specialized reading techniques. No one remedial reading method works for all reading disabled students. Therefore it is important that the teacher have mastery of many different techniques. WHAT ARE SOME OF THE CHARACTERISTICS OF DYSLEXIA? An individual is identified as dyslexic when a significant discrepancy exists between intellectual ability and reading performance without an apparent physical, emotional, or cultural cause. Common findings in the history include, but are not limited to: (1) family history of reading problems; (2) a predominant occurrence in males (males to females 8:1); (3) an average or above average IQ and, not uncommonly, a proficiency in math: (4) no enjoyment of reading as a leisure activity; (5) problems of letter and word reversal; (6) developmental history of problems in coordination and left/right dominance; (7) poor visual memory for language symobols; (8) auditory language difficulties in word finding, fluency, meaning, or sequence; (9) difficulty transferring information from what is heard to what is seen and vice versa. Specific reading problems associated with dyslexia include difficulty in pronouncing new words, difficulty distinguishing similarities and differences in words (no for on), and difficulty discriminating differences in letter sound (pin, pen). Other problems may include reversal of words and letters, disorganization of word order, poor reading comprehension, and difficulty applying what has been read to social or learning situations. WHAT FACTORS CONTRIBUTE TO DYSLEXIA? Ocular Problems Several reliable studies (Helveston 1969; Blika 1982; Keys 1982; Hiatt 1984) have found that dyslexic individuals have no greater incidence of eye problems than do individuals with normal reading ability. Such parameters as visual acuity, stereo acuity, ocular alignment and motility, fusion status (break point amplitude), and refractive error have not been shown to be significantly different in poor versus normal readers. Individuals with reading problems should, however, have a careful eye examination as part of an overall medical examination. There is no scientific evidence that visual training (including eye muscle exercises, ocular tracking or pursuit exercises, or glasses with bifocals or prisms) leads to significant improvement in the performance of dyslexic individuals. Language Problems According to Mattis (1978), the primary contributing factor to dyslexia is an auditory language deficit. Approximately 86% of the individuals identified as dyslexic evidence an auditory language disorder that prevents the individual from linking the spoken form of a word with its written equivalent. In light of this, any individual with reading problems should have a careful evaluation of his or her language capabilities and where indicated, appropriate speech and language intervention should be provided. Visuo-Spatial-Motor Problems In contrast to language problems, visuo-spatial-motor factors of dyslexia appear less frequently (Robinson and Schwartz 1973). Approximately 5% of the individuals identified as dyslexic have a visuo-spatial-motor problem that interferes with sequential organization, scanning, and the perception of temporal and spatial cues. Although visuo-spatial-motor confusion is common in young children who are just learning to read, these problems do not tend to account for severe and persistent reading difficulties unless the child has missed so much basic reading instruction that he cannot get caught up. Assessment of visual, spatial, and motor capacities should be included in the diagnosis of any coordination or orientation disorder; however, there is no scientific evidence that interventions such as neurological and sensory organizational training, laterality training, dominance training, balance beam, or reflex inhibition will significantly accelerate reading performance. Other Factors The importance of general intelligence in learning to read has been examined and shown to be a critical factor in both reading and language abilities. Investigations of the role of dominance in handedness, eyedness, and mixed laterality have produced no consistent conclusions. Studies investigating low birth weight, EEG abnormalities, temperamental attributes, attention deficit disorders, birth order, food additives, and chemical allergies have yielded mixed results. What is clear is that a wide range of factors can be associated with reading difficulties but that these factors work differently in different children. There is no simple formula for diagnosing and treating a dyslexic child. Each one requires his or her own individual program. FOR MORE INFORMATION Benton, A. L., and D. Pearl. DYSLEXIA. New York: Oxford University Press, 1978. Blika, S. "Opthalmological Findings in Pupils of a Primary School with Particular Reference to Reading Difficulties." ACTA OPTHALMOLOGICA 60 (1982):927-934. Helveston, E. M. "Editorial." THE SIGHT SAVING REVIEW 39 (1969):1. Hiatt, R. L. "Reading Problems and the Opthalmologist." ANNALS OF OPTHALMOLOGY 16 (1984):116-122. Keys, M. P. READING DISABILITIES. AMERICAN ACADEMY OF OPTHALMOLOGY INSTRUCTION COURSE #117 (1982). Mattis, S. "Dyslexia Syndromes: A Working Hypothesis." In DYSLEXIA, edited by A. L. Benton and D. Pearl. New York: Oxford University Press, 1978. Robinson, M. E., and L. B. Schwartz. "Visuo-motor Skills and Reading Ability: A Longitudinal Study." DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 15 (1973):281-286. Rourke, B. P. "Neuropsychological Research in Reading Retardation, A Review. In DYSLEXIA, edited by A.L. Benton and D. Pearl. New York: Oxford University Press, 1978. This Digest was prepared for the ERIC Clearinghouse on Handicapped and Gifted Children, 1984. ! * THE DYSTONIAS What are the dystonias? The dystonias are movement disorders in which sustained muscle contractions cause twisting and repetitive movements or abnormal postures. The movements, which are involuntary and sometimes painful, may affect a single muscle; a group of muscles such as those in the arms, legs or neck; or the entire body. Diminished intelligence and emotional imbalance are not usually features of the dystonias. What are the symptoms? Early symptoms may include a deterioration in handwriting after writing several lines, foot cramps, and a tendency of one foot to pull up or drag after running or walking some distance. The neck may turn or pull involuntarily, especially when the patient is tired. Other possible symptoms are tremor and voice or speech difficulties. The initial symptoms can be very mild and may be noticeable only after prolonged exertion, stress or fatigue. Over a period of time, the symptoms may become more noticeable and widespread and be unrelenting; sometimes, however, there is little or no progression. How are the dystonias classified? One way to classify the dystonias is according to the parts of the body they affect: o Generalized dystonia affects most or all of the body. o Focal dystonia is localized to a specific part of the body. o Muftifocal dystonia involves two or more unrelated body parts. o Segmental dystonia affects two or more adjacent parts of the body. o Hemidystonia involves the arm and leg on the same side of the body. This type of dystonia often results from stroke. Some patterns of dystonia are defined as specific syndromes: Torsion dystonia, previously called dystonia musculorum deformans, is a rare, generalized dystonia that may be inherited, usually begins in childhood, and becomes progressively worse. It can leave individuals seriously disabled and confined to a wheelchair. Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward. Torticollis can occur at any age, although most individuals first experience symptoms in middle age. It often begins slowly and usually reaches a plateau. About 10 to 20 percent of those with torticollis experience a spontaneous remission, but unfortunately the remission may not be lasting. Blepharospasm, the second most common focal dystonia, is the involuntary, forcible closure of the eyelids. The first symptom may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal. Cranial dystonia is a term used to describe dystonia that affects the muscles of the head, face, and neck. Oromandibular dystonia affects the muscles of the jaw, lips, and tongue. The jaw may be pulled either open or shut, and speech and swallowing can be difficult. Spasmodic dysphonia involves the muscles of the throat that control speech. Also called spastic dysphonia or laryngeal dystonia, it causes strained and difficult speaking or breathy and effortful speech. Meige's syndrome is the combination of blepharospasm and oromandibular dystonia and sometimes spasmodic dysphonia. Spasmodic torticollis can be classified as a type of cranial dystonia. Writer's cramp is a dystonia that affects the muscles of the hand and sometimes the forearm, and only occurs during handwriting. Similar focal dystonias have also been called typist's cramp, pianist's cramp, musician's cramp, and golfer's cramp. Dopa-responsive dystonia (DRD), of which Segawa's dystonia is an important variant, is a condition successfully treated with drugs. Typically, DRD begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. In Segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise. Some scientists feel DRD is not only rare but also rarely diagnosed since it mimics many of the symptoms of cerebral palsy. What do scientists know about the dystonias? Investigators believe that the dystonias result from an abnormality in an area of the brain called the basal ganglia where the messages to initiate muscle contractions are believed to originate. Scientists suspect a defect in the body's ability to process a group of chemicals called neurotransmitters that help cells in the brain communicate with each other. Some of these neurotransmitters include: o GABA (gamma-aminobutyric acid), an inhibitory substance that helps the brain maintain muscle control. o Dopamine, an inhibitory chemical that influences the brain's control of complex movement. o Acetylcholine, an excitatory chemical that helps regulate dopamine in the brain. In the body, acetylcholine released at nerve endings causes muscle contraction. o Norepinephrine and serotonin, inhibitory chemicals that help the brain regulate acetylcholine. Acquired dystonia; also called secondary dystonia, results from environmental or disease related damage to the basal ganglia. Birth injury (particularly due to lack of oxygen), certain infections, reactions to certain drugs, heavy-metal or carbon monoxide poisoning, trauma, or stroke can cause dystonic symptoms. Dystonias can also be symptoms of other diseases, some of which may be hereditary. About half the cases of dystonia have no connection to disease or injury and are called primary or idiopathic dystonia. Of the primary dystonias, many cases appear to be inherited in a dominant manner; i.e., only one carrier parent need contribute the dystonia gene for the disease to occur, each child having a 50150 chance of being a carrier. In dystonia, however, there is consider-able variation in the extent to which symptoms are present in an individual carrier, and in how frequently symptoms appear in a specific group of carriers such as a family. This means that a carrier may or may not develop a dystonia and that the symptoms may vary widely even among members of the same family. The product of one defective gene appears to be sufficient to cause the chemical imbalances that may lead to dystonia; but the possibility exists that another gene or genes and environmental factors may play a role. Some cases of primary dystonia may have different types of hereditary patterns. Knowing the pattern of inheritance can help families understand the risk of passing dystonia along to future generations. When do symptoms occur? In some individuals, symptoms of a dystonia appear in childhood between the ages of 5 and 16, usually in the foot or in the hand. In generalized dystonia, the involuntary dystonic movements may progress quickly to involve all limbs and the torso, but the rate of progression usually slows noticeably after adolescence. For other individuals, the symptoms emerge in late adolescence or early adulthood. In these cases, the dystonia often begins in upper body parts, with symptoms progressing slowly. A dystonia that begins in adulthood is more likely to remain as a focal or segmental dystonia. Dystonias often progress through various stages. Initially, dystonic movements are intermittent and appear only during voluntary movements or stress. Later, individuals may show dystonic postures and movements while walking and ultimately even while they are relaxed. Dystonic motions may lead to permanent physical deformities by causing tendons to shorten. In secondary dystonias due to injury or stroke, people often have abnormal movements of just one side of the body, which may begin at the time of the brain injury or sometime afterward. Symptoms generally plateau and do not usually spread to other parts of the body. Are them any treatments? No one treatment has been found universally effective. Instead, physicians use a variety of therapies aimed at reducing or eliminating muscle spasms and pain. o Medication. Several classes of drugs that may help correct imbalances in neurotransniitters have been found useful. But response to drugs varies among patients and even in the same person over time. The most effective therapy is often individualized, with physicians prescribing several types of drugs at different doses to treat symptoms and produce the fewest side effects. Frequently, the first drug administered belongs to a group that reduces the level of the neurotransmitter acetylcholine. Drugs in this group include trihcxyphenidyl, benztropine, and procyclidine HCI. Drugs that regulate the neurotransmitter GABA may be used in combination with these drugs or alone in patients with mild symptoms. GABA regulating drugs include the muscle relaxants diazepam, lorazepam, clonazepam, and baclofen. Other drugs act on dopamine, a neurotransmitter that helps the brain fine-tune muscle movement. Some drugs which increase dopamine include levodopa/carbidopa and bromocriptine. DRD has been remarkably responsive to small doses of this dopamine-boosting treatment. On the other hand, patients have occasionally benefitted from drugs that decrease dopamine, such as reserpine or the investigational drug tetrabenazine. Anticonvulsants including carbamazepine, usually prescribed to control epilepsy, have occasionally helped individuals with dystonia. o Botulinum toxin. Minute amounts of this familiar toxin can be injected into affected muscles to provide temporary relief of focal dystonias. First used to treat blepharospasm, such injections have gained wider acceptance among physicians for treating other focal dystonias. The toxin stops muscle spasms by blocking the excitatory neurotransmitter acetylcholine. The effect lasts for several months before the injections have to be repeated. o Surgery and other treatments. Surgery may be recommended for some patients when medication is unsuccessful or the side effects are too severe. In selected cases, advanced generalized dystonias have been helped, at least temporarily, by surgical destruction of parts of the thalamus, a structure deep in the brain that helps control movement. Speech disturbance is a special risk accompanying this procedure, since the thalamus lies near brain structures that help control speech. Surgically cutting or removing the nerves to the affected muscles has helped some focal dystonias, including blepharospasm, spasmodic dysphonia and torticollis. The benefits of these operations, however, can be short-lived. They also carry the risk of disfigurement, can be unpredictable, and are irreversible. Some patients with spasmodic dysphonia may benefit from treatment by a speech-language pathologist. Physical therapy, splinting, stress management, and biofeedback may also help individuals with certain forms of dystonia. What research is being done? The ultimate goals of research are to find the cause(s) of the dystonias so that they can be prevented, and to find ways to cure or more effectively treat people now affected. The National Institute of Neurological Disorders and Stroke (NINDS), a unit of the Federal government's National Institutes of Health (NIH), is the agency with primary responsibility for brain and neuromuscular research. NINDS sponsors research on dystonia both in its facilities at the NIH and through grants to medical centers throughout the country. Scientists working at the National Institute on Deafness and Other Communication Disorders, also part of the NIH, are studying improved treatments for speech and voice disorders associated with dystonias. Support for dystonia research is also provided by privately funded organizations such as the Dystonia Medical Research Foundation. Scientists at the NINDS laboratories have conducted detailed investigations of the pattern of muscle activity in persons with focal dystonias. One of the most important characteristics is the failure of reciprocal inhibition, a normal process in which muscles with opposite actions work without opposing each other. In dystonia, the tightening of muscles is associated with an abnormal pattern of muscles fighting each other. Studies at the NINDS have probed the spinal reflex function and found abnormalities consistent with the defect in reciprocal inhibition. Other studies are probing brain activity and its relation to these observations. The search for the gene or genes responsible for some forms of dominantly inherited dystonias has been narrowed to chromosome 9. The eventual discovery of the actual gene(s) involved should lead to a laboratory test to diagnose primary dystonia, the identification of the abnormal gene product, and the rational development of specific therapies or cures. Scientists are also reviewing data on populations thought to inherit the disease in other ways. Investigators are asking why the symptoms in primary dystonia vary so widely in type and severity since such patients show no obvious cell degenerations or changes in the basal ganglia. Studies in this area of the brain are complicated by the large number of distinct but interrelated neurochemical systems. Meanwhile, scientists continue their search for therapies that may help treat dystonic symptoms. Investigators are seeking improved methods of administering botulinum toxin and better surgical techniques to treat symptoms. Where can I get more information? Five privately supported voluntary health agencies supply information about the dystonias and their own activities and services: American Speech-Language-Hearing Association 10801 Rockville Pike Rockville, Maryland 20852 (301)897-8682 (800)638-8255 (toll free, except Alaska, Hawaii andMaryland) Benign Essential Blepharospasm Research Foundation, Inc. P.O. Box 12468 Beaumont, Tx 77726-2468 (409) 832-0788 Dystonia Medical Research Foundation 8383 Wilshire Boulevard, Suite 800 Beverly Hills, California 90210 (213) 852-1630 National Foundation for Jewish Genetic Diseases, Inc. 250 Park Avenue, Suite 1000 New York, New York 10177 (212) 371-1030 National Spasmodic Torticollis Association, Inc. P.O. Box 873 Royal Oak, Michigan 48068-0873 (800) 487-8385 For further information, contact: Office of Scientific and Health Reports National Institute of Neurological Disorders and Stroke National Institutes of Health Bethesda, Maryland 20892 (301) 496-5751 July 1991 ! * E. coli, ESCHERICHIA COLI Type O157:H7 CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 FOOD AND WATER BORNE BACTERIAL DISEASES ESCHERICHIA COLI Type O157:H7 E. coli is a bacteria with many strains, most of which live normally in the intestines of humans and animals without causing disease. A newly recognized strain, E. coli type O157:H7, was first reported to cause bloody diarrhea in 1982, and is now known to cause bloody and non-bloody diarrhea, both accompanied by abdominal cramps. The infection it causes can lead to the hemolytic uremic syndrome (or HUS) (a blood and kidney illness) and thrombotic thrombocytopenic purpura (or TTP) (a blood and kidney illness that also affects the nervous system). E. coli type O157:H7 infections have been linked to eating under-cooked ground beef and drinking unpasteurized milk. The organism can also spread easily from person to person, especially in day care centers and nursing homes. Young children and the elderly are at increased risk for the severe complications of this infection, occasionally resulting in death. Dairy cattle appear to be a major reservoir for this type of E. coli. Diagnosis is usually made by culturing the stool. In many clinical laboratories, testing for this pathogen is not done routinely. Requests for culture should specify using MacConkey-sorbitol agar. E. coli O157:H7 ferments sorbitol slowly and appears sorbitol negative at 24 hours. To prevent infection with E. coli O157:H7, beef, especially ground beef, should be cooked thoroughly and held thereafter at an appropriately hot or cold temperature. Undercooked beef should not be served to young children, the elderly, and the immunocompromised. No one should drink unpasteurized milk. When caring for an infected person, careful hygiene with frequent handwashing is necessary to prevent person-to-person spread. Treatment with antibiotics has not proven useful for this acute infection. Therapy includes replacement of fluids and electrolytes. Hemolytic uremic syndrome (or HUS) and thrombotic thrombocytopenic purpura (or TTP) require hospitalization and supportive care. Due to the relatively recent recognition of E. coli, few statistics are available on its frequency. At this time it is not reported through the public health surveillance system, however some states are beginning to collect data. The data suggest that infections with the organism are increasing. ! * 10 Tips To Healthy Eating April 1994 Cosponsored by: The American Dietetic Association --------------------------------------------------------------------------- Experts agree the key to healthy eating is the time-tested advice of balance, variety and moderation. In short, that means eating a wide variety of foods without getting too many calories or too much of any one nutrient. These 10 tips can help you follow that advice while still enjoying the foods you eat. 1. Eat a variety of nutrient-rich foods. You need more than 40 different nutrients for good health, and no single food supplies them all. Your daily food selection should include bread and other whole-grain products; fruits; vegetables; dairy products; and meat, poultry, fish and other protein foods. How much you should eat depends on your calorie needs. Use the Food Guide Pyramid and the Nutrition Facts panel on food labels as handy references. 2. Enjoy plenty of whole grains, fruits and vegetables. Surveys show most Americans don't eat enough of these foods. Do you eat 6-11 servings from the bread, rice, cereal and pasta group, 3 of which should be whole grains? Do you eat 2-4 servings of fruit and 3-5 servings of vegetables? If you don't enjoy some of these at first, give them another chance. Look through cookbooks for tasty ways to prepare unfamiliar foods. 3. Maintain a healthy weight. The weight that's right for you depends on many factors including your sex, height, age and heredity. Excess body fat increases your chances for high blood pressure, heart disease, stroke, diabetes, some types of cancer and other illnesses. But being too thin can increase your risk for osteoporosis, menstrual irregularities and other health problems. If you're constantly losing and regaining weight, a registered dietitian can help you develop sensible eating habits for successful weight management. Regular exercise is also important to maintaining a healthy weight. 4. Eat moderate portions. If you keep portion sizes reasonable, it's easier to eat the foods you want and stay healthy. Did you know the recommended serving of cooked meat is 3 ounces, similar in size to a deck of playing cards? A medium piece of fruit is 1 serving and a cup of pasta equals 2 servings. A pint of ice cream contains 4 servings. Refer to the Food Guide Pyramid for information on recommended serving sizes. 5. Eat regular meals. Skipping meals can lead to out-of-control hunger, often resulting in overeating. When you're very hungry, it's also tempting to forget about good nutrition. Snacking between meals can help curb hunger, but don't eat so much that your snack becomes an entire meal. 6. Reduce, don't eliminate certain foods. Most people eat for pleasure as well as nutrition. If your favorite foods are high in fat, salt or sugar, the key is moderating how much of these foods you eat and how often you eat them. Identify major sources of these ingredients in your diet and make changes, if necessary. Adults who eat high-fat meats or whole-milk dairy products at every meal are probably eating too much fat. Use the Nutrition Facts panel on the food label to help balance your choices. Choosing skim or low-fat dairy products and lean cuts of meat such as flank steak and beef round can reduce fat intake significantly. If you love fried chicken, however, you don't have to give it up. Just eat it less often. When dining out, share it with a friend, ask for a take-home bag or a smaller portion. 7. Balance your food choices over time. Not every food has to be "perfect." When eating a food high in fat, salt or sugar, select other foods that are low in these ingredients. If you miss out on any food group one day, make up for it the next. Your food choices over several days should fit together into a healthy pattern. 8. Know your diet pitfalls. To improve your eating habits, you first have to know what's wrong with them. Write down everything you eat for three days. Then check your list according to the rest of these tips. Do you add a lot of butter, creamy sauces or salad dressings? Rather than eliminating these foods, just cut back your portions. Are you getting enough fruits and vegetables? If not, you may be missing out on vital nutrients. 9. Make changes gradually. Just as there are no "superfoods" or easy answers to a healthy diet, don't expect to totally revamp your eating habits overnight. Changing too much, too fast can get in the way of success. Begin to remedy excesses or deficiencies with modest changes that can add up to positive, lifelong eating habits. For instance, if you don't like the taste of skim milk, try low-fat. Eventually you may find you like skim, too. 10. Remember, foods are not good or bad. Select foods based on your total eating patterns, not whether any individual food is "good" or "bad." Don't feel guilty if you love foods such as apple pie, potato chips, candy bars or ice cream. Eat them in moderation, and choose other foods to provide the balance and variety that are vital to good health. --------------------------------------------------------------------------- Figuring Out Fat With so much information available about the effects of dietary fat on health, understanding the role fat plays in a well-balanced diet can be pretty confusing. To cut through the confusion, it's important to remember that fat is an essential nutrient that everyone needs to stay healthy. Fat is a valuable energy source and carries fat-soluble vitamins needed for proper growth and development. It also contributes important taste and textural qualities that are part of enjoying food. Too much fat, however, can increase the risk of heart disease, obesity and other health problems. When moderating fat intake, it's important to consider these points: * Health authorities recommend Americans consume 30 percent or less of their total daily calories from fat, with 10 percent or less of those calories from saturated fat. Remember, the 30 percent refers to your total fat intake over time, not single foods or meals. Use the following chart to guide your fat intake. If you eat this Total fat Total saturated number of calories per day fat per day per day: (grams) (grams) 1,600 53 or less 18 or less 2,000 65 or less 20 or less 2,200 73 or less 24 or less 2,500 80 or less 25 or less * Use the Nutrition Facts panel on the food label to help determine how much fat is in foods. Remember, it's the total fat intake over time that's important. A food high in fat can be part of a healthy diet as long as it's balanced with other lower-fat food choices. * All fats are a combination of saturated, polyunsaturated and monounsaturated fatty acids. Each of these types of fats have different effects on the body, but all contain nine calories per gram. * Blood cholesterol levels are influenced by family history, weight, age, smoking, physical activity and eating habits. Studies have shown that diets which are too high in certain saturated fatty acids and dietary cholesterol can raise blood cholesterol. --------------------------------------------------------------------------- The Food Guide Pyramid The Food Guide Pyramid is a practical tool to help you make food choices that are consistent with the Dietary Guidelines for Americans. Using the Pyramid enables you to eat a variety of foods daily so that you can get the nutrients you need. To make the most of the Pyramid, you need to know what counts as a serving. Food Group--Serving Size * Bread--1 slice bread, 1\2 bagel or English muffin, 1 ounce ready-to-eat cereal, 1\2 cup cooked cereal, rice or pasta, or 5-6 small crackers * Vegetable--1 cup raw, leafy vegetables, 1\2 cup cooked or chopped raw vegetables or 3\4 cup vegetable juice * Fruit--1 medium piece of fruit, 1\2 cup mixed fruit or 3\4 cup fruit juice * Milk--1 cup milk or yogurt, 11\2 ounces natural cheese or 2 ounces process cheese * Meat--2 - 3 ounces cooked lean meat, poultry or fish (about the size of a deck of cards) * Other foods which count as 1 ounce meat: 1\2 cup cooked dry beans, 1 egg, 2 tablespoons peanut butter or 1\3 cup nuts --------------------------------------------------------------------------- If You Want To Know More A nutrition expert can help you develop a personal action plan for improving your eating habits while keeping the fun in food. A registered dietitian (R.D.) is an authority on food, nutrition and health, and can provide valuable information and advice. To locate a registered dietitian in your area, ask your physician, or call the consumer nutrition hot line (800/366-1655) of the National Center for Nutrition and Dietetics, the public education center of The American Dietetic Association. Registered dietitians are available to answer your food and nutrition questions Monday through Friday from 9 a.m. to 4 p.m. central time. In addition, you can listen to nutrition messages in English and Spanish, Monday through Friday from 8 a.m. to 8 p.m. central time. --------------------------------------------------------------------------- The American Dietetic Association National Center for Nutrition and Dietetics 216 West Jackson Boulevard Chicago, IL 60606-6995 International Food Information Council Foundation 1100 Connecticut Avenue, N.W. Suite 430 Washington, DC 20036 --------------------------------------------------------------------------- Reprinted from the International Food Information Council Foundation and the American Dietetic Association, 1994 ! * EMPHYSEMA In emphysema, the lungs become less and less efficient because of damage to some of the millions of alveoli, or air-sacs, at the ends of the bronchioles in the lungs. It is in the alveoli that oxygen and carbon dioxide exchange takes place. Healthy lungs have an elastic spongy texture, so they contract and expand fully. If the alveoli become stretched or rupture, the elasticity of the lungs is gradually destroyed. This type of damage occurs when the alveoli are constantly subjected to higher pressure than normal. This happens to people who have long-standing lung disease. Chronic bronchitis or asthma, for example, cause narrowing of the lung airways. The labored, forceful breathing that results strains, weakens and may ultimately damage the alveoli. WHAT ARE THE SYMPTOMS? The main symptom of emphysema is shortness of breath, which is likely to become gradually worse over a period of years. If you have emphysema, your chest is probably distended into a barrel-like shape. The name of the disease comes from the Greek word for inflation. If you also wheeze, cough, and bring up phlegm, these are symptoms of other kinds of lung trouble, not of emphysema. WHAT ARE THE RISKS? Emphysema usually occurs in people who have bronchitis or asthma. It is much more common in men than in women, and your chances of having it increase if you smoke and/or live in an area where the air is polluted. Some people are particularly susceptible to emphysema because of an inherited defect in the chemical make-up of their lungs. If your job requires exceptionally forceful use of lung power, you may also be highly susceptible. Some examples of such professions are glass-blowing and playing a wind musical instrument. If you have increasing shortness of breath, you risk death from eventual respiratory failure. Emphysema also makes you more susceptible to chest infections such as pneumonia that can be life-threatening. There is also a risk of a pneumothorax (lung collapse). In addition, since blood cannot flow freely through damaged alveoli, the resulting strain on the right side of the heart, which pumps blood to the lungs, can lead to heart failure. WHAT SHOULD BE DONE? If you are troubled by breathlessness, you should consult your physician. In the initial examination, the physician will probably percuss, or finger-tap, your chest, and listen to it with a stethoscope. The doctor may also ask you to have a chest X-ray, and to blow hard into a peak-flow meter, a machine that measures your breathing capacity. Special breathing tests called pulmonary function tests may also be necessary. Because emphysema is usually associated with other lung disorders, it is not an easy disease to diagnose independently. WHAT IS THE TREATMENT? If you smoke, stop. Avoid places with polluted air. Keep away from people who have coughs or colds. Exercise moderately but regularly in fresh, clean air. Physicians can relieve the symptoms and delay the progress of emphysema, but they cannot cure it. If you have bronchitis along with emphysema, you may be told to inhale bronchodilator drugs, which widen the airways and help prevent further damage to the alveoli. Since bronchitis and lung infections of any kind aggravate emphysema, the best way to help control the disease is to prevent respiratory infection. Thus your physician may prescribe antibiotics as a preventive measure. ! * General Information about EPILEPSY Fact Sheet Number 6 (FS6), 1993 ______________________________________________________________________________ NICHCY National Information Center for Children and Youth with Disabilities P.O. Box 1492 Washington, DC 20013 (703) 893-6061 (Local) (703) 893-8614 (TT) 1-800-999-5599 (Toll-free) ______________________________________________________________________________ DEFINITION OF EPILEPSY According to the Epilepsy Foundation of America, epilepsy is a physical condition that occurs when there is a sudden, brief change in how the brain works. When brain cells are not working properly, a person' consciousness, movement, or actions may be altered for a short time. These physical changes are called epileptic seizures. Epilepsy is therefore sometimes called a seizure disorder. Epilepsy affects people in all nations and of all races. Some people can experience a seizure and not have epilepsy. For example, many young children have convulsions from fevers. These febrile convulsions are one type of seizure. Other types of seizures not classified as epilepsy include those caused by an imbalance of body fluids or chemicals or by alcohol or drug withdrawal. A single seizure does not mean that the person has epilepsy. INCIDENCE About two million Americans have epilepsy; of the 125,000 new cases that develop each year, up to 50% are in children and adolescents. CHARACTERISTICS Although the symptoms listed below are not necessarily indicators of epilepsy, it is wise to consult a doctor if you or a member of your family experiences one or more of them: - "Blackouts" or periods of confused memory; - Episodes of staring or unexplained periods of unresponsiveness; - Involuntary movement of arms and legs; - "Fainting spells" with incontinence or followed by excessive fatigue; or - Odd sounds, distorted perceptions, episodic feelings of fear that cannot be explained. Seizures can be generalized, meaning that all brain cells are involved. One type of generalized seizure consists of a convulsion with a complete loss of consciousness. Another type looks like a brief period of fixed staring. Seizures are partial when those brain cells not working properly are limited to one part of the brain. Such partial seizures may cause periods of ╥automatic behavior╙ and altered consciousness. This is typified by purposeful- looking behavior, such as buttoning or unbuttoning a shirt. Such behavior, however, is unconscious, may be repetitive, and is usually not recalled. EDUCATIONAL IMPLICATIONS Students with epilepsy or seizure disorders are eligible for special education and related services under the Individuals with Disabilities Education Act (IDEA), formerly the Education of the Handicapped Act (Public Law 94-142). Epilepsy is classified as "other health impaired" and an Individualized Education Program (IEP) would be developed to specify appropriate services. Some students may have additional conditions such as learning disabilities along with the seizure disorders. Seizures may interfere with the child's ability to learn. If the student has the type of seizure characterized by a brief period of fixed staring, he or she may be missing parts of what the teacher is saying. It is important that the teacher observe and document these episodes and report them promptly to parents and to school nurses. Depending on the type of seizure or how often they occur, some children may need additional assistance to help them keep up with classmates. Assistance can include adaptations in classroom instruction, first aid instruction on seizure management to the student's teachers, and counseling, all of which should be written in the IEP. It is important that the teachers and school staff be informed about the child's condition, possible effects of medication, and what to do in case a seizure occurs at school. Most parents find that a friendly conversation with the teacher(s) at the beginning of the school year is the best way to handle the situation. Even if a child has seizures that are largely controlled by medication, it is still best to notify the school staff about the condition. School personnel and the family should work together to monitor the effectiveness of medication as well as any side effects. If a child's physical or intellectual skills seem to change, it is important to tell the doctor. There may also be associated hearing or perception problems caused by the brain changes. Written observations of both the family and school staff will be helpful in discussions with the child's doctor. Children and youth with epilepsy must also deal with the psychological and social aspects of the condition. These include public misperceptions and fear of seizures, uncertain occurrence, loss of self control during the seizure episode, and compliance with medications. To help children feel more confident about themselves and accept their epilepsy, the school can assist by providing epilepsy education programs for staff and students, including information on seizure recognition and first aid. Students can benefit the most when both the family and school are working together. There are many materials available for families and teachers so that they can understand how to work most effectively as a team. RESOURCES Epilepsy Foundation of America. (1987). Epilepsy: You and Your Child, Information for Parents. Landover, MD: Epilepsy Foundation of America. (Telephone: 301-577-0100 for publications.) Freeman, John M., Vining, Eileen, Pillas, Diana J. (1993). Seizures and Epilepsy in Childhood: A Guide for Parents (rev. ed.). Baltimore, MD: The Johns Hopkins University Press. (Telephone: 800-537-5487.) Kobrin, Eileen R. (1991). Issues and Answers: A Guide for Parents of Teens and Young Adults with Epilepsy. Landover, MD: Epilepsy Foundation of America. (Telephone: 301-577-0100 for publications.) Reisner, H. (Ed.). (1988). Children with Epilepsy: A Parent's Guide. Kensington, MD: Woodbine House. (Telephone: 301-468-8800 (in D.C.); 800-843-7323.) ORGANIZATIONS Epilepsy Foundation of America (EFA) 4351 Garden City Drive, Suite 406 Landover, MD 20785 (301) 459-3700; (800) EFA-1000 (Toll Free) (301) 577-0100 for publications National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health Building 31, Room 8A06 9000 Rockville Pike Bethesda, MD 20892 (301) 496-5751 ! * How to Choose a Doctor and Hospital à If You Have Epilepsy That Is Difficult to Control Hospitals and doctors are not all alikeà à they vary in quality due to differences in their training, experience and services. These differences in quality become greater and matter more when you need sophisticated medical care for a complex condition. A surgeon, for example, who performs a complex procedure often, has better success with it than a surgeon who does the same procedure only occasionally. The complication rate and the death rate for the same procedure may be many times higher at one hospital than another. Clearly, the doctor and hospital that you choose have a direct impact on how well you do ù especially when you need treatment for a condition such as epilepsy, a chronic recurrence of seizures due to brain abnormalities. Epilepsy is not rare. It affects nearly one in every 100 Americans, or more than 2 million of us. Seizures can be controlled with medications in about 75 percent of people. When epilepsy can't be controlled with medications it is called "intractable." This means that disabling seizures continue to occur even though the patient has received the maximum medical treatment. Intractable epilepsy may be helped by surgery. In the past 10 years, major advances have been made in the accuracy of diagnosing epilepsy, in drug and surgical treatment, and in understanding the daily problems people with epilepsy face. As a result of advances in surgery, each year 2,000 to 5,000 new patients could benefit from surgery, whereas only 500 people are helped currently. But taking advantage of these advances means making some difficult and important decisions such as choosing a doctor and a hospital. No one has more at stake than you; it's one of the most important decisions of your life. This guide deals with difficult-to-control epilepsy. You may be reading it because you or a family member have just been told you have epilepsy, because your epilepsy is not being controlled by medications, or because you are considering epilepsy surgery. By making the comparisons we talk about, you will be prepared should the need for surgery arise. How Do You Judge Quality? Most of us do more research when we buy a car or television set than when we choose a doctor and hospital. That may be because we don't know what questions to ask or what to base our evaluation on. There is no consumer magazine that rates doctors and hospitals the way Consumer Reports rates air conditioners. There are many different ways to measure quality care, and there is no universal agreement on which should be used. However, at The Cleveland Clinic Foundation, we believe that you can use the following six points, or quality indicators, to compare health care providers: -Credentials -Experience -Range of services -Participation in research and education -Patient satisfaction -Outcome Choosing a doctor or hospital is often influenced by values. You may want a hospital that is close to home. You may want a hospital with a specific religious affiliation. But when you need specialized medical care for difficult-to-control epilepsy, it is essential that you also include in your decision a doctor's qualifications and a hospital's track record. These quality indicators will help you with that kind of evaluation should you require surgery for epilepsy. Sidebar A Step-by-Step Guide This guide helps you choose a doctor and hospital by: -explaining intractable epilepsy and how it's diagnosed -describing treatment for difficult-to-control epilepsy ù seizure-preventing drug therapy, monitoring and epilepsy surgery; -describing how patients are monitored and evaluated for surgery -explaining six points that indicate quality; and -providing questions and answers from The Cleveland Clinic Foundation that you can use to compare doctors and hospitals. Epilepsy Epilepsy is a neurological disease, a disease of the central nervous system. Seizures occur when discharges of electrical energy from brain cells become uncontrolled. A sudden medical problem can trigger a seizure, but this doesn't mean the diagnosis is epilepsy. Epilepsy involves seizures that continue to occur. Seizures that involve all of the brain are called generalized. Those that are limited to one part of the brain are called partial, or focal, seizures. This guide deals mainly with the most common form of focal seizure ù the anterior temporal lobe seizure. It's important for people with epilepsy to be treated at the appropriate level of care, according to the National Association of Epilepsy Centers (NAEC). Patients whose epilepsy is hard to control should be referred to specialized centers, according to the NAEC, while those whose epilepsy can be more easily controlled ordinarily need not be referred to such centers. If you have a seizure, your family doctor may start treatment. If seizures can't be controlled within three months, "a referral to a general neurologist is indicated," according to the NAEC. If the seizures can't be controlled within nine months after that, a referral to a specialty epilepsy center is the next step. And if a person is likely to need epilepsy surgery, the NAEC recommends referral to a fourth-level surgical epilepsy center. See the box for more information. Sidebar What Is a Fourth-Level Surgical Epilepsy Center? This is the highest level of specialty epilepsy center described by the NAEC. At this level, the center should be capable of conducting complete preoperative evaluation and monitoring. Its staff should have the expertise to perform a broad range of surgical procedures for epilepsy. How is it treated? Evaluation. A thorough evaluation to find the cause of seizures or localize their source includes a detailed medical history as well as a complete physical and neurological examination. In addition, most patients require further testing such as blood chemistry and urine tests; electroencephalograms (EEGs); and skull x-rays and brain scans such as computerized tomography (CT scans), magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Medication. Most seizures can be controlled by medication. But anti-convulsive drug therapy is individualized. The drug selected depends upon the type of seizure being treated. Even in patients with the same seizure type, the effective dose will vary with age, weight, sex and other factors. The majority of people may be treated with a single drug. However, if that fails, various drug combinations may be tried. The process of finding the most effective drug, drug dose, or drug combination can take weeks or months. It also involves taking systematic measurements to monitor the amount of drugs present in the blood. When seizures can't be controlled by drugs, surgery is considered. In the past, it could take more than 10 years to determine that drugs couldn't control seizures. That now can be determined within two years. Monitoring for Surgery. Patients must be tested and monitored to determine if surgery is the right choice. This involves making sure that the seizures really are caused by epilepsy and that the seizures can't be controlled ù even by drugs given in the highest possible doses. Finally, intensive monitoring is essential in determining the location of the seizures, which dictates the type of surgery necessary. This process generally begins with prolonged video-EEG and monitoring. With electrodes attached to the scalp, EEG equipment and video cameras are used to record seizures and monitor the brain's activity. If doctors can find the seizure source using this technique, surgery is considered. If more information is needed, the brain itself is monitored. This involves placing electrodes or grids inside the skull over a specific region of the brain. Testing also includes the intracarotid amobarbital test (Wada Test), which is used prior to surgery to delineate areas of the brain that control speech and memory function. Surgery. Different types of seizures require different surgeries. -Anterior temporal lobe resections: Patients who have focal seizures originating in the anterior temporal lobe can benefit the most from surgery. That is because their seizures are restricted to an area of the brain that can be removed without damaging vital functions such as speech, memory and movement. The operation that is performed is called resection, or removal, of a specific area, or section, of the brain. If seizures originate in the anterior temporal lobe, the appropriate operation is called anterior temporal lobe resection. Other areas of brain tissue can be removed depending upon the seizure source. -Corpus callosotomy is done to reduce the frequency of disabling seizures for patients who have intractable generalized seizures which result in frequent falls and injuries to the body. -Hemispherectomy, which involves removing one of the brain's hemispheres, is done to stop seizures for patients who have hemiplegia (paralysis of one side of the body). After surgery, some patients may be completely free of seizures; others may find their seizures reduced by varying degrees. Some patients may have to continue to take medication, but their seizures are better controlled. Surgery may not be successful for some people, and a second operation may be needed. Controlling seizures is only the first step in treating the whole person. Educational, social and psychological counseling are all part of the total treatment plan. Sidebar How Can You Judge Monitoring Facilities? The NAEC recommends that these facilities include the following: -An inpatient recording suite with access to full resuscitative capabilities. -A dedicated unit with a nursing staff whose sole function is to care for individuals with epilepsy. The unit's design and furnishings should minimize risk of injury to patients subject to seizures and falls. -On-site, 24-hour medical coverage. -Availability of the full spectrum of imaging services on-site. -Fourth-level surgical programs that perform monitoring of patients with indwelling electrodes must ensure electrical safety and must meet the American EEG Society's recommendations for intensive neuro-diagnostic monitoring. Where Do You Begin? Measuring quality in ways that are useful to consumers is a new idea in health care. Because of that, if may not be possible to get complete information for each of these quality indicators. But when providers are willing to give you as much information as possible, it's a good sign. It shows that they are dedicated to maintaining and improving their quality, responsive to patients, and confident of their capability. If you are told that you have epilepsy, if your seizures cannot currently be controlled, or if you may need epilepsy surgery, talk to your family doctor or the neurologist who is treating you. Ask about having an epilepsy specialist review your diagnosis and treatment plan. Epilepsy specialists have training and experience in epilepsy treatment and devote a major portion of their practice and research to epilepsy. Get the names of several doctors and hospitals with the most experience. Ask the questions we suggest. Make comparisons. Then make your decision. Be an informed consumer for yourself and your family. How to Use Quality Indicators How can you use these indicators to judge if one doctor or hospital is better for you than another? By combining information from more than one quality indicator, according to a report "The Quality of Medical Care: Information for Consumers" produced by the U.S. Congress, Office of Technology Assessment. The report states that patients about to have surgery can be confident if the hospital performs a high number of relevant procedures, if it has a low mortality (death) rate, and if the surgeon has extensive training and experience in the procedure. On the other hand, the report states: "...if a hospital had a high mortality rate and a low volume of procedures, the patient might wish to question the surgeon about that hospital and about alternatives, even if other hospitals required longer travel." 1. Credentials Do the doctor and hospital measure up? Credentials have been set by nationally recognized medical professional organizations to verify that doctors and hospitals meet certain standards in the delivery of health care. Doctors: Board certification, or an international equivalent, is a sign that doctors are highly trained in their field. Doctors who specialize should be board certified in the specialty in which they are practicing. Each specialty has a national board which is responsible for setting standards doctors must meet in order to be certified. Doctors who are board certified in their specialty have completed the amount of training that the specialty board requires, have practiced for a specified number of years in that specialty, and have passed a difficult examination in their specialty area. Some excellent doctors are not board certified. Board certification, however, is generally a good indication of competence and experience. Doctors who specialize in epilepsy are board certified in the specialty of neurology or neurosurgery. Has the doctor been board certified in neurology? All 8 Cleveland Clinic epilepsy specialists are board certified in neurology by the American Board of Psychiatry and Neurology. All have completed epilepsy and/or neurophysiology fellowships. Our 6 child neurologists are board certified in neurology with special qualification in child neurology by the American Board of Psychiatry and Neurology. All are board certified in pediatrics by the American Board of Pediatrics. Does the doctor who monitors and interprets the EEG tracings have board certification and special expertise in monitoring? Seven of 8 Cleveland Clinic epilepsy specialists who monitor and interpret EEG data are board certified in clinical neurophysiology by the American Board of Clinical Neurophysiology. Is the epilepsy surgeon board certified in neurological surgery? All 4 epilepsy surgeons in the epilepsy program are board certified in neurological surgery by the American Board of Neurological Surgery. Hospitals: The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) is the nationwide authority that surveys hospitals. The JCAHO decides whether a hospital gets, keeps, or loses accreditation based on its meeting certain criteria for staffing, equipment and facility safety requirements. Although accreditation is voluntary, most hospitals go through the process. If the hospital that you are considering is not accredited, it is important to know why. Although no organization exists to accredit epilepsy centers, the National Association of Epilepsy Centers has recommended some guidelines for services offered as well as staffing. Hospitals that do measure up are often in the public spotlight for their medical advances and the quality of their care. Information about a hospital's reputation is available through the mass media, books such as The Best Hospitals in America, the government, and consumer groups. Sidebar For information about a hospital's status, call the Joint Commission on Accreditation of Healthcare Organizations at 708/916-5800. Is the hospital accredited by the JCAHO? Yes. Does the facility meet guidelines for services and staff for fourth-level specialized epilepsy centers as recommended by the National Association of Epilepsy Centers? Yes. The Cleveland Clinic's Epilepsy Center meets and exceeds the guidelines for both fourth-level medical and fourth-level surgical epilepsy centers. These include the categories of personnel (doctors, nurses, technologists) that staff the program; their credentials; tests that should be performed; and equipment that should be available for accurate evaluation and monitoring. Has the hospital been positively and consistently recognized for medical excellence and leadership by the news media, consumer advocates and government agencies? Yes. Most recently, the Cleveland Clinic was recognized as one of the six best neurology centers in America, based on the responses of 400 medical specialists, in the August 5, 1991 issue of U.S. News & World Report. A previous physician survey in the April 30, 1990 issue of the magazine also recognized the Cleveland Clinic as a leader in neurology. For two years in a row, those same issues of U.S. News have named the Clinic one of "America's Best Hospitals." The Cleveland Clinic has also been singled out for excellence in "The Best in Medicine: Where to Get the Finest Health Care For You and Your Family" (Crown, 1990). 2. Experience Does practice make perfect? In the case of complex, specialized medical and surgical care for epilepsy, the more experience the doctor and hospital have with the necessary procedures, the better the results usually will be. Board-certified neurologists and neurosurgeons gain experience by devoting a major portion of their practice and research to epilepsy and often receive further training when available. Neurologists may complete one- or two-year fellowships in epilepsy. Expertise in epilepsy surgery comes from the number, variety and complexity of cases neurosurgeons and epilepsy centers perform over a period of years. The small number of epilepsy centers that perform 75 or more resections a year have developed expert, specialized teams that handle epilepsy surgery on a routine basis, according to The National Association of Epilepsy Centers (NAEC). Centers that perform 25 to 50 resections a year can be quite expert as well. "One procedure every other week appears to be the minimum number necessary for a team to maintain its skills and do complex procedures on a routine basis," according to NAEC guidelines. However, many U.S. hospitals do only five to 10 of these surgeries a year. And, while this low volume is to be expected in new programs, it is not enough to maintain skills necessary for the proper surgical treatment of patients with epilepsy. It may be important to ask whether the doctor performs all procedures at one hospital or several. If the doctor performs procedures at more than one hospital, this increases the volume but means the doctor is working with different teams. The teams, therefore, don't have as much experience working together as they would if the doctor were working with the same team at the same hospital all the time. How many patients are treated at the hospital each year? We provide follow-up care to more than 1,000 patients with epilepsy, approximately half of whom are infants, children or adolescents. How many patients undergo epilepsy monitoring at the facility yearly? The Cleveland Clinic monitors approximately 300 patients per year. How long has the hospital been performing epilepsy surgery? Our program began in 1978. Since that time, we have performed more than 400 epilepsy surgeries. How many epilepsy surgeries are performed each year? The Cleveland Clinic currently performs more than 100 epilepsy surgeries yearly. Approximately one-third of these surgeries are done to help infants, children or adolescents who have intractable epilepsy. How many of these surgeries are resections? The Cleveland Clinic performs approximately 75 resections each year. Were all procedures performed by the doctor at one hospital or several? Our physicians perform all procedures exclusively at the Cleveland Clinic. Have the doctors established a special expertise in epilepsy and epilepsy surgery? Our neurologists and neurosurgeons have developed special expertise in epilepsy by devoting a major portion of their training, practice and research to this field. Sidebar Volume Guidelines: Some organizations have suggested volume guidelines for the number of times a procedure should be performed in order for it to be done competently. -Surgical procedures for epilepsy should only be performed in centers doing at least 25 resective procedures for epilepsy a year, according to the National Association of Epilepsy Centers. 3. Range of Services What services are available? Hospitals with a broad range of services can treat more complex medical conditions and better handle complications that may occur. If complications arise, you want the best care available, and you want it immediately. Range of specialty departments: Medical conditions don't always exist in isolation. Related conditions could endanger the health of other organs. Therefore, immediate access to a full range of specialty departments within a facility is critical. Range of diagnostic and treatment options: Surgery for epilepsy is not the only treatment option. Even when surgery is required, it usually follows a long period of medical treatment. It's important, therefore, to go to a facility that can treat epilepsy in a variety of ways. That way you will get the most effective, appropriate and cost-effective treatment available. Fourth-level epilepsy centers, as defined by the NAEC, are facilities that provide comprehensive diagnostic and treatment services designed for patients with intractable seizures. These centers may have separate medical and surgical programs or one combined medical and surgical program. A fourth-level surgical epilepsy center, according to the NAEC, should be able to do complete surgical evaluations and should have staff with the expertise to perform a broad range of epilepsy surgeries. The range of electrodiagnostic, surgical and imaging services that should be provided, according to the NAEC, are presented in the box* to the right. Is help available from a full range of specialty departments should complications arise due to related conditions? The Cleveland Clinic's 500 physicians ù who are all on staff full-time ù provide care in 100 specialties and subspecialties. Because all of these specialties, including pediatrics, are represented at one facility, prompt consultation, diagnosis and treatment are available. Does the hospital offer a wide variety of options for diagnosing and treating epilepsy? The Cleveland Clinic' s combined medical and surgical epilepsy program meets and exceeds the requirements of a fourth-level epilepsy surgery center suggested by NAEC in the box* to the left. The Cleveland Clinic's comprehensive range of services includes: -A testing site for experimental anti-convulsants; comprehensive programs for monitoring blood-drug levels -On-site radiology and nuclear medicine facilities with the full range of imaging services for epilepsy, including PET, SPECT, computerized tomography (CT), magnetic resonance imaging (MRI) and angiography of the brain -Two, four-bed epilepsy and seizure monitoring units -The full range of electrodiagnostic services, including 24-hour video EEG monitoring with surface and sphenoidal electrodes -Invasive 24-hour recording with three different types of invasive electrodes -Intracarotid amobarbital test (Wada Test) -A wide range of epilepsy surgeries: anterior temporal lobe resection; cortical resections of extra-temporal areas of brain tissue; corpus callosotomy; hemispherectomy; and the use of stereotactic and microsurgical techniques -Awake surgery -A nursing staff whose sole function is to care for people with epilepsy -Psychological, rehabilitation and social services Sidebar Fourth-Level Epilepsy Center Services* Electrodiagnostic -24-hour video/EEG with surface and sphenoidal electrodes -Invasive 24-hour recording with subdural electrodes, depth electrodes -Intracarotid amobarbital (Wada) testing -Functional cortical mapping utilizing subdural electrodes or intraoperative stimulation -Evoked potential recording, capable of being used safely with implanted electrodes -Electrocorticography Epilepsy surgery -Emergency neurosurgery -Complication management -Open biopsy -Stereotactic biopsy -Lesional excision -Intracranial electrodes and cortical resection -Corpus callosotomy -Cortical resection, including hemispherectomy Imaging -Magnetic resonance imaging -Computerized axial tomography -Cerebral angiography Pharmacological expertise -Quality-assured anti-epileptic drug levels -24-hour anti-epileptic drug level service -Pharmacokinetic consultative services 4. Participation in Research and Education What type of hospital is it? There are many advantages to selecting a hospital that combines patient care with research and education. Ideally, the individuals engaged in patient care, research and teaching are organized around a given disease or class of patients, facilitating the sharing of knowledge, research and clinical findings. This approach results in the most rapid transfer of basic scientific knowledge from the laboratory to care delivered at the patient's bedside. Those individuals on the staff of such a hospital are exposed to an important interchange of ideas. They are also exposed to the newest treatments and forms of technology. At teaching hospitals, physicians are available 24 hours a day. There may be other advantages to choosing a teaching hospital. Private, not-for-profit, teaching hospitals had lower mortality rates than other types of hospitals, a study in the December 1989 issue of the New England Journal of Medicine suggested. Sidebar Private, not-for-profit, teaching hospitals had lower mortality rates than other types of hospitalsà Is the hospital associated with a teaching program? Yes. Incorporated in 1935, The Cleveland Clinic Educational Foundation sponsors one of the nation's largest physician postgraduate training programs. Does the hospital conduct research or clinical trials related to epilepsy? Basic research in the laboratory is being conducted into the causes of epilepsy. Epilepsy Monitoring Unit staff are researching the fundamental anatomy and mechanisms that cause epilepsy, using data from long-term implantation of subdural electrodes in epilepsy patients. Clinical research is being conducted into improving and individualizing intensive presurgical monitoring, modifying surgical techniques, memory function in patients before and after surgery, brain tumors and epilepsy, and epilepsy seizure classification. Research into the natural history of how and why seizures recur following epilepsy surgery is ongoing. The effectiveness of experimental anti-convulsants along with various drug combinations is being studied. This gives patients, whose seizures the new drugs are meant to control, access to drugs that will not be available to the public for many years. Cleveland Clinic neurologists are studying ways to streamline and accelerate epilepsy therapy to allow patients û adults and children û to change drug regimens in only five days instead of the usual weeks to months. Does the hospital have residency training programs in neurology and neurosurgery? The departments of Neurology and Neurological Surgery train five to 10 fellows each year in one- and two-year fellowship programs and five residents each year who are interested in advanced work in epilepsy and clinical neurophysiology. The Cleveland Clinic offers an EEG training program. 5. Patient Satisfaction Is everybody happy? If you ask one person about his or her experience with a doctor or hospital, you get one person's point of view. Patient satisfaction surveys allow you to judge quality based on the experience of many previous patients. This provides you with a more objective measure to use. Most hospitals routinely use surveys to learn if patients are satisfied with their medical experience. They can use these results to improve their services. Patient satisfaction often reflects the personal side of care. Surveys ask questions such as, How willing are the doctors and nurses to listen? Do they answer questions and explain treatments? How much time does the doctor spend with the patient? Is the hospital clean? Is the food good? Patient satisfaction information can predict what your experience in a particular hospital is likely to be. How satisfied are hospitalized patients with their experience at this facility? 87% of patients who are hospitalized at the Cleveland Clinic for a neurological condition such as epilepsy are satisfied with their hospital care. 94% say they would return. How satisfied are outpatients with their experience at this facility? 91% of patients with a neurological problem such as epilepsy who come to the Cleveland Clinic for outpatient services are satisfied with their experience. 90% say they would return. Is there a program to help patients and their families with the difficulties that may arise during a hospital stay? Cleveland Clinic Foundation patients may call an ombudsman û another name for a patient-relations representative û if they have concerns about their care. Patients in the Cleveland Clinic hospital may dial a 24-hour Helpline from their hospital room if they have any problems, questions, suggestions or concerns related to service. 6. Outcome Indicators How did the patient do? Many outcome indicators can be used to measure the success of treatment. The importance of each varies with the treatment. For procedures used to treat life-threatening conditions, death rates and complication rates are important. For epilepsy surgery, however, death and complications are uncommon. The way outcome is measured for epilepsy surgery û including anterior temporal lobe surgery which this guide emphasizes û is in terms of the operation's impact on seizure control. Successful epilepsy surgery will result in eliminating or significantly reducing the number of seizures. Seizure-free patients may still experience auras û warning feelings that may occur before a seizure û and take medication. However, while seizures couldn't be controlled with drugs before surgery, they can be controlled after surgery. Although success can't be guaranteed, especially for people who are seriously ill, chances for a good outcome are increased by choosing a hospital with good outcomes for the treatment that you are undergoing. If you can't get information about outcome from a doctor or hospital, look at alternatives. Try to compare results for patients like yourself to learn what your risks or chances of success really are. However, comparing epilepsy centers on the basis of outcomes is not easy. Centers define improvement differently (see the box on the next page). You're comparing apples and oranges when one hospital defines success as reducing seizures by 90 percent or more and another defines success as reducing seizures by 75 percent or more. Seizure patterns change over time. Some people are seizure-free right after surgery and then have a seizure. Others have seizures after surgery that decrease in frequency and eventually stop. This means success rates change depending on whether they are reported at six months or two years. Success also depends on the type of patient you are. The more localized, or confined, the source of your seizure, the better the chances that surgery can make you seizure-free. In general, following anterior temporal lobectomy, 60 percent of people are seizure-free and 80 percent show worthwhile improvement. This is according to outcomes reported by our center and other large centers. Specific outcome information is presented on the opposite page. What is the hospital's success rate for anterior temporal lobe resection? Overall, 70 percent of patients continued to be seizure- free or to have the frequency of their seizures reduced by 90 percent or more one year after surgery. These results are from our most recently published study in the Journal of Epilepsy. Within what range can you generally expect success rates for anterior temporal resection to be? Anterior temporal resection has resulted in success rates of 55 to 70 percent, according to a National Institutes of Health Consensus Development Conference on Surgery for Epilepsy held in 1990. Success by this panel was defined as no seizures for five years after surgery, although some auras may still be present and some patients may still be taking medication. Sidebar How Are Outcomes Reported? Outcomes are reported by the degree to which seizures are reduced following surgery. Results are expressed by first telling what percentage of patients were seizure-free. Next, there is a group of patients who have a significant reduction in the number of their seizures. This is where centers differ in the way they classify successful outcomes: -Some define success as reducing seizures by 90 percent or more. -Others define success as reducing seizures by 75 percent or more. A center's results will be higher if it defines success as reducing seizures by 75 percent or more. Its results will be lower if it defines success as reducing seizures by 90 percent or more. At the Cleveland Clinic, we consider surgery successful when it makes a patient seizure-free or reduces that patient's seizures by 90 percent or more. The Epilepsy Program The Cleveland Clinic's epilepsy team is a national and international pacesetter in treating epilepsy, both medically and surgically. The Cleveland Clinic is one of only a few U.S. medical centers with the technology and experience necessary to map the brain's electrical activity, localize the seizure source, and then, if advisable, remove it. -The sections of Epilepsy and Sleep Disorders are staffed by nine physicians, including child neurologists, adult neurologists and a psychiatrist. Approximately 25 technologists and five nurses are involved in patient care activities. Working closely with this group are specialists from neurosurgery, psychiatry, nuclear medicine, radiology and neuropathology. -The Section of Epilepsy Surgery includes four staff surgeons. These surgeons perform more than 150 epilepsy surgeries of all types each year. These include implantation of stereotactic depth electrodes, and epidural peg and foramen ovale electrodes; microsurgical temporal lobectomy; extratemporal resection; hemispherectomy; and corpus callosotomy. -Epilepsy specialists utilize three different types of invasive recording devices to monitor patients being considered for surgery, whereas most centers employ only one of the techniques. With all of these options available, the epilepsy team can individualize the screening and mapping of each patient prior to surgery and operate with more precision. -The Cleveland Clinic has developed a program to train personnel from the Bodelschwinghsche Clinics in Bethel, Germany, in state-of-the-art brain mapping and surgical techniques. -Since 1988, the Cleveland Clinic has sponsored three international conferences on epilepsy-related topics. -The Cleveland Clinic is one of only a handful of epilepsy centers currently performing second operations for people whose first operation has not succeeded in controlling seizures. Nearly half of 15 patients in a recently published study have remained seizure-free for periods of up to 82 months, giving selected patients a second chance at seizure control. Pioneering Contributions Epilepsy surgeons must precisely distinguish between tissue that is causing seizures from that which is not so that they can remove as much of the seizure source as possible without disturbing normal brain tissue. The Cleveland Clinic's team has contributed greatly to this process: -Development of sophisticated brain mapping techniques in 1980 for patients with intractable epilepsy, allowing surgeons to more precisely delineate the source of seizures and enabling them to remove more tissue without damaging vital functions. This increases the likelihood of eliminating seizures. -Pioneering of a microsurgical technique, for use in anterior temporal lobe surgery, that allows removal of more of the anterior temporal lobe without unnecessarily removing adjacent tissue. -Development of a new approach to evaluating the effects of extent of resection on surgical outcome and complications. This approach, using postoperative MRI, may allow comparisons of surgical techniques practiced at different institutions. -Development of a computerized, paperless EEG system to collect and store data. This permits sorting, manipulation and analysis of data on screen, making the most critical highlights of the data rapidly accessible. -Development of a program in collaboration with the Cleveland Clinic's Neurological Computing Section that permits on-line calculation of single-dose pharmacokinetic studies. -Development of the epidural peg electrode, which may be necessary to accurately localize the seizure source during monitoring. -Development of a technique that uses the epidural peg with the foramen ovale electrode to allow some patients to avoid more invasive procedures. -Adaptation of electrodes and other surgical techniques to be used in the presence of scarring that exists in difficult second operations for patients whose seizures recur. Sidebar For Information If you need more information or want to make an appointment with a Cleveland Clinic epilepsy specialist, please call one of the numbers below: 216/444-8919 (in Cleveland) 800/545-7718 ! * Exstrophy of the Bladder is a rare developmental abnormality that is present at birth (congenital) and is characterized by the absence of a portion of the lower abdominal wall and the front part of the bladder wall (anterior vesical wall). The rear portion of the bladder wall (posterior vesical wall) turns outward (exstrophy) through the opening in the abdominal wall and urine is excreted through this opening. The exact cause of Exstrophy of the Bladder is not known. The physical characteristics of this disorder are the result of developmental abnormalities during embryonic or fetal growth. Symptoms -------- Exstrophy of the Bladder is a rare birth defect characterized by the absence of part of the lower abdominal wall as well as the front portion of the bladder wall. The rear wall of the bladder turns outward (exstrophy) through the opening in the abdominal wall. Exstrophy of the Bladder results in the inability to control the release of urine (incontinence). The physical characteristics of Exstrophy of the Bladder include: a highly arched pubic bone; a wide separation between the bones that form the hips (ischia); and unusual fibrous tissue growth between the separated ischia. The connection between the kidneys and the tubes that carry urine from the kidneys to the bladder (ureters) may be abnormally narrow. The ureters may also be wider than normal (dilated). In males with Exstrophy of the Bladder, the scrotum is usually very broad and the testes are typically retracted. The penis may be unusually short and displaced to one side. In females with Exstrophy of the Bladder, the halves of the clitoris and labia are usually widely separated. The opening to the vagina is typically misplaced and, in some cases, unusually narrow. If Exstrophy of the Bladder is not surgically corrected, urine can flow back into the kidneys from the ureters (reflux). The kidneys may become overloaded with urine (hydronephrosis), leading to acute infection of the kidneys (pyelonephritis) and eventual kidney failure. Affected Population ------------------- Exstrophy of the Bladder is a rare disorder that affects males 3 times more frequently than females. The physical characteristics of this developmental defect are obvious at birth (congenital). Related Disorders ----------------- Symptoms of the following disorders can be similar to those of Exstrophy of the Bladder. Comparisons may be useful for a differential diagnosis: Exstrophy of the Cloaca Sequence is a rare developmental defect that is obvious at birth. Infants with this disorder are missing a portion of the lower abdominal wall as well as the front portion of the bladder wall (anterior vesical wall). This birth defect is more severe than Exstrophy of the Bladder. The rear portion of the bladder wall is also exposed through the abdomen. A part of the intestinal lining (mucosa) may also protrude through the abdominal wall. The opening of the rectum to the outside of the body is usually missing or abnormally small (stenotic). Most infants with Exstrophy of the Cloaca Sequence also have a sac on the outside of the abdomen that contains portions of the intestines (omphalocele). Therapies: Standard -------------------- The diagnosis of Exstrophy of the Bladder may be made before birth (prenatally). Ultrasound studies of the developing fetus can reveal specific features that are characteristic of this abnormality (e.g., protrusion of the bladder wall through the abdomen). Early prenatal diagnosis can lead to surgical intervention shortly after birth. The treatment of Exstrophy of the Bladder consists of corrective surgery to reunite the walls of the bladder and to close the opening in the lower abdomen. During surgery, the lower abdominal wall is surgically closed and the bladder is reconstructed using a segment of the colon to form the front and upper portions of the bladder wall. Approximately 70 percent of infants with Exstrophy of the Bladder are successfully treated with this surgical procedure. If this surgery is not successful in establishing continence, an alternative but rarely used procedure may be performed. During the surgery, the ureters are implanted into a portion of the large intestine (ureterosigmoidostomy) and an opening between the colon and the surface of the abdominal wall is created (colostomy). Yearly follow-up with ultrasound studies and laproscopic studies is recommended for people who have had this type of surgery. They may be at slightly higher risk for abnormal cellular changes of the colon at the site of the diversion. In another corrective procedure used to treat infants who have Exstrophy of the Bladder, urinary flow is surgically diverted by connecting the ureters to the lower portion of the small intestine (ileal loop diversion) or to part of the large intestine (colon loop diversion). In some cases, infants with Exstrophy of the Bladder may also require a series of surgical procedures to reconstruct the external genitalia. These surgeries are usually performed before the age of 2 years. The outlook for maintaining normal kidney function after surgical correction and reconstruction is good. However, some individuals with this disorder may experience long-term urinary problems such as kidney stones, kidney infections, and varying degrees of urinary incontinence. Other treatment is symptomatic and supportive. Therapies: Investigational --------------------------- Research on birth defects and their causes is ongoing. The National Institutes of Health (NIH) is sponsoring the Human Genome Project which is aimed at mapping every gene in the human body and learning why they sometimes malfunction. It is hoped that this new knowledge will lead to prevention and treatment of birth defects in the future. This disease entry is based upon medical information available through October 1994. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder. Resources --------- For more information on Exstrophy of the Bladder, please contact: National Organization for Rare Disorders (NORD) P.O. Box 8923 New Fairfield, CT 06812-1783 (203) 746-6518 (203) 746-6927 (TDD for the hearing impaired) National Support Group for Exstrophy of the Bladder 5075 Medhurst St. Solon, OH 44139 (216) 248-6851 NIH/National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) 9000 Rockville Pike Bethesda, MD 20892 (301) 468-6345 Simon Foundation P.O. Box 815 Wilmette, IL 60091 (708) 864-3913 Help for Incontinent People (HIP) P.O. Box 544 Union, SC 27379 (803) 579-7900 (800) 252-3337 March of Dimes Birth Defects Foundation 1275 Mamaroneck Ave. White Plains, NY 10605 (914) 428-7100 ! * Facts for Consumers from the Federal Trade Commission Eye Wear -- May 1994 Produced in cooperation with the American Academy of Ophthalmology, the National Association of Optometrists and Opticians, and the Opticians Association of America If you, like many Americans, wear eyeglasses or contact lenses, you probably know that comparison shopping can help you find quality eye wear that meets your budget. In fact, your ability to comparison shop for eyeglasses is aided by a Federal Trade Commission Regulation. Under federal law, you have a right to a copy of your eyeglass prescription so that you can shop for the best value in eye wear. If you are buying contact lenses, comparison shopping also can help you find an eye care specialist who offers products and services suited for you. This fact sheet explains what rights you have under the law and gives you information about various types of eye care professionals. It also gives some suggestions about selecting an eye care specialist and shopping for eye exams, eyeglasses, and contact lenses. Your Legal Rights Eyeglasses The Federal Trade Commission's (FTC) "Prescription Release Rule" requires eye doctors to give you your eyeglass prescription, at no extra cost, immediately after an eye exam that includes a refraction (a test that determines the prescription needed to correct your vision). Your eye doctor may withhold your eyeglass prescription until you have paid for your eye exam, but only if your eye doctor requires immediate payment whether or not a visual correction is needed. With prescription in hand, you can shop for eyeglasses just as you would for other health-related products and services, looking for the best quality at the best price. You have a legal right to your eyeglass prescription, so request it if it is not provided immediately after an eye examination in which a refraction is performed. Contact lenses Although not required by federal law, many eye care specialists will give you a copy of your contact lens specifications. Some states require eye care specialists to give you a copy of your contact lens specifications. It is important to have a copy of these specifications if you want to buy your contact lenses, especially replacement or duplicate lenses, from a different specialist. Otherwise, you may have to pay for another lens fitting exam. Selecting An Eye Care Specialist Price is not your only consideration in choosing someone to examine your eyes, fill your prescription, or fit you for contact lenses. You also might be concerned about: the type of eye care specialist you wish to visit; the quality of eye care and eye wear you may receive; and the service that is promised, especially if some adjustments or modifications prove necessary. Eye Professionals Before selecting an eye care specialist, you should know the difference among the three types of eye care specialists _ ophthalmologists, optometrists, and opticians _ and the services each is qualified to perform. Only ophthalmologists and optometrists may issue eyeglass and contact lens prescriptions. Ophthalmologists are physicians who are either medical doctors (M.D.'s) or osteopathic physicians (D.O.'s). They specialize in diagnosing and treating diseases of the eyes. They can prescribe drugs, perform examinations and eye surgery, and dispense eyeglasses and contact lenses. Optometrists have doctor of optometry degrees (O.D.'s). Though they are not medical doctors, they can examine eyes for vision problems and eye diseases and dispense eyeglasses and contact lenses. State law determines the extent to which optometrists may diagnose and treat eye diseases and prescribe drugs, and laws vary from state to state. In states where optometrists are not permitted to provide certain treatments, they will normally refer you to an ophthalmologist or other appropriate medical practitioner for such treatments. Opticians fill prescriptions for eye wear written by ophthalmologists and optometrists. They may not examine eyes or prescribe lenses. They dispense eyeglasses and in some states are permitted to fit and dispense contact lenses. About half the states require opticians to be licensed. Quality of Eye Care and Eye Wear It may be difficult to predict the quality of the eye care, eye wear, and related services you will receive. Studies show that price and the type of practitioner are not necessarily indications of quality. To help ensure quality care, you might ask for recommendations from your friends. You also might want to check with local consumer affairs offices and consumer organizations to see if any complaints have been lodged against the eye care specialist you are considering. Services Investigate what kind of service eye care providers will give you, especially if you have a problem. You may want to consider the following information. Eye Exams: A thorough eye examination includes a refraction, tests for other vision conditions, and an eye health exam. An eye exam also can reveal whether you are a good candidate for contact lenses. Remember, only M.D.'s, D.O.'s and O.D.'s may perform eye exams. Eyeglasses: If your eye exam shows you need a visual correction, you may decide you want eyeglasses. Ask about the delivery time for eyeglasses, any refund policy, and who pays for replacement lenses or frames if there are problems with either the lenses or the frames. Contact Lenses: Contact lenses are important health care devices that require proper fitting and care. Thus, if you decide you want to buy contact lenses, additional steps are necessary beyond the basic eye exam -_ the contact lens evaluation and the fitting. They include measuring the curvature of your eye and determining which lens is best for you. The evaluation and fitting may be performed by ophthalmologists, optometrists, and, in some states, opticians. Comparison Shopping For Contacts Because buying contact lenses is more complicated than buying eyeglasses, here are some questions you might ask eye care specialists. What do you charge for an eye exam, lenses, a contact lens evaluation, fittings, a lens care kit, follow-up visits, and "insurance" service agreements? These items may be priced individually or sold as a package. Some advertisements for contact lenses quote bargain prices for the contact lenses alone. But bargain-priced contact lenses may not be the best purchase if the other essential goods and services are not included in the price. If you are a first-time wearer of contact lenses, you will need services like fittings and follow-up visits in addition to lenses. Even experienced contact wearers may require several appointments before they get a proper fit. So before you select an eye care specialist, ask about the total cost of care, including what tests are included in the eye exam. A reasonably-priced package may be a better deal than bargain-priced goods that do not include free follow-up visits. What is your refund policy? Not everyone who wants to wear contacts is able to adapt to them. With a good refund policy, you will not lose your entire investment if you cannot wear the contacts. How many types and brands of contacts do you sell? It may take several visits to find the right contact lenses for your eyes. If the specialist carries a large selection of contact lenses, it can increase your chances of getting a good fit. How much do you charge for replacement lenses? It is possible to lose or damage contact lenses. Find out how much you will be charged and how long you will have to wait if you need a replacement lens. Many providers offer service agreements, also known as "insurance" arrangements, that will cover the full or partial cost of replacing lost or damaged lenses. Find out whether such an agreement is available, what it covers, and how much it costs compared to the cost of replacement lenses. What is your policy on the release of my contact lens specifications? Under the FTC Rule, the eye care specialist must provide you with your eyeglass prescription, but not your contact lens specifications. Without these measurements, comparison shopping for contact lenses is difficult, if not impossible. Ask about the doctor's policy before you make an appointment for an eye exam. If you want a copy of your contact lens specifications, shop for an eye care provider who will release it to you. For More Information If you have questions about your rights under the FTC's Rule governing eyeglasses, write: Correspondence Branch, Federal Trade Commission, Washington, DC 20580. Although the FTC generally does not intervene in individual disputes, the information you provide helps in its law enforcement efforts. For information about other consumer issues, send for a list of more than 100 free FTC publications. Write: Best Sellers, Public Reference, Federal Trade Commission, Washington, DC 20580. Eyeglasses: 8/78;11/80;6/83;4/86;12/87. Looking for Contact Lenses: 10/82;1/85;4/86. ! * Fever Fever is a symptom experienced by almost everyone at some time. The body's normal temperature is not necessarily 98.6 degrees Fahrenheit or 37.7 degrees Celsius. Rather, there is a "range of normal" varying from 96.8 to 100 degrees orally. A rectal temperature is one degree higher than oral; an axillary or underarm temperature is one degree lower. For any individual there is a temperature cycle of two to three degrees during a 24 hour period, with the highest temperature usually occuring in late afternoon, and the lowest in the early morning hours. Factors such as external cold or warmth, exercise, and activity also influence body temperature, especially in infants and children. The reading of an oral thermometer is also influenced by the recent intake of cold or hot food or fluids, by smoking, or by inability to hold the mouth closed. The normal range of temperature is maintained by a balance between heat PRODUCED in the body and heat LOST by the body. When this balance of heat production and heat loss is upset, the temperature rises and the person experiences a fever, defined as an oral temperature of more than 100 degrees Fahrenheit, or 37.7 degrees Celsius. It is important to know that a fever is a symptom and not a disease. There are some body signs and symptoms that are typical effects of the rise in temperature. A person with fever appears and feels flushed. The pulse and breath rate increase and perspiration may be heavy. There may be a general feeling of chilling. Shivering and shaking result, often followed by a rise in the temperature. One feels generally "achey", tired, or weak; a headache or sore eyes may also be present. A feeling of being very thirsty results from the dehydration that occurs when fever is present. As a result, urination may be less frequent and the urine a darker color, the lips, mouth, and tongue may feel dry and "coated". It is a very rare occurrence for a fever to go beyond 105-106 degrees Fahrenheit or 40.5-41.1 degrees Celsius. Now - what to do about this symptom of fever? Identifying the cause of the fever is important. Some fever causing illnesses such as ear infections or kidney infections respond to direct treatment. However, fever also commonly accompanies "flu" or cold symptoms, mono, or other virus infections for which there is no direct cure. In such illnesses, treatment is aimed at relieving symptoms. Treatment of the fever involves the following points: 1. Let heat evaporate from the skin - do not overdress. Wear light clothing indoors and use only what covering is needed to keep from feeling chilled. Sponge, bathe, or shower with lukewarm water if you can do so safely. Do not use ice packs or very cold water, as extreme cold constricts blood vessels and prevents the loss of heat. 2. Drink 2-3 quarts of liquid each 24 hours to replace fluid lost because of the fever. Soups, juices, gelatin, fruit drinks, soda pop, popsicles and ice cream are suggestions for fluids to use. It makes sense to avoid alcohol or excess caffeine such as in coffee, as those liquids excessively increase the output of urine. 3. Take aspirin, acetaminophen or ibuprofen. These medications are fever reducers and pain relievers. Consult the bottle label or your health care provider for the usual dosage. You should avoid ibuprofen if you are allergic to aspirin. Aspirin should NOT be used for fever in children or teens up to 19 years old because t's use has been associated with the development of Reye Syndrome (a rare childhood disease that causes coma, liver damage and death). 4. Since heat is produced by action of skeletal muscles, it is sensible to avoid strenuous activity even though you may feel well enough to be active. It is expected that a fever will be present early in the course of a viral illness such as a cold or other respiratory illness. It usually does not exceed 102.5 degrees Fahrenheit or 39.1 degrees Celsius in adults and goes down over a period of 2-3 days. Seek medical advice if adequate doses of aspirin or aspirin substitutes and sponging do not temporarily reduce the fever, or if the fever continues to be 102 degrees or above for over 48 hours. If the fever has returned to normal and then suddenly rises again a few days later, seek attention for a possible secondary infection. Fever in the absence of other symptoms is also significant, so if a fever continues without obvious reason, seek medical advice. Medical evaluation of the significance of a fever is made easier if you can answer some of the following questions: How high is the fever? What is the pattern to the highs and lows? Do you have shaking chills or periods of sweating? What have you done to bring the fever down and has this helped? What other symptoms are present? ! * Fibromyalgia -- a guide for patients David A. Nye MD What is fibromyalgia? Fibromyalgia is a common and disabling disorder affecting 2-4% of the population, women more often than men. Despite the condition's frequency, the diagnosis is often missed. Patients with fibromyalgia usually ache all over, sleep poorly, are stiff on waking, and are tired all day. They are prone to headaches, memory and concentration problems, dizziness, numbness and tingling, itching, fluid retention, crampy abdominal or pelvic pain and diarrhea, and several other symptoms. There are no diagnostic lab or x-ray abnormalities, but a physician can confirm the diagnosis by finding multiple tender points in characteristic locations. Fibromyalgia often runs in families, suggesting an inherited predisposition. It may lie dormant until triggered by an injury, stress, or sleep disturbance. It is closely related to the chronic fatigue and irritable bowel syndromes. Some have suggested that these are all just different facets of the same underlying disorder. What causes it? Fibromyalgia has mistakenly been thought to be either an inflammatory or a psychiatric condition. However, no evidence of inflammation or arthritis has been found, and patients with fibromyalgia are now known to be no more depressed or anxious than those with other chronic, painful, debilitating conditions. It is now believed that depression and anxiety when present are more often the result than the cause of fibromyalgia. There is some evidence that fibromyalgia may be due to an abnormality of deep sleep. Abnormal brain waveforms have been found in deep sleep in many patients with fibromyalgia. Fibromyalgia-like symptoms can be produced in normal volunteers by depriving them of deep sleep for a few days. Low levels of somatostatin, a hormone important in maintaining good muscle and other soft tissue health, have been found in patients with fibromyalgia. This hormone is produced almost exclusively in deep sleep, and it's production is increased by exercise. I should point out though that while this is my personal favorite among the theories of the cause of fibromyalgia, there are several others, and at this time there is probably not a majority of fibromyalgia researchers that supports any one theory. How is it treated? Fibromyalgia is difficult to treat, not because treatment isn't usually successful (it is), but because it will take a lot of work, education, and involvement on your part for it to be successful. Simply starting the right medication will have little effect. Successful treatment of fibromyalgia requires: 1) Regular sleep hours and an adequate amount of sleep. 2) Medication to improve deep sleep. 3) Daily gentle aerobic exercise. 4) Avoidance of physical and emotional stress. 5) Treatment of any coexisting sleep disorders. If any of these five are omitted, significant improvement is unlikely. Regular sleep Patients with FMS must get to bed by the same time every night and sleep as long as they need to. Staying up just one hour late may precipitate an exacerbation that lasts for several days. Many patients with fibromyalgia have exacerbations triggered by the change over to or from Daylight Savings time. Try to make the switch in fifteen minute increments every few days instead of by one hour overnight. I have had no success getting patients truly feeling well who work off shifts that prevent them from having a consistent bedtime. Medications Amitriptyline (Elavil), a medication commonly used to treat depression, also helps fibromyalgia, probably by improving the quality and depth of deep sleep rather than by any effect on mood. When sleep is normalized, the symptoms of fibromyalgia begin to improve. Patients taking amitriptyline usually don't note significant improvement until they are on enough to make them sleep through the night and have a dry mouth throughout the day. A few patients with fibromyalgia experience no trouble with sleep an night, but still seem to respond in the same way to amitriptyline. It is suspected that even though these patients are asleep, sleep function is not normal, accounting for their feeling that sleep is not refreshing. Some morning grogginess should be expected when amitriptyline is begun. Starting at a low dose and increasing gradually helps minimize any initial side effects. If you are having lots of trouble with side effects, go up more slowly. By the end of two weeks, most patients find that the side effects are settling down and the fibromyalgia symptoms are starting to improve. It usually takes a lot of fiddling with the dose to get it exactly right. The dose that is initially effective may become less effective after a period of time and it may need to be increased slightly. Most patients will need to continue on medication indefinitely. Almost everyone on enough amitriptyline to help fibromyalgia gets a dry mouth. Some patients have a paradoxical stimulant effect from it, with rapid heart beat and some trouble falling asleep. If these side effects are severe, other medications can be added to block them. Amitriptyline may also cause a craving for sweets and weight gain. I recommend you avoid sweets entirely while on amitriptyline. Exercise will also help to keep your weight down, as will eating a low-fat diet such as the Weight Watchers one. Some patients report that such a diet also helps their fibromyalgia symptoms. Constipation is another frequent side effect. Magnesium supplements are often helpful for constipation and may also help fibromyalgia symptoms in some patients. Several other medications have been used to treat fibromyalgia, although none seems to work quite as often as amitriptyline. These include cyclobenzaprine (Flexeril), diphenhydramine (Benadryl), and alprazolam (Xanax). These have many of the same side effects as amitriptyline but they also have shorter durations of action so side effects tend not to last into the day as much. None of these other medications cause weight gain the way amitriptyline does. There are several herbal and other "alternative" remedies that some patients feel are helpful. While I can't recommend them simply because they haven't been adequately studied for efficacy or long term harm, I don't discourage patients from using them if they find them helpful. Exercise Daily gentle aerobic exercise is very important. While patients who do too much exercise too soon or of the wrong kind will make themselves temporarily worse, most patients who don't begin a daily aerobic exercise regimen will notice little improvement in their fibromyalgia symptoms. Aerobic exercise is defined as exercise that gets your heart rate up to a target heart rate for the duration of the exercise period. Heart rates are measured in beats per minute. It is accurate enough for our purposes just to take your pulse for 6 seconds and multiply by 10. The aerobic target heart rate is calculated from the following formula: (220 - age - rhr) x .6 + rhr where age is your age in years and rhr your resting heart rate, determined by taking your pulse when you wake up but before getting out of bed. A good place to feel your pulse is at the wrist turned palm up, next to the large bone on the thumb side at the end of your forearm. If you are exercising hard enough you should be able to feel your heart beating and can just count that. For most people, the aerobic target heart rate is at about the point where they can no longer sing but can still talk comfortably. The kind of exercise is unimportant. Just make sure to pick something that doesn't make you hurt worse. It may take trying several different kinds before finding one or more types that agree with you. Popular kinds include walking, regular or exercise bicycles, ski simulators, rowing machines, rebounders, swimming, and *gentle* aerobic dance. Jogging, vigorous aerobic dance, and weight lifting tend not to very good choices. If your pain is mainly in your legs or back, consider exercising just your arms with a Thighmaster or similar equipment. While many patients insist that they get plenty of exercise at work, doing housework, or in their yard, this is rarely the case. These types of exercise are rarely helpful, as they don't result in a sustained elevation of the heart rate, and often increase pain and make patients feel worse. You need to set aside a time specifically for daily excercise. Particularly if you are out of shape, start out with just 3-5 minutes of exercise and gradually increase as tolerated, shooting for twenty to thirty minutes. Take a few minutes to stretch your muscles, then start out slowly, increasing to full speed after a minute or two. Slow down again for the last minute or two and repeat the stretches. There are five recommended stretches, each done for 20 seconds a side. They should be gentle and painless. Hold onto a tree or post for support for #s 3-5: 1) Shrug your shoulders in a circular motion. 2) Reach your arm over your head and bend to the opposite side. 3) Bend forward with your legs straight. 4) Pull your foot towards your buttock while standing on the other leg. 5) With your feet flat on the ground and one foot ahead of the other, lean forward, bending just the front knee. Exercise is more effective if done in the late afternoon or evening. If you absolutely can't do it then, exercising earlier in the day is better than not exercising at all, but you will probably need to exercise longer for the same effect. Some patients find that exercise provides an immediate benefit, making them feel more alert and comfortable for several hours. If you experience this effect, you may want to try exercising three times a day instead of just once. Patients who can do this are the ones most likely to eventually be able to get off medication. Exercise seems not to work through conditioning of muscles but rather through a direct, possibly hormonal effect on pain and sleep. Patients who have been exercising regularly and then miss a day usually find that their fibromyalgia symptoms are significantly worse the next day. Avoid physical and emotional stress Exercise is an indispensible component of successful treatment, but too much physical activity of the wrong kind can precipitate a relapse. Rather than doing housecleaning, yard work, or other physical activity all on one day, break up the task so that you do a half hour or an hour every day until it is done. While it is difficult to learn to do this, it is essential that you be able to sense when you have reached your limit and stop. You need to be able to say no to family and friends when you are not up to some outing or other activity. Don't take on extra stressful responsibilities if you don't have to. If you have ongoing problems with depression or anxiety, consider seeking help for them from your family doctor or psychiatrist in an attempt to lower your overall stress level. Relaxation techniques or a chronic pain program can also help lower your stress level. Fibromyalgia patients must learn to manage their physical and emotional resources. Treat other sleep disorders Several other sleep disorders besides insomnia may aggrevate fibromyalgia. Almost half of men with fibromyalgia and some women have obstructive sleep apnea. In this condition the patient snores loudly and has periodic pauses in breathing after which he starts breathing again with a snort. Periodic limb movements of sleep is a condition in which patients twitch every 30 to 90 seconds for long periods during the night. Patients may be completely unaware of either of these conditions until the spouse complains. Not only will it be difficult to get fibromyalgia symptoms to improve without treating these disorders, but if sleep apnea is left untreated it may lead to accidental death or injury as well as early strokes or heart attacks. Other common sources of repeated sleep disturbance are a spouse's snoring and young children. If the spouse drinks alcohol in the evenings or is overweight, then avoidance of alcohol after supper or weight may eliminate snoring. Sleeping propped up on the side will often help. At the very least, the patient can wear earplugs. Children are harder to put off but fortunately most soon outgrow their need for care at night. It is important to avoid prescription tranquilizers and sleeping medications of the benzodiazepine group. While these may help you get to sleep, they supress deep sleep and therefore often make fibromyalgia worse. Alcohol and narcotic pain medications taken in the evenings have the same effect on deep sleep and should be avoided. Try not to exercise just before bed, as this may make it harder to fall asleep. Patients with fibromyalgia should probably give up caffeine completely as even one cup in the morning can sometimes disrupt sleep at night and may also directly increase muscle pain and headaches. If you are drinking more than a cup a day you should gradually taper yourself off caffeine-containing beverages over two weeks or so to minimize caffeine withdrawal symptoms such as headaches. Support and education For best results, you need to be actively involved in your treatment and to have as clear an understanding of this complicated disorder as possible. I recommend that you keep this handy and re-read it periodically. Patients with fibromyalgia often elicit less sympathy and support from family, friends, and employers than they deserve because of the lack of outward evidence of disease. Many patients have been told by other physicians that there is nothing wrong with them or that it is "all in your head" which can be very demoralizing. For these reasons, and just because it is good to know that you are not alone, I strongly encourage attending support group meetings. There are local chapters in most areas now of the Fibromyalgia Network. This organization produces an excellent newsletter which is well worth getting. Here's how to contact them: Fibromyalgia Network 5700 Stockdale Hwy, Suite 100 Bakersfield, CA 93309 info line: 1-805-631-1950 from 10am-2pm Pacific Time publication: FM Newsletter (quarterly); $15/yr USA, $17/yr Canada Conclusion With a little work, most patients can make it to the point where they feel good most of the time. Even with good results from treatment however brief relapses are common, perhaps caused by staying up as little as one hour late one evening, skipping exercise, a disruption in your routine, increased stress, a storm front moving in, or often for no apparent reason. You will do best if you "give in to it" when this happens and try to get extra rest. Ibuprofen or naproxen and hot baths may help at these times. If at all possible, try not to stop exercising when this happens, even if you have to back off on the amount a little. Once you have had a period of feeling relatively well, it should always be possible to get you back to that point again by trying to identify what derailed you and correcting the problem. ----- David Nye, MD * Neurology Dept., Midelfort Clinic, Eau Claire, Wisconsin Your comments and suggestions are always welcome! Write to the MARRTC Arthritis Resource Center developer Janet Elizabeth Horton, BGS at the Fibromyalgia Resource Center. Last Modified: 5/24/95 ! * DEAR DOCTOR COLUMNS ARE WRITTEN BY UAB UNIVERSITY OF ALABAMA AT BIRMINGHAM) EXPERTS AND PUBLISHED WEEKLY IN THE BIRMINGHAM NEWS FOOT PAIN Question: For years I've had pain in my right foot, which started with a sharp pain like pins sticking in the top of my toes. It started after I stepped on a sharp stick, which didn't go through my shoe but caused a sharp pain. It's gotten worse over the years and is severe at times, along with burning and numbness. The doctor biopsied the nerve in my ankle but found no cause for the pain. He said my vitamin B-12 levels were low and gives me shots, but they don't help the pain. Answer: Vitamin B-12 can be low for a number of reasons, but one that can result in pain and numbness in the feet is pernicious anemia. Pernicious anemia causes abnormal red blood cells and also damages nerves, which can result in numbness, tingling, and pain in the feet and legs as well as the arms and hands. Pernicious anemia is caused by failure to absorb B-12 from the intestinal tract because an essential chemical called intrinsic factor is not present in the stomach. If the cause of your foot pain were pernicious anemia, it would most likely cause pain in both feet rather than one, and B-12 injections would probably have relieved the pain. UAB neurologists, physicians who specialize in problems related to nerves and the nervous system, note that because the pain is limited to the toes of the right foot, it may be due to the injury you mention or to some other local problem that is irritating or pressing on the nerve to the toe. To determine whether the problem is a localized one or whether it is related to an underlying medical problem, you may want to ask your doctor about tests called nerve conduction studies. These tests are done in conjunction with a complete neurological examination. They are designed to determine how well the nerves function in the extremities, which often can tell the neurologist whether the pain is related to a local problem with the nerve or related to a more general medical problem. ! * Frostbite THIS IS A HEALTH-LINE MESSAGE FROM THE UNIVERSITY OF WISCONSIN-MADISON. Take steps to avoid frostbite! If you expect to be outside in the cold wear suitable clothing and keep dry. Since water is a better conductor of heat than air, you will become chilled rapidly if your clothing is wet. Low temperatures and wind combine to produce the chill factor which determines how long a body part can be exposed before freezing begins. Our toes, fingers, cheeks, nose, and ears are particularly susceptible to frostbite, If you are not moving actively, circulation to your skin slows, and freezing may occur more rapidly. Dressing appropriately, keeping active, staying dry, and warming-up often are positive steps you can take to prevent frostbite. Don't touch metal with your bare hands or allow gasoline or fuel stored outside to come in contact with the skin. In both cases, freezing is almost a certainty. How do you know if there is frostbite? The early signs of frostbite are whiteness and pain of the area followed by numbness. The skin feels cold, hard, and there is little or no sensation when you run your finger over the area. Frostbite is freezing of the skin and underlying tissues causing swelling and clotting in the small blood vessels. If the injury from freezing is extreme, there may be complete death of the tissue resulting in gangrene. Treatment should be directed toward rapid rewarming of the affected area and prevention of further injury. The involved tissue should never be rubbed or messaged. Small areas such as nose, ears or fingers can be warmed by the hands. Fingers and hands can be warmed by blowing warm breath on them or tucking them under your armpit. Larger areas should be warmed by the use of continuous warm compresses, or, ideally, by soaking in a water bath. With either method, the temperature of the water should be about 104 degrees Fahrenheit, which is just above body temperature and feels comfortably warm, but, not hot. Continue rewarming until a pink color returns to the tip of the frozen part. This usually takes about 30 minutes. Treat the thawing or thawed part very gently as the damaged tissues are very prone to injury. Typically, persons with frostbite complain of aching pain as the injured parts become warmer and are more comfortable when the parts are cool. Despite this, frostbitten areas must be warmed up to body temperature to avoid further tissue damage. After thawing, avoid exposure to the frostbitten area to further cold or injury. If you suspect possible frostbite injury, consult you physician or other health professional. Thank you. ! * Fact Sheet Gas in the Digestive Tract National Institutes of Health National Institute of Diabetes & Digestive & Kidney Disease DD Clearinghouse Gas in the digestive tract is not a subject that most people like to talk about, but the truth is that all of us have it and must get rid of it in some way. Normally, the gas passes out through the rectum or is belched through the mouth. These are both necessary functions of the body that allow us to eliminate gas. When gas does not pass out of the body easily, it can collect in some part of the digestive tract, causing bloating and discomfort. Even normal amounts of gas in the body can bother people who are sensitive to this pressure. Although gas usually is not a sign of a medical problem, it can be. So if you have persistent or extreme gassiness (flatulence), mention it to your doctor when you have a checkup. What Causes Gas? A common source of upper intestinal gas is swallowed air. Each time we swallow, small amounts of air enter the stomach. This gas in the stomach is usually passed into the small intestine where part of it is absorbed. The rest travels into the colon (large intestine) to be passed out through the rectum. In some people, part of the gas is belched out instead of being passed from the stomach into the intestine. This happens for several reasons. People under a lot of stress often swallow large amounts of air. Some people swallow air frequently because they have postnasal drip, chew gum, or smoke. Rapid eating or poorly fitting dentures also may cause too much air to be swallowed. Also, drinking beverages that contain carbonated water may increase gas in the digestive tract. These drinks contain carbon dioxide, which can produce large amounts of gas when warmed in the stomach. People with a gas problem should avoid carbonated or "sparkling" drinks. What Causes Repetitive Belching? Some people experience frequent belching. This might occur after a person has swallowed air without realizing it. Sometimes belching accompanies movement of stomach material back up (reflux) into the esophagus (swallowing tube). To clear material from the esophagus, a person may swallow frequently, which leads to more intake of air and further belching. Another cause of repeated belching is gastritis (inflammation of the stomach). There are many causes of acute or chronic gastritis, but the most common cause is infection with a bacterium called Helicobacter pylori. When this organism gets into the stomach, it can produce bloating. This condition usually can be diagnosed by a specialist in digestive diseases (gastroenterologist). The doctor may detect the infection with a breath test or a blood test. The doctor also may take a sample of tissue (biopsy) from the stomach, using a lighted, flexible tube (endoscope) that is inserted through the mouth. Helicobacter pylori infection usually is treated with antibiotics and a bismuth preparation. Do Any Foods Cause Gas? The foods we eat can be a factor in the production of gas in the lower intestine. Some foods such as cauliflower, brussels sprouts, dried beans, broccoli, cabbage, and bran are not completely digested in the small intestine. When the undigested bits of food reach the colon, they are fermented by the bacteria that live in the colon, causing gas. Today many people are trying to improve their nutrition and health by eating more fiber. However, some people discover that adding large amounts of fiber to their diets causes gassiness. This can happen when someone begins eating more whole grain cereals such as whole bran, oatmeal, or oat bran, or whole grain breads or fresh fruits, and vegetables. They get a feeling of being bloated when they first begin the high-fiber diet, but within 3 weeks or so, they may adapt to it. Some people, however, don't adapt, and the bloating from eating a lot of fiber can be a permanent problem. A common cause of excess lower intestinal gas is that a person's body may not have enough lactase, and enzyme normally found in the small intestine. Lactase is needed to digest lactose, the sugar found in milk and other dairy products. When this sugar passes undigested into the colon, it is fermented by bacteria, and gas forms. This can be a cause of excessive flatulence. If lactase deficiency is suspected of causing your gas, your doctor may tell you to stop eating dairy products for a while to see if you will have less gas. The doctor also may give you a blood test or a breath test to find out if you are lactose intolerant. The breath test detects hydrogen that is released by the bacteria as the undigested lactose ferments in the colon. How Much Gas Does the Body Produce? The amounts of gas that people produce vary. Most people produce between a pint and a half gallon of gas each day. Oxygen, carbon dioxide, and nitrogen from swallowed air make up a large part of flatus. Fermenting foods in the colon produce hydrogen and methane as well as carbon dioxide and oxygen. All of these components of flatus (gas) are odorless. The unpleasant odor of some flatus is the result of trace gases, such as hydrogen sulfide, indole, and skatole, which are produced when foods decompose in the colon. What Causes the Abdominal Pain and Bloating? Eating a lot of fatty food can cause bloating and discomfort because that fat delays stomach emptying, allowing gas to build up there. This problem can avoided by eating less fatty meals. The feeling of bloating in the abdomen may increase during the day and become most severe after a large meal. Many people think the bloated feeling after eating is caused by large amounts of gas. Researchers, however, have not found any connection between this symptoms and the total amount of gas in the abdomen. Studies show that in some people even modest amounts (1 ounce to 1/2 pint) of gas in the intestine can cause spasms there, especially after eating. Gas in the upper abdomen often is relieved by belching. Sometimes people try to swallow air to make themselves belch. This doesn't work, however, because it only adds to the amount of gas in the stomach and does not reduce the discomfort. Gas can collect anywhere in the lower intestine. Often if collects on the left side of the colon, and the pain can be confused with heart disease. When gas collects on the right side of the colon, the pain can be like that caused by gallbladder disease or even appendicitis. A bloated feeling is probably not anything to be concerned about, but it can be a symptom of a more serious problem,m such as an intestinal obstruction. If your problem is chronic, or if you are experiencing a severe increase in gassiness, you should talk to your doctor. Is Gassiness Caused by a Disease? If excess gas is your only symptom, it is probably not caused by a disease. The problem may occur simply because you swallow air or digest food incompletely. It could be that your intestines have the kind of bacteria that produce a lot of gas. You could have a sluggish bowel that does not get rid of air readily. You might have an irritable bowel, often called spastic colon, which means that you cannot tolerate gas accumulating inside of the intestines, so even small amounts of air feel uncomfortable. Do Over-the-Counter Drugs Relieve Gas? Many claims are made for over-the-counter drugs intended to relieve gassiness. Often people find that these drugs do not help much, but some of them do help some people. Simethicone, activated charcoal, and digestive enzymes, such as the lactose supplement lactase, are among those doctors often recommend. Sometimes doctors prescribe drugs called gastrointestinal stimulants that help move gas through the intestines more readily and that may help gassiness in some cases. Some Suggestions on How To Reduce Gas in the Digestive Tract If you are bothered by excessive belching or flatus, and your physician has determined that you have no serious disease, the following suggestions may be helpful: ■Check with a dentist to make sure dentures fit properly. ■Avoid chewing gum or sucking on hard candies (especially sugarless gum or dietetic candies that contain sorbitol). ■Eliminate carbonated beverages from your diet. ■Avoid milk and milk products if you have lactose intolerance. ■Eat fewer gas-producing food such as cauliflower, brussels sprouts, bran, beans, broccoli, and cabbage. ■Walking, jogging, calisthenics, and other exercised help to stimulate the passage of gas through the digestive tract. If your symptoms persist or worsen, see your doctor to make sure that the condition is not caused by abnormalities in your digestive tract. Additional Readings Clayman, CB, ed. The American Medical Association Encyclopedia of Medicine. New York: Random House, 1989. Reference guide with sections on digestive tract gas and other digestive problems. Available in libraries and bookstores. Jain, NK, Vela, JS, Pitchumoni, CS. Intestinal gas: insights into an ancient malady. Practical Gastroenterology 1987; 11(6): 32-44. Review article for physicians discusses the causes and treatments of gas. Available in medical libraries. Levitt, MD. Intestinal gas: what do we offer the patient? Endoscopy Review 1991; 9(5): 43-46. Article for physicians discusses the causes, evaluations, and treatments for gas. Available in medical libraries. Larson, DE, Editor-in-chief. Mayo Clinic Family Health Book. New York: William Morrow and Company, Inc., 1990. General medical guide with section on intestinal gas. Available in libraries and bookstores. National Digestive Diseases Information Clearinghouse Box NDDIC 9000 Rockville Pike Bethesda, MD 20892 (301) 468-6344 The National Digestive Diseases Information Clearinghouse is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, under the U.S. Public Health Service. The clearinghouse was authorized by Congress to focus a national effort on providing information to the public, patients and their families, and doctors and other health care professionals. The clearinghouse works with organizations to educate people about digestive health and disease. The clearinghouse answers inquires; develops, reviews, and distributes publications; and coordinates informational resources about digestive diseases. Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, appropriateness of content, and readability. Publications produced by sources other than the clearinghouse also are viewed for scientific accuracy and are used, along with clearinghouse publications, to answer requests. This publication is not copyrighted. The clearinghouse urges users of this fact sheet to duplicate and distribute as many copies as desired. U.S. Department of Health and Human Services Public Health Service National Institutes of Health ! * GAUCHER DISEASE: CURRENT ISSUES IN DIAGNOSIS AND TREATMENT National Institutes of Health Technology Assessment Conference Statement February 27-March 1, 1995 This statement will be published as: Gaucher Disease: Current Issues in Diagnosis and Treatment. NIH Technol Assess Statement 1995 Feb 27-Mar1:1-__. For making reference to technology assessment statement no. 16 in the electronic form displayed here, it is recommended that the following format be used: Gaucher Disease: Current Issues in Diagnosis and Treatment. NIH Technol Assess Statement Online 1995 Feb 27-Mar 1 [cited year month day]:1-__. Introduction Gaucher disease is a rare inherited enzyme deficiency, which researchers estimate may be present in 10,000-20,000 Americans. It is a panethnic disorder, with highest prevalence in the Ashkenazi Jewish population. During the past decade, much progress has been made in understanding the molecular biology of the disease and in the ability to treat patients with the disorder. However, many issues regarding diagnosis, population screening, and therapy for patients with Gaucher disease are controversial. Gaucher disease is characterized by a remarkable degree of variability in its clinical signs and symptoms, ranging from severely affected infants to asymptomatic adults. Many patients suffer from anemia, bone damage, and enlarged livers and spleens; a few develop severe central nervous system damage. Gaucher disease is a potentially lethal disorder. All patients with Gaucher disease have a genetic defect in the enzyme glucocerebrosidase, which results in the accumulation of the lipid glucocerebroside within intracellular structures known as lysosomes. Patients with Gaucher disease have been classified into three major types on the basis of clinical signs and symptoms: type 1, non-neuronopathic (adult); type 2, acute neuronopathic (infantile); and type 3, subacute neuronopathic (juvenile). All types of Gaucher disease can be diagnosed by demonstrating a deficiency of glucocerebrosidase activity. The most striking differences among the three types are the presence or absence of neurologic manifestations and the rate of their progression. However, people with the same type of the disorder may differ in their clinical presentation. For example, certain patients with type 1 Gaucher disease, which is by far the most common type, may display some combination of anemia, low blood platelet levels, massively enlarged livers and spleens, and extensive skeletal disease. In contrast, other type 1 patients may have no symptoms and can be identified only by screening or during evaluation for other diseases. The gene for glucocerebrosidase, which is located on chromosome 1q21, has been characterized and sequenced. Many mutations in the glucocerebrosidase gene have been identified in DNA from different patients; several of these mutations are frequent. Although some patients with the same DNA mutations have similar clinical courses, other patients with the same mutations have very different clinical manifestations. It is still not clear to what extent a person's clinical features (phenotype) or prognosis can be accurately predicted through current mutation analysis. Furthermore, although the molecular techniques can be used for early prenatal diagnosis, detection of individuals carrying the disease gene, and population screening, the appropriate clinical application of these molecular techniques remains unresolved. Gaucher disease has been traditionally managed by supportive therapy including total or partial removal of the spleen, blood transfusions, orthopedic procedures, and occasionally bone marrow transplantation. More recently, enzyme replacement therapy has become available and has proven effective in many patients. Enzyme replacement therapy has successfully reversed many of the manifestations of the disorder, including abnormal blood counts, increased liver and spleen size, and some skeletal abnormalities. The therapy is very costly, however, ranging from $100,000 to $400,000 annually for each patient. The purpose of this Technology Assessment Conference was to evaluate current concepts concerning diagnosis, screening, genetic counseling, and management of Gaucher disease. In this effort, the National Institute of Mental Health, together with the Office of Medical Applications of Research of the National Institutes of Health, convened a Technology Assessment Conference, Gaucher Disease: Current Issues in Diagnosis and Treatment. The conference was cosponsored by the National Institute of Child Health and Human Development, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Diseases and Stroke, the National Center for Research Resources, the National Center for Human Genome Research, and the Office of Rare Disease Research. Following 1-1/2 days of presentations by experts in the relevant fields and discussions with the audience, an independent panel composed of specialists and generalists from the medical and other related scientific disciplines, as well as a public representative, considered the evidence and formulated a consensus statement in response to the following six previously stated questions: * What is the natural history of Gaucher disease, and what is the appropriate technology to assess the severity and to predict the progression of this disorder? * What are the roles of current molecular and enzymatic assays for ascertaining affected individuals and carriers in various populations? * What are the indications for treatment of patients with Gaucher disease, and what are the appropriate modes of therapy? * What are the goals for and consequences of treatment, and how can the therapeutic interventions be assessed? * Under what circumstances could genotype/phenotype correlations be used for patient care and counseling? * What are appropriate directions for future research and other relevant issues that should be pursued? What Is the Natural History of Gaucher Disease, and What Is the Appropriate Technology to Assess the Severity and to Predict the Progression of This Disorder? The natural history of Gaucher disease is incompletely documented. The progression and outcome are well understood only in type 2 disease (infantile form). Type 3 disease (juvenile form) has a more variable course. The type 1 (adult) form is most common, especially variable, and least well characterized. Furthermore splenectomy, orthopedic intervention, and enzyme replacement therapy for type 1 Gaucher disease alter its course, natural progression, and outcome. Thus, it is important to standardize the reporting of the effects of these interventions. Type 1 disease typically presents after infancy and often not until adult life. Indeed, some genotypically affected individuals may never come to medical attention, and their number is unknown. With DNA analysis of family members, many such individuals will be diagnosed. Current technologies may unmask and identify organ-specific manifestations in these asymptomatic individuals. Simple hematologic and biochemical assays and imaging techniques can be used to assess disease progression. Skeletal disease is especially difficult to assess. Mutation analysis provides precise diagnosis but may not give information concerning the severity or progression of the disease. In addition, there are considerable differences in the degree to which organ systems are affected. Furthermore, there are reports of intrafamilial variation. Differences in disease severity have been demonstrated even in identical twins. Thus, other genetic and nongenetic factors appear to be involved in the expression of the disease. Prenatal diagnosis now affords an opportunity to assess the natural progression of the disease from before birth. Such information may be critical in choosing appropriate technology for prognosis and therapy. Appropriate systematic and quantitative description of the disease is essential to understand its natural course. Patient characterization requires clarification of the terminology used to describe patients, which at this time is confused (e.g., "asymptomatic" versus "asymptomatic but with physical signs and laboratory evidence of disease"). What Are the Roles of Current Molecular and Enzymatic Assays for Ascertaining Affected Individuals and Carriers in Various Populations? Enzyme analysis of leukocyte or fibroblast extracts is appropriate to confirm or exclude the diagnosis of Gaucher disease. Several methodologies for enzymatic diagnosis are currently available and are reliable in experienced hands. No consensus has yet been reached on a single most appropriate method, which makes it essential that each laboratory have rigid internal quality assurance and quality control of the method it uses. The prognosis for patients with type 1 disease cannot be predicted from the residual enzyme activity measured in tissues. Enzymatic analysis cannot be used to detect carriers reliably. Analysis of DNA for mutations by molecular methods (genotyping) is appropriate in all individuals with glucocerebrosidase deficiency. Genotyping of siblings and parents of affected individuals is important to ascertain other potentially affected individuals who may be asymptomatic and to identify carriers for genetic counseling. Enzyme analysis of parents of affected individuals is also valuable to exclude the possibility of asymptomatic glucocerebrosidase deficiency in a parent with two mutant alleles, only one of which was identified by genotyping. Although current genotype/phenotype correlations are imperfect, genotyping may indicate that neurologic complications are unlikely. It has less value in predicting the likelihood of other complications. Molecular methods can provide accurate carrier detection, particularly in defined populations. For example, in the Ashkenazi Jewish population, screening for five mutations allows detection of approximately 95 percent of heterozygous individuals. The greater variety of mutations in non-Jewish populations makes carrier detection in these populations more challenging with currently available technology. Analysis of some mutations by DNA amplification can be complicated by the presence of a highly homologous pseudogene that is located nearby. Quality control of the molecular techniques is important, as is awareness of the complexities in interpreting data produced by these amplification methods. Widespread application of genetic screening to detect either presymptomatic patients with Gaucher disease or heterozygous carriers is not appropriate at this time. The medical value of presymptomatic diagnosis of patients with Gaucher disease and carrier testing has not been established. For this reason, pilot studies examining the potential benefits and/or harms of such screening programs should be encouraged. Ideally, the target community should be involved in the implementation and evaluation of such pilot studies. What Are the Indications for Treatment of Patients With Gaucher Disease, and What Are the Appropriate Modes of Therapy? The clinical features of type 1 glucocerebrosidase deficiency are highly variable, ranging from serious multisystem involvement to the absence of signs or symptoms. In addition, the age of onset of clinical features in those who develop symptoms is variable. This degree of variability raises several important issues that must be considered before initiating treatment. First, the characteristic signs of the disorder, which include anemia, thrombocytopenia without bleeding, hepatosplenomegaly without pain or discomfort, and radiologic changes without evidence of fractures or bone pain, must be differentiated from the symptoms of the disorder, such as bleeding, somatic pain, bone crises, and fractures. Second, knowledge is inadequate on the effect of treatment for patients who display signs but no symptoms of the disease. There is a reasonable consensus to treat those who exhibit symptoms; however, no agreement exists on the clinical criteria for initiating treatment. No consistent guidelines are available at this time because of the lack of sufficient information about the natural history of the disease. In addition, a group of individuals, of unknown number, have the enzyme deficiency but have not developed signs or symptoms. Because we cannot predict whether these individuals will ever become symptomatic, the appropriateness of prophylactic therapy has not been determined. A systematic evaluation of enzyme-deficient individuals to define the natural history of the disease is lacking. For symptomatic patients, there should be sufficient extant data given the number of patients who have already been identified, treated, and extensively followed. For asymptomatic individuals, it is necessary to develop protocols for longitudinal evaluation. Conservative therapy has a role in Gaucher disease, such as hydration, analgesics, and narcotics for pain in bone crises and orthopedic surgical intervention for fractures. The use of vitamin D, calcium, and bisphosphonate in bone crises and for bone growth requires further study. Although bone marrow transplantation is an effective form of therapy, the risk of mortality and morbidity makes this mode of treatment less desirable. In type 1 disease, there is good evidence that enzyme replacement therapy with mannose-terminated placental or recombinant glucocerebrosidase is beneficial in reducing hepatosplenomegaly, improving hematologic parameters, and, to a lesser extent, in alleviating bone disease. Enzyme therapy appears to obviate the need for splenectomy in most cases. Several patients with type 2 disease are reported to have been treated with enzyme replacement therapy, and there was no substantial improvement in their neurologic problems. With current technology, enzyme replacement therapy is unlikely to prove efficacious for patients with type 2 disease. The efficacy of enzyme replacement for neurologic abnormalities in type 3 disease remains to be established. For individuals with type 1 disease, controversies continue over aspects of enzyme replacement therapy, such as dosage, methods and frequency of administration of the enzyme, and cost. The most contentious issue, and potentially the most difficult for patients and their physicians, is enzyme dosage. Clinical successes have been observed with both the "high" and "low" dosage regimens (described as amount of enzyme administered during a 4-week internval for purposes of comparison, independent of dosage schedule): the 120 U/kg/4 weeks and the 30 U/kg/4 weeks, respectively. Inadequate clinical responses were also reported for all dosage regimens tested. The debate about dosage is complicated by the failure to compare data adequately and by the diversity of protocols. Review of the data indicates two salient points. First, patients vary considerably and unpredictably in their responses. Second, many patients do well on lower dosage regimens. The use of low-dosage regimens for such patients would markedly reduce costs. Debates focusing on minimal differences in degrees and rate of improvement have detracted from the appreciation of the treatment's value. Current studies are evaluating regimens with dosages even lower than 30 U/kg/4 weeks. The patients in these studies may respond well, but some respond more slowly. Initial and maintenance therapy should be directed at achieving sustained benefit with the lowest possible dosage. The choice of dosage and frequency of enzyme administration will have to be adjusted individually while each patient's progress is monitored. Response may be slow regardless of dosage. Given the limited number of patients, the treatment strategies, including criteria for intake, dosage, and periodic reevaluation, should be standardized to ensure that data from multiple centers can be pooled to evaluate the proposed treatment regimens. The resolution of these treatment issues can be addressed best through carefully designed, cooperative, clinical trials. The questions to be answered by such trials will be refined if existing data sets are pooled and analyzed without preconceived constraints. In addition, further studies should include the development of more efficient cellular targeting and uptake of the enzyme. The clinical and ethical ramifications of enzyme therapy and the funding of clinical trials must be considered. Studies to evaluate alternative forms of enzyme replacement therapy and alternative approaches, such as the use of inhibitors of sphingolipid biosynthesis, should be encouraged. Moreover, Gaucher disease is an excellent candidate for gene therapy, and continued research on this modality, including the use of animals models, is therefore indicated. What Are the Goals for and Consequences of Treatment, and How Can the Therapeutic Interventions Be Assessed? The goals of treatment are the amelioration of the manifestations of Gaucher disease and the overall improvement of the health and quality of life of patients. Although alglucerase has been shown to ameliorate many of the manifestations of type 1 Gaucher disease, the major current concerns are the proper indications to begin treatment, the most appropriate treatment regimens, and cost. Answering the many questions concerning the management of Gaucher disease will require a cooperative effort of considerable scale. For this cooperative effort to have its intended impact, the organizer of the cooperative effort must be free of real or perceived bias. The National Institutes of Health should take the initiative and foster the establishment of a cooperative group of investigators involved in the diagnosis and treatment of patients with Gaucher disease. Three phases in the operation of the proposed group are (1) establishment of a patient registry, (2) analysis of the existing data on natural history and response to therapy, and (3) design and conduct of clinical trials to address unanswered questions. It would be advantageous to enter all patients with Gaucher disease into a registry. Such a registry would provide a valuable resource for increasing our knowledge of the natural history of the disease, help to identify predictors of response, and facilitate clinical trials to answer specific questions about therapy. Clinical trials will be most informative if recruitment numbers are adequate to answer the questions addressed, if individuals are stratified for the most relevant variables (e.g., genotypes or baseline levels) to ensure comparability of the various subject groups, and if patients are randomized to treatment arms where appropriate. A high priority for an early clinical trial is comparison of the dosage and frequency of enzyme administration to symptomatic patients. Outcomes to be assessed should include not only hemoglobin concentration, platelet count, spleen and liver size, and bone integrity but also the patients' functional state, convenience, satisfaction, quality of life, impact on the family, and cost. A second priority for a clinical trial is to assess the need for enzymatic treatment of asymptomatic patients. Such a trial might initially be confined to high-risk, asymptomatic patients to increase the likelihood of observing a preventive effect of treatment. Under What Circumstances Could Genotype/Phenotype Correlations Be Used for Patient Care and Counseling? More than 50 mutations of the glucocerebrosidase gene have been identified. Investigators are using disparate nomenclature for mutations with reference to genomic DNA, cDNA, the exon involved, and the amino acid alteration in the enzyme. For consistency and ease of communication, mutations should be described using both the amino acid sequence and cDNA, when appropriate. Most investigators have categorized their study populations into Ashkenazi Jewish and non-Jewish cohorts. Four mutations are reported to account for 89-94 percent of type 1 Gaucher alleles in the Ashkenazi Jewish population and 60-75 percent of type 1 Gaucher alleles in non-Jewish populations. However, these studies do not provide an unbiased estimate of the allele frequencies. Therefore, accurate calculations of the number of individuals who carry the disease genotype are not possible. Concordance between the genotype and phenotype in Gaucher disease is imperfect. Families with multiple affected members with different clinical presentations and families having discordant identical twins further demonstrate the imprecision of genotype/phenotype correlation. However, the following general conclusions can be drawn based on current data. 1. 1. Homozygosity for N370S (1226G) precludes neuronopathic involvement; that is, it produces type 1 disease only. Nevertheless, this genotype is present in individuals with considerable variability in expression, ranging from absence of signs and symptoms, to mild to moderate disease, to, less commonly, severe type 1 Gaucher disease. 2. 2. Compound heterozygotes with one N370S (1226G) allele have non- neuronopathic Gaucher disease (the one exception a child with oculomotor involvement). These individuals generally have more severe type 1 disease than do N370S (1226G) homozygotes. 3. 3. Homozygotes for L444P (1448C) in the Swedish Norrbottnian population generally present with neuronopathic type 3 disease of variable severity. This same genotype in the Japanese population is associated with non-neuronopathic disease, indicating that genotype/phenotype correlations, to the extent that they exist, may vary with genetic background. The lack of predictability of phenotype from genotype suggests other genetic and/or nongenetic effects on the phenotype. The opportunity exists to study ethnic isolates, such as the Swedish Norrbottnian and Israeli Jenin Arab populations, each with a single Gaucher genotype and variable expression, to determine the nature of these other genetic and nongenetic factors. This imperfect agreement between genotype and phenotype limits the ability to establish the prognosis for individual patients and also restricts the usefulness of genotyping for population screening and prenatal diagnosis. The failure of genotype to predict phenotype complicates genetic counseling for newly diagnosed patients and their families, and for prenatal diagnosis. Testing has been conducted for affected individuals, for carriers, and for prenatal diagnosis. Another reason for genotyping is to estimate carrier and affected frequencies in various populations. Genotyping of anonymous unselected populations is recommended to determine allele frequencies. The benefits of general population screening for affected individuals are not clear, because treatment of individuals with glucocerebrosidase deficiency who do not have signs or symptoms has not yet been demonstrated to be necessary or efficacious. In addition, the genotype offers limited prognostic information for the individual. Extensive education of health care providers about Gaucher disease should be initiated to ensure accurate and early diagnosis of symptomatic patients. Carrier screening has most commonly been conducted to provide reproductive counseling and options to couples. This requires (1) a simple, accurate, and relatively inexpensive test to identify most of the carriers (>95 percent sensitivity) with few false positives (high specificity); (2) a disorder of significant clinical severity; (3) a defined population for screening; (4) a test that allows accurate prediction of the clinical course of the disease; (5) a public and professional education program; and (6) informed consent for screening. Although genotyping for Gaucher disease meets the test criteria, genetic counseling can provide only a risk assessment of passing on the gene but not a specific prognosis for future affected children. The uncertainty of disease severity in each affected individual and the lack of public and professional awareness of Gaucher disease argue against carrier screening in the general population at this time. Cultural mores within specific communities should be considered and may justify carrier screening. Carrier testing for family members of affected individuals is appropriate. In addition, peer-reviewed pilot studies of carrier screening programs may be of value. Prenatal diagnosis for Gaucher disease is possible and allows couples at risk to make informed reproductive decisions. Because of the considerable variability in disease severity, personal experience with Gaucher disease in a family member will influence the genetic counseling process and ultimate decision. Genetic counseling is confounded by the inability to predict clinical prognosis uniformly, by the heightened anxiety engendered by facing probabilistic information, and by the availability of an encouraging but extremely expensive enzyme replacement therapy. The description of the illness, its manifestations, and its potential response to therapy all influence the decisions made by couples, individuals, and families. What Are Appropriate Directions for Future Research and Other Relevant Issues That Should Be Pursued? Nomenclature must be standardized throughout the field, from the clinical setting to the molecular genetic laboratory. For example, a term as basic as "asymptomatic" is used by workers in the field in very different ways. It is recommended that the term asymptomatic be reserved for individuals who are truly without symptoms. The mutation designation also needs to be standardized for improved ease of communication. A uniform clinical severity score for type 1 Gaucher disease must be developed and formally validated to permit effective communication regarding the efficacy of treatment. This clinical rating scale should be sensitive to both the signs and the symptoms of the disorder. A nationwide clinical database should be established that is independent of any corporate entity, particularly those involved in the screening, diagnosis, management, or treatment of Gaucher disease. This will facilitate research to elucidate the natural history of the disease, identify key prognostic factors for disease progression, and determine the influence of various therapies. The database should accumulate extant information and collect missing data on extant patients to permit evaluation of enzyme targeting, uptake efficiency, optimal dosage and schedule, and clinical outcome. In the event of prenatal diagnosis, the neonatal, childhood, adolescent, and adult course of the disease should be carefully documented. Molecular genetic data should be determined and correlated with the clinical information to refine the limits of genotype/phenotype correlations. Such a database will permit the use of mathematical modeling to investigate these questions. The information in the database should be made available to investigators after formal review of their research proposals. Within the database, it should be recognized that multiplex families and identical twins represent unique groups for the study of other factors influencing phenotype. Nationwide, cooperative, controlled clinical trials should be conducted to establish optimal regimens and to determine their efficacy for asymptomatic individuals with minimal clinical signs. These clinical trials should be free of influence from any commercial entity. The available technology is not yet appropriate for large-scale, population-based screening for Gaucher disease. However, we recommend that additional pilot projects be supported, independent of corporate influence, to identify carriers and affected individuals. Examples of potential projects include estimation of the true prevalence of the various mutant alleles in defined or mixed populations by anonymous testing; further evaluation of educational needs within screened populations; and elucidation of the value of enzyme delivery to asymptomatic, enzyme-deficient individuals with varying clinical signs. Laboratories providing screening or diagnostic testing should participate in national quality assurance/quality control programs. Studies to better understand the basic biochemistry and cell biology of the enzyme are needed. Identifying and developing animal models should be encouraged. They provide opportunities to improve the understanding of the pathogenesis and to test experimental strategies including gene therapy. Enzyme replacement therapy clearly has improved the health and quality of life of individuals with Gaucher disease. This treatment has been made possible through the efforts of investigators at the National Institutes of Health and other researchers nationally and internationally. The cooperative efforts of government and industry have also proven effective. The contributions of the patients and their families, who have participated so willingly in many therapeutic trials, have been especially important. The experience with enzyme replacement therapy to date has led to new understanding about the disease and its treatment. At the same time, this experience has raised concerns about the development of costly therapies for disorders of very low prevalence. These concerns include the following: * Should the rights to exclusive marketing of an orphan drug be coupled to Federal approval of the price charged for the drug, and should uniform accounting practices be required? * Can such price regulation of orphan drugs be imposed without deterring the development of effective drugs for uncommon diseases? * How can it be ensured that the price citizens pay for a drug reflects the Federal contribution to its development? * Should society be informed of corporate and other relationships between entities engaged in screening and the manufacturers of therapeutic agents? * Should pharmaceutical companies and their representatives have direct access to patients? * Given the potentially extraordinary costs of treatment, how should the benefits to affected individuals and their families be balanced with the other health care needs of society? * Regarding costly treatments such as alglucerase, what are the implications for the future health care of patients and their families when insurance becomes exhausted and/or when coverage is provided by managed care systems employing fixed capitation limits? Conclusions The success of enzyme replacement therapy for Gaucher disease is a credit to the investigators, the National Institutes of Health, the pharmaceutical manufacturer, and the many patients and their families. Evidence presented at this Technology Assessment Conference leads to the following conclusions: * Despite the success of enzyme therapy, treatment is limited by the cost of the agent. * The cost of the treatment makes it imperative to determine the lowest effective initial and maintenance dosages, to define the appropriate clinical indications for treatment, and to establish uniform methods in order to optimize outcome assessment. * The value of treatment for asymptomatic individuals has not been determined. * General population screening for affected individuals and for carriers is not appropriate at this time. * As a prototype for all rare diseases, the plight of the patients with Gaucher disease raises difficult financial and ethical issues that we as a society must address. ! * Don't lose sight of glaucoma [Graphic Omitted] Information for people at risk National Eye Institute National Institutes of Health Public Health Service U.S. Department of Health and Human Services NIH Publication No. 91-3251 1. What is glaucoma ? Glaucoma is an eye disease in which the normal fluid pressure inside the eyes slowly rises, leading to vision loss-or even blindness. This brochure is about open-angle glaucoma, the most common form of the disease. 2. What causes it? At the front of the eye, there is a small space called the anterior chamber. Clear fluid flows in and out of the chamber to bathe and nourish nearby tissues. In glaucoma, for still unknown reasons, the fluid drains too slowly out of the eye. As the fluid builds up, the pressure inside the eye rises. Unless this pressure is controlled, it may cause damage to the optic nerve and other parts of the eye and loss of vision. [Graphic Omitted] 3. Who is most likely to get it? Nearly 3 million people have glaucoma, a leading cause of blindness in the United States. Although anyone can get glaucoma, some people are at higher risk. They include: [Graphic Omitted] * Blacks over the age of 40. * Anyone over the age of 60. * People with a family history of glaucoma. * Among Blacks, studies show that glaucoma is: * Five times more likely to occur in Blacks than in Whites. * About four times more likely to cause blindness in Blacks than in Whites. * Fifteen times more likely to cause blindness in Blacks between the ages of 45-64 than in Whites of the same age group. 4. What are the symptoms? At first, there are no symptoms. Vision stays normal, and there is no pain. However, as the disease progress, a person with glaucoma may notice his or her side vision gradually failing. That is, objects in front may still be seen clearly, but objects to the side may be missed. As the disease worsens, the field of vision narrows and blindness results. 5. How is it detected? Many people may know of the "air puff" test or other tests used to measure eye pressure in an eye examination. But, this test alone cannot detect glaucoma. Glaucoma is found most often during an eye examination through dilated pupils. This means drops are put into the eyes during the exam to enlarge the pupils. This allows the eye care professional to see more of the inside of the eye to check for signs of glaucoma. 6. How can it be treated? Although open-angle glaucoma cannot be cured, it can usually be controlled. The most common treatments are: Medications These may be either in the form of eyedrops or pills. Some drugs are designed to reduce pressure by slowing the flow of fluid into the eye. Others help to improve fluid drainage. For most people with glaucoma, regular use of medications will control the increased fluid pressure. But, these drugs may stop working over time. Or, they may cause side effects. If a problem occurs, the eye care professional may select other drugs, change the dose, or suggest other ways to deal with the problem. Laser Surgery During laser surgery, a strong beam of light is focused on the part of the anterior chamber where the fluid leaves the eye. This results in a series of small changes, which makes it easier for fluid to exit the eye. Over time, the effect of laser surgery may wear off. Patients who have this form of surgery may need to keep taking glaucoma drugs. Surgery Surgery can also help fluid escape from the eye and thereby reduce the pressure. However, surgery is usually reserved for patients whose pressure cannot be controlled with eyedrops, pills, or laser surgery. 7. What research is being done? A large amount of research is being done in the U.S. to learn what causes glaucoma and to improve its diagnosis and treatment. For instance, the National Eye Institute (NEI) is funding a number of studies to find out what causes fluid pressure to increase in the eye. By learning more about this process, doctors may be able to learn the exact cause of the disease and learn better how to prevent and treat it. The NEI also supports clinical trials of new drugs and surgical techniques that show promise against glaucoma. 8. What can you do to protect your vision Studies have shown that early detection and treatment of glaucoma, before it causes major vision loss, is the best way to control the disease. So, if you fall into one of the high-risk groups for the disease, make sure to have your eyes examined through dilated pupils every two years by an eye care professional. To learn more about glaucoma, write: National Eye Health Education Program, Box 20/20, Bethesda, MD 20892. [Graphic Omitted] NATIONAL EYE HEALTH EDUCATION PROGRAM ! * Primary Open Angle Glaucoma Glaucoma is is one of the leading causes of irreversable blindness in America and effects one in every hundred people. It is a disease where the optic nerve is damaged which results in loss of vision. If untreated, it often leads to blindness, but in the majority of cases, treatment can be effective in stopping the progression of vision loss. Unfortunately, in most cases, we cannot restore vision that has been lost, but we are relatively effective with both medical and surgical techniques in preventing further visual loss. Glaucoma occurs in all races of people. However it is much more common in African Americans than in whites. Primary open angle glaucoma is unusual in people under 40 years of age but the risk increases with increasing years. At 40 - 50 years the risk is about one in one hundred increasing to about one in ten by age 80. It is also more common in diabetics, hypertensives, the near sighted and those who have had trauma to their eyes (often forgotten because the trauma may have occurred many years before onset). A family history of glaucoma increases the risk fourfold. The eye is a closed system where a nutritional fluid (known as aquous humor) is made by the eye. There is also a drain, called the trabecular meshwork which allows the fluid to exit. In glaucoma, as one gets older or due to some other causes, the drain of the eye does not work as it should, the fluid backs up and the pressure in the eye rises. If one considers the eye to be like a ball, as the pressure rises, increased pressure is placed on the wall of the eye. There is only one weak spot in the wall where the optic nerve is located. The optic nerve is like a bundle of wires originating in the retina going to the brain. In order to exit the eye, there has to be a weak spot in the wall and this is the sight of damage due to increased eye pressure from glaucoma. As in a ball with a weak spot, it bulges. When this bulge occurs, there is a kinking of these "wires" that compress the optic nerve. This causes them to be damaged. For both good and bad, the damage tends to affect your peripheral vision first. This damage usually does not occur very rapidly, and often it is not noticed by the patient. That is the reason we need to do specific tests to see if any damage has occurred to the peripheral vision. If the pressure remains elevated, continued damage will occur until finally the center of vision (which contains the ability to read) is finally affected. The eye pressure at which this damage occurs is different in all people, but in general the more damage that has occurred, like a snowball rolling down a hill, the easier it is for more damage to occur and lower pressures are necessary. If untreated, glaucoma does lead to blindness. ! * GONORRHEA Nearly 750,000 cases of gonorrhea are reported annually in the United States. Another 750,000 unreported cases, mostly among teenagers and young adults, are believed to occur each year. The annual cost of gonorrhea and its complications is estimated at close to $1 billion. Gonorrhea is caused by the gonococcus, a bacterium that grows and multiplies quickly in moist, warm areas of the body such as the cervix, urethra, mouth, or rectum. In women, the cervix is the most common site of infection. However, the disease can spread to the uterus (womb) and fallopian tubes, resulting in pelvic inflammatory disease (PID); this can cause infertility and ectopic (tubal) pregnancy. Gonorrhea is most commonly spread during genital contact, but it can also be passed from the genitals of one partner to the throat of the other during oral sex (pharyngeal gonorrhea). Gonorrhea of the rectum can occur in people who practice anal intercourse and may also occur in women due to spread of the infection from the vaginal area. Gonorrhea can be passed from an infected woman to her newborn infant during delivery. When the infection occurs in children, it is most commonly due to sexual abuse. Symptoms The early symptoms of gonorrhea often are mild, and most women who are infected have no symptoms of the disease. If symptoms of gonorrhea develop, they usually appear within 2 to 10 days after sexual contact with an infected partner, although a small percentage of patients may be infected for several months without showing symptoms. The initial symptoms in women include a painful or burning sensation when urinating or an abnormal vaginal discharge. More advanced symptoms, which indicate progression to PID, include abdominal pain, bleeding between menstrual periods, vomiting, or fever. Men usually have a discharge from the penis and a burning sensation during urination that may be severe. Symptoms of rectal infection include discharge, anal itching, and sometimes painful bowel movements. Diagnosis Two techniques, gram stain and culture, are generally used to diagnose gonorrhea. Many doctors prefer to use both tests to increase the chance of an accurate diagnosis. The gram stain is quite accurate for men but less so for women. The test involves placing a smear of the discharge on a slide that has been stained with a dye and then examining it under a microscope for the presence of the gonococcus. Test results usually can be given to the patient at the time of an office or clinic visit. The culture test, the preferred method of diagnosing gonorrhea in women, involves placing a sample of the discharge onto a culture plate and incubating it for up to 2 days to allow the bacteria to multiply. The accuracy of this test depends on the site from which the sample is taken. Cervical samples are accurate, for example, approximately 90 percent of the time. Throat cultures can also be done to detect pharyngeal gonorrhea. Treatment Ampicillin, amoxicillin, or some type of penicillin used to be recommended for the treatment of gonorrhea. Because penicillin- resistant gonorrhea is increasing, other antibiotics that are given by injection such as ceftriaxone or spectinomycin now are used to treat most gonococcal infections. Other new antibiotics can be taken by mouth. Gonorrhea often occurs together with chlamydial infection, another common sexually transmitted disease (STD). Therefore, doctors usually prescribe a combination of antibiotics, such as ceftriaxone and doxycycline, to treat both diseases. Women who are pregnant should not take doxycycline and are usually given an alternative antibiotic such as erythromycin. Regardless of what drug is prescribed, it is important that the patient take the full course of medication and that he or she return to the doctor's office or clinic for followup. All sex partners of a person with gonorrhea should be tested and treated appropriately even if they do not have symptoms of infection. Complications If gonorrhea is not treated, the bacteria can spread to the bloodstream and infect the joints, heart valves, or the brain. The most common consequence of gonorrhea, however, is PID, a serious infection of the female reproductive organs, that occurs in an estimated 1 million American women each year. PID can scar or damage cells lining the fallopian tubes, resulting in infertility in as many as 10 percent of women affected. In others, the damage prevents the proper passage of the fertilized egg into the uterus. If this happens, the egg may implant in the tube; this is called an ectopic or tubal pregnancy and is life- threatening to the mother if not detected early. An infected woman who is pregnant may give the infection to her infant as the baby passes through the birth canal during delivery. Most states require that the eyes of newborns be treated with silver nitrate or other medication immediately after birth to prevent gonococcal infection of the eyes, which can lead to blindness. Because of the risk of gonococcal infection to both mother and child, doctors recommend that a pregnant woman have at least one test for gonorrhea during her pregnancy. Prevention Because gonorrhea is highly contagious and yet may cause no symptoms, all men and women who have sexual contact with more than one partner should be tested regularly for the disease. Using condoms (rubbers) during sexual intercourse is very effective in preventing the spread of infection. Diaphragms may also reduce the risk of transmission. Constant awareness and precautions are necessary because a person who has once contracted the disease does not become immune--many people acquire gonorrhea more than once. Research Scientists supported by NIAID are continuing to learn more about the organism that causes gonorrhea and are working on better methods to prevent, diagnose, and treat it. The dramatic rise of antibiotic-resistant strains of the gonococcus underscores the need for a means of preventing gonorrhea. A method has been developed to detect these resistant strains, which helps the physician select an appropriate treatment. An effective vaccine against gonorrhea remains a key research priority for NIAID- supported scientists. This work is complicated by the fact that the gonococcus is a complex organism that infects only humans. It has a remarkable ability to protect itself by changing or mutating. The gonococcus also uses a protein on its surface that "tricks" the immune system into protecting the invading organism. Excluding this protein from any future vaccine will be critical. Several experimental vaccines are being developed by NIAID-supported investigators. By using protective measures during sexual activity, by being tested for gonorrhea whether or not symptoms are present, by taking medication promptly and properly if infection occurs, and by abstaining from intercourse until the infection is cured, sexually active people can reduce their risk of gonorrhea and its complications. Prepared by: Office of Communications National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service, August 1992 ! * Gout Symptoms -------- Pseudogout can appear in a chronic or acute form, or a combination of these two types. About one-fourth of patients with Pseudogout experience one or more acute (sudden) attacks characterized by rapid swelling and pain in a joint, stiffness and occasional redness and heat over the affected area. An attack usually reaches its peak within 12 to 36 hours and can last several days to weeks. In most people the symptoms of acute attacks will disappear eventually even without treatment. The most commonly affected joint is the knee, although any joint may be affected. The milder non-acute forms of the disorder are more likely to occur in several joints such as the wrists and fingers, as well as the knee. Pain and swelling occur, not as severe as in a sudden attack, but they tend to last longer. People with chronic Pseudogout find that pain becomes worse with activity. Some experience acute attacks as well as the chronic form, while others with the chronic form may never experience an acute attack. General Discussion ------------------ Pseudogout is a disorder resembling gout, characterized by deposits of calcium pyrophosphate dihydrate crystals in a single joint or multiple joints which causes mild chronic inflammation of those joints. Causes ------ The cause of Pseudogout is unknown. Its frequent association with other conditions such as osteoarthritis, diabetes mellitus, hyperparathyroidism, gout or hemochromatosis suggests that the deposits of the CPPD crystals in the cartilage are secondary to degenerative changes in the joints. A familial pattern of incidence has been observed in several countries. Related Disorders ----------------- Gout is a recurrent acute arthritis of peripheral joints which results from deposition, in and about the joints and tendons, of monosodium urate crystals from supersaturated hyperuricemic body fluids. This disorder may become chronic and deforming, but in most cases it is responsive to drugs and diet therapy. Therapies: Standard -------------------- Acute attacks of Pseudogout are treated by removing the excess fluid and CPPD crystals from the affected joint. The drugs used most often for treatment of Pseudogout are aspirin and the other non-steroidal anti-inflammatory drugs such as those commonly prescribed for many types of arthritis. These drugs reduce the pain and swelling caused by inflammation. Stomach upset is a common side effect of these drugs which may be avoided if they are taken with milk or food. If an acute attack has occurred in only one joint, a corticosteroid may be injected into the joint. During an attack of Pseudogout the affected joint may need rest. Splints, canes and other devices for protecting joints may be fitted. Once the episode subsides, or in cases of the milder chronic form, rest should be balanced with appropriate exercise prescribed by a doctor or a physical therapist. In a very few people with Pseudogout, surgery may be necessary to correct a joint that is badly damaged, very painful or unstable. Surgery can be performed either to repair a joint or to replace it entirely with an artificial joint. Surgery can be effective for reducing pain, improving movement and correcting disability. Therapies: Investigational --------------------------- Researchers at the Mayo Clinic in Rochester, MN have tested the experimental anti-inflammatory drug colchicine as a treatment in severe cases of Pseudogout when symptoms did not respond to any other treatment. More research is needed before this drug can be recommended for treatment of Pseudogout. This disease entry is based upon medical information available through June 1988. Resources --------- For more information on Pseudogout, please contact: National Organization for Rare Disorders (NORD) P.O. Box 8923 New Fairfield, CT 06812-1783 (203) 746-6518 (203) 746-6927 (TDD for the hearing impaired) The Arthritis Foundation 1314 Spring St., NW Atlanta, GA 30309 (404) 872-7100 (800) 283-7800 NIH/National Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Information Clearinghouse 9000 Rockville Pike Bethesda, MD 20892 (301) 495-4484 References ---------- Pseudogout. Schumacher: Arthritis Medical Information Series (1983). THE MERCK MANUAL 15th ed: R. Berkow, et al: eds; Merck, Sharp & Dohme Research Laboratories, 1987. P. 1266. CECIL TEXTBOOK OF MEDICINE, 18th ed.: James B. Wyngaarden, and Lloyd H. Smith, Jr., Eds.: W. B. Saunders Co., 1988. P. 2037. ! * Guillain-Barre syndrome Definition: Inflammation of nerves (neuritis) associated with fever. Description: Guillain-Barre' syndrome (GBS) is also known as acute demyelinating polyneuropathy because of its adverse effect on myelin, a sheath that protects normal nerve tissue. This acute illness is frequently severe and fulminant and occurs at a rate of one case per million population per month. This represents approximately 3,500 cases per year in the United States and Canada. In over two-thirds of cases GBS a viral infection precedes the onset of the disease by 1-3 weeks. Herpes infections, cytomegalovirus, or Epstein-Barr virus (causative agent in mononucleosis) account for a large percentage of viral-triggered cases. Approximately 5-10% of GBS cases can occur within 1-4 weeks of a surgical procedure or associated with lymphoma, Hodgkin's disease, or systemic lupus erythematosus. GBS is thought to be somehow immune-mediated but the exact pathogenesis of the disease remains unknown. The signs and symptoms of GBS include absent reflexes and progressive limb paralysis. There may also be some mild disturbances in sensation. Eventual involvement of the respiratory muscles is also seen. Most patients with GBS will require hospitalization and about one-quarter will require respiratory support on a mechanical ventilator. The prognosis is good with approximately 85% of patients making a complete recovery. The mortality rate is 3- 4%. Management is largely supportive, but a technique of filtering the blood known as plasmapheresis has shown to be effective. Treatment with steroids has been used in the past but a beneficial role has yet to be proven. ___________________________________________________________ ADDITIONAL REFERENCES ___________________________________________________________ InfoTrac * Health Reference Center ■Dec '91 - Dec '94 THE MATERIAL CONTAINED IN HEALTH REFERENCE CENTER IS PROVIDED ONLY FOR INFORMATIONAL PURPOSES AND SHOULD NOT BE CONSTRUED AS MEDICAL ADVICE OR INSTRUCTION. CONSULT YOUR HEALTH PROFESSIONAL FOR ADVICE RELATING TO A MEDICAL PROBLEM OR CONDITION. Heading: GUILLAIN-BARRE SYNDROME ■Dictionary definition DEFINITION (15 lines) Mosby's Medical, Nursing, and Allied Health Dictionary, 4th Edition COPYRIGHT 1994 by Mosby-Year Book, Inc. Guillain-Barre syndrome ------------------------------------------------------------------------ an idiopathic, peripheral polyneuritis occurring between 1 and 3 weeks after a mild episode of fever associated with a viral infection or with immunization. Symmetric pain and weakness affect the extremities, and paralysis may develop. The neuritis may spread, ascending to the trunk and involving the face, arms, and thoracic muscles. The course of the disease is variable; some people may have minimal symptoms, whereas others may have symptoms severe enough to require critical nursing care, including respiratory assistance and a CircOlectric bed. The disease resolves itself completely in a few weeks or a few months. There is no treatment other than supportive care. Also called acute febrile polyneuritis, acute idiopathic polyneuritis, infectious polyneuritis. -END- InfoTrac * Health Reference Center ■Dec '91 - Dec '94 THE MATERIAL CONTAINED IN HEALTH REFERENCE CENTER IS PROVIDED ONLY FOR INFORMATIONAL PURPOSES AND SHOULD NOT BE CONSTRUED AS MEDICAL ADVICE OR INSTRUCTION. CONSULT YOUR HEALTH PROFESSIONAL FOR ADVICE RELATING TO A MEDICAL PROBLEM OR CONDITION. Heading: POLYRADICULONEURITIS 12. Guillain-Barre syndrome. v16 Medical Update June '93 p6(1) TEXT / HEADINGS TEXT (16 lines) COPYRIGHT 1993 Medical Education and Research Foundation Guillain-Barre syndrome (GBS) is characterized by muscular weakness and mild sensory loss. Although the cause is unknown, usually the syndrome begins shortly after a person experiences an infection, surgery, or an immunization. Weakness usually begins in the legs and progresses to the arms. Ninety percent of GBS patients reach their worst state of the syndrome in the second or third week after symptoms start. Some patients may have symptoms of unsteadiness in walking and severe loss of tactile sensation. About 10 percent of patients relapse after initial improvement and enter a chronic state. However, the patient normally experiences considerable improvement over a period of months. Convalescence may last for months or years and should include physical therapy. Although 30 percent of adults with the syndrome still have residual weakness that may require retraining, use of orthopedic appliances, or operations, most make an almost complete recovery. -END- InfoTrac * Health Reference Center ■Dec '91 - Dec '94 Heading: POLYRADICULONEURITIS 21. The Guillain-Barre syndrome. (Review Article)(Current Concepts) by Allan H. Ropper il v326 The New England Journal of Medicine April 23 '92 p1130(7) ABSTRACT / HEADINGS / IN LIBRARY ABSTRACT (22 lines) The neurological disorder Guillain-Barre syndrome is the most common cause of generalized paralysis. Patients with Guillain-Barre syndrome experience muscle weakness, pain and paralysis. Extreme cases can affect breathing, eye movement and the autonomic nervous system; about 3% to 8% of patients die from complications. For these reasons, patients with Guillain-Barre syndrome should be watched closely in the hospital. Diagnosis of Guillain-Barre syndrome can be confirmed by evaluation of nerve conduction and examination of cerebrospinal fluid. Approximately two- thirds of Guillain-Barre patients develop the disorder after a viral infection, and some have an underlying condition such as cancer. Most Guillain-Barre patients recover within weeks or months, but have long-lasting, usually minor complications. Activated T-cells, or cells of the immune system, may be responsible for the inflammation that occurs in the protective sheath that surrounds nerve cells. Research indicates that plasma exchange and infusion of gamma globulin may be more effective therapy than the no-longer-used corticosteroid treatment. -END- InfoTrac * Health Reference Center ■Dec '91 - Dec '94 THE MATERIAL CONTAINED IN HEALTH REFERENCE CENTER IS PROVIDED ONLY FOR INFORMATIONAL PURPOSES AND SHOULD NOT BE CONSTRUED AS MEDICAL ADVICE OR INSTRUCTION. CONSULT YOUR HEALTH PROFESSIONAL FOR ADVICE RELATING TO A MEDICAL PROBLEM OR CONDITION. Heading: POLYRADICULONEURITIS 1. Guillain-Barre syndrome. (Brain, Nerve, and Muscle Disorders) by Timothy A. Pedley The Columbia Univ. Coll. of Physicians & Surgeons Complete Home Medical Guide Edition 2 '89 p639(1) TEXT / HEADINGS TEXT (22 lines) COPYRIGHT 1989 Crown Publishers Inc. Guillain-Barre, Syndrome The Guillain-Barre syndrome is an illness that usually occurs one to two weeks after a mild viral infection such as a sore throat, bronchitis, or flu. Symmetric weakness of the limbs develops over a few days, sometimes progressing to complete paralysis. The face muscles may be paralyzed as well, making it impossible to swallow normally. In severe cases, paralysis of respiratory muscles requires tracheostomy and artificial ventilation. With intensive medical treatment and support, the majority of patients recover, but about one-third are left with some residual weakness. The illness results from inflammation and destruction of myelin similar to that seen in multiple sclerosis. The main difference, however, is that multiple sclerosis attacks the central nervous system, whereas in the Guillain-Barre syndrome it is the peripheral nerves that are affected. Another difference is that Guillain-Barre syndrome does not recur except in rare instances. The nerve damage is thought to be the result of an abnormal immune reaction directed against the myelin of the peripheral nervous system. Diagnosis is made by the clinical features, characteristic changes in cerebrospinal fluid, and electrical studies of the peripheral nerves and muscles, a procedure known as electromyography (EMG). -END- ! * FACT SHEET: What is Guillain-Barre Syndrome? Guillain-Barre (ghee-yan bah-ray) syndrome is a disorder in which the body's immune system attacks part of the nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling sensations in the legs. In many instances the weakness and abnormal sensations spread to the arms and upper body. These symptoms can increase in intensity until the muscles cannot be used at all and the patient is almost totally paralyzed. In these cases the disorder is life threatening - potentially interfering with blood pressure, heart rate, and breathing - and is considered a medical emergency. The patient is often put on a respirator to assist with breathing and is watched closely for problems such as an abnormal heart beat, infections, blood clots, and high or low blood pressure. Most patients, however, recover from even the most severe cases of Guillain-Barre syndrome, although some continue to have minor problems. Guillain-Barre syndrome can affect anybody. It can strike at any age and both sexes are equally prone to the disorder. The syndrome is rare, however, afflicting only about one person in 100,000. Usually Guillain-Barre occurs a few days or weeks after the patient has had symptoms of a respiratory or gastrointestinal viral infection. Occasionally pregnancy, surgery, or vaccinations will trigger the syndrome. The disorder can develop over the course of hours or days, or it may take up to 3 to 4 weeks. Most people reach the stage of greatest weakness within the first 2 weeks after symptoms appear, and by the third week of the illness 90 percent of all patients are at their weakest. What causes Guillain-Barre syndrome? No one yet knows why Guillain-Barre strikes some people and not others. Nor does anyone know exactly what sets the disease in motion. What scientists do know is that the body's immune system begins to attack the body itself, causing what is known as an autoimmune disease. Usually the cells of the immune system attack only foreign material and invading organisms. In Guillain-Barre syndrome, however, the immune system starts to destroy the myelin sheath that surrounds the axons of many nerve cells, or even the axons themselves (axons are long, thin extensions of the nerve cells; they carry nerve signals). The myelin sheath surrounding the axon speeds up the transmission of nerve signals and allows the transmission of signals over long distances. In diseases in which the nerve cells' myelin sheaths are injured or degraded, the nerves cannot transmit signals efficiently. That is why the muscles begin to lose their ability to respond to the brain's commands, commands that must be carried through the nerve network. The brain also receives fewer sensory signals from the rest of the body, resulting in an inability to feel textures, heat, pain, and other sensations. Alternately, the brain may receive inappropriate signals that result in tingling, "crawling-skin," or painful sensations. Because the signals to and from the arms and legs must travel the longest distances they are most vulnerable to interruption. Therefore, muscle weakness and tingling sensations usually first appear in the hands and feet. When Guillain-Barre is preceded by a viral infection, it is possible that the virus has changed the nature of cells in the nervous system so that the immune system treats them as foreign cells. It is also possible that the virus makes the immune system itself less discriminating about what cells it attacks. Scientists are investigating these possibilities and others to find why the immune system goes awry in Guillain-Barre syndrome and other autoimmune diseases. The cause and course of Guillain-Barre syndrome is an active area of neurological investigation, incorporating the cooperative efforts of neurological scientists, immunologists, and virologists. How is Guillain-Barre syndrome diagnosed? Guillain-Barre is called a syndrome rather than a disease because it is not clear that a specific disease-causing agent is involved. A syndrome is a medical condition characterized by a collection of symptoms (what the patient feels) and signs (what a doctor can observe or measure). Because the signs and symptoms of the syndrome can be quite varied, doctors may find it difficult to diagnose Guillain-Barre in its earliest stages. Several disorders have symptoms similar to those found in Guillain- Barre, so doctors examine and question patients carefully before making a diagnosis. Collectively, the signs and symptoms form a certain pattern that helps doctors differentiate Guillain-Barre from other disorders. For example, physicians will note whether the symptoms appear on both sides of the body (most common in Guillain-Barre) and the quickness with which the symptoms appear (in other disorders muscle weakness may progress over months rather than days or weeks). In Guillain Barre, reflexes such as knee jerks are usually lost. Because the signals traveling along the nerve are slower, a nerve conduction velocity (NCV) test can give a doctor clues to aid the diagnosis. In Guillain-Barre patients, the cerebrospinal fluid that bathes the spinal cord and brain contains more protein than usual. Therefore a physician may decide to perform a spinal tap, a procedure in which the doctor inserts a needle into the patient's lower back to draw cerebrospinal fluid from the spinal column. Laboratory scientists, working with clinical neurologists, are conducting research that may help provide physicians with more precise and reliable diagnostic tests for this disorder. How is Guillain-Barre treated? There is no known cure for Guillain-Barre syndrome. However, there are therapies that lessen the severity of the illness in most patients, and there are a number of ways to treat the complications of the disease. Currently, plasmapheresis and high-dose immunoglobulin therapy are used in the more serious cases of Guillain-Barre syndrome. Plasmapheresis is a method by which whole blood is removed from the body and processed so that the red and white blood cells are separated from the plasma, or liquid portion of the blood. The blood cells are then returned to the patient without the plasma, which the body quickly replaces. Scientists still don't know exactly why plasmapheresis works, but the technique seems to reduce the severity and duration of the Guillain Barre episode. This may be because the plasma portion of the blood contains elements that the immune system needs to function. When these elements are removed along with the plasma, the immune system is not able to attack the nervous system as effectively. In high-dose immunoglobulin therapy, doctors give intravenous injections of the proteins that the immune system uses to attack invading organisms. Investigators have found that these immunoglobulins, when given to Guillain-Barre patients, can lessen the immune attack on the nervous system. Investigators don't know why this is, but some suggest that the immunoglobulins may overwhelm the immune system and keep it from attacking the nerve cells and their myelin sheaths. The use of steroid hon-nones has also been tried as a way to reduce the severity of Guillain-Barre, but controlled clinical trials have not demonstrated that this treatment is effective. Much of the treatment for this syndrome consists of keeping the patient's body functioning during recovery of the nervous system. This can sometimes require placing the patient on a respirator, a heart monitor, or other machines that assist body function. The need for this sophisticated machinery is one reason why Guillain- Barre syndrome patients are usually treated in hospitals, often in an intensive care ward. In the hospital, doctors can also look for and treat the many problems that can afflict any paralyzed patient- complications such as pneumonia or bed sores. Often, even before recovery begins, caregivers may be instructed to manually move the patient's limbs to help keep the muscles flexible and strong. Later, as the patient begins to recover limb control, physical therapy begins. Carefully planned clinical trials of new and experimental therapies are the key to improving the treatment of patients with Guillain-Barre syndrome. Such clinical trials begin with the research of basic and clinical scientists who, working with clinicians, identify new approaches to treating patients with the disease. What is the long-term outlook for those with Guillain-Barre syndrome? Guillain-Barre syndrome can be a devastating disorder because of its sudden and unexpected onset. In addition, recovery is not necessarily quick. As noted previously, patients usually reach the point of greatest weakness or paralysis days or weeks after the first symptoms occur. Symptoms then stabilize at this level for a period of days, weeks, or, sometimes, months. The recovery period may be as little as a few weeks or as long as a few years. About 30 percent of those with Guillain-Barre still feel a residual weakness after 3 years. About 3 to 5 percent may suffer a relapse of muscle weakness and tingling sensations many years after the initial attack. Guillain-Barre syndrome patients face not only physical difficulties, but emotionally painful periods as well. It is often extremely difficult for patients to adjust to sudden paralysis and dependence on others for help with routine daily activities. Patients sometimes need psychological counseling to help them adapt. What research is being done? Scientists are concentrating on finding new treatments and refining existing ones. Scientists are also looking at the workings of the immune system to find which cells are responsible for beginning and carrying out the attack on the nervous system. The fact that so many cases of Guillain-Barre begin after a viral infection suggests that certain characteristics of these viruses may activate the immune system inappropriately. Investigators are searching for those characteristics. As noted previously, neurological scientists, immunologists, virologists, and pharmacologists are all working collaboratively to learn how to prevent this disorder and to make better therapies available when it strikes. Where can I go for more information? The National Institute of Neurological Disorders and Stroke conducts and supports a wide range of research on neurological disorders, including Guillain-Barre syndrome. For more information on this or other neurological disorders, or on the Institute and its research programs, contact: Office of Scientific and Health Reports Neurological Institute P.O. Box 5801 Bethesda, MD 20824 (301)496-5751 (800)352-9424 The organization listed below provides printed information and assistance to Guillain-Barre patients and other interested parties. Guillain-Barre Syndrome Foundation International P.O. Box 262 Wynnewood, PA 19096 (215) 667-0131 September 1992 Prepared by Office of Scientific and Health Reports National Institute of Neurological Disorders and Stroke National Institutes of Health Bethesda, Maryland 20892 ! * HANTAVIRUS ILLNESS IN THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION Date Last Rev'd: March 9, 1995 HANTAVIRUS ILLNESS IN THE UNITED STATES An outbreak of unexplained illness occurred in the Southwestern part of the United States in 1993. Laboratory findings from the Centers for Disease Control and Prevention indicate that the illness is caused by a hantavirus. The newly recognized hantavirus-associated disease, called Hantavirus Pulmonary Syndrome (HPS), begins with one or more symptoms including fever, severe muscle aches, headache, and cough which progress rapidly to severe lung disease, often requiring intensive care treatment. Since the hantavirus was discovered in 1993, less than 100 cases of HPS have been identified in 20 states. These states encompass the western half of the United States and most recently a few eastern states as well. Over half the people who get HPS die from the illness. In 1994, about two dozen cases have been confirmed. It is predicted that less than 50 cases will occur this year. So far the earliest known case dates back to 1975. Almost all cases have had evidence of close contact with rodents (deer mice or cotton rats). Rodents are the primary reservoir host of the recognized hantaviruses. Each hantavirus appears to have a preferred rodent host, but other small mammals can be infected as well. Data strongly suggests that the deer mouse is the primary carrier of the hantavirus seen in all parts of the United States except the Eastern Coast and the Southeast. In the Southeast, the cotton rat has been identified as a carrier for the virus causing HPS. Evidence of infection has also been found in pinon mice, brush mice and western chipmunks. The deer mouse is highly adaptable and is found in different habitats, including human residences in rural and semirural areas, but generally not in urban centers. Hantaviruses do not cause obvious illness in their rodent hosts. Infected rodents shed virus in saliva, urine, and feces for many weeks, but the duration and period of maximum infectivity are unknown. Human infection may occur when infective saliva or excreta are inhaled as aerosols produced directly from the animal. Transmission may also occur when fresh or dried materials contaminated by rodent excreta are disturbed, directly introduced into broken skin, introduced into the eyes, or, possibly, ingested in contaminated food or water. Persons have also become infected after being bitten by rodents. Ticks, fleas, mosquitos and other biting insects are not known to have a role in the transmission of hantaviruses. Person-to-person transmission has not been associated with any of the previously identified hantaviruses or with the recent outbreak in the Southwest. Cats and dogs are not known to be a reservoir host of hantaviruses in the United States. However, these domestic animals may bring infected rodents into contact with humans. Hantavirus pulmonary syndrome does not appear to be limited to a particular age, race, ethnic group, or gender. The chance of exposure to hantavirus is greatest when individuals work, play or live in closed spaces where there is an active rodent infestation. It is important to be aware of possible rodent exposure, for example, when working in crawl spaces, opening phone line stations or using air condition equipment after winter storage. Travel to and within all areas where hantavirus infection has been reported is safe. The possibility of exposure to hantavirus for campers, hikers, and tourists is very small and reduced even more if steps are taken to reduce rodent contact. Cleaning of areas with small numbers of rodents should include wearing latex or rubber gloves and wetting down affected areas with general household disinfectant solutions such as Lysol or bleach and water or Amonia. Cleaning of areas with large numbers of rodents includes wearing latex or rubber gloves, goggles, HEPAfilter mask and wetting the area with disinfectant solutions or bleach and water. Remember that the chances of getting HPS are very low. However, if you do get the disease, it can be very serious. RECOMMENDATIONS FOR PREVENTION AND CONTROL Summary This report provides interim recommendations for prevention and control of hantavirus infections associated with rodents in the southwestern United States. It is based on principles of rodent and infection control and contains specific recommendations for reducing rodent shelter and food sources in and around the home, recommendations for eliminating rodents inside the home and preventing them from entering the home, precautions for preventing hantavirus infection while rodent-contaminated areas are being cleaned up, prevention measures for persons who have occupational exposure to wild rodents, and precautions for campers and hikers. INTRODUCTION The recently recognized hantavirus-associated disease among residents of the southwestern United States and the identification of rodent reservoirs for the virus in the affected areas warrant recommendations to minimize the risk of exposure to rodents for both residents and visitors. While information is being gathered about the causative virus and its epidemiology, provisional recommendations can be made on the basis of knowledge about related hantaviruses. These recommendations are based on current understanding of the epidemiologic features of hantavirus infections in the Southwest; they will be periodically evaluated and modified as more information becomes available. Rodents are the primary reservoir hosts of recognized hantaviruses. Each hantavirus appears to have preferential rodent hosts, but other small mammals can be infected as well. Available data strongly suggest that the deer mouse (Peromyscus maniculatus) is the primary reservoir of the newly recognized hantavirus in the southwestern United States. Serologic evidence of infection has also been found in pi±on mice (P. truei), brush mice (P. boylii), cotton rats (Sigmodon hispidus), and western chipmunks (Tamias spp.). P. maniculatus is highly adaptable and is found in different habitats, including human residences in rural and semirural areas, but generally not in urban centers. Hantaviruses do not cause apparent illness in their reservoir hosts. Infected rodents shed virus in saliva, urine, and feces for many weeks, but the duration and period of maximum infectivity are unknown. The demonstrated presence of infectious virus in saliva of infected rodents and the marked sensitivity of these animals to hantaviruses following inoculation suggests that biting may be an important mode of transmission among rodents. Human infection may occur when infective saliva or excreta are inhaled as aerosols produced directly from the animal. Persons visiting laboratories where infected rodents were housed have been infected after only a few minutes of exposure to animal holding areas. Transmission may also occur when dried or fresh materials contaminated by rodent excreta are disturbed, directly introduced into broken skin, introduced onto the conjunctivae, or, possibly, ingested in contaminated food or water. Persons have also become infected after being bitten by rodents. Arthropod vectors are not known to have a role in the transmission of hantaviruses. Person-to-person transmission has not been associated with any of the previously identified hantaviruses or with the recent outbreak in the Southwest. Cats and dogs are not known to be reservoir hosts of hantaviruses in the United States. However, these domestic animals may bring infected rodents into contact with humans. Known hantavirus infections of humans occur primarily in adults and are associated with domestic, occupational, or leisure activities that bring humans into contact with infected rodents, usually in a rural setting. Patterns of seasonal occurrence differ, depending on the virus, species of rodent host, and patterns of human behavior, cases have been epidemiologically associated with the following situations: ƒ planting or harvesting field crops; ƒ occupying previously vacant cabins or other dwellings; ƒ cleaning barns and other outbuildings; ƒ disturbing rodent-infested areas while hiking or camping; ƒ inhabiting dwellings with indoor rodent populations; ƒ residing in or visiting areas in which the rodent population has shown an increase in density. Hantaviruses have lipid envelopes that are susceptible to most disinfectants (e.g., dilute hypochlorite solutions, detergents, ethyl alcohol [70%], or most general-purpose household disinfectants). How long these viruses survive after being shed in the environment is uncertain. The reservoir hosts of the hantavirus in the southwestern United States also act as hosts for the bacterium Yersinia pestis, the etiologic agent of plague. Although fleas and other ectoparasites are not known to play a role in hantavirus epidemiology, rodent fleas transmit plague. Control of rodents without concurrent control of fleas may increase the risk of human plague as the rodent fleas seek an alternative food source. Eradicating the reservoir hosts of hantaviruses is neither feasible nor desirable. The best currently available approach for disease control and prevention is risk reduction through environmental hygiene practices that deter rodents from colonizing the home and work environment. GENERAL HOUSEHOLD PRECAUTIONS IN AFFECTED AREAS Although epidemiologic studies are being conducted to identify specific behaviors that may increase the risk for hantavirus infection in humans in the United States, rodent control in and around the home will continue to be the primary prevention strategy (Box 1). CDC has issued recommendations for rodent-proofing urban and suburban dwellings and reducing rodent populations through habitat modification and sanitation. Box 1. General precautions for residents of affected areas Eliminate rodents and reduce the availability of food sources and nesting sites used by rodents inside the home. ƒ Follow the recommendations in the section on Eliminating Rodents Inside the Home. ƒ Keep food (including pet food) and water covered and stored in rodent- proof metal or thick plastic containers with tight-fitting lids. ƒ Store garbage inside homes in rodent-proof metal or thick plastic containers with tight-fitting lids. ƒ Wash dishes and cooking utensils immediately after use and remove all spilled food. ƒ Dispose of trash and clutter. ƒ Use spring-loaded rodent traps in the home continuously. ƒ As an adjunct to traps, use rodenticide with bait under a plywood or plastic shelter (covered bait station) on an ongoing basis inside the house. Note: Environmental Protection Agency (EPA)-approved rodenticides are commercially available. Instructions on product use should always be followed. Products that are used outdoors should be specifically approved for exterior use. Any use of a rodenticide should be preceded by use of an insecticide to reduce the risk of plague transmission. Insecticide sprays or powders can be used in place of aerosols if they are appropriately labeled for flea control. Prevent rodents from entering the home. Specific measures should be adapted to local circumstances. ƒ Use steel wool or cement to seal, screen, or otherwise cover all openings into the home that have a diameter greater than or equal to 1/4 inch. ƒ Place metal roof flashing as a rodent barrier around the base of wooden, earthen, or adobe dwellings up to a height of 12 inches and buried in the soil to a depth of 6 inches. ƒ Place 3 inches of gravel under the base of homes or under mobile homes to discourage rodent burrowing. Reduce rodent shelter and food sources within 100 feet of the home. ƒ Use raised cement foundations in new construction of sheds, barns, outbuildings, or woodpiles. ƒ When possible, place woodpiles 100 feet or more from the house, and elevate wood at least 12 inches off the ground. ƒ Store grains and animal feed in rodent-proof containers. ƒ Near buildings, remove food sources that might attract rodents, or store food and water in rodent-proof containers. ƒ Store hay on pallets, and use traps or rodenticide continuously to keep hay free of rodents. ƒ Do not leave pet food in feeding dishes. ƒ Dispose of garbage and trash in rodent-proof containers that are elevated at least 12 inches off the ground. ƒ Haul away trash, abandoned vehicles, discarded tires, and other items that may serve as rodent nesting sites. ƒ Cut grass, brush, and dense shrubbery within 100 feet of the home. ƒ Place spring-loaded rodent traps at likely spots for rodent shelter within 100 feet around the home, and use continuously. ƒ Use an EPA-registered rodenticide approved for outside use in covered bait stations at places likely to shelter rodents within 100 feet of the home. NOTE: Follow the recommendations specified in the section on Clean-Up of Rodent-Contaminated Areas if rodent nests are encountered while these measures are being carried out. ELIMINATING RODENTS INSIDE THE HOME AND REDUCING RODENT ACCESS TO THE HOME Rodent infestation can be determined by direct observation of animals or inferred from the presence of feces in closets or cabinets or on floors or from evidence that rodents have been gnawing at food. If rodent infestation is detected inside the home or outbuildings, rodent abatement measures should be completed (Box 2). The directions in the section on Special Precautions should be followed if evidence of heavy rodent infestation (e.g., piles of feces or numerous dead animals) is present or if a structure is associated with a confirmed case of hantavirus disease. Box 2. Eliminating rodent infestation: Guidance for residents of affected areas ƒ Before rodent elimination work is begun, ventilate closed buildings or areas inside buildings by opening doors and windows for at least 30 minutes. Use an exhaust fan or cross ventilation if possible. Leave the area until the airing-out period is finished. This airing may help remove any aerosolized virus inside the closed-in structure. ƒ Second, seal, screen, or otherwise cover all openings into the home that have a diameter of greater than or equal to │1/4 inch. Then set rodent traps inside the house, using peanut butter as bait. Use only spring- loaded traps that kill rodents. ƒ Next, treat the interior of the structure with an insecticide labeled for flea control; follow specific label instructions. Insecticide sprays or powders can be used in place of aerosols if they are appropriately labeled for flea control. Rodenticides may also be used while the interior is being treated, as outlined below. ƒ Remove captured rodents from the traps. Wear rubber or plastic gloves while handling rodents. Place the carcasses in a plastic bag containing a sufficient amount of a general-purpose household disinfectant to thoroughly wet the carcasses. Seal the bag and then dispose of it by burying in a 2- to 3-foot-deep hole or by burning. If burying or burning are not feasible, contact your local or state health department about other appropriate disposal methods. Rebait and reset all sprung traps. ƒ Before removing the gloves, wash gloved hands in a general household disinfectant and then in soap and water. A hypochlorite solution prepared by mixing 3 tablespoons of household bleach in 1 gallon of water may be used in place of a commercial disinfectant. When using the chlorine solution, avoid spilling the mixture on clothing or other items that may be damaged. Thoroughly wash hands with soap and water after removing the gloves. ƒ Leave several baited spring-loaded traps inside the house at all times as a further precaution against rodent reinfestation. Examine the traps regularly. Disinfect traps no longer in use by washing in a general household disinfectant or the hypochlorite solution. Disinfect and wash gloves as described above, and wash hands thoroughly with soap and water before beginning other activities. NOTE: EPA-approved rodenticides are commercially available. Instructions on product use should always be followed. Products that are used outdoors should be specifically approved for exterior use. Any use of a rodenticide should be preceded by use of an insecticide to reduce the risk of plague transmission. Insecticide sprays or powders can be used in place of aerosols if they are appropriately labeled for flea control. CLEAN-UP OF RODENT-CONTAMINATED AREAS Areas with evidence of rodent activity (e.g., dead rodents, rodent excreta) should be thoroughly cleaned to reduce the likelihood of exposure to hantavirus-infected materials. Clean-up procedures must be performed in a manner that limits the potential for aerosolization of dirt or dust from all potentially contaminated surfaces and household goods (Box 3). Box 3. Clean-up of rodent-contaminated areas: Guidance for residents of affected areas ƒ Persons involved in the clean-up should wear rubber or plastic gloves. ƒ Spray dead rodents, rodent nests, droppings, or foods or other items that have been tainted by rodents with a general-purpose household disinfectant. Soak the material thoroughly, and place in a plastic bag. When clean-up is complete (or when the bag is full), seal the bag, then place it into a second plastic bag and seal. Dispose of the bagged material by burying in a 2- to 3-foot-deep hole or by burning. If these alternatives are not feasible, contact the local or state health department concerning other appropriate disposal methods. ƒ After the above items have been removed, mop floors with a solution of water, detergent, and disinfectant. Spray dirt floors with a disinfectant solution. A second mopping or spraying of floors with a general-purpose household disinfectant is optional. Carpets can be effectively disinfected with household disinfectants or by commercial-grade steam cleaning or shampooing. To avoid generating potentially infectious aerosols, do not vacuum or sweep dry surfaces before mopping. ƒ Disinfect countertops, cabinets, drawers, and other durable surfaces by washing them with a solution of detergent, water, and disinfectant, followed by an optional wiping-down with a general-purpose household disinfectant. ƒ Rugs and upholstered furniture should be steam cleaned or shampooed. If rodents have nested inside furniture and the nests are not accessible for decontamination, the furniture should be removed and burned. ƒ Launder potentially contaminated bedding and clothing with hot water and detergent. (Use rubber or plastic gloves when handling the dirty laundry; then wash and disinfect gloves as described in the section on Eliminating Rodents Inside the Home.) Machine-dry laundry on a high setting or hang it to air dry in the sun. SPECIAL PRECAUTIONS FOR HOMES OF PERSONS WITH CONFIRMED HANTAVIRUS INFECTION OR BUILDINGS WITH HEAVY RODENT INFESTATIONS Special precautions are indicated in the affected areas for cleaning homes or buildings with heavy rodent infestations (Box 4). Persons conducting these activities should contact the responsible local, state, or federal public health agency for guidance. These precautions may also apply to vacant dwellings that have attracted numbers of rodents while unoccupied and to dwellings and other structures that have been occupied by persons with confirmed hantavirus infection. Workers who are either hired specifically to perform the clean-up or asked to do so as part of their work activities should receive a thorough orientation from the responsible health agency about hantavirus transmission and should be trained to perform the required activities safely. Box 4. Special precautions for clean-up in homes of persons with hantavirus infection or buildings with heavy rodent infestation ƒ A baseline serum sample, preferably drawn at the time these activities are initiated, should be available for all persons conducting the clean- up of homes or buildings with heavy rodent infestation. The serum sample should be stored at -20 C. ƒ Persons involved in the clean-up should wear coveralls (disposable if possible), rubber boots or disposable shoe covers, rubber or plastic gloves, protective goggles, and an appropriate respiratory protection device, such as a half-mask air-purifying (or negative-pressure) respirator with a high-efficiency particulate air (HEPA) filter or a powered air-purifying respirator (PAPR) with HEPA filters. Respirators (including positive-pressure types) are not considered protective if facial hair interferes with the face seal, since proper fit cannot be assured. Respirator practices should follow a comprehensive user program and be supervised by a knowledgeable person. ƒ Personal protective gear should be decontaminated upon removal at the end of the day. If the coveralls are not disposable, they should be laundered on site. If no laundry facilities are available, the coveralls should be immersed in liquid disinfectant until they can be washed. ƒ All potentially infective waste material (including respirator filters) from clean-up operations that cannot be burned or deep buried on site should be double bagged in appropriate plastic bags. The bagged material should then be labeled as infectious (if it is to be transported) and disposed of in accordance with local requirements for infectious waste. ƒ Workers who develop symptoms suggestive of HPS within 45 days of the last potential exposure should immediately seek medical attention. The physician should contact local health authorities promptly if hantavirus- associated illness is suspected. A blood sample should be obtained and forwarded with the baseline serum through the state health department to CDC for hantavirus antibody testing. PRECAUTIONS FOR WORKERS IN AFFECTED AREAS WHO ARE REGULARLY EXPOSED TO RODENTS Persons who frequently handle or are exposed to rodents (e.g., mammalogists, pest-control workers) in the affected area are probably at higher risk for hantavirus infection than the general public because of their frequency of exposure. Therefore, enhanced precautions are warranted to protect them against hantavirus infection (Box 5). Box 5. Precautions for workers in affected areas who are exposed to rodents ƒ A baseline serum sample, preferably drawn at the time of employment, should be available for all persons whose occupations involve frequent rodent contact. The serum sample should be stored at -20C. ƒ Workers in potentially high-risk settings should be informed about the symptoms of the disease and be given detailed guidance on prevention measures. ƒ Workers who develop a febrile or respiratory illness within 45 days of the last potential exposure should immediately seek medical attention and inform the attending physician of the potential occupational risk of hantavirus infection. The physician should contact local health authorities promptly if hantavirus-associated illness is suspected. A blood sample should be obtained and forwarded with the baseline serum through the state health department to CDC for hantavirus antibody testing. ƒ Workers should wear a half-face air-purifying (or negative-pressure) respirator or PAPR equipped with HEPA filters when removing rodents from traps or handling rodents in the affected area. Respirators (including positive-pressure types) are not considered protective if facial hair interferes with the face seal, since proper fit cannot be assured. Respirator use practices should be in accord with a comprehensive user program and should be supervised by a knowledgeable person. ƒ Workers should wear rubber or plastic gloves when handling rodents or handling traps containing rodents. Gloves should be washed and disinfected before removing them, as described above. ƒ Traps contaminated by rodent urine or feces or in which a rodent was captured should be disinfected with a commercial disinfectant or bleach solution. Dispose of dead rodents as described in the section on Eliminating Rodents inside the Home. ƒ Persons removing organs or obtaining blood from rodents in affected areas should contact the Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, [telephone (404) 639-1115] for detailed safety precautions. PRECAUTIONS FOR OTHER OCCUPATIONAL GROUPS WHO HAVE POTENTIAL RODENT CONTACT Insufficient information is available at this time to allow general recommendations regarding risks or precautions for persons in the affected areas who work in occupations with unpredictable or incidental contact with rodents or their habitations. Examples of such occupations include telephone installers, maintenance workers, plumbers, electricians, and certain construction workers. Workers in these jobs may have to enter various buildings, crawl spaces, or other sites that may be rodent infested. Recommendations for such circumstances must be made on a case-by-case basis after the specific working environment has been assessed and state or local health departments have been consulted. PRECAUTIONS FOR CAMPERS AND HIKERS IN THE AFFECTED AREAS There is no evidence to suggest that travel into the affected areas should be restricted. Most usual tourist activities pose little or no risk that travelers will be exposed to rodents or their excreta. However, persons engaged in outdoor activities such as camping or hiking should take precautions to reduce the likelihood of their exposure to potentially infectious materials (Box 6). Box 6. Reducing risk of hantavirus infection: Guidance for hikers and campers ƒ Avoid coming into contact with rodents and rodent burrows or disturbing dens (such as pack rat nests). ƒ Do not use cabins or other enclosed shelters that are rodent infested until they have been appropriately cleaned and disinfected. ƒ Do not pitch tents or place sleeping bags in areas in proximity to rodent feces or burrows or near possible rodent shelters (e.g., garbage dumps or woodpiles). ƒ If possible, do not sleep on the bare ground. Use a cot with the sleeping surface at least 12 inches above the ground. Use tents with floors. ƒ Keep food in rodent-proof containers. ƒ Promptly bury (or--preferably--burn followed by burying, when in accordance with local requirements) all garbage and trash, or discard in covered trash containers. ƒ Use only bottled water or water that has been disinfected by filtration, boiling, chlorination, or iodination for drinking, cooking, washing dishes, and brushing teeth. CONCLUSION The control and prevention recommendations in this report represent general measures to minimize the likelihood of human exposure to hantavirus- infected rodents in areas of the southwestern United States affected by the outbreak of hantavirus-associated respiratory illness. Many of the recommendations may not be applicable or necessary in unaffected locales. The impact and utility of the recommendations will be assessed as they are implemented and will be continually reviewed by CDC and the involved state and local health agencies as additional epidemiologic and laboratory data related to the outbreak become available. These recommendations (which were developed in July) will be supplemented or modified in the future. To receive additional recommendations for the prevention and control of hantavirus infections associated with rodents in the United States, you will need to call 404-332-4565 and follow the prompts. The following documents on Hantavirus are available: 310031, Hantavirus Illness in the United States; 310032, Hantavirus Illness Prevention Information; 310033, Guidelines for Removing Organs or Obtaining Blood from Rodents Potentially Infected with Hantavirus; 310034, Laboratory Management of Agents Associated with Hantavirus Pulmonary Syndrome: Interim Biosafety Guidelines; 310035, State Contacts for Hantavirus Information ! * HAY FEVER (ALLERGIC RHINITIS) Hay fever (the common term for allergic rhinitis) is the body's response to normally harmless foreign particles inhaled into the nose and throat. The reaction is often caused by inhaling pollen, such as ragweed, tree or grass pollen, but may also result from mold spores generated in dead or decaying organic matter, as well as dust, animal dander and feathers. Allergic rhinitis affects approximately 20 million Americans. The term "hay fever" dates back to a time when harvesting and haying in late summer widely led to discomfort in farm workers. However, the most common symptoms of allergic rhinitis - itching and tearing eyes, a runny nose, uncontrollable sneezing and a scratchy, sore throat - may occur at any time of the year during a particular pollen season (seasonal allergic rhinitis) or throughout the year, depending on what someone is allergic to (perennial allergic rhinitis). Despite the name, fever is not a sign of such conditions, and allergic rhinitis is not contagious. For most people allergens, the substances that cause allergies, do not threaten general health. When people breathe in foreign substances, their immunological system produces antibodies, which resist and defend the body against disease and thus fend off any harmful effects. In people who suffer from allergic rhinitis, however, the body produces allergic antibodies that react with the allergens, and the familiar symptoms of allergies appear. Allergies seem to run in families, although different family members may be allergic to different factors. The mechanism of allergy Allergic symptoms result from a chain of events. First, allergens (such as pollens) reach the mucous membranes of the nose, eyes and throat after they are inhaled. Allergic antibodies (IgE) are manufactured by the body of allergic individuals; these antibodies then attach to cells known as mast cells in the mucous membranes. When allergic individuals are reexposed to these allergens, the IgE attached to the mast cells combines with the offending allergens. The mast cells then release chemicals such as histamine into the bloodstream. As a result of this release, a variety of allergic symptoms occur, such as itching, swelling of the mucous membranes lining the nose and throat caused by a widening of blood vessels, and a release of fluids caused by an increase in the permeability ("leakiness") of small blood vessels. Skin testing When the cause of an allergic reaction is difficult to identify or important to confirm, skin tests are the easiest way to find out what substances are responsible for the symptoms. Usually, more than one substance plays a part in allergies. In these tests a very small, dilute, highly purified amount of a particular allergen is placed on a scratched area of the skin or injected just under the skin. When the substance causes the skin to become red and swollen at the scratched or injected area, the allergen has probably been pinpointed. These tests are usually performed by an allergist. Drug therapy Fortunately, there are many medications available that effectively reduce and, in some cases, practically eliminate symptoms in most hay fever sufferers. Different drugs work in different ways to interfere with and prevent the chemical reactions leading to allergic attacks. The best known of these drugs, antihistamines, compete with histamine for receptors on the mucous membranes of the nose, eyes and throat. Through this blocking action, histamine never reaches its target, thus preventing and relieving the symptoms of hay fever. Different people vary in their response to the same antihistamine. Therefore, it may take experimentation with several medications before the best antihistamine is found. Drowsiness is a typical side effect of most, but not all, antihistamines; if you find that you become very tired after taking an antihistamine, you should avoid driving or doing anything else that requires you to be fully alert. Also, it is sensible to avoid alcohol or tranquilizers when taking antihistamines, since these substances can cause added drowsiness. Some over-the-counter and prescription allergy medicines contain a combination of an antihistamine with a decongestant. Nose drops or a nasal decongestant spray may be used occasionally if sinus pressure is particularly troublesome. However, too frequent use of these direct- acting preparations may make your condition worse by building tolerance to the drug contained in them. Prescription eye drops may be used when itching, burning, and weeping eyes interfere with normal activities. Cromolyn sodium is another very effective agent that prevents allergic attacks. This drug is available as a nasal spray and as eye drops. Instead of blocking histamine from reaching its target (like antihistamines do), cromolyn prevents the release of histamine and other substances from mast cells altogether. Corticosteroids, another group of drugs, may be tried in severe cases of allergic rhinitis. These drugs may be used alone or in combination with other drugs when alternative forms of therapy are ineffective and/or when the person has other medical conditions requiring special treatment. They help provide relief by decreasing the swelling of the mucous membranes lining the nose and throat and by preventing the release of substances from the mast cells which cause allergic reactions. Nasal steroids are often used for hay fever because they are less likely than oral steroids to affect other parts of the body. Immunotherapy When antihistamines or other medications provide insufficient relief, many allergens are involved, or a particular allergy season is prolonged, immunotherapy may be the answer for some allergy sufferers. Immunotherapy is particularly effective against ragweed, grass and tree pollens and mites and reportedly relieves two-thirds of all patients of their symptoms. After skin testing is done to pinpoint the particular allergens one is allergic to, immunotherapy is begun. It consists of a series of injections with increasingly stronger concentrations of an allergen extract on a regular schedule. These allergen extracts produce allergen-specific immunoglobulin-G (IgG) antibodies, which block the combination of an allergen with IgE antibodies and thereby prevent the release of histamine and other substances from mast cells. Booster shots are given at longer intervals throughout the season. This procedure is more expensive than drug therapy and must be maintained without interruption during one or more pollen seasons; it is usually undertaken by people with a prior condition that has ruled out other forms of therapy or whose symptoms are too severe to be relieved by any other method. Avoiding allergens The severity of seasonal allergic rhinitis symptoms often is directly related to the weather. The pollen count is highest on breezy, dry summer afternoons; rides in an open car increase exposure to the allergens. The pollen count falls dramatically when the weather is cold or humid and when heavy rains occur in the morning. Whatever the climate, the hay fever sufferer will almost certainly be more comfortable in the city than in the country and indoors rather than outdoors, especially if the interior is air-conditioned. If exposure to the outdoors during the height of a pollen season cannot be avoided, wearing a face mask to avoid inhalation of pollen granules may be helpful. Rarely, moving to an area that has a low pollen count, at least during the pollen season, may be the only alternative to immunotherapy. If the cause of the symptoms is known to be mold spores, damp woods should be avoided; newspapers should be discarded promptly, and bed pillows (avoid those with feathers and down) should be aired regularly in the sun. Raking leaves, spreading mulch, or other interactions with decaying vegetation should be completely avoided, since mold spores flourish in such materials; if such exposure is absolutely necessary, a face mask can be worn. Dehumidifiers placed in damp, moist areas of the home (such as bathrooms and laundry rooms) or use of antimildew sprays and mold-resistant paint will limit mold growth. For allergies to animal dander, the only source of relief may be elimination of pets from the home; if this is not possible, then the pet should be kept outside. Again, a face mask may be helpful, especially for people who work with animals. Elimination of feather pillows and down quilts and jackets may also help if an allergy to feathers is diagnosed; pillows and mattresses with hypoallergenic fillings, such as foam, are widely available. Dust is more difficult to deal with, but it, too, can be limited. For example, mattresses, boxsprings and pillows should be covered with vinyl or synthetic waterproof coverings that can be sponged clean periodically. Upholstered furniture, stuffed toys, wall hangings, wall-to-wall carpeting, and curtains are all dust collectors; vinyl-covered furniture, venetian blinds, and hardwood, linoleum, and tile floors are kept clean easily. The area should be vacuumed and wet mopped frequently to catch loose balls of dust. Another good strategy is to maintain clean, adequate filters for heating and air-conditioning systems so that allergens are not dispersed throughout the home; many people have sneezing attacks during the winter because dust hidden in heating ducts is discharged with warm air from the ducts. ! * Writer: Mary Beth Howley SUGGESTIONS, WARNINGS FOR HAY FEVER SUFFERERS BIRMINGHAM, Ala...With the prime time for allergies almost upon us, Dr. James R. Bonner, director of the University of Alabama at Birmingham (UAB) allergy clinic, offers some suggestions and warnings for those people who will be doing a lot of sneezing and sniffling in the months ahead. Nearly 20 percent of the population suffers from allergies, according to Bonner, and for those people suffering from hay fever, late summer is a prime time for their allergies to "act up." Ragweed pollen counts are particularly high beginning in mid-August until mid-October. "If a person is pollen allergic, there is not a whole lot they can do to avoid these symptoms except stay indoors, keep the windows shut and run the air conditioner," Bonner says. But as most people have to leave the confines of their homes at some point, Bonner recommends drug intervention. Common symptoms of hay fever include itching, sneezing, drainage and blockage of the nose, sore throat and sometimes severe cases of asthma. Most people, whose hay fever is nothing more than a minor nuisance, can alleviate their symptoms with over-the- counter antihistamines and decongestants. Antihistamines help symptoms such as drainage, sneezing and itching. Symptoms such as blockage and stuffy nose need a decongestant. Bonner cautions people that one of the major side effects of the over-the-counter antihistamines is drowsiness and should not be combined with other sedating medications or with alcohol. Decongestants tend to make some people jittery and may cause sleepless nights. People with high blood pressure should be careful when taking decongestants as those drugs cause a slight increase in blood pressure. Bonner says a physician's intervention may be needed for those whose hay fever allergies become incapacitating. In that instance, Bonner says he recommends prescription antihistamines, decongestants and allergy shots. The prescription drugs do not cause side effects associated with the over-the- counter brands. He also prescribes nasal inhalers which are very effective with pollens and work best if taken before the season starts. For more information call the allergy information service at 934-9777 or 1-800-822-4413. ! * HEADACHES An estimated 40 million Americans experience chronic headaches. For at least half of these people, the problem is severe and sometimes disabling. It can also be costly: headache sufferers make over 8 million visits a year to doctors' offices, according to the National Institutes of Health. Migraine sufferers alone lose over 64 million workdays because of headache pain. Several areas of the head can hurt during a headache, including a network of nerves which extends over the scalp and nerves in the face, mouth, and throat. Also sensitive to pain, because they contain delicate nerve fibers, are the muscles of the head and blood vessels found along the surface and at the base of the brain. The bones of the skull and tissues of the brain itself, however, never hurt, because they lack pain-sensitive nerve fibers. The ends of these pain-sensitive nerves, called nociceptors, can be stimulated by stress, muscular tension, dilated blood vessels, and other triggers of headache. Once stimulated, a nociceptor sends a message up the length of the nerve fiber to the nerve cells in the brain, signaling that a part of the body hurts. The message is determined by the location of the nociceptor. A person who suddenly realizes "My toe hurts," is responding to nociceptors in the foot that have been stimulated. A number of chemicals help transmit pain-related information to the brain. Some of these chemicals are natural painkilling proteins called endorphins. One theory suggests that people who suffer from severe headache and other types of chronic pain have lower levels of endorphins than people who are generally pain free. Should You Call or See a Physician? Not all headaches require medical attention. Some headaches can be caused by missed meals or occasional muscle tension and are easily remedied through lifestyle modifications. Some headaches, however, may be signals of more serious disorders such as head injury that call for prompt medical care. According to the National Institutes of Health, these include: 1. Sudden, severe headache 2. Headache associated with convulsions 3. Headache accompanied by confusion or loss of consciousness 4. Headache following a blow on the head 5. Headache associated with pain in the eye or ear 6. Persistent headache in a person who was previously headache free 7. Recurring headache in children 8. Headache associated with fever When professional medical care is needed, headache sufferers are advised to first visit a primary care or family practitioner. Sometimes, individuals are referred to specialists, such as internists, neurologists or dentists for additional diagnosis and treatment options. Sometimes, too, referrals to psychologists are recommended. How Are Headaches Diagnosed? Experts agree that a detailed medical history, and question-and-answer session with a headache sufferers can often produce enough information for a diagnosis. Many types of headaches have clear-cut symptoms which fall into an easily recognizable pattern. Among the questions are: 1. How often do you have headaches? 2. Where is the pain? 3. How long do the headaches last? 4. When did you first develop headaches? 5. What, if any, over-the-counter or prescription medications do you use? 6. What is your medical history with regard to head trauma and surgery? The individual's sleep and lifestyle habits, as well as work and family situations, may also be probed. Blood tests are sometimes used to rule out thyroid disease, anemia or infections which might be the cause of the headache. Sometimes, x-rays are recommended to screen for the possibility of a brain tumor or blood clot. Sometimes, although rarely, a test called an electroencephalogram (EEG) may be recommended to measure brain activity. While EEG's can indicate a malfunction in the brain, they cannot usually pinpoint a problem that might be causing a headache. In unusual instances, it may be recommended that a headache sufferer undergo a computed tomographic (CT) scan. The CT scan produces images of the brain that show variations in the density of different types of tissue. The scan enables the physician to distinguish, for example between a bleeding blood vessel in the brain and a brain tumor. The CT scan is an important diagnostic tool in cases of headache associated with brain lesions or other serious disease. Experts generally agree, however, that this sophisticated and expensive technology is not required to diagnose simple or periodic headache. An eye exam is usually performed to check for weakness in the eye muscle or unequal pupil size. Both of these symptoms are evidence of a possible aneurysm--an abnormal ballooning of a blood vessel. A physician who suspects that a headache patient has an aneurysm may also recommend an angiogram. In this test, a special fluid which can be seen on an X ray is injected into the patient and carried in the bloodstream to the brain to reveal any abnormalities in the blood vessels there. Thermography, an experimental technique for diagnosing headache, may become a useful clinical tool. In thermography, an infrared camera converts skin temperature into a color picture or thermogram with different degrees of heat appearing as different colors. Skin temperature is affected primarily by blood flow. Research scientists have found that thermograms of headache patients show strikingly different heat patterns from those of people who never or rarely get headaches. Types of Headaches Headaches are classified as one or more of the following types: 1. Vascular 2. Muscle contraction 3. Traction, or 4. Inflammatory Vascular headaches -- a group that includes the well-known migraine -- are so named because they are thought to involve abnormal function of the brain's blood vessels or vascular system. Muscle contraction headaches appear to involve the tightening or tensing of facial and neck muscles. Traction and inflammatory headaches are symptoms of other disorders, ranging from stroke to sinus infection. Some people have more than one type of headache. Migraine Headaches The most common type of vascular headache is migraine. Migraine headaches are usually characterized by severe pain on one or both sides of the head, an upset stomach, and at times disturbed vision. There are two primary types of migraine-caused headache: classic and common. The major difference between the two types is the appearance of neurological symptoms 10 minutes to 30 minutes before a classic migraine attack. These symptoms are called an aura. The person may see flashing lights or zigzag lines, or may temporarily lose vision. Other classic symptoms include speech difficulty, weakness of an arm or leg, tingling of the face or hands, and confusion. The pain of a classic migraine headache is described as intense, throbbing, or pounding and is felt in the forehead, temple, ear, jaw, or around the eye. Classic migraine starts on one side of the head but may eventually spread to the other side. An attack lasts 1 to 2 days. The common migraine -- a term that reflects the disorder's greater occurrence in the general population -- is not preceded by an aura. But some people experience a variety of vague symptoms beforehand, including mental fuzziness, mood changes, fatigue, and unusual retention of fluids. During the headache phase of a common migraine, a person may have diarrhea and increased urination, as well as nausea and vomiting. Common migraine pain can last 3 or 4 days. Both classic and common migraine can strike as often as several times a week, or as rarely as once every few years. Both types can occur at any time. Some people, however, experience migraines at predictable times-- near the days of menstruation or every Saturday morning after a stressful week of work. What Causes a Migraine Headache? Research scientists are unclear about the precise cause of migraine headaches. There seems to be general agreement, however, that a key element is blood flow changes in the brain. People who get migraine headaches appear to have blood vessels that overreact to various triggers. Scientists have devised one theory of migraine which explains these blood flow changes and also certain biochemical changes that may be involved in the headache process. According to this theory, the nervous system responds to a trigger such as stress by creating a spasm in the nerve-rich arteries at the base of the brain. The spasm closes down or constricts several arteries supplying blood to the brain, including the scalp artery and the carotid or neck arteries. As these arteries constrict, the flow of blood to the brain is reduced. At the same time, blood-clotting particles called platelets clump together--a process which is believed to release a chemical called serotonin. Serotonin acts as a powerful constrictor of arteries, further reducing the blood supply to the brain. Reduced blood flow decreases the brain's supply of oxygen. Symptoms signaling a headache, such as distorted vision or speech, may then result, similar to symptoms of stroke. Reacting to the reduced oxygen supply, certain arteries within the brain open wider to meet the brain's energy needs. This widening or dilation spreads, finally affecting the neck and scalp arteries. The dilation of these arteries triggers the release of pain-producing substances called prostaglandins from various tissues and blood cells. Chemicals which cause inflammation and swelling, and substances which increase sensitivity to pain are also released. The circulation of these chemicals and the dilation of the scalp arteries stimulate the pain-sensitive nociceptors. The result, according to this theory: a throbbing pain in the head. Women and Migraines Although males and females seem to be equally affected by migraine, the condition appears to be more common in adult women than in men. Both sexes may develop migraine in infancy, but most often the disorder begins between the ages of 5 and 35. The relationship between female hormones and migraine is still unclear. Women may have "menstrual migraine"--headaches around the time of their menstrual period--which may disappear during pregnancy. Other women develop migraine for the first time when they are pregnant. Some are first affected after menopause. The effect of oral contraceptives on headaches is perplexing. Scientists report that some migrainous women who take birth control pills experience more frequent and severe attacks. However, a small percentage of women have fewer and less severe migraine headaches when they take birth control pills. And normal women who do not suffer from headaches may develop mi- graines as a side effect when they use oral contraceptives. Investigators around the world are studying hormonal changes in migrainous women in the hope of identifying the specific ways these naturally occurring chemicals may cause headaches. Migraine "Triggers" and the Migraine "Personality" The existence of a migraine personality is a controversial theory which suggests that migraine patients are compulsive, rigid, and perfectionistic. However, not all migraine patients have these traits and that not all individuals with these personality characteristics have migraines. Rather than focusing on character traits, scientists are turning to heredity to identify the causes of migraines. It is possible that the abnormal regulation of blood vessels which leads to migraines is an inherited trait. Many migrained sufferers have a family history of migraine, but the exact hereditary nature of this condition is still unknown. Factors believed to "trigger" migraines include: 1. Stress 2. Emotions 3. Biological conditions 4. Environmental conditions 5. Fatigue 6. Glaring or flickering lights 7. The weather 8. Certain foods It may seem hard to believe that eating such seemingly harmless foods as yogurt, nuts, and lima beans can result in a painful migraine headache. However, some scientists believe that these foods and several others contain chemical substances such as tyramine which constrict arteries--the first step of the migraine process. Other scientists believe that foods cause headaches by setting off an allergic reaction in susceptible people. While a food-triggered migraine usually occurs soon after eating, other triggers may not cause immediate pain. Scientists report that people can develop migraine not only during a period of stress but also afterwards when their vascular systems are still reacting. Other Forms of Migraine In addition to classic and common, migraine headache can take several other forms including: 1. Hemiplegic migraine 2. Opthalmoplegic migraine 3. Basilar artery migraine 4. Benign exertional headache 5. Status migrainosus, and 6. Headache-free migraine Individuals with hemiplegic migraine have temporary paralysis on one side of the body, a condition known as hemiplegia. Some people may experience vision problems and vertigo--a feeling that the world is spinning. These symptoms begin 10 minutes to 90 minutes before the onset of headache pain. In ophthalmoplegic migraine, the pain is around the eye and is associated with a droopy eyelid, double vision, and other sight problems. Basilar artery migraine involves a disturbance of a major brain artery. Preheadache symptoms include vertigo, double vision, and poor muscular coordination. This type of migraine occurs primarily in adolescent and young adult women and is often associated with the menstrual cycle. Benign exertional headache is brought on by running, lifting, coughing, sneezing, or bending. The headache begins at the onset of activity, and pain rarely lasts more than several minutes. Status migrainosus is a rare and severe type of migraine that can last 72 hours or longer. The pain and nausea are so intense that people who have this type of headache are often hospitalized. The use of certain drugs can trigger status migrainosus. Neurologists report that many of their status migrainosus patients were depressed and anxious before they experienced headache attacks. Headache-free migraine is characterized by such migraine symptoms as visual problems, nausea, vomiting, constipation, or diarrhea. Individuals, however, do not experience head pain. Headache specialists have suggested that unexplained pain in a particular part of the body, fever, and dizziness could also be possible types of headache-free migraine. Treatment Options For Migraine Headache Medications, biofeedback, stress reduction, and elimination of certain foods from the diet are the most common methods of preventing and controlling migraine and other vascular headaches. Regular exercise, such as swimming or vigorous walking, can also reduce the frequency and severity of migraine headaches. During a migraine headache, temporary relief can sometimes be obtained by using cold packs or by pressing on the artery found in front of the ear on the painful side of the head. Medications There are two ways that medications are used for migraines: 1. To prevent the attacks 2. To relieve symptoms after the headache occurs For infrequent migraine, medication is sometimes taken at the first sign of a headache in order to stop it or to ease the pain. People who get occasional mild migraine may benefit by taking aspirin or acetaminophen at the start of an attack. Aspirin raises a person's tolerance to pain and also discourages clumping of blood platelets. Small amounts of caffeine may be useful if taken in the early stages of migraine. For migraine sufferers who get moderate to severe headaches, stronger drugs may be recommended to control the pain. One of the most commonly used drugs for the relief of classic and common migraine symptoms is ergotamine tartrate, a vasoconstrictor which helps counteract the painful dilation stage of the headache. For optimal benefit, the drug is taken during the early stages of an attack. If a migraine has been in progress for about an hour and has passed into the final throbbing stage, ergotamine tartrate will probably not help. Because ergotamine tartrate can cause nausea and vomiting, it may be combined with antinausea drugs. Research scientists caution that ergotamine tartrate should not be taken in excess or by people who have angina pectoris, severe hypertension, or vascular, liver, or kidney disease. Patients who are unable or who choose not to take ergotamine tartrate may benefit from other drugs that constrict dilated blood vessels or help reduce blood vessel inflammation. For headaches that occur three or more times a month, preventive treatment is often recommended. Medications used to prevent classic and common migraine include methysergide maleate, which counteracts blood vessel constriction, propranolol, which stops blood vessel dilation, and amitriptyline, an antidepressant. According to the National Institutes of Health, in a study of propranolol, amitriptyline, and biofeedback conducted by the Houston Headache Clinic, scientists found that migraine patients improved most on a combination of propranolol and biofeedback. Patients who had mixed migraine and muscle-contraction headaches received the greatest benefit from a combination of propranolol, amitriptyline, and biofeedback. Another study showed that propranolol may continue to prevent migraine headaches even after patients have stopped taking the drug. The scientists who conducted the study speculate that long-term therapy with propranolol may have a lasting effect on blood vessels, training them to react less than usual to the triggers of migraine. Antidepressants called MAO inhibitors also prevent migraine. These drugs block an enzyme called monoamine oxidase which normally helps nerve cells absorb the artery-constricting chemical, serotonin. MAO inhibitors can have potentially serious side effects -- particularly if taken while ingesting foods or beverages that contain tyramine, a substance that closes down arteries. Several new drugs for the prevention of migraine have been developed in recent years, including papaverine hydrochloride, which produces blood vessel dilation, and cyproheptadine, which counteracts serotonin. All these antimigraine drugs can have adverse side effects. To avoid long-term side effects of preventive medications, headache specialists advise patients to reduce the dosage of these drugs and then to stop taking them as soon as possible. All medications, including such over-the-counter drugs as aspirin, carry risks. Only the individual migraine sufferer can assess the best treatment for him- or herself. Individuals should always question their physicians about the benefits, risks and costs of medications and treatment alternatives. Biofeedback and Relaxation Training The use of medications for the prevention or treatment of migraine is often combined with biofeedback and relaxation training. Biofeedback--a technique once considered "fringe medicine" by mainstream medical practitioners--is now an acceptable and safe way to allow individuals to better control such body function indicators as blood pressure, heart rate, temperature, muscle tension, and brain waves. Thermal biofeedback allows a patient to consciously raise hand temperature. Some patients who are able to increase hand temperature can reduce the number and intensity of migraines. The mechanism of this hand-warming effect is being studied by research scientists. An individual learning thermal biofeedback wears a device which transmits the temperature of an index finger or hand to a monitor. While the individual tries to warm his hands, the monitor provides feedback either on a gauge that shows the temperature reading or by emitting a sound or beep that increases in intensity as the temperature increases. The patient is not told how to raise hand temperature, but is given suggestions such as "Imagine that your hands feel very warm and heavy." In another type of biofeedback called electromyographic or EMG training, the patient learns to control muscle tension in the face, neck, and shoulders. Either kind of biofeedback may be combined with relaxation training, during which patients learn to relax the mind and body. Biofeedback can be practiced at home with a portable monitor. But the ultimate goal of treatment is to wean the individual from the machine. The machine is used primarily to provide feedback to the individual. Overtime, with practice and commitment, the individual can do biofeedback without the machine's direct feedback. The Antimigraine Diet Scientists estimate that a small percentage of migraine sufferers will benefit from a treatment program focused solely on eliminating headache provoking foods and beverages. Other migraine patients may be helped by a diet to prevent low blood sugar. Low blood sugar, or hypoglycemia, can cause dilation of the blood vessels in the head. This condition can occur after a period without food: overnight, for example, or when a meal is skipped. People who wake up in the morning with a headache may be reacting to the low blood sugar caused by the lack of food overnight. Treatment for headaches caused by low blood sugar consists of scheduling smaller, more frequent meals for the individual. A special diet designed to stabilize the body's sugar-regulating system is sometimes recommended. For the same reason, many specialists also recommend that migraine patients avoid oversleeping on weekends. Sleeping late can change the body's normal blood sugar level and lead to a headache. Other Vascular Headaches After migraine, the most common type of vascular headache is the toxic headache produced by fever. Pneumonia, measles, mumps, and tonsillitis are among the diseases that can cause severe toxic vascular headaches. Toxic headaches can also result from the presence of foreign chemicals in the body. Other kinds of vascular headaches include "clusters," which cause repeated episodes of intense pain, and headaches resulting from a rise in blood pressure. The Impact of Chemicals Repeated exposure to nitrite compounds can result in a dull, pounding headache that may be accompanied by a flushed face. Nitrite, which dilates blood vessels, is found in such products as heart medicine and dynamite. Hot dogs and other meats containing sodium nitrite can also cause headaches. "Chinese restaurant headache" can occur when a susceptible individual eats foods prepared with monosodium glutamate (MSG)--a staple in many Oriental kitchens. Soy sauce, meat tenderizer, and a variety of packaged foods contain this chemical which is touted as a flavor enhancer. Vascular headache can also result from exposure to poisons, even common household varieties like insecticides, carbon tetrachloride, and lead. Children who eat flakes of lead paint may develop headaches. So may anyone who has contact with lead batteries or lead glazed pottery. Painters, printmakers, and other artists may experience headaches after exposure to art materials that contain chemicals called solvents. Solvents, like benzene, are found in turpentine, spray adhesives, rubber cement, and inks. Drugs such as amphetamines can cause headaches as a side effect. Another type of drug-related headache occurs during withdrawal from long-term therapy with the antimigraine drug ergotamine tartrate. According to some, "the hangover headache" may be reduced by taking honey, which speeds alcohol metabolism, or caffeine, a constrictor of dilated arteries. Caffeine, however, can cause headaches as well as cure them. Heavy coffee drinkers often get headaches when they try to break the caffeine habit. Cluster Headaches Cluster headaches, named for their repeated occurrence in groups or clusters, begin as a minor pain around one eye, eventually spreading to that side of the face. The pain quickly intensifies, compelling the individual to pace the floor or rock in a chair. Other symptoms include a stuffed and runny nose and a droopy eyelid over a red and tearing eye. Cluster headaches last between 30 minutes and 45 minutes. But the relief people feel at the end of an attack is usually mixed with dread as they await a recurrence. Clusters can strike several times a day or night for several weeks or months. Then, mysteriously, they may disappear for months or years. Many people have cluster bouts during the spring and fall. At their worst, chronic cluster headaches can last continuously for years. Cluster attacks can strike at any age but usually start between the ages of 20 and 40. Unlike migraine, cluster headaches are more common in men and do not run in families. Research scientists have observed certain physical similarities among people who experience cluster headache. People who get cluster headaches tend to be heavy smokers and drinkers. Paradoxically, both nicotine, which constricts arteries, and alcohol, which dilates them, trigger cluster headaches. The exact connection between these substances and cluster attacks is not known. Despite a cluster headache's distinguishing characteristics, its relative infrequency and similarity to such disorders as sinusitis can lead to misdiagnosis. Some cluster patients have had tooth extractions, sinus surgery, or psychiatric treatment in a futile effort to cure their pain. Research studies have turned up several clues as to the cause of cluster headache, but no answers. One clue is found in the thermograms of untreated cluster patients, which show a "cold spot" of reduced blood flow above the eye. The sudden start and brief duration of cluster headaches can make them difficult to treat. By the time medicine is absorbed into the body, the attack is often over. However, research scientists have identified several effective drugs for these headaches. The antimigraine drug ergotamine tartrate can subdue a cluster, if taken at the first sign of an attack. Injections of dihydroergotamine, a form of ergotamine tartrate, are sometimes used to treat clusters. Some cluster patients can prevent attacks by taking propranolol or methysergide. Investigators have also discovered that mild solutions of cocaine hydrochloride applied inside the nose can quickly stop cluster headaches in most patients. This treatment may work because it both blocks pain impulses and it constricts blood vessels. Another option that works for some cluster patients is rapid inhalation of pure oxygen through a mask for 5 minutes to 15 minutes. The oxygen seems to ease the pain of cluster headache by reducing blood flow to the brain. In chronic cases of cluster headache, certain facial nerves may be surgically cut or destroyed to provide relief. However, these procedures have had limited success. Some cluster patients have had facial nerves cut only to have them regenerate years later. Chronic high blood pressure can cause headache, as can rapid rises in blood pressure like those experienced during anger, vigorous exercise, or sexual excitement. Muscle-Contraction Headaches Tension headache is named not only for the role of stress in triggering the pain, but also for the contraction of neck, face, and scalp muscles brought on by stressful events. Tension headache is a severe but temporary form of muscle-contraction headache. The pain is mild to moderate and feels like pressure is being applied to the head or neck. The headache usually disappears after the period of stress is over. By contrast, chronic muscle-contraction headaches can last for weeks, months, and sometimes years. The pain of these headaches is often described as a tight band around the head or a feeling that the head and neck are in a cast. The pain is steady, and is usually felt on both sides of the head. Chronic muscle-contraction headaches can cause sore scalps -- even combing one's hair can be painful. Many scientists believe that the primary cause of the pain of muscle-contraction headache is sustained muscle tension. Other studies suggest that restricted blood flow may cause or contribute to the pain. Occasionally, muscle-contraction headaches will be accompanied by nausea, vomiting, and blurred vision, but there is no preheadache syndrome as with migraine. Muscle-contraction headaches have not been linked to hormones or foods, as has migraine, nor is there a strong hereditary connection. Research has shown that for many people, chronic muscle-contraction headaches are caused by depression and anxiety. These people tend to get their headaches in the early morning or evening when conflicts in the office or home are anticipated. Emotional factors are not the only triggers of muscle contraction headaches. Certain physical postures--such as holding one's chin down while reading--can lead to head and neck pain. Tensing head and neck muscles during sexual excitement can also cause headache. So can prolonged writing under poor light, or holding a phone between the shoulder and ear, or even gum-chewing. More serious problems that can cause muscle contraction headaches include degenerative arthritis of the neck and temporomandibular joint dysfunction, or TMJ. TMJ is a disorder of the joint between the temporal bone (above the ear) and the mandible or lower jaw bone. The disorder results from poor bite and jaw clenching. Treatment for Muscle-Contraction Headaches Treatment for muscle-contraction headache varies. The first consideration is to treat any specific disorder or disease that may be causing the headache. For example, arthritis of the neck is treated with anti-infammatory medication and temporomandibular joint dysfunction may be helped by corrective devices for the mouth and jaw. Acute tension headaches not associated with a disease are treated with muscle relaxants and analgesics like aspirin and acetaminophen. Stronger analgesics, such as propoxyphene and codeine, are sometimes prescribed. As prolonged use of these drugs can lead to dependence patients taking them should have periodic medical check ups and follow their physicians' instructions carefully. All medications carry risks. Individuals should weigh the benefits, risks and costs of treatment alternatives. Nondrug therapy for chronic muscle-contraction headaches includes biofeedback, relaxation training, and counseling. A technique called cognitive restructuring teaches people to change their attitudes and responses to stress. Individuals might be encouraged, for example, to imagine that they are coping successfully with a stressful situation. In progressive relaxation therapy, people are taught to first tense and then relax individual muscle groups. Finally, the individual tries to relax his or her whole body. Many people imagine a peaceful scene or memory. Passive relaxation does not involve tensing of muscles. Instead, individuals are encouraged to focus on different muscles, suggesting that they relax. Individuals with chronic muscle-contraction headaches may also be helped by taking antidepressants or MAO inhibitors. Mixed muscle-contraction and migraine headaches are sometimes treated with barbiturate compounds, which slow down nerve function in the brain and spinal cord. Some individuals who suffer infrequent muscle-contraction headaches benefit from hot showers or moist heat applied to the back of the neck. Cervical collars are sometimes recommended as an aid to good posture. Physical therapy, massage, and gentle exercise of the neck may also be helpful. When Is Headache a Warning for More Serious Disorders? Like other types of pain, headaches can serve as warning signals of more serious disorders. This is particularly true for headaches caused by traction or inflammation. Traction headaches can occur if the pain-sensitive parts of the head are pulled, stretched, or displaced, as for example, when eye muscles are tensed to compensate for eyestrain. Headaches caused by inflammation include those related to meningitis as well as those resulting from diseases of the sinuses, spine, neck, ears, and teeth. Ear and tooth infections and glaucoma can cause headaches. In oral and dental disorders, headache may be experienced as pain in the entire head, including the face. Traction and inflammatory headaches are treated by curing the underlying problem. This may involve surgery, antibiotics or other drugs. Characteristics of the various types of traction and inflammatory headaches vary by disorder: Brain tumors: Brain tumors are diagnosed in about 11,000 people every year. As they grow, these tumors sometimes cause headache by pushing on the outer layer of nerve tissue that covers the brain or by pressing against pain-sensitive blood vessel walls. Headache resulting from a brain tumor may be periodic or contin- uous. Typically, it feels like a strong pressure is being applied to the head. The pain is relieved when the tumor is destroyed by surgery, radiation, or chemotherapy. Stroke: Headache may accompany several conditions that can lead to stroke, including hypertension or high blood pressure, arteriosclerosis, and heart disease. Headaches are also associated with completed stroke, the latter occurs when brain cells die from lack of sufficient oxygen. Many stroke-related headaches can be prevented by careful management of the person's condition through diet, exercise, and medication. Mild to moderate headaches are associated with transient ischemic attacks (TIA's), which result from a temporary lack of blood supply to the brain. The head pain occurs near the clot or lesion that blocks blood flow. The similarity between migraine and symptoms of TIA can make diagnosis difficult. The rare person under age 40 who suffers a TIA may be misdiagnosed as having migraine; similarly, TlA-prone older patients who suffer migraine may be misdiagnosed as having stroke-related headaches. Spinal Tap: About one-fourth of the people who undergo a lumbar puncture or spinal tap develop a headache. Many scientists believe tnese headaches result from leakage of the cerebrospinal fluid that flows through pain-sensitive membranes around the brain and down to the spinal cord. The fluid, they suggest, drains through the tiny hole created by the spinal tap needle, causing the membranes to rub painfully against the bony skull. Since headache pain occurs only when the patient stands up, the "cure" is to remain lying down until the headache runs its course--anywhere from a few hours to several days. Head trauma: Headaches may develop after a blow to the head, either immediately or months later. There is little relationship between the severity of the trauma and the intensity of headache pain. One cause of trauma headache is scar formation in the scalp. Another is ruptured blood vessels which result in an accumulation of blood called a hematoma. This mass of blood can displace brain tissue and cause headaches as well as weakness, confusion, memory loss, and seizures. Hematomas can be drained to produce rapid relief of symptoms. Arteritis and meningitis: Arteritis, an inflammation of certain arteries in the head, primarily affects people over age 50. Symptoms include throbbing headache, fever, and loss of appetite. Some patients experience blurring or loss of vision. Prompt treatment with corticosteroid drugs helps to relieve symptoms. Headaches are also caused by infections of meninges, the brain's outer covering, and phlebitis, a vein inflammation. Tic douloureux: Tic douloureux, or trigeminal neuralgia, results from a disorder of the trigeminal nerve. This nerve supplies the face, teeth, mouth, and nasal cavity with feeling and also enables the mouth muscles to chew. Symptoms are headache and intense facial pain that comes in short, excruciating jabs set off by the slightest touch to or movement of trigger points in the face or mouth. People with tic douloureux often fear brushing their teeth or chewing on the side of the mouth that is affected. Many tic douloureux patients are controlled with drugs, including carbamazepine. Patients who do not respond to drugs may be helped by surgery on the trigeminal nerve. Sinus infection: In a condition called acute sinusitis, a viral or bacterial infection of the upper respiratory tract spreads to the membrane which lines the sinus cavities. When one or all four of these cavities are filled with bacterial or viral fluid, they become inflamed, causing pain and sometimes headache. Treatment of acute sinusitis may include antibiotics, analgesics, or decongestants. Chronic sinusitis may be caused by an allergy to such irritants as dust, ragweed, animal hair, and smoke. Research scientists disagree about whether chronic sinusitis triggers headache. A Childhood Problem Like adults, children experience the infections, trauma, and stresses that can lead to headaches. In fact, research shows that as young people enter adolescence and encounter the stresses of puberty and secondary school, the frequency of headache increases. Migraine headaches often begin in childhood or adolescence. The National Institutes of Health report that over 1 million children age 16 and under experience migraine and other vascular headaches. Children with migraine often have nausea and excessive vomiting. Some children have periodic vomiting, but no headache--the so-called "abdominal migraine." Research scientists have found that these children usually develop headaches when they are older. Phenobarbital, cypropheptadine, and certain anticonvulsant drugs are used to treat migraines in children. A diet may be prescribed to protect the child from foods that trigger headache. Sometimes psychological counseling or other psychiatric treatments for the child and the parents are recommended. Studies have shown that thermal biofeedback can help children with migraines control their headaches. Childhood headache can be a sign of depression. Parents should alert the family pediatrician if a child develops headaches along with other symptoms such as a change in mood or sleep habits. Antidepressant medication and psychotherapy may be effective treatments for childhood depression and related headache. All medications, however, carry risks. Parents should carefully weigh the benefits, risks and costs of treatment alternatives for their children. Source: Adapted from Headache: Hope Through Research U.S. Department of Health and Human Services, National Institutes of Health ! * Headaches HEADACHES TYPES OF HEADACHES All of us suffer from an occasional headache; in fact, 20 million Americans see their doctors each year because of headaches. Although headaches can be very uncomfortable and temporarily disabling, most are not associated with serious illness and can be relieved by resting in a quiet room or by taking a nonprescription painkiller, such as aspirin or acetaminophen. Some types of headaches, however, may require stronger prescription medications, and others are warning signs to seek immediate medical attention. These warning signs include: * Severe, sudden headaches that seem to come on like a "bolt out of the blue." * Headaches accompanied by loss of consciousness, alertness or sensation; confusion; visual blurring, or other neurological changes. * Recurrent headaches affecting one particular area, such as an eye, temple, etc. * Recurrent headaches of increasing intensity or frequency. * Headaches accompanied by neck stiffness and fever. * Headaches that wake you up. * Any unexplained change in the nature or frequency of headaches. TENSION HEADACHES The most common headaches are those associated with tension or muscle contractions and are directly related to stress. The pain tends to be steady and dull rather than throbbing. It is usually felt in the temples, forehead, neck or back of the head. Sometimes, the pain seems to encircle the head like a tight band. Tension headaches may occur at any time, but are most commonly experienced during periods of stress or worry. Treatment involves relieving the tension through massage, heat, a hot shower, relaxation techniques or any activity that puts aside the worries of the moment. Nonprescription painkillers, such as aspirin or acetaminophen, may also help. For severe muscle tension headaches, other slightly more potent drugs may be prescribed. These drugs may cause drowsiness and slow reflexes and should be taken with caution by people who work with machinery or drive. Most doctors also recommend that such medication be used for only short periods of time (not more than a few days). MIGRAINE HEADACHES Migraine headaches vary from person to person, but typically they are throbbing headaches affecting one side of the head. They are often accompanied by a number of other symptoms, which also vary according to individual cases. Some people have very little head pain but suffer from distorted vision and hearing or feelings of intense anxiety. Others may suffer from incapacitating pain lasting for several days. Most migraine patients fall between these two extremes. Many people are warned of an impending migraine attack by bizarre distortions of size, position, time and place -- the so- called "Alice-in-Wonderland syndrome." Others see flashing lights or bright colors in unusual shapes. Nausea, vomiting, chills, fever, dizziness, diarrhea; abdominal, arm or leg pain; and sensitivity to light are still other symptoms that may accompany a migraine. Regardless of the differing symptoms, all migraine headaches are related to changes in the blood vessels of the head and neck. This is why they are often referred to as vascular headaches. Early warning symptoms of a migraine are thought to be caused by a narrowing of these blood vessels, while the head pain is believed to be a result of the subsequent expanding or dilating of the vessels. What causes these changes is unknown, although many researchers now belie